货号:A605325 同义名: 胰高血糖素 / Porcine glucagon;Glucagon
Glucagon is a peptide hormone, exhibits therapeutic potential for metabolic disease.
There will be a HazMat fee per item when shipping a dangerous goods. The HazMat fee will be charged to your UPS/DHL/FedEx collect account or added to the invoice unless the package is shipped via Ground service. Ship by air in Excepted Quantity (each bottle), which is up to 1g/1mL for class 6.1 packing group I or II, and up to 25g/25ml for all other HazMat items.
Type | HazMat fee for 500 gram (Estimated) |
Excepted Quantity | USD 0.00 |
Limited Quantity | USD 15-60 |
Inaccessible (Haz class 6.1), Domestic | USD 80+ |
Inaccessible (Haz class 6.1), International | USD 150+ |
Accessible (Haz class 3, 4, 5 or 8), Domestic | USD 100+ |
Accessible (Haz class 3, 4, 5 or 8), International | USD 200+ |
规格 | 价格 | 会员价 | 库存 | 数量 | |||
---|---|---|---|---|---|---|---|
{[ item.pr_size ]} |
{[ getRatePrice(item.pr_rmb, 1,1) ]} {[ getRatePrice(item.pr_rmb_sale, 1,1) ]} {[ suihuo_tips(item.pr_am, item.pr_size) ]} |
{[ getRatePrice(item.pr_rmb, 1,1) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,1) ]} {[ suihuo_tips(item.pr_am, item.pr_size) ]} |
{[ getRatePrice(item.pr_rmb, 1,1) ]}{[ suihuo_tips(item.pr_am, item.pr_size) ]} | {[ getRatePrice(item.pr_rmb_sale, 1,1) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate) ]} | 现货 | 咨询 | - + |
快速发货 顺丰冷链运输,1-2 天到达
品质保证
技术支持
免费溶解
描述 | Glucagon, encoded by proglucagon gene and manufactured by the α cells in the pancreatic islets, stimulates glucose production through glycogenolysis and gluconeogenesis. Glucagon and insulin work together to maintain euglycemia and glucose transport to the tissues. The blood glucose levels determine whether glucagon or insulin is activated or inhibited. Low plasma glucose stimulates glucagon secretion which in turn promotes hepatic gluconeogenesis and glycogenolysis to normalize plasma glucose levels. Administration of glucagon increases glucose levels via gluconeogenesis and glycogenolysis in fasted or fed animals and in humans. But excessive glucagon might result from a tumor in the tail or the body of the pancreas, potentially leading to the glucagonoma syndrome, comprising weight loss, necrolytic migratory erythema (NME), diabetes, and mucosal abnormalities including stomatitis, cheilitis, and glossitis [3]. |
作用机制 | Glucagon binds to its membrane-bound receptor, a seven-pass transmembrane G-protein-coupled receptor [3]. |
NCT号 | 适应症或疾病 | 临床期 | 招募状态 | 预计完成时间 | 地点 |
NCT00655603 | Type 2 Diabetes Mellitus | Not Applicable | Unknown | September 2009 | - |
NCT00515801 | Diabetes Mellitus, Type 1 | Phase 2 Phase 3 | Completed | - | Switzerland ... 展开 >> University Hospital Basel Basel, Switzerland, 4031 收起 << |
NCT03667053 | Hypoglycemia | Phase 3 | Recruiting | August 1, 2019 | United States, California ... 展开 >> AMCR Institute, Inc Recruiting Escondido, California, United States, 92025 Contact: Tim Bailey 收起 << |
计算器 | ||||
存储液制备 | 1mg | 5mg | 10mg | |
1 mM 5 mM 10 mM |
0.29mL 0.06mL 0.03mL |
1.44mL 0.29mL 0.14mL |
2.87mL 0.57mL 0.29mL |
CAS号 | 16941-32-5 |
分子式 | C153H225N43O49S |
分子量 | 3482.747 |
别名 | 胰高血糖素 ;Porcine glucagon;Glucagon;Glucagon HCl |
运输 | 蓝冰 |
存储条件 |
液体 -20°C:3-6个月-80°C:12个月 粉末 Keep in dark place,Sealed in dry,2-8°C |
溶解度 |
DMSO: 2 mg/mL(0.57 mM),配合低频超声助溶,注意:DMSO长时间开封后,会吸水并导致溶解能力下降,请避免使用长期开封的DMSO H2O: 6.5 mg/mL(1.87 mM),配合低频超声,并调节pH至3 |
动物实验配方 |
Tags: Glucagon (1-29), bovine, human, porcine | Porcine glucagon;Glucagon;Glucagon HCl | 胰高血糖素 | Glucagon Receptor | AmBeed-信号通路专用抑制剂 | Glucagon (1-29), bovine, human, porcine 纯度/质量文件 | Glucagon (1-29), bovine, human, porcine 生物活性 | Glucagon (1-29), bovine, human, porcine 临床数据 | Glucagon (1-29), bovine, human, porcine 参考文献 | Glucagon (1-29), bovine, human, porcine 实验方案 | Glucagon (1-29), bovine, human, porcine 技术信息
请填写此表格索取QC报告。我们很快就会发送到您的邮箱。您的信息在我们这里是安全的。*是必填项.
靶点 | 数值 |
需要的总药量: mg
您需要配制的工作液浓度为:mg/mL
细胞系 | 浓度 | 检测类型 | 检测时间 | 活动说明 | 数据源 |
NCT号 | 适应症或疾病 | 临床期 | 招募状态 | 预计完成时间 | 地点 |
NCT00655603 | Type 2 Diabetes Mellitus | Not Applicable | Unknown | September 2009 | - |
NCT00515801 | Diabetes Mellitus, Type 1 | Phase 2 Phase 3 | Completed | - | Switzerland ... 展开 >> University Hospital Basel Basel, Switzerland, 4031 收起 << |
NCT03667053 | Hypoglycemia | Phase 3 | Recruiting | August 1, 2019 | United States, California ... 展开 >> AMCR Institute, Inc Recruiting Escondido, California, United States, 92025 Contact: Tim Bailey 收起 << |
NCT00817271 | Type 2 Diabetes | Phase 1 | Completed | - | United States, California ... 展开 >> Research Site Chula Vista, California, United States 收起 << |
NCT03350191 | Type 2 Diabetes Mellitus | Phase 1 | Completed | - | Sweden ... 展开 >> Investigational Site Number 7520001 Uppsala, Sweden, 75237 收起 << |
NCT01536665 | Diabetes Diab... 展开 >>etes Mellitus, Type 1 收起 << | Phase 1 | Completed | - | Austria ... 展开 >> Novo Nordisk Investigational Site Graz, Austria, 8036 收起 << |
NCT01162499 | Postprandial Hypoglycemia | Not Applicable | Completed | - | United States, Pennsylvania ... 展开 >> The Children's Hospital of Philadelphia Philadelphia, Pennsylvania, United States, 19104 收起 << |
NCT01162499 | - | Completed | - | - | |
NCT01684956 | Type 1 Diabetes | Phase 2 | Unknown | December 2017 | United States, Massachusetts ... 展开 >> Massachusetts General Hospital Boston, Massachusetts, United States, 02114 收起 << |
NCT02701257 | Diabetes Mellitus Type 1 | Not Applicable | Terminated | - | United States, Massachusetts ... 展开 >> MGH Diabetes Research Center Boston, Massachusetts, United States, 02114 收起 << |
NCT02635243 | Type 1 Diabetes Mellitus | Phase 1 | Withdrawn | November 2016 | - |
NCT00704795 | - | Unknown | October 2009 | Denmark ... 展开 >> Gentofte University Hospital Hellerup, Denmark, 2900 收起 << | |
NCT01847313 | Diabetic Kidney Disease | Phase 3 | Completed | - | Ireland ... 展开 >> St Vincent's Healthcare Group Dublin, Ireland, Dublin 4 收起 << |
NCT03081676 | Maturity-Onset Diabetes of the... 展开 >> Young, Type 3 收起 << | Not Applicable | Completed | - | Denmark ... 展开 >> Center for Diabetes Research, Gentofte Hospital Hellerup, Denmark, 2900 收起 << |
NCT00732602 | Diabetes Mellitus | Not Applicable | Completed | - | Denmark ... 展开 >> University Hospital, Gentofte Hellerup, Capital Region, Denmark, 2900 收起 << |
NCT02578498 | Type 1 Diabetes ... 展开 >> Hypoglycemia 收起 << | Phase 4 | Completed | - | Denmark ... 展开 >> Hvidovre University Hospital Hvidovre, Denmark, 2650 收起 << |
NCT02944110 | Diabetes After Total Pancreate... 展开 >>ctomy 收起 << | Not Applicable | Enrolling by invitation | December 2017 | - |
NCT01219400 | Diabetes | Phase 4 | Completed | - | Sweden ... 展开 >> Lund University Lund, Sweden, 22184 收起 << |
NCT02778113 | Healthy | Phase 1 | Completed | - | Canada, Quebec ... 展开 >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Mount-Royal, Quebec, Canada, H3P 3P1 收起 << |
NCT02010827 | - | Completed | - | Denmark ... 展开 >> Diabetes Research Division, University Hospital Gentofte Hellerup, Denmark, 2900 收起 << | |
NCT01958775 | Dyslipidemia | Phase 3 | Completed | - | Canada, Ontario ... 展开 >> Toronto General Hospital Toronto, Ontario, Canada, M5G 1L7 收起 << |
NCT01147276 | Diabetes Hypo... 展开 >>glycemia 收起 << | Phase 4 | Completed | - | Sweden ... 展开 >> Department of Clinical Sciences Lund, Lund University Lund, Sweden, 221 84 收起 << |
NCT00206258 | Type 1 Diabetes | Phase 3 | Completed | - | United States, Texas ... 展开 >> Baylor College of Medicine Houston, Texas, United States, 77030 收起 << |
NCT03378635 | Hypoglycemia ... 展开 >>Diabetes Mellitus, Type 1 收起 << | Phase 3 | Completed | - | United States, California ... 展开 >> ProSciento Chula Vista, California, United States, 91911 Austria Clinical Research Center, Medizinische Universität Graz Graz, Austria Canada LMC Diabetes & Manna Research Toronto, Canada Germany Profil Mainz, Germany Profil Neuss, Germany 收起 << |
NCT03181191 | Glucose Metabolism Disorders | Not Applicable | Recruiting | December 31, 2018 | Denmark ... 展开 >> Center for Diabetes Research Recruiting Hellerup, Denmark, 2900 Contact: Mille Baekdal, MD +45 26700782 mille.baekdal.nielsen@regionh.dk Contact: Filip Knop, MD, PhD filipknop@dadlnet.dk 收起 << |
NCT02881060 | Hypoglycemia ... 展开 >>Diabetes Mellitus, Type 1 收起 << | Phase 4 | Completed | - | Denmark ... 展开 >> Hvidovre University Hospital Hvidovre, Denmark, 2650 收起 << |
NCT03424044 | Type1diabetes | Phase 1 | Recruiting | June 30, 2019 | United States, Oregon ... 展开 >> Oregon Health and Science University Recruiting Portland, Oregon, United States, 97239 Contact: Deborah Branigan, BA CCRP 503-418-9070 branigad@ohsu.edu Contact: Jessica Castle, MD 503-494-7072 castleje@ohsu.edu Principal Investigator: Peter Jacobs, PhD Principal Investigator: Jessica Castle, MD Sub-Investigator: Kathryn Hanavan, RN MSN ANP-BC BC-ADM Sub-Investigator: Joseph El Youssef, MBBS Sub-Investigator: Leah Wilson, MD Sub-Investigator: Roula Zahr, MD 收起 << |
NCT02584582 | Type 1 Diabetes | Phase 2 Phase 3 | Unknown | - | - |
NCT02256189 | Type 2 Diabetes | Phase 4 | Completed | - | Sweden ... 展开 >> Skane University Hospital Malmö Malmö, Sweden, 20502 收起 << |
NCT02475070 | Type 2 Diabetes | Phase 4 | Completed | - | Sweden ... 展开 >> Lund University Lund, Sweden, 22184 收起 << |
NCT02625636 | Type 1 Diabetes Mellitus | Phase 1 | Completed | - | United States, California ... 展开 >> Investigational Site Number 840001 Chula Vista, California, United States, 91911 收起 << |
NCT03129594 | - | Completed | - | - | |
NCT02398383 | Cystic Fibrosis ... 展开 >> Cystic Fibrosis Related Diabetes 收起 << | Early Phase 1 | Unknown | January 2018 | United States, Connecticut ... 展开 >> Yale New Haven Hospital Recruiting New Haven, Connecticut, United States, 06511 收起 << |
NCT00304538 | Type 1 Diabetes | Phase 1 | Completed | - | United States, California ... 展开 >> University Of California, San Diego San Diego, California, United States, 92103-8765 收起 << |
NCT00797823 | Type 1 Diabetes | Phase 2 | Completed | - | United States, Oregon ... 展开 >> Legacy Research Portland, Oregon, United States, 97232 收起 << |
NCT02129179 | Heart Failure | Phase 1 | Completed | - | United Kingdom ... 展开 >> Papworth Hospital NHS Foundation Trust Papworth Everard, United Kingdom, CB23 3RE 收起 << |
NCT00434772 | Hypoglycemia | Phase 2 | Completed | - | Israel ... 展开 >> Share Zedek Medical Center Jerusalem, Israel, 91031 收起 << |
NCT03444467 | Diabetes Diab... 展开 >>etes Mellitus, Type 1 Diabetes Mellitus, Type 2 收起 << | Phase 1 | Completed | - | Germany ... 展开 >> Novo Nordisk Investigational Site Berlin, Germany, 10117 收起 << |
NCT03176524 | Type 1 Diabetes Mellitus | Phase 1 | Completed | - | Germany ... 展开 >> Profil Institut für Stoffwechselforschung GmbH Neuss, Germany, 41460 收起 << |
NCT00797823 | - | Completed | - | - | |
NCT01282164 | - | Completed | - | - | |
NCT01556594 | - | Completed | - | - | |
NCT00745186 | Hypoglycemia | Phase 1 | Completed | - | United Kingdom ... 展开 >> Charles River Laboratories Edinburgh, United Kingdom, EH14 4AP 收起 << |
NCT03547427 | Type 1 Diabetes Mellitus | Not Applicable | Recruiting | November 30, 2018 | United States, Virginia ... 展开 >> University of Virginia Center for Diabetes Technology Recruiting Charlottesville, Virginia, United States, 22903 Contact: Leon S. Farhy, PhD 434-924-2496 lsf8n@virginia.edu Sub-Investigator: Stacey M. Anderson, MD Sub-Investigator: Andy Basu, MD Sub-Investigator: Marc D. Breton, PhD 收起 << |
NCT03246828 | MODY1 MODY3 | Not Applicable | Recruiting | August 2018 | United Kingdom ... 展开 >> Clinical Research Unit, OCDEM, Churchill Hospital Recruiting Oxford, Oxfordshire, United Kingdom, OX3 7LE Contact: Ioannis Spiliotis, MD +44-1865857255 ioannis.spiliotis@ocdem.ox.ac.uk Principal Investigator: Ioannis Spiliotis, MD 收起 << |
NCT01282164 | Adult Growth Hormone Deficienc... 展开 >>y Hypothalamic-pituitary Disorders 收起 << | Not Applicable | Completed | - | United States, Massachusetts ... 展开 >> Massachusetts General Hospital Boston, Massachusetts, United States, 02199 United States, Ohio Cleveland Clinic Endocrinology, Diabetes and Metabolism Cleveland, Ohio, United States, 44195 United States, Oregon Oregon Health and Sciences University Portland, Oregon, United States, 97239 United States, Pennsylvania Allegheny Endocrinology Associates Pittsburgh, Pennsylvania, United States, 15212 收起 << |
NCT01556594 | Hypoglycemia | Phase 2 | Completed | - | Canada, Quebec ... 展开 >> Algorithme Pharma Montreal, Quebec, Canada, H3P 3P1 收起 << |
NCT01972152 | Hypoglycemia | Phase 2 | Completed | - | United States, Texas ... 展开 >> Texas Diabetes Institute, University Health System San Antonio, Texas, United States, 78207 收起 << |
NCT01573286 | Intestinal Failure ... 展开 >> Short Bowel Syndrome 收起 << | Phase 1 Phase 2 | Terminated(GLP-2 Drug product ... 展开 >>stability concerns) 收起 << | August 2015 | Canada, Alberta ... 展开 >> Alberta Children's Hospital Calgary, Alberta, Canada, T3B 6A8 Stollery Children's Hospital Edmonton, Alberta, Canada, T6G 2C8 Canada, British Columbia British Columbia Children's Hospital Vancouver, British Columbia, Canada, V6H 3V4 Canada, Ontario Hospital for Sick Children Toronto, Ontario, Canada, M5G 1X8 收起 << |
NCT02663661 | Diabetes Mellitus, Type 1 | Not Applicable | Recruiting | December 2018 | United States, Virginia ... 展开 >> University of Virginia, Center for Diabetes Technology Recruiting Charlottesville, Virginia, United States, 22903 Contact: Jennifer Puskaric, RN 434-924-71643 jlw5k@virginia.edu Contact: Mary Oliveri, MS, CCRP 434-960-6818 mc7m@virginia.edu Sub-Investigator: Boris Kovatchev, Ph.D. Sub-Investigator: Marc Breton, Ph.D. Sub-Investigator: Mark DeBoer, MD, MSc., MCR Sub-Investigator: Anthony McCall, MD, PhD Sub-Investigator: Daniel Cherñavvsky, MD, CRC Sub-Investigator: Stephen Patek, PhD Sub-Investigator: Christian Wakeman, M.S. 收起 << |
NCT03216226 | Hypoglycemia ... 展开 >>Diabetes Mellitus, Type 1 收起 << | Phase 3 | Completed | - | United States, Florida ... 展开 >> Compass Research Orlando, Florida, United States, 32806 United States, Idaho Advanced Clinical Research Meridian, Idaho, United States, 83642 Austria CRC - Clinical Research Center, Medizinische Universität Graz Graz, Austria Canada LMC Manna Research Barrie, Canada LMC Calgary Calgary, Canada LMC Diabetes & Manna Research Toronto, Canada Germany Diabeteszentrum Hamburg West, Gemeinschaftspraxis für Innere Medizin Hamburg, Germany 收起 << |
NCT02660242 | Diabetes Mellitus, Type 1 | Phase 2 | Completed | - | United States, Massachusetts ... 展开 >> Joslin Diabetes Center Boston, Massachusetts, United States, 02215 United States, Pennsylvania University of Pennsylvania Philadelphia, Pennsylvania, United States, 19104 收起 << |
NCT01972152 | - | Completed | - | - | |
NCT03765502 | Healthy | Phase 1 | Recruiting | December 21, 2018 | United States, North Carolina ... 展开 >> High Point Clinical Trials Center Recruiting High Point, North Carolina, United States, 27265 Contact 855-687-4257 Principal Investigator: Melanie Fein 收起 << |
NCT02660242 | - | Completed | - | - | |
NCT01674283 | Women With Fertility Disorder | Phase 4 | Withdrawn(Uterine contractilit... 展开 >>y not possible to visualize with our ultrasound machines) 收起 << | - | Canada, Quebec ... 展开 >> Clinique Ovo Montréal, Quebec, Canada, H4P 2S4 收起 << |
NCT01804413 | Adults Growth Hormone Deficien... 展开 >>cy. 收起 << | Not Applicable | Unknown | December 2013 | United States, Oregon ... 展开 >> Oregon Health & Science University Recruiting Portland, Oregon, United States, 97239 Contact: Kevin C.J. Yuen, MRCP(UK),MD 503 4940175 yuenk@ohsu.edu Contact: Sharon A. Rhoads, RN 503 4949197 rhoadss@ohsu.edu Sub-Investigator: David M. Cook, MD 收起 << |
NCT02403648 | Hypoglycemia | Phase 1 | Completed | - | - |
NCT01483651 | Type 1 Diabetes Mellitus | Not Applicable | Completed | - | United States, Oregon ... 展开 >> Legacy Health System Portland, Oregon, United States, 97210 收起 << |
NCT00929812 | Healthy Subjects ... 展开 >> Obesity Diabetes Mellitus, Type 1 收起 << | Phase 3 | Unknown | December 2009 | Germany ... 展开 >> Charite Campus Benjamin Franklin Berlin, Germany, 12200 收起 << |
NCT03061227 | Metabolic Syndrome ... 展开 >> Diabetes 收起 << | Not Applicable | Active, not recruiting | February 2019 | Germany ... 展开 >> University Hospital Tübingen Tübingen, Germany, 72076 收起 << |
NCT01916265 | Diabetes Mellitus Type 1 | Phase 1 | Completed | - | Germany ... 展开 >> Profil Institut für Stoffwechselforschung GmbH Neuss, NRW, Germany, 41460 收起 << |
NCT02423980 | Hypoglycemia | Phase 2 | Completed | - | United States, California ... 展开 >> Diablo Clinical Research, Inc. Walnut Creek, California, United States, 94598 收起 << |
NCT02423980 | - | Completed | - | - | |
NCT02882737 | Type 1 Diabetes Mellitus | Not Applicable | Completed | - | Denmark ... 展开 >> Isabelle Steineck Hvidovre, Denmark, 2650 收起 << |
NCT01795235 | Healthy | Not Applicable | Unknown | July 2014 | United States, Virginia ... 展开 >> University of Virginia Recruiting Charlottesville, Virginia, United States, 22902 Contact: Ralf Nass, MD rmn9a@virginia.edu Principal Investigator: Michael O Thorner 收起 << |
NCT01483651 | - | Completed | - | - | |
NCT03255629 | Post-bariatric Hypoglycemia | Phase 1 Phase 2 | Completed | - | United States, Massachusetts ... 展开 >> Joslin Diabetes Center Boston, Massachusetts, United States, 02215 收起 << |
NCT02966275 | Hypoglycemia | Not Applicable | Completed | - | United States, Massachusetts ... 展开 >> Massachusetts General Hospital Boston, Massachusetts, United States, 02114 收起 << |
NCT02966275 | - | Completed | - | - | |
NCT02181127 | Type 1 Diabetes | Not Applicable | Completed | - | United States, Massachusetts ... 展开 >> Massachusetts General Hospital Boston, Massachusetts, United States, 02114 收起 << |
NCT02740829 | Diabetes | Phase 1 | Completed | - | - |
NCT03650582 | Obesity | Phase 2 Phase 3 | Recruiting | October 30, 2018 | Canada, Ontario ... 展开 >> Toronto General Hospital Recruiting Toronto, Ontario, Canada, M5G 2C4 Contact: Priska Stahel, PhD 415-581-7487 priska.stahel@uhn.ca Contact: Satya Dash, MD 416-340-4800 ext 8094 satya.dash@uhn.ca 收起 << |
NCT02232971 | Diabetes Mellitus, Type 1 | Phase 4 | Unknown | July 2015 | Denmark ... 展开 >> Hvidovre University Hospital Hvidovre, Denmark, 2650 收起 << |
NCT02591849 | Post-transplant Diabetes Melli... 展开 >>tus 收起 << | Not Applicable | Completed | - | Norway ... 展开 >> Oslo University Hospital, Rikshospitalet Oslo, Norway, N-0424 收起 << |
NCT02018627 | Type 1 Diabetes | Phase 2 Phase 3 | Active, not recruiting | December 2018 | United States, Massachusetts ... 展开 >> Massachusetts General Hospital Boston, Massachusetts, United States, 02114 收起 << |
NCT02411578 | Diabetes Mellitus, Type 1 | Phase 2 | Completed | - | United States, Colorado ... 展开 >> University of Colorado/Barbara Davis Center for Diabetes Aurora, Colorado, United States, 80045 United States, Connecticut Yale University of Medicine New Haven, Connecticut, United States, 06510 United States, Massachusetts Joslin Diabetes Center Boston, Massachusetts, United States, 02215 United States, New York SUNY Upstate Medical University Syracuse, New York, United States, 13210 United States, Pennsylvania University of Pennsylvania Philadelphia, Pennsylvania, United States, 19104 收起 << |
NCT03139305 | Obesity | Phase 1 | Active, not recruiting | July 2019 | United States, Florida ... 展开 >> Translational Research Institute for Metabolism and Diabetes Orlando, Florida, United States, 32804 收起 << |
NCT02411578 | - | Completed | - | - | |
NCT02660008 | Hypoglycemia | Phase 2 | Completed | - | Germany ... 展开 >> Profil Institut für Stoffwechselforschung GmbH Neuss, Germany, 41460 收起 << |
NCT02916251 | Diabetes Mellitus Type 1 | Phase 2 | Completed | - | Germany ... 展开 >> Profil Institut für Stoffwechselforschung GmbH Neuss, North Rhine-Westphalia, Germany, 41460 收起 << |
NCT01997411 | Diabetes Mellitus, Type 1 | Phase 2 Phase 3 | Completed | - | United States, Colorado ... 展开 >> Barbara Davis Center for Diabetes Aurora, Colorado, United States, 80045 United States, Connecticut Yale University New Haven, Connecticut, United States, 06520 United States, Florida University of Florida Gainesville, Florida, United States, 32605 Nemours Children's Clinic Jacksonville, Florida, United States, 32207 United States, Indiana Riley Hospital for Children Indiana University Health Indianapolis, Indiana, United States, 46202 United States, Minnesota University of Minnesota Minneapolis, Minnesota, United States, 55454 United States, New York UPA Buffalo Buffalo, New York, United States, 14222 收起 << |
NCT02181127 | - | Completed | - | - | |
NCT02078726 | Colon Cancer | Phase 4 | Active, not recruiting | July 2018 | United States, California ... 展开 >> San Francisco General Hospital San Francisco, California, United States, 94117 收起 << |
NCT03682172 | Effect of Glucagon-like Peptid... 展开 >>e 2 on Gallbladder Motility 收起 << | Early Phase 1 | Active, not recruiting | August 31, 2019 | Denmark ... 展开 >> Clinical Metabolic Physiology, Steno Diabetes Center Copenhagen Hellerup, Region Hovedstaden, Denmark, 2900 收起 << |
NCT02516150 | Type 1 Diabetes Mellitus | Phase 4 | Completed | - | United States, Massachusetts ... 展开 >> Massachusetts General Hospital Diabetes Research Center Boston, Massachusetts, United States, 02114 收起 << |
NCT02459938 | Hypoglycemia | Phase 1 | Completed | - | Australia, Victoria ... 展开 >> Nucleus Network Melbourne, Victoria, Australia, 3005 收起 << |
NCT02516150 | - | Completed | - | - | |
NCT01828125 | Type 1 Diabetes | Phase 2 | Withdrawn | December 2013 | Canada, Quebec ... 展开 >> Institut de recherches cliniques de Montréal Montreal, Quebec, Canada, H2W 1R7 收起 << |
NCT02171130 | Hypoglycemia ... 展开 >>Diabetes Mellitus Drug-Specific Antibodies 收起 << | Phase 3 | Completed | - | United States, Massachusetts ... 展开 >> New England Diabetes and Endocrinology Center (NEDEC) Waltham, Massachusetts, United States, 02451-1136 United States, Minnesota University of Minnesota Minneapolis, Minnesota, United States, 55455 United States, New York Albany Medical College Division of Community Endocrinology Albany, New York, United States, 12206 Canada, Manitoba Winnipeg Clinic Winnipeg, Manitoba, Canada, R3C 0N2 Canada, Ontario Diabetes Clinic Smiths Falls, Ontario, Canada, K7A 4W8 Canada, Quebec IRCM Montreal, Quebec, Canada, H2W 1R7 Centre de recherche d'endocrinologie Godin & St-Pierre Sherbrooke, Quebec, Canada, J1G 5K2 Applied Medical Informatics Research Westmount, Quebec, Canada, H3Z 1E5 Canada Centre Hospitalier de l'Université de Québec Quebec, Canada, G1V 4G2 收起 << |
NCT01994746 | Diabetes Mellitus, Type 1 | Phase 3 | Completed | - | United States, Colorado ... 展开 >> Barbara Davis Center for Diabetes Aurora, Colorado, United States, 80045 United States, Connecticut Yale University New Haven, Connecticut, United States, 06520 United States, Florida University of Florida Gainesville, Florida, United States, 32605 United States, Indiana Riley Hospital for Children Indiana University Health Indianapolis, Indiana, United States, 46202 United States, Minnesota University of Minnesota Minneapolis, Minnesota, United States, 55454 United States, New York UPA Buffalo Buffalo, New York, United States, 14222 United States, Oregon Oregon Health and Science University Portland, Oregon, United States, 97239 United States, Pennsylvania University of Pennsylvania Philadelphia, Pennsylvania, United States, 19104 收起 << |
NCT02086227 | Hypoglycemia | Phase 1 | Completed | - | United States, Texas ... 展开 >> West Houston Clinical Research Services, 2026 Wirt Road Houston, Texas, United States, 77055 收起 << |
NCT02402933 | Hypoglycemia ... 展开 >>Diabetes Mellitus 收起 << | Phase 3 | Completed | - | United States, Florida ... 展开 >> Private Clinic Tallahassee, Florida, United States, 32308 United States, Maryland Private Clinic Baltimore, Maryland, United States, 21229 United States, Massachusetts New England Diabetes and Endocrinology Center (NEDEC) Waltham, Massachusetts, United States, 02451-1136 收起 << |
NCT02402933 | - | Completed | - | - | |
NCT02081001 | Hypoglycemia | Phase 2 | Completed | - | United States, Oregon ... 展开 >> Oregon Health & Science University Portland, Oregon, United States, 97239 收起 << |
NCT02937558 | Congenital Hyperinsulinism | Phase 2 | Completed | - | United States, California ... 展开 >> UCLA Mattel Children's Hospital Los Angeles, California, United States, 90095 UCSF School of Medicine, Division of Pediatric Endocrinology San Francisco, California, United States, 94143 United States, Missouri Washington University, St. Louis Children's Hospital Saint Louis, Missouri, United States, 63130 United States, Texas Cook Children's Medical Center Fort Worth, Texas, United States, 76104 Baylor College of Medicine, Texas Children's Hospital Houston, Texas, United States, 77030 收起 << |
NCT02081014 | Hypoglycemia | Phase 2 | Completed | - | United States, Texas ... 展开 >> Baylor College of Medicine, Children's Nutritional Research Center, Texas Children's Hospital Houston, Texas, United States, 77030 收起 << |
NCT02081001 | - | Completed | - | - | |
NCT03490942 | Hypoglycemia Unawareness ... 展开 >> Diabetes Mellitus, Type 1 收起 << | Phase 2 | Recruiting | September 30, 2019 | United States, Alabama ... 展开 >> University of Alabama, Birmingham Recruiting Birmingham, Alabama, United States, 35294 Contact: Tammy Perkins 205-934-4112 tlperkins@uabmc.edu Contact: Fernando Ovalle, MD fovalle@uabmc.edu Principal Investigator: Fernando Ovalle, MD United States, California University of California, San Diego Recruiting San Diego, California, United States, 92037 Contact: Adrienne Armstrong 858-246-2151 a3armstrong@ucsd.edu Principal Investigator: Robert Henry, MD VA San Diego Healthcare System Recruiting San Diego, California, United States, 92161 Contact: Debra Armstrong 858-646-7329 debra.armstrong@va.gov Principal Investigator: Robert Henry, MD United States, Georgia Emory University - Grady Memorial Hospital Recruiting Atlanta, Georgia, United States, 30303 Contact: Saumeth Cardona 404-251-8957 emily.k.tamponi@emory.edu Principal Investigator: Guillermo Umpierrez, MD Atlanta Diabetes Associates Recruiting Atlanta, Georgia, United States, 30318 Contact: Betsy Childs BChilds@atlantadiabetes.com Principal Investigator: Bruce Bode, MD United States, Pennsylvania University of Pennsylvania Recruiting Philadelphia, Pennsylvania, United States, 19104 Contact: Cornelia Dalton-Bakes 215-746-2085 Cornelia.dalton-bakes@uphs.upenn.edu Principal Investigator: Michael Rickels, MD 收起 << |
NCT02081014 | - | Completed | - | - | |
NCT01997411 | - | Completed | - | - | |
NCT03526445 | Non-Alcoholic Fatty Liver Dise... 展开 >>ase Total Pancreatectomy Diabetes Mellitus 收起 << | Not Applicable | Recruiting | May 2019 | Denmark ... 展开 >> Steno Diabetes Center Copenhagen Recruiting Hellerup, Denmark, 2900 Contact: Iben Rix Petersen, MD +45 24917125 iben.rix.petersen@regionh.dk 收起 << |
NCT01155206 | Diabetes | Phase 4 | Completed | - | Canada, Ontario ... 展开 >> University Health Network, Toronto General Hospital Toronto,, Ontario, Canada, M5G 2C4 收起 << |
NCT03421379 | Diabetes Mellitus | Phase 3 | Completed | - | Japan ... 展开 >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Fukuoka, Japan, 812-0025 For additional information regarding investigative sites for this trial, contact 1-888-545-5972 Mon - Fri, 9 AM to 4 PM or 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri, 9 AM to 5 PM Eastern Time or speak with your personal physician. Shinjuku-Ku, Japan, 162-0053 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Sumida, Japan, 130-0004 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Tokyo, Japan, 169-0073 收起 << |
NCT01994746 | - | Completed | - | - | |
NCT02733588 | Hypoglycemia ... 展开 >>Complications of Bariatric Procedures 收起 << | Phase 2 | Completed | - | United States, Massachusetts ... 展开 >> Joslin Diabetes Center Boston, Massachusetts, United States, 02215 收起 << |
NCT01959334 | Drug-specific Antibodies ... 展开 >> Hypoglycemia Diabetes Mellitus 收起 << | Phase 3 | Completed | - | Canada, Quebec ... 展开 >> Algorithme Pharma Inc. Laval, Quebec, Canada, H7V 4B3 收起 << |
NCT02656069 | - | Completed | - | - | |
NCT02475421 | Diabetes | Not Applicable | Completed | - | Denmark ... 展开 >> Center for Diabetes Research, Department of Medicine, Gentofte Hospital Hellerup, Copenhagen, Denmark, 2900 收起 << |
NCT03339453 | Hypoglycemia ... 展开 >>Diabetes Mellitus, Type 1 收起 << | Phase 1 | Completed | - | Germany ... 展开 >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri, 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST) or speak with your personal physician. Mainz, Germany, 55116 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri, 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST) or speak with your personal physician. Neuss, Germany 收起 << |
NCT03091673 | - | Completed | - | - | |
NCT03091673 | Diabetes Mellitus, Type 1 | Phase 3 | Completed | - | United States, California ... 展开 >> Stanford University Stanford, California, United States, 94305 United States, Colorado Barbara Davis Center for Childhood Diabetes Aurora, Colorado, United States, 80045 United States, Connecticut Yale University New Haven, Connecticut, United States, 06511 United States, Florida University of Florida Gainesville, Florida, United States, 32611 United States, Indiana Indiana University Indianapolis, Indiana, United States, 46202 United States, Iowa University of Iowa Iowa City, Iowa, United States, 52422 United States, New York Women & Children's Hospital of Buffalo Buffalo, New York, United States, 14222 收起 << |
NCT01986231 | - | Completed | - | - | |
NCT02733588 | - | Completed | - | - | |
NCT02817659 | Obesity | Phase 1 | Active, not recruiting | August 2018 | United States, Florida ... 展开 >> Translational Research Institute for Metabolism and Diabetes Orlando, Florida, United States, 32804 收起 << |
NCT02656069 | Hypoglycemia ... 展开 >>Diabetes Mellitus, Type 1 收起 << | Phase 3 | Completed | - | United States, Alabama ... 展开 >> University of Alabama at Birmingham Birmingham, Alabama, United States, 35294 United States, California ProSciento, Inc. Chula Vista, California, United States, 91911 AMCR Institute Escondido, California, United States, 92025 Diablo Clinical Research Walnut Creek, California, United States, 94598 United States, Texas Clinical Trials of Texas, Inc. San Antonio, Texas, United States, 78229 United States, Washington Rainier Research Renton, Washington, United States, 98057 Canada, Ontario LMC Diabetes & Endocrinology Toronto, Ontario, Canada, M4G 3E8 收起 << |
NCT03738865 | Insulin Hypoglycemia ... 展开 >> Type 1 Diabetes Mellitus Severe Hypoglycemia 收起 << | Phase 3 | Recruiting | April 2019 | United States, California ... 展开 >> Diablo Clinical Research Recruiting Walnut Creek, California, United States, 94598 Contact: Erica Bingham, RN 925-930-7267 ebingham@diabloclinical.com Principal Investigator: Mark Christiansen, MD United States, Georgia Atlanta Diabetes Associates Recruiting Atlanta, Georgia, United States, 30318 Contact: Betsy Childs, BSN, RN 404-355-4393 ext 864 bchilds@atlantadiabetes.com Principal Investigator: Bruce Bode, MD United States, Nevada PPD-Las Vegas Clinical Research Unit Recruiting Las Vegas, Nevada, United States, 89113 Contact: Marjorie Hyderkhan 702-963-1580 Marjorie.Hyderkhan@ppdi.com Principal Investigator: Samer Nakhle, MD United States, Washington Rainier Research Center Recruiting Renton, Washington, United States, 98057 Contact: Lisa Aaker 425-251-1720 ext 19 laaker@rainier-research.com Principal Investigator: Leslie Klaff, MD, PhD Austria Medizinische Universität Graz-Center for Medical Research Not yet recruiting Graz, Austria, 8010 Contact: Daniela Schwarzenbacher 43-316-385-82383 daniela.schwarzenbacher@medunigraz.at Principal Investigator: Thomas Pieber, PhD Canada, Ontario LMC Diabetes & Endocrinology Recruiting Toronto, Ontario, Canada, M4G 3E8 Contact: Nichole McKay 41+-645-2929 ext 9225 nichole.mckay@lmcmanna.com Principal Investigator: Ronnie Aronson, MD Germany Profil Institut für Stoffwechselforschung GmbH Not yet recruiting Neuss, Germany, 41460 Contact: Andre Feldmann 49 (0) 2131-4018-450 andre.feldmann@profil.com Principal Investigator: Oliver Klein, MD Institut für Diabetes-Technologie Not yet recruiting Ulm, Germany, 89081 Contact: Tobias Naser 0731-50-99-00 tobias.naser@idtulm.De Principal Investigator: Theodor Rudolf, MD 收起 << |
NCT03770637 | Hyperinsulinemic Hypoglycemia | Phase 2 | Not yet recruiting | June 2019 | United States, Colorado ... 展开 >> University of Colorado-Denver Not yet recruiting Aurora, Colorado, United States, 80045 Contact: Emma Hulseberg-Dwyer 720-848-5146 EMMA.HULSEBERGDWYER@UCDENVER.EDU Principal Investigator: Helen Lawler, MD United States, Maryland Johns Hopkins Hospital Not yet recruiting Baltimore, Maryland, United States, 21287 Contact: Alexis Page 410-502-0993 apage20@jhmi.edu Principal Investigator: Clare Lee, MD United States, Massachusetts Joslin Diabetes Center Not yet recruiting Boston, Massachusetts, United States, 02215 Contact: Charlene Coneys 617-732-2400 Charlene.coneys@joslin.harvard.edu Principal Investigator: Mary-Elizabeth Patti, MD United States, Minnesota Mayo Clinic- Rochester Not yet recruiting Rochester, Minnesota, United States, 55905 Contact: Paula Giesler 507-255-8345 giesler.paula@mayo.edu Principal Investigator: Adrian Vella, MD United States, North Carolina Duke Early Phase Clinical Research Not yet recruiting Durham, North Carolina, United States, 27701 Contact: Jenny Tong, MD 919-684-1672 jenny.tong@duke.edu Principal Investigator: Jenny Tong, MD 收起 << |
NCT03439072 | Insulin Hypoglycemia ... 展开 >> Type 1 Diabetes Mellitus Severe Hypoglycemia 收起 << | Phase 3 | Completed | - | United States, California ... 展开 >> ProSciento, Inc. Chula Vista, California, United States, 91911 Diablo Clinical Research, Inc. Walnut Creek, California, United States, 94598 United States, Georgia Atlanta Diabetes Associates Atlanta, Georgia, United States, 30318 United States, Washington Rainier Clinical Research Center, Inc. Renton, Washington, United States, 98057 Canada, Ontario LMC ESD, Inc. Toronto, Ontario, Canada, M4G 3E8 Canada, Quebec Altasciences Algorithme Pharma Montréal, Quebec, Canada, H3P 3P1 收起 << |
NCT03533179 | Drug Overdose ... 展开 >> Overdose of Beta-adrenergic Blocking Drug 收起 << | Phase 4 | Recruiting | December 1, 2018 | Denmark ... 展开 >> University Hospital Bispebjerg Recruiting Copenhagen, Denmark Contact: Mikkel B Christensen, MD 004538635593 mikkel.bring.christensen@regionh.dk Contact: Kasper M Petersen, MD 004538635805 kasper.meidahl.petersen.03@regionh.dk 收起 << |
NCT01986231 | Type 1 Diabetes Mellitus | Not Applicable | Completed | - | United States, Oregon ... 展开 >> Oregon Health and Science University Portland, Oregon, United States, 97239 收起 << |
NCT02735031 | Diabetes Mellitus, Type 1 ... 展开 >> Hypoglycemia 收起 << | Phase 2 Phase 3 | Completed | - | Netherlands ... 展开 >> Radboud university medical centre Nijmegen, Netherlands 收起 << |
NCT02445508 | Diabetes Mellitus, Type 2 | Not Applicable | Completed | - | Denmark ... 展开 >> Center for Diabetes Research Hellerup, Denmark, 2900 收起 << |
NCT03195257 | Type 1 Diabetes Mellitus | Not Applicable | Completed | - | - |
NCT02401880 | Type 2 Diabetes Mellitus | Phase 4 | Completed | - | Germany ... 展开 >> Profil Mainz GmbH & Co. KG Mainz, Germany, 55116 Profil Institut für Stoffwechselforschung GmbH Neuss, Germany, 41460 收起 << |
NCT02497313 | Diabetes Mellitus, Type 2 | Not Applicable | Completed | - | Denmark ... 展开 >> Center for Diabetes Research, Herlev-Gentofte Hospital Hellerup, Denmark, 2900 收起 << |
NCT00013910 | Diabetes Mellitus, Non-Insulin... 展开 >>-Dependent 收起 << | Phase 1 | Completed | - | United States, Michigan ... 展开 >> University of Michigan Ann Arbor, Michigan, United States, 48109 收起 << |
NCT00615264 | - | Completed | - | - | |
NCT00615264 | Type 1 Diabetes | Phase 3 | Completed | - | - |
NCT01795144 | Monogenic Diabetes | Phase 1 | Completed | - | United States, Illinois ... 展开 >> University of Chicago Chicago, Illinois, United States, 60637 收起 << |
NCT02217826 | Healthy | Phase 1 | Completed | - | - |
NCT01800734 | Diabetes Mellitus Type 1 | Phase 4 | Unknown | February 2015 | Italy ... 展开 >> Division of Endocrinology and Metabolic Diseases - University Hospital of Verona-Piazzale Stefani 1 Recruiting Verona, Italy, 37126 收起 << |
NCT02862730 | - | Completed | - | - | |
NCT02585505 | Diabetes Mellitus, Non-Insulin... 展开 >>-Dependent 收起 << | Phase 1 Phase 2 | Completed | - | - |
NCT02862730 | Type 1 Diabetes | Not Applicable | Completed | - | United States, Oregon ... 展开 >> Oregon Health and Science University Portland, Oregon, United States, 97239 收起 << |
NCT01972893 | Type 2 Diabetes Mellitus | Phase 1 | Completed | - | India ... 展开 >> Zydus Research Centre, Survey No. 396/403, Opp. Sarvotam Hotel, Nr. Nova Petrochemicals, Sarkhej-Bavla N.H. No. 8A, Village : Moraiya, Ahmedabad, Gujarat, India, 382213 收起 << |
NCT02984644 | Type II; Diabetes | Phase 3 | Recruiting | January 31, 2020 | United States, Texas ... 展开 >> University of Texas Health Science Center Recruiting San Antonio, Texas, United States, 78229 Contact: Eugenio Cersosimo Principal Investigator: Ralph A DeFronzo, MD 收起 << |
NCT03574064 | Healthy | Not Applicable | Recruiting | December 1, 2018 | Denmark ... 展开 >> Hvidovre University Hospital Recruiting Hvidovre, Denmark, 2650 Contact: Kirsa Skov-Jeppesen kirsa@sund.ku.dk Contact: Sten Madsbad 收起 << |
NCT00799435 | Diabetes Mellitus, Type 2 ... 展开 >> Heart Failure, Diastolic 收起 << | Phase 4 | Terminated(Inability to recrui... 展开 >>t adequate Sample Size who met the entry criteria) 收起 << | - | United States, Texas ... 展开 >> Baylor College of Medicine Houston, Texas, United States, 77030 收起 << |
NCT02589626 | Diabetes Mellitus, Type 2 | Phase 4 | Completed | - | Japan ... 展开 >> 1245.106.81011 Boehringer Ingelheim Investigational Site Fukuoka, Fukuoka, Japan 1245.106.81001 Boehringer Ingelheim Investigational Site Fukushima, Koriyama, Japan 1245.106.81010 Boehringer Ingelheim Investigational Site Hiroshima, Fukuyama-shi, Japan 1245.106.81005 Boehringer Ingelheim Investigational Site Ibaraki, Naka, Japan 1245.106.81007 Boehringer Ingelheim Investigational Site Kanagawa, Kawasaki, Japan 1245.106.81016 Boehringer Ingelheim Investigational Site Kanagawa, Yamato-shi, Japan 1245.106.81015 Boehringer Ingelheim Investigational Site Kanagawa, Yokohama-shi, Japan 1245.106.81008 Boehringer Ingelheim Investigational Site Mie, Yokkaichi, Japan 1245.106.81012 Boehringer Ingelheim Investigational Site Osaka, Kashiwara-shi, Japan 1245.106.81013 Boehringer Ingelheim Investigational Site Osaka, Osaka-shi, Japan 1245.106.81009 Boehringer Ingelheim Investigational Site Osaka, Suita, Japan 1245.106.81003 Boehringer Ingelheim Investigational Site Tokyo, Chuo-ku, Japan 1245.106.81006 Boehringer Ingelheim Investigational Site Tokyo, Chuo-ku, Japan 1245.106.81014 Boehringer Ingelheim Investigational Site Tokyo, Hachioji-shi, Japan 1245.106.81002 Boehringer Ingelheim Investigational Site Tokyo, Shinjuku-ku, Japan 1245.106.81004 Boehringer Ingelheim Investigational Site Tokyo, Shinjuku-ku, Japan 收起 << |
NCT00799435 | - | Terminated(Inability to recrui... 展开 >>t adequate Sample Size who met the entry criteria) 收起 << | - | - | |
NCT03108521 | Diabetes Mellitus | Phase 4 | Recruiting | March 2019 | China, Sichuan ... 展开 >> Sichuan provincial people's hospital Recruiting Chengdu, Sichuan, China, 610000 Contact: Enwu Long, Master +86 2887393316 dragon984169@126.com 收起 << |
NCT01453842 | Type 2 Diabetes Mellitus | Early Phase 1 | Completed | - | Denmark ... 展开 >> Department of Clinical Physiology Glostrup, Denmark, 2600 收起 << |
NCT03507621 | - | Active, not recruiting | December 15, 2018 | Turkey ... 展开 >> Kahramanmaras Sutcu Imam Univercity Faculty of edicine Kahramanmaraş, Onikişubat, Turkey, 251/A 46040 收起 << | |
NCT02189694 | Type 1 Diabetes | Phase 2 | Completed | - | Canada, Quebec ... 展开 >> Institut de recherches cliniques de Montréal Montreal, Quebec, Canada, H2W 1R7 收起 << |
NCT01755572 | Type 2 Diabetes ... 展开 >> Systolic Hypertension 收起 << | Phase 4 | Completed | - | Canada, Ontario ... 展开 >> Leadership Sinai Centre for Diabetes, Mount Sinai Hospital, Canada Toronto, Ontario, Canada 收起 << |
NCT03712098 | Smoking Cessation ... 展开 >> Weight, Body 收起 << | Phase 2 | Recruiting | May 2021 | United States, Pennsylvania ... 展开 >> Center for Interdisciplinary Research on Nicotine Addiction, University of Pennsylvania Recruiting Philadelphia, Pennsylvania, United States, 19104 Contact: Kristin Tederstrom 215-746-7142 tederstr@pennmedicine.upenn.edu 收起 << |
NCT01373450 | Type 2 Diabetes Mellitus | Phase 1 | Completed | - | - |
NCT01373450 | - | Completed | - | - | |
NCT02050074 | Type 2 Diabetes | Phase 4 | Completed | - | Denmark ... 展开 >> Diabetes Research Division, Department of Medicine, Gentofte Hospital Hellerup, Copenhagen, Denmark, 2900 收起 << |
NCT03768518 | - | Recruiting | February 1, 2019 | Netherlands ... 展开 >> Radboudumc Recruiting Nijmegen, Netherlands, 6500HB Contact: Marti Boss +31243667243 marti.boss@radboudumc.nl 收起 << | |
NCT00460941 | Diabetes Mellitus Type 2 | Phase 2 | Completed | - | - |
NCT02490098 | Type 1 Diabetes | Phase 2 | Withdrawn(Funding terminated) | July 2018 | Canada, Quebec ... 展开 >> Institut de recherches cliniques de Montréal Montreal, Quebec, Canada, H2W 1R7 收起 << |
NCT01413542 | Hypertension ... 展开 >>Diabetes Type 2 收起 << | Not Applicable | Completed | - | United States, Tennessee ... 展开 >> Vanderbilt University- General Clinic Research Center Nashville, Tennessee, United States, 37232 收起 << |
NCT00625040 | - | Terminated(Not enough patients... 展开 >> in the follow-up period) 收起 << | - | Denmark ... 展开 >> Glostrup Hospital Glostrup, Denmark, 2600 收起 << | |
NCT01413542 | - | Completed | - | - | |
NCT01185119 | Healthy | Phase 2 Phase 3 | Completed | - | Denmark ... 展开 >> Aarhus University, Institute of Pharmacology Aarhus C, Aarhus, Denmark, 8000 收起 << |
NCT02537834 | Type 2 Diabetes Mellitus | Phase 4 | Completed | - | Japan ... 展开 >> Atsuta-ku, Aichi, Japan, 456-0058 Minato-ku, Aichi, Japan, 455-0018 Kisarazu, Chiba, Japan, 292-0038 Annaka, Gunma, Japan, 379-0116 Naka, Ibaraki, Japan, 311-0113 Sagamihara, Kanagawa, Japan, 252-0302 Kasaoka, Okayama, Japan, 714-0043 Shimono, Tochigi, Japan, 329-0433 Adachi-ku, Tokyo, Japan, 123-0845 Chuo-ku, Tokyo, Japan, 103-0027 Mitaka, Tokyo, Japan, 181-0013 收起 << |
NCT03414333 | Glucose Metabolism Disorders ... 展开 >> Obesity Degenerative Brain Disorder 收起 << | Not Applicable | Completed | - | Italy ... 展开 >> Dept.Clinical and Experimental Medicine.Section of Diabetes. Pisa, Italy 收起 << |
NCT01760772 | Heart Disease | Not Applicable | Unknown | February 2015 | United States, Ohio ... 展开 >> Veteran's Affairs Clinical Research Unit Not yet recruiting Cincinnati, Ohio, United States, 45220 Contact: Michelle R Adams, PhD 513-558-6920 michelle.adams@uc.edu Principal Investigator: Michelle R Adams, PhD Principal Investigator: David D'Alessio, MD 收起 << |
NCT03688711 | Hypoglycemia ... 展开 >>Diabetes Mellitus, Type 1 收起 << | Phase 3 | Recruiting | April 18, 2019 | United States, California ... 展开 >> ProSciento, Inc. Recruiting Chula Vista, California, United States, 91911 Contact: Julie Willard, MD AMCR Institute Recruiting Escondido, California, United States, 92025 Contact: Tim Bailey, MD United States, Washington Rainier Clinical Research, Inc. Recruiting Renton, Washington, United States, 98057 Contact: Leslie Klaff, MD, PhD 收起 << |
NCT01801540 | Glucose Metabolism | Not Applicable | Completed | - | - |
NCT03373435 | Postbariatric Hypoglycemia | Phase 2 | Recruiting | October 2018 | United States, California ... 展开 >> Stanford University Recruiting Palo Alto, California, United States, 94304 Contact: Aileen Muno munoai@stanford.edu Contact: Marilyn Tan, MD mjtan@stanford.edu Principal Investigator: Marilyn Tan, MD United States, Colorado University of Colorado, Denver Recruiting Aurora, Colorado, United States, 80045 Contact: Helen Lawler, MD 720-848-5146 Endo.ClinicalTrials@ucdenver.edu United States, Maryland Johns Hopkins University Recruiting Baltimore, Maryland, United States, 21287 Contact: Dezeray Cephas 443-507-8222 dcephas1@jhu.edu Principal Investigator: Clare Lee, MD, MHS United States, North Carolina Duke Early Phase Clinical Research Recruiting Durham, North Carolina, United States, 27710 Contact 919-613-6246 DCRIvolunteer@duke.edu United States, Wisconsin University of Wisconsin Recruiting Madison, Wisconsin, United States, 53792 Contact: Constance B Trantow 608-265-7814 收起 << |
NCT03500484 | Obesity, Childhood ... 展开 >> Neural Development 收起 << | Phase 2 | Recruiting | April 30, 2020 | United States, Connecticut ... 展开 >> Yale University Recruiting New Haven, Connecticut, United States, 06511 Contact: Ania Jastreboff, PhD, MD 收起 << |
NCT00612950 | Type 2 Diabetes | Not Applicable | Completed | - | Denmark ... 展开 >> Dept. of Endocrinology, Hvidovre Hospital Copenhagen, Denmark 收起 << |
NCT01855490 | Type 1 Diabetes | Phase 1 | Completed | - | United States, Connecticut ... 展开 >> Yale School of Medicine New Haven, Connecticut, United States, 06519 收起 << |
NCT00686972 | Bariatric Surgery | Phase 2 | Terminated(PI left JHU) | - | United States, Maryland ... 展开 >> Johns Hopkins Bayview Medical Center Baltimore, Maryland, United States, 21224 收起 << |
NCT00876213 | - | Completed | - | Denmark ... 展开 >> Hvidovre Hospital Hvidovre, Denmark, 2650 收起 << | |
NCT00686972 | - | Terminated(PI left JHU) | - | - | |
NCT03141632 | Thirst Water-... 展开 >>Electrolyte Imbalance 收起 << | Phase 2 | Completed | - | Switzerland ... 展开 >> University Hospital Basel Basel, Switzerland, 4031 收起 << |
NCT01373216 | Coronary Artery Disease ... 展开 >> Decreased Left Ventricular Function 收起 << | Phase 3 | Completed | - | Czech Republic ... 展开 >> General University Hospital Prague, Czech Republic, 128 08 收起 << |
NCT01931982 | Type 2 Diabetes ... 展开 >> Microvascular Dysfunction 收起 << | Phase 4 | Completed | - | Denmark ... 展开 >> Bispebjerg Hospital Copenhagen, Capital region, Denmark, 2400 收起 << |
NCT02105324 | - | Completed | - | - | |
NCT01891617 | Endocrine and Metabolic Respon... 展开 >>ses to Exercise and Diets 收起 << | Not Applicable | Completed | - | United States, Michigan ... 展开 >> Michigan Clinical Research Unit Ann Arbor, Michigan, United States, 48109 收起 << |
NCT02241889 | Type 1 Diabetes | Not Applicable | Completed | - | United States, Oregon ... 展开 >> Oregon Health and Science University Portland, Oregon, United States, 97239 收起 << |
NCT02241889 | - | Completed | - | - | |
NCT03079921 | Type1diabetes ... 展开 >> Hypoglycemia Hypoglycemia Unawareness 收起 << | Early Phase 1 | Recruiting | December 2020 | United States, Pennsylvania ... 展开 >> University of Pennsylvania - Institute for Diabetes, Obesity and Metabolism Recruiting Philadelphia, Pennsylvania, United States, 19104 Contact: Eileen Markmann 215-350-0364 eileen.markmann@uphs.upenn.edu Contact: Cornelia Dalton Bakes 2155274490 ext Dalton Bakes cornelia.dalton-bakes@uphs.upenn.edu Principal Investigator: Michael R Rickels, MD., MS 收起 << |
NCT02731664 | Functional Gastrointestinal Di... 展开 >>sorders 收起 << | Phase 1 | Completed | - | Sweden ... 展开 >> Uppsala University Uppsala, Uppsala County, Sweden, 75185 收起 << |
NCT01747967 | Type 1 Diabetes | Not Applicable | Completed | - | France ... 展开 >> INSERM U1016 - DeAR Lab Avenir, Hôpital Cochin Paris, France, 75014 收起 << |
NCT00256256 | Type 2 Diabetes ... 展开 >> Stroke Myocardial Infarction 收起 << | Not Applicable | Completed | - | Denmark ... 展开 >> Department of pharmacology, Aarhus university Aarhus, Denmark, 8000 收起 << |
NCT02105324 | Type 1 Diabetes | Not Applicable | Completed | - | United States, Massachusetts ... 展开 >> Massachusetts General Hospital Boston, Massachusetts, United States, 02114 收起 << |
NCT01656057 | To Assess the Impact of Bile A... 展开 >>cids on Human Glukagon-like-peptide-1 Secretion 收起 << | Not Applicable | Completed | - | Denmark ... 展开 >> University Hospital of Copenhagen, Gentofte Hospital, Diabetic Research Division Copenhagen, Hellerup, Denmark, 2900 收起 << |
NCT01304823 | Taste Disorder, Primary, Sweet | Phase 1 | Completed | - | Switzerland ... 展开 >> University Hospital Basel, Phase 1 Research Unit Basel, Switzerland, 4031 收起 << |
NCT03659461 | Type 2 Diabetes Mellitus ... 展开 >> PreDiabetes 收起 << | Not Applicable | Recruiting | January 2020 | Malaysia ... 展开 >> Hospital Sultan Ismail Recruiting Johor Bahru, Johor, Malaysia, 81100 Contact: Chong Shiau Chin, MPHARM +6073565000 shiauchin83@hotmail.com Contact +60361455555 收起 << |
NCT02092220 | Diabetes Mellitus Type 1 | Not Applicable | Completed | - | United States, California ... 展开 >> Stanford University Stanford, California, United States, 94305 United States, Massachusetts Massachusetts General Hospital (MGH) Diabetes Research Center Boston, Massachusetts, United States, 02114 UMass Medical Center Worcester, Massachusetts, United States, 01655 United States, North Carolina University of North Carolina Chapel Hill Chapel Hill, North Carolina, United States, 27514 收起 << |
NCT02092220 | - | Completed | - | - | |
NCT02509065 | - | Completed | - | - | |
NCT02509065 | Type 1 Diabetes ... 展开 >> Type 2 Diabetes 收起 << | Not Applicable | Completed | - | United States, Massachusetts ... 展开 >> Masscahusetts General Hospital Boston, Massachusetts, United States, 02114 收起 << |
NCT02282254 | Type 1 Diabetes | Phase 2 | Completed | - | Canada, Quebec ... 展开 >> Institut de recherches cliniques de Montréal Montreal, Quebec, Canada, H2W 1R7 收起 << |
NCT01832532 | Sleep Apnea S... 展开 >>leep Disordered Breathing 收起 << | Phase 1 Phase 2 | Completed | - | United States, Ohio ... 展开 >> Cincinnati Children's Hospital Medical Center Cincinnati, Ohio, United States, 45229 收起 << |
NCT03232112 | Alcohol Dependence, in Remissi... 展开 >>on Addiction, Alcohol 收起 << | Phase 2 | Recruiting | November 1, 2019 | Denmark ... 展开 >> Novavì ambulatorierne Recruiting Copenhagen, Frederiksberg, Denmark, 2000 Contact: Signe W. Düring, MD SDUR@novavi.dk Contact: Mette K Klausen, MD +45 22649599 mette.kruse.klausen@regionh.dk 收起 << |
NCT02487342 | Appetite Regulation | Not Applicable | Completed | - | - |
NCT01892254 | Polycystic Ovary Syndrome | Phase 4 | Completed | - | Denmark ... 展开 >> Copenhagen University Hospital Gentofte Hellerup, Select A State, Denmark, 2900 收起 << |
NCT01173978 | Insulin Resistance ... 展开 >> Deteriorated Glucose Homeostasis Inactivity 收起 << | Not Applicable | Completed | - | Denmark ... 展开 >> Department of Clinical Physiology Glostrup, Denmark, DK-2600 收起 << |
NCT00950677 | Type 2 Diabetes | Phase 4 | Completed | - | United States, Texas ... 展开 >> Baylor College of Medicine Houston, Texas, United States, 77030 收起 << |
NCT02328040 | Diabetes Mellitus, Type 1 | Phase 1 | Completed | - | United States, New York ... 展开 >> Albert Einstein College of Medicine CRC Bronx, New York, United States, 10461 收起 << |
NCT02846857 | Type 1 Diabetes | Phase 2 | Not yet recruiting | February 2019 | - |
NCT02940184 | Physiology | Not Applicable | Recruiting | October 2018 | Denmark ... 展开 >> Department of Surgery C, Rigshospitalet Recruiting Copenhagen, Denmark, 2100 Contact: Simon Veedfald, MD +45 41 10 25 95 Contact: Lars Bo Svendsen, Dr.Med.Sci +45 35 45 21 22 Lars.Bo.Svendsen@regionh.dk Principal Investigator: Simon Veedfald, MD 收起 << |
NCT00442767 | Type 1 Diabetes Mellitus | Phase 4 | Completed | - | United States, New York ... 展开 >> Montefiore Medical Center Bronx, New York, United States, 10467 收起 << |
NCT00937079 | - | Completed | - | Switzerland ... 展开 >> University Hospital Basel, Institute of Nuclear Medicine Basel, Basel-Stadt, Switzerland, CH-4031 收起 << | |
NCT02328040 | - | Completed | - | - | |
NCT00442767 | - | Completed | - | - | |
NCT00843232 | - | Completed | - | Brazil ... 展开 >> LIMED (Laboratory of Investigation of Metabolism and Diabetes)/GASTROCENTRO/Univeristy of Campinas (UNICAMP) Campinas, SP, Brazil 收起 << | |
NCT01640834 | - | Completed | - | - | |
NCT01762059 | Type 1 Diabetes | Not Applicable | Completed | - | United States, Massachusetts ... 展开 >> Massachusetts General Hospital Boston, Massachusetts, United States, 02114 收起 << |
NCT00609154 | Type 2 Diabetes | Phase 1 | Unknown | November 2008 | United States, New York ... 展开 >> Albert Einstein College of Medicinie Recruiting Bronx, New York, United States, 10461 Contact: Cynthia Rivera, RN 718-430-2446 carivera@aecom.yu.edu Principal Investigator: Daniel Stein, MD 收起 << |
NCT02036710 | - | Completed | - | United States, Minnesota ... 展开 >> University of Minnesota Minneapolis, Minnesota, United States, 55455 收起 << | |
NCT01640834 | Diabetes Mellitus, Type 1 | Phase 1 | Completed | - | Germany ... 展开 >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Neuss, Germany, 41460 收起 << |
NCT01740921 | Type 2 Diabetes | Not Applicable | Completed | - | United Kingdom ... 展开 >> Peninsula Clinical Research Facility Exeter, United Kingdom, EX2 5DW 收起 << |
NCT02416765 | Type 1 Diabetes | Phase 2 | Completed | - | Canada, Quebec ... 展开 >> Institut de recherches cliniques de Montréal Montreal, Quebec, Canada, H2W1R7 收起 << |
NCT01218633 | Pancreatic Effects of 9,39-Exe... 展开 >>ndin and 9,36-GLP-1 收起 << | Phase 1 | Completed | - | United States, Minnesota ... 展开 >> Mayo Clinic Rochester, Minnesota, United States, 55905 收起 << |
NCT01865760 | Obesity Hypog... 展开 >>lycemia Surgery 收起 << | Not Applicable | Unknown | March 2016 | Denmark ... 展开 >> Department of Endocrinology, Aarhus University Hospital Recruiting Aarhus C, Denmark, 8000 Contact: Joan Bach Nielsen, Dr 0045+24818454 joanni@rm.dk Sub-Investigator: Joan Bach Nielsen, MD 收起 << |
NCT01762059 | - | Completed | - | - | |
NCT03713190 | End Stage Renal Disease | Phase 2 | Recruiting | December 2020 | Italy ... 展开 >> Department of Endocrinology and Metabolism, University of Pisa Recruiting Pisa, Italy, 56124 Contact: Stefano Del Prato, MD +39 050 995103 stefano.delprato@med.unipi.it Sub-Investigator: Giuseppe Daniele, MD 收起 << |
NCT02516657 | - | Unknown | December 2018 | United States, New York ... 展开 >> Women and Children's Hospital of Buffalo Recruiting Buffalo, New York, United States, 14222 Contact: Lucy D Mastrandrea, MD, PhD 716-878-7588 lmastrandrea@upa.chob.edu 收起 << | |
NCT00473733 | Diabetes Mellitus Type 2 | Phase 4 | Unknown | - | Israel ... 展开 >> Assaf Harofeh Medical Center Not yet recruiting Zerifin, Israel, 70300 Contact: eFRAT Broide, MD 972-8-9779722 efibroide@yahoo.com Principal Investigator: Efrat Broide, MD 收起 << |
NCT02796950 | Diabetes Mellitus Type 2 | Not Applicable | Completed | - | Denmark ... 展开 >> University Hospital of Aarhus Aarhus, Denmark, 8000 收起 << |
NCT01664624 | - | Completed | - | - | |
NCT00612625 | Diabetes Mellitus Type 2 | Not Applicable | Completed | - | Denmark ... 展开 >> Dept. of Endocrinology, Hvidovre Hospital Copenhagen, Denmark 收起 << |
NCT03241706 | Hypoglycemia; Iatrogenic | Phase 1 | Not yet recruiting | May 31, 2022 | - |
NCT01741103 | Diabetes Type I | Not Applicable | Unknown | September 2013 | United States, New York ... 展开 >> 115 Flint Road Recruiting Williamsville, New York, United States, 14221 Contact: Paresh Dandona, MD 716-626-7998 pdandona@kaleidahealth.org 收起 << |
NCT01232244 | - | Completed | - | Denmark ... 展开 >> Gentofte University Hospital Hellerup, Denmark, 2900 收起 << | |
NCT01664624 | Type 2 Diabetes | Phase 1 | Completed | - | United States, California ... 展开 >> Chula Vista, California, United States United States, Florida Orlando, Florida, United States 收起 << |
NCT01818648 | Short Bowel Syndrome | Phase 4 | Withdrawn(Study was withdrawn ... 展开 >>by PI due to decision to study a different medication.) 收起 << | - | - |
NCT01161862 | Diabetes Mellitus | Not Applicable | Completed | - | United States, Massachusetts ... 展开 >> Massachusetts General Hospital Boston, Massachusetts, United States, 02114 收起 << |
NCT02237521 | - | Completed | - | Denmark ... 展开 >> Department of Nephrology, Rigshospitalet Copenhagen, Denmark, 2100 收起 << | |
NCT02920190 | Monoclonal Gammopathies ... 展开 >> Overweight Obesity 收起 << | Phase 4 | Not yet recruiting | December 31, 2020 | - |
NCT01999504 | Insulin Resistance ... 展开 >> Satiety 收起 << | Not Applicable | Completed | - | United Kingdom ... 展开 >> Leatherhead Food Research Leatherhead, Surrey, United Kingdom, KT22 7RY 收起 << |
NCT01579981 | Type 2 Diabetes | Not Applicable | Completed | - | Denmark ... 展开 >> Dept. of Endocrinology, Hvidovre Hospital Hvidovre, Denmark, DK-2650 收起 << |
NCT02001363 | Acute Myocardial Infarction | Not Applicable | Unknown | March 2016 | China, Beijing ... 展开 >> PLA General Hospital Recruiting Beijing, Beijing, China, 100853 Contact: Wei Ren Chen, M.D. +8610-66939709 chen_weiren@sina.com Principal Investigator: Yun Dai Chen, M.D. 收起 << |
NCT01161862 | - | Completed | - | - | |
NCT01341028 | Morbid Obesity | Not Applicable | Completed | - | Greece ... 展开 >> University Hospital of Patras Rion, Achaia, Greece, 26500 收起 << |
NCT01784965 | Pre-diabetes ... 展开 >>Older Adults 收起 << | Phase 3 | Completed | - | - |
NCT01784965 | - | Completed | - | - | |
NCT01300260 | - | Completed | - | - | |
NCT01509742 | Diabetes Diab... 展开 >>etes Mellitus, Type 2 收起 << | Phase 1 | Completed | - | Germany ... 展开 >> Novo Nordisk Investigational Site Bad Lauterberg, Germany, 37431 收起 << |
NCT01300260 | Diabetes Mellitus, Type 2 | Phase 1 | Completed | - | Germany ... 展开 >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Neuss, Germany, D-41460 收起 << |
NCT02673931 | Coronary Disease ... 展开 >> Shock, Cardiogenic Renal Failure Stroke Brain Injury Aortic Valve Disease 收起 << | Not Applicable | Recruiting | January 2020 | Denmark ... 展开 >> Rigshospitalet - Copenhagen University Hospital Recruiting Copenhagen, Denmark, 2100 Contact: Jens C Nilsson, MD, PhD Jens.Christian.Nilsson@regionh.dk 收起 << |
NCT02372526 | - | Active, not recruiting | June 2017 | Denmark ... 展开 >> Endocrinology Research Center, Hvidovre University Hospital Hvidovre, Copenhagen, Denmark, 2650 收起 << | |
NCT00952991 | Diabetes Mellitus, Non-Insulin... 展开 >>-Dependent 收起 << | Phase 3 | Completed | - | United States, Minnesota ... 展开 >> Mayo Clinic Rochester, Minnesota, United States, 55905 收起 << |
NCT01779622 | Healthy Volunteers Recruited F... 展开 >>rom the General Population 收起 << | Not Applicable | Completed | - | Sweden ... 展开 >> Department of Clinical Sciences, Lund University Lund, Sweden, 22184 收起 << |
NCT00540215 | Regional Blood Flow | Not Applicable | Completed | - | Denmark ... 展开 >> Glostrup University Hospital Glostrup, Region Hovedstaden, Denmark, 2600 收起 << |
NCT02895672 | - | Completed | - | - | |
NCT02910518 | Type1 Diabetes Mellitus | Phase 1 | Completed | - | Germany ... 展开 >> Investigational Site Number 276001 Neuss, Germany, 41460 收起 << |
NCT02477761 | Diabetes | Not Applicable | Unknown | September 2015 | Italy ... 展开 >> Azienda Ospedaliero-Universitaria Pisana Pisa, PI, Italy, 56127 收起 << |
NCT03704818 | Type1 Diabetes Mellitus | Phase 1 | Recruiting | December 31, 2020 | United States, California ... 展开 >> UC San Diego Altman Clinical & Translational Research Institute Recruiting La Jolla, California, United States, 92037 Contact: Todd May, MS tmay@ucsd.edu 收起 << |
NCT01919684 | Type 2 Diabetes Mellitus | Phase 1 | Completed | - | United States, Ohio ... 展开 >> Medpace Clinical Pharmacology Cincinnati, Ohio, United States, 45227 收起 << |
NCT02971202 | Type 1 Diabetes Mellitus ... 展开 >> Maturity-Onset Diabetes of the Young, Type 2 MODY2 Insulin Resistance 收起 << | Phase 1 | Recruiting | June 2019 | United States, Tennessee ... 展开 >> Vanderbilt University Medical Center Recruiting Nashville, Tennessee, United States, 37232 Contact: Justin M Gregory, M.D. 615-322-7427 metabolism@vumc.org 收起 << |
NCT02765204 | Diabetes Mellitus, Type 2 | Phase 4 | Completed | - | Sweden ... 展开 >> Dept of Medical Sciences Uppsala University Hospital Uppsala, Sweden, 75185 收起 << |
NCT00713440 | Type 2 Diabetes Mellitus ... 展开 >> Steroids 收起 << | Not Applicable | Completed | - | Denmark ... 展开 >> Clinical Physiology Department; Glostrup Univesity Hospital Glostrup, Region Hovedstaden, Denmark, 2600 收起 << |
NCT00897676 | Congenital Hyperinsulinism | Phase 1 Phase 2 | Completed | - | United States, Pennsylvania ... 展开 >> The Children's Hospital of Philadelphia Philadelphia, Pennsylvania, United States, 19104 收起 << |
NCT02379299 | Type 1 Diabetes | Phase 2 Phase 3 | Withdrawn | - | Denmark ... 展开 >> Hvidovre University Hospital Hvidovre, Denmark, 2650 收起 << |
NCT02089438 | Type 2 Diabetes | Phase 4 | Completed | - | Sweden ... 展开 >> Clinical Research Department Lund, Sweden, 22185 收起 << |
NCT01297946 | Type 1 Diabetes | Phase 1 Phase 2 | Completed | - | Canada, Quebec ... 展开 >> Institut de Recherches Cliniques de Montréal (IRCM) Montreal, Quebec, Canada, H2W 1R7 收起 << |
NCT00603031 | Type-1 Diabetes Mellitus | Not Applicable | Completed | - | Denmark ... 展开 >> Dept. of Endocrinology, Hvidovre Hospital Copenhagen, Denmark, 2650 收起 << |
NCT00588380 | Diabetes | Not Applicable | Completed | - | United States, Minnesota ... 展开 >> Mayo Clinic Rochester, Minnesota, United States, 55905 收起 << |
NCT00885638 | Healthy Type ... 展开 >>2 Diabetes 收起 << | Phase 4 | Completed | - | Sweden ... 展开 >> Department of Clinical Sciences Lund, Lund University Lund, Sweden, 221 84 收起 << |
NCT00885638 | - | Completed | - | - | |
NCT03660332 | Postprandial Glucose Homeostas... 展开 >>is 收起 << | Not Applicable | Completed | - | Denmark ... 展开 >> Rigshospitalet, Centre of Inflammation and Metabolism (CIM) Centre for Physical Activity Research (CFAS) Copenhagen, Denmark, 2100 收起 << |
NCT03426956 | Overweight | Not Applicable | Recruiting | May 1, 2019 | Denmark ... 展开 >> Dept. of Endocrinology Recruiting Hvidovre, Denmark, 2650 Contact: Christoffer Martinussen, MD +4538623032 christoffer.martinussen@regionh.dk Principal Investigator: Christoffer Martinussen, MD 收起 << |
NCT02304081 | Type2 Diabetes Mellitus | Phase 4 | Completed | - | Germany ... 展开 >> Profil Mainz GmbH & Co. KG Mainz, Germany, 55116 收起 << |
NCT00588380 | - | Completed | - | - | |
NCT00822003 | Glucose Homeostasis | Phase 1 Phase 2 | Completed | - | Switzerland ... 展开 >> Clinical Research Center, University Hospital Basel Basel, Basel-Stadt, Switzerland, 4031 收起 << |
NCT03103009 | Hyperinsulinemic Hypoglycemia ... 展开 >> Post Gastrointestinal Tract Surgery Hypoglycaemia 收起 << | Phase 1 | Recruiting | March 22, 2019 | United States, Colorado ... 展开 >> University of Colorado Denver Recruiting Aurora, Colorado, United States, 80045 收起 << |
NCT00639613 | - | Completed | - | Denmark ... 展开 >> Department of Internal Medicine F' laboratory Hellerup, Copenhagen County, Denmark, 2900 收起 << | |
NCT02147431 | Diabetes Diab... 展开 >>etes Mellitus, Type 2 收起 << | Phase 1 | Completed | - | Austria ... 展开 >> Novo Nordisk Investigational Site Graz, Austria, 8010 收起 << |
NCT00897676 | - | Completed | - | - | |
NCT01905020 | Type 1 Diabetes | Phase 2 | Completed | - | Canada, Ontario ... 展开 >> Mount Sinai Hospital Toronto, Ontario, Canada Canada, Quebec Institut de recherches cliniques de Montréal Montreal, Quebec, Canada Montreal Children Hospital Montreal, Quebec, Canada 收起 << |
NCT02846168 | - | Unknown | December 2017 | China, Beijing ... 展开 >> Li Jing-Wei Recruiting Beijing, Beijing, China, 100853 Contact: Jing-Wei Li, PhD +8601055499309 jingwei6829@sina.com 收起 << | |
NCT00362063 | Growth Hormone Deficiency | Not Applicable | Active, not recruiting | April 2018 | United States, Texas ... 展开 >> Baylor College of Medicine Houston, Texas, United States, 77030 收起 << |
NCT01333163 | Kidney Functional | Not Applicable | Completed | - | Denmark ... 展开 >> Klinisk Institut, Afd. MEA, Aarhus Sygehus, NBG Aarhus C, Denmark, 8000 收起 << |
NCT01660386 | Type 2 Diabetes | Phase 4 | Unknown | March 2013 | China ... 展开 >> Shanghai Jiao Tong University School of Medicine Recruiting Shanghai, China, 200021 Contact: Guang Ning, MD,PHD +8621-64370045 ext 665340 guangning@medmail.com.cn Principal Investigator: Guang Ning, MD,PHD 收起 << |
NCT00637338 | Diabetes Mellitus, Type 2 | Phase 1 | Terminated(See termination rea... 展开 >>son in detailed description.) 收起 << | - | United States, Arizona ... 展开 >> Pfizer Investigational Site Phoenix, Arizona, United States, 85013 United States, Florida Pfizer Investigational Site Miami, Florida, United States, 33169 United States, Kansas Pfizer Investigational Site Wichita, Kansas, United States, 67214 United States, Oregon Pfizer Investigational Site Portland, Oregon, United States, 97239 收起 << |
NCT01274052 | - | Completed | - | Denmark ... 展开 >> Department of Internal Medicine, Glostrup Hospital Glostrup, Denmark, 2600 收起 << | |
NCT00845182 | - | Completed | - | - | |
NCT02777073 | Type 1 Diabetes | Phase 3 | Completed | - | United States, New York ... 展开 >> ECMC Ambulatory Center, 3rd Floor Buffalo, New York, United States, 14215 收起 << |
NCT01698502 | - | Completed | - | - | |
NCT02879955 | Overweight | Not Applicable | Completed | - | Denmark ... 展开 >> Dept. of Endocrinology Hvidovre, Denmark, 2650 收起 << |
NCT00845182 | Type 2 Diabetes ... 展开 >> Healthy Impaired Glucose Tolerance 收起 << | Phase 4 | Completed | - | United States, Texas ... 展开 >> Barter Research Center, ALM VA Hospital San Antonio, Texas, United States, 78229 收起 << |
NCT00264199 | Heart Failure, Congestive | Not Applicable | Completed | - | Denmark ... 展开 >> Afdeling B, Skejby Hospital Aarhus, Denmark, 8200 收起 << |
NCT02094183 | Obesity | Not Applicable | Completed | - | Denmark ... 展开 >> University of Copenhagen Copenhagen, Denmark, 2200 Hvidovre University Hospital Hvidovre, Denmark, 2650 收起 << |
NCT02061124 | Type 2 Diabetes | Not Applicable | Completed | - | Denmark ... 展开 >> Diabetes Research Division, Gentofte Hospital, Copenhagen Hellerup, Denmark, 2900 收起 << |
NCT00411411 | Type 2 Diabetes | Phase 3 | Completed | - | Denmark ... 展开 >> Gentofte Hospital Hellerup, Denmark, 2900 收起 << |
NCT01966393 | Type 1 Diabetes | Phase 2 | Completed | - | Canada, Quebec ... 展开 >> Institut de recherches cliniques de Montréal Montreal, Quebec, Canada, H2W 1R7 收起 << |
NCT01698502 | - | Completed | - | Denmark ... 展开 >> University of Copenhagen, Faculty of Health Sciences Copenhagen, North, Denmark, 2200 收起 << | |
NCT00811317 | Type 1 Diabetes | Not Applicable | Completed | - | United States, Massachusetts ... 展开 >> Massachusetts General Hospital Boston, Massachusetts, United States, 02114 收起 << |
NCT00811317 | - | Completed | - | - | |
NCT01959984 | Diabetes | Not Applicable | Unknown | December 2013 | China, Shanghai ... 展开 >> Shanghai Jiao Tong University School of Medicine Shanghai, Shanghai, China, 200021 收起 << |
NCT00511108 | Type 2 Diabetes Mellitus (T2DM... 展开 >>) 收起 << | Phase 1 | Completed | - | - |
NCT00230464 | Type 2 Diabetes Mellitus | Phase 3 | Completed | - | United States, Texas ... 展开 >> Audie L Murphy VA Hospital San Antonio, Texas, United States, 78229 收起 << |
NCT00566358 | Diabetes Mellitus, Type 2 | Phase 1 Phase 2 | Completed | - | Brazil ... 展开 >> LIMED (Laboratory of Investigation of Metabolism and Diabetes)/GASTROCENTRO/Univeristy of Campinas (UNICAMP) Campinas, SP, Brazil 收起 << |
NCT00411411 | - | Completed | - | - | |
NCT00511108 | - | Completed | - | - | |
NCT00644241 | Type 2 Diabetes Mellitus | Phase 2 | Completed | - | India ... 展开 >> Pgimer Chandigarh, India 收起 << |
NCT01898286 | - | Terminated(A corporate decisio... 展开 >>n to suspend development of DiaPep277®) 收起 << | - | - | |
NCT01559779 | - | Completed | - | Denmark ... 展开 >> Dpt. of Endocrinology (215) at Hvidovre Hospital Hvidovre, Copenhagen, Denmark, 2650 收起 << | |
NCT02302976 | Cocaine Dependence | Phase 1 | Recruiting | November 2019 | United States, Connecticut ... 展开 >> Connecticut Mental Health Center Recruiting New Haven, Connecticut, United States, 06519 Contact: Jessica Costeines, MSW 203-974-7559 jessica.costeines@yale.edu Principal Investigator: Robert T Malison, MD 收起 << |
NCT02463656 | - | Completed | - | - | |
NCT01759823 | Type 2 Diabetes Mellitus | Phase 2 Phase 3 | Completed | - | India ... 展开 >> Postgraduate Institute of Medical Education and Research Chandigarh, UT, India, 160012 收起 << |
NCT02006459 | - | Completed | - | Denmark ... 展开 >> Diabetes Research Division, University Hospital Gentofte Hellerup, Denmark, 2900 收起 << | |
NCT02639130 | Type 2 Diabetes | Phase 4 | Completed | - | Germany ... 展开 >> Diabeteszentrum Bad Lauterberg Bad Lauterberg, Niedersachsen, Germany, 37431 收起 << |
NCT03159741 | Healthy | Not Applicable | Completed | - | Denmark ... 展开 >> Hvidovre University Hospital Hvidovre, Denmark, 2650 收起 << |
NCT02802514 | Diabetes Mellitus | Phase 4 | Terminated | - | United States, Massachusetts ... 展开 >> GSK Investigational Site Boston, Massachusetts, United States, 02114 收起 << |
NCT01898286 | Type 1 Diabetes | Phase 3 | Terminated(A corporate decisio... 展开 >>n to suspend development of DiaPep277®) 收起 << | - | United States, Georgia ... 展开 >> Atlanta Diabetes associates Atlanta, Georgia, United States, 30318 United States, Michigan Henry Ford Medical Centers - New Center One Detroit, Michigan, United States, 48202 United States, North Carolina Mountain Diabetes and Endocrine Center Asheville, North Carolina, United States, 28803 收起 << |
NCT01413126 | Type 2 Diabetes Mellitus | Not Applicable | Completed | - | Brazil ... 展开 >> Federal University of Viçosa Viçosa, Minas Gerais, Brazil, 36570-000 收起 << |
NCT01559025 | Type 1 Diabetes ... 展开 >> Insulin Dependent Diabetes Juvenile Onset Diabetes Mellitus Autoimmune Diabetes 收起 << | Phase 3 | Unknown | March 2017 | Brazil ... 展开 >> Federal University of São Paulo Recruiting São Paulo, Brazil, 04022-001 Contact: Tatiana Valente 55119614616 valentetati@yahoo.com.br Contact: Sergio Dib 551197397776 sergio.dib@unifesp.br Sub-Investigator: Monica Gabbay 收起 << |
NCT01434901 | Type 2 Diabetes Mellitus | Phase 1 | Completed | - | United States, Missouri ... 展开 >> Washington University School of Medicine Saint Louis, Missouri, United States, 63131 收起 << |
NCT01800188 | - | Completed | - | Denmark ... 展开 >> Nephrology department, Rigshospitalet Copenhagen, Denmark, 2100 收起 << | |
NCT01754337 | Type 1 Diabetes | Phase 2 | Completed | - | Canada, Quebec ... 展开 >> Institut de recherches cliniques de Montréal Montreal, Quebec, Canada, H2W 1R7 收起 << |
NCT02099084 | Short Bowel Syndrome | Phase 4 | Completed | - | United States, Minnesota ... 展开 >> Mayo Clinic in Rochester Rochester, Minnesota, United States, 55905 收起 << |
NCT02778100 | Common Cold | Phase 1 | Completed | - | Canada, Quebec ... 展开 >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Mount-Royal, Quebec, Canada, H3P 3P1 收起 << |
NCT01930110 | Type 1 Diabetes | Phase 2 | Completed | - | Canada, Quebec ... 展开 >> Institut de recherches cliniques de Montréal Montreal, Quebec, Canada, H2W 1R7 收起 << |
NCT02099084 | - | Completed | - | - | |
NCT02665715 | Bariatric Surgery (Gastric Byp... 展开 >>ass) 收起 << | Not Applicable | Completed | - | Denmark ... 展开 >> Endocrinology Research Center, Hvidovre University Hospital Hvidovre, Copenhagen, Denmark, 2650 收起 << |
NCT01065298 | - | Completed | - | India ... 展开 >> Post Graduate Institute of Medical Education and Research Chandigarh, Chandigarh UT, India 收起 << | |
NCT01519102 | Type-1 Diabetes | Phase 2 | Completed | - | Canada, Quebec ... 展开 >> Institut de Recherches Cliniques de Montréal (IRCM) Montreal, Quebec, Canada, H2W 1R7 收起 << |
NCT01968148 | - | Completed | - | Finland ... 展开 >> Helsinki Emergency Medical Services Helsinki, Finland Helsinki Area Helicopter Emergency Medical Services Vantaa, Finland 收起 << | |
NCT03456687 | Parkinson's Disease | Phase 1 | Recruiting | April 2021 | United States, Florida ... 展开 >> Laboratory for Rehabilitation Neuroscience Recruiting Gainesville, Florida, United States, 32611 收起 << |
NCT02798250 | Type 1 Diabetes | Phase 2 | Completed | - | Canada, Quebec ... 展开 >> Institut de recherches cliniques de Montréal Montreal, Quebec, Canada, H2W 1R7 收起 << |
NCT02725502 | Type 1 Diabetes Mellitus | Not Applicable | Unknown | May 2016 | India ... 展开 >> Department of Endocrinology, PGIMER Recruiting Chandigarh, India, 160012 Contact: Snajay Kr Bhadada, MD, DM bhadadask@rediffmail.com Contact: Soham Mukherjee, MD 9914743222 drsoham.mukherjee@gmail.com Principal Investigator: sanjay Kr Bhadada, MD, DM 收起 << |
NCT01744236 | Type 2 Diabetes | Phase 4 | Completed | - | Netherlands ... 展开 >> VU University Medical Center Amsterdam, Netherlands, 1081HV 收起 << |
NCT03707171 | Type 2 Diabetes Mellitus | Phase 3 | Not yet recruiting | May 1, 2019 | China, Chongqing ... 展开 >> The third hospital affiliated to the Third Military Medical University Chongqing, Chongqing, China, 400042 收起 << |
NCT01879917 | Diabetes Mellitus, Type 1 | Phase 2 Phase 3 | Active, not recruiting | December 2018 | Denmark ... 展开 >> Dep. of Endocrinology, Hvidovre University Hospital Hvidovre, Capital, Denmark, 2650 收起 << |
NCT02887625 | Type 2 Diabetes | Not Applicable | Unknown | May 2017 | Qatar ... 展开 >> Hamad General Hospital Recruiting Doha, Qatar Contact: Osama Mujahed, MD 66703172 pvedromigahid@gmail.com Contact: Ayman Mujahed, MD 44391208 ymndodo20@gmail.com 收起 << |
NCT01269034 | Type 1 Diabetes | Phase 4 | Recruiting | June 2019 | United States, New York ... 展开 >> Albert Einstein CRC- West Campus Recruiting Bronx, New York, United States, 10467 Sub-Investigator: Mariam Gangat, MD Principal Investigator: Rubina A Heptulla, MD 收起 << |
NCT02336659 | Severe Obesity | Not Applicable | Completed | - | Denmark ... 展开 >> Hvidovre University Hospital Hvidovre, Denmark, DK-2650 收起 << |
NCT00969566 | Diabetes | Phase 4 | Completed | - | Korea, Republic of ... 展开 >> Seoul National University Bundang Hospital Seongnam, Gyeonggi, Korea, Republic of, 463-707 收起 << |
NCT00109434 | - | Completed | - | United States, California ... 展开 >> Division of Pediatric Endocrinology and Diabetes, Stanford University Stanford, California, United States, 94305-5208 United States, Colorado Barbara Davis Center for Childhood Diabetes, University of Colorado Denver, Colorado, United States, 80262 United States, Connecticut Department of Pediatrics, Yale University School of Medicine New Haven, Connecticut, United States, 06519 United States, Florida Nemours Children's Clinic Jacksonville, Florida, United States, 32207 United States, Iowa Department of Pediatrics, University of Iowa Carver College of Medicine Iowa City, Iowa, United States, 52242 收起 << | |
NCT02626936 | Type 1 Diabetes | Phase 2 | Completed | - | Canada, Quebec ... 展开 >> Institut de recherches cliniques de Montréal Montreal, Quebec, Canada, H2W 1R7 收起 << |
NCT03537131 | Diabetes Mellitus, Type 1 | Phase 2 | Recruiting | December 22, 2018 | United Kingdom ... 展开 >> Clinical Research Unit, OCDEM, Churchill Hospital Recruiting Oxford, Oxfordshire, United Kingdom, OX3 7LE Contact: Lia Anguelova, MD lia.anguelova@ocdem.ox.ac.uk Principal Investigator: Ioannis I Spiliotis, MD 收起 << |
NCT00705952 | Type 2 Diabetes | Not Applicable | Completed | - | - |
NCT01408862 | - | Completed | - | - | |
NCT02235584 | Type 2 Diabetes | Not Applicable | Completed | - | Denmark ... 展开 >> Bispebjerg University Hospital Copenhagen NV, Denmark, 2400 收起 << |
NCT00843479 | - | Completed | - | Brazil ... 展开 >> LIMED (Laboratory of Investigation of Metabolism and Diabetes)/GASTROCENTRO/Univeristy of Campinas (UNICAMP) Campinas, SP, Brazil 收起 << | |
NCT00490893 | Diabetes Mellitus ... 展开 >> Hypoglycemia 收起 << | Phase 4 | Terminated | - | Germany ... 展开 >> University of Tübingen, Medical Department Tübingen, Germany, 72076 收起 << |
NCT00843479 | - | Completed | - | - | |
NCT02465515 | Diabetes Mellitus | Phase 4 | Completed | - | - |
NCT01492283 | - | Completed | - | Denmark ... 展开 >> Diabetes Research Division, Gentofte University Hospital, Niels Andersens Vej 65, opgang 4b, 1. sal Hellerup, Denmark, 2900 收起 << | |
NCT01408862 | - | Completed | - | - | |
NCT02380846 | Metabolic Diseases | Not Applicable | Active, not recruiting | January 26, 2018 | - |
NCT01722266 | Type 1 Diabetes | Phase 3 | Completed | - | United States, New York ... 展开 >> Diabetes-Endocrinology Center of Western NY Williamsville, New York, United States, 14221 收起 << |
NCT01103284 | Type 1 Diabetes Mellitus | Phase 3 | Completed | - | - |
NCT00994435 | - | Completed | - | Italy ... 展开 >> Department of Metabolic Diseases, Institute of Internal Medicine - Catholic University Rome, Italy, 00168 收起 << | |
NCT00747383 | Type 2 Diabetes Mellitus | Not Applicable | Completed | - | United Kingdom ... 展开 >> Royal Bournemouth Hospital Bournemouth, Dorset, United Kingdom, BH7 7DW 收起 << |
NCT01103284 | - | Completed | - | - | |
NCT01234649 | Gestational Diabetes Mellitus ... 展开 >> Type 2 Diabetes Mellitus Metabolic Syndrome Impaired Glucose Tolerance Disorder of Glucose Regulation 收起 << | Phase 3 | Active, not recruiting | August 2019 | United States, Louisiana ... 展开 >> Woman's Hospital Baton Rouge, Louisiana, United States, 70815 收起 << |
NCT00418288 | Type 2 Diabetes ... 展开 >> Stroke Myocardial Infarction 收起 << | Not Applicable | Completed | - | Denmark ... 展开 >> Department of pharmacology, Aarhus university Aarhus, Denmark, 8000 收起 << |
NCT01722266 | - | Completed | - | - | |
NCT01880827 | Type 2 Diabetes ... 展开 >> Obesity 收起 << | Phase 1 | Unknown | January 2016 | Finland ... 展开 >> Turku univercity hospital, PET center Recruiting Turku, Finland, 20540 Contact: Jukka P Koffert, MD, PhD student +35823130000 jukka.koffert@tyks.fi Sub-Investigator: Jukka P Koffert, MD,PhDstudent 收起 << |
NCT03246451 | Glucose Metabolism Disorders | Not Applicable | Completed | - | Denmark ... 展开 >> Center for Diabetes Research Gentofte, Copenhagen, Denmark, 2900 收起 << |
NCT01109927 | Diabetes, Autoimmune ... 展开 >> Diabetes Mellitus, Adult-Onset 收起 << | Phase 4 | Completed | - | - |
NCT01460069 | Psoriasis | Not Applicable | Completed | - | Denmark ... 展开 >> Gentofte Hospital Hellerup, Denmark, 2900 收起 << |
NCT03018665 | Diabetes Mellitus, Type 2 | Phase 4 | Not yet recruiting | - | China, Jilin ... 展开 >> First Hospital of Jilin University Not yet recruiting Changchun, Jilin, China, 130021 Contact: Guixia Wang, PhD gwang168@jlu.edu.cn 收起 << |
NCT00529048 | - | Completed | - | Denmark ... 展开 >> Endokrinologisk afd. J, Herlev Hospital Herlev, Region Hovedstaden, Denmark, 2730 收起 << | |
NCT01595789 | Coronary Artery Disease ... 展开 >> Diabetes Mellitus, Type 2 收起 << | Phase 4 | Completed | - | Denmark ... 展开 >> Copenhagen University Hospital, Bispebjerg Copenhagen, Bispebjerg, Denmark, 2400 收起 << |
NCT03520062 | Obesity | Not Applicable | Recruiting | January 1, 2019 | Denmark ... 展开 >> Department of Endocrinology Recruiting Hvidovre, Denmark, 2650 Contact: Sten Madsbad, MD, DMSci 38622291 Sten.Madsbad@regionh.dk Contact: Maria Svane, MD 38626357 mariasvane@hotmail.com 收起 << |
NCT01303315 | Diabetes Mellitus, Type 2 | Not Applicable | Terminated(Company strategic d... 展开 >>ecision) 收起 << | - | Czech Republic ... 展开 >> Fakultni Nemocnice U SV. Anny V Brne Brno, Czech Republic, 656 91 Klinika gerontologická a metabolická, Hradec Kralove, Czech Republic, 500 05 General University Hospital, Prague, Czech Republic, 128 08 Prednosta OB Kliniky a.s., Prague, Czech Republic, 130 00 Germany Diabetes Zentrum Bad Mergentheim, Germany Asklepios Klinik St. Georg Hamburg, Germany, 20099 Diabetes-Praxis Muenster Münster, Germany, 48153 Romania 'N. Paulescu' National Institute of Diabetes, Nutrition and Metabolic Diseases Bucharest, Romania, 79811 CMI Dr Busegeanu Mihaela Magdalena-Ploiesti Bucharest, Romania, A Fundeni Hospital - Surgical Bucharest, Romania, A Sanatatea Ta Medical Center Bucharest, Romania, A Sf. Ioan Hospital - Surgical Bucharest, Romania, A Spitalul Pelican, Orada Bucharest, Romania, A 收起 << |
NCT03444142 | Diabetes Mellitus, Type 2 | Phase 4 | Recruiting | December 30, 2018 | Mexico ... 展开 >> Instituto de terapeutica Experimental y Clinica. Centro universitario de Ciencias de la Salud. Universidad de Guadalajara Recruiting Guadalajara, Jalisco, Mexico, 44340 收起 << |
NCT01676116 | - | Completed | - | - | |
NCT01607931 | Type 2 Diabetes | Not Applicable | Completed | - | Denmark ... 展开 >> Rigshospitalet Copenhagen, Denmark 收起 << |
NCT02569684 | Diabetes Type 2 | Not Applicable | Active, not recruiting | December 2019 | Norway ... 展开 >> Oslo University Hospital Oslo, Norway, 0424 收起 << |
NCT01666964 | - | Unknown | May 2015 | United States, Maryland ... 展开 >> Walter Reed National Military Medical Center Not yet recruiting Bethesda, Maryland, United States, 20889 Principal Investigator: Andrew J Brackbill, M.D. Sub-Investigator: Kate H Kinnaird, M.D. Sub-Investigator: Louis French, PhD Sub-Investigator: Patrick W. Clyde, M.D. Sub-Investigator: Peter McIntyre, M.D. 收起 << | |
NCT01128192 | Hyperglycemia | Phase 2 | Completed | - | United States, California ... 展开 >> CMR Center for Metabolic Research VASDHS San Diego, California, United States, 92161 收起 << |
NCT03680482 | Diabetes Mellitus, Type 2 | Not Applicable | Completed | - | - |
NCT02370745 | Sarcopenia | Not Applicable | Completed | - | United Kingdom ... 展开 >> Division of Medical Sciences and Graduate Entry Medicine - School of Medicine - University of Nottingham Derby, United Kingdom, DE22 3DT 收起 << |
NCT00802971 | Hypoglycemia | Not Applicable | Completed | - | - |
NCT01422590 | Type 2 Diabetes Mellitus | Phase 1 | Completed | - | Korea, Republic of ... 展开 >> Samsung Medical Center Seoul, Korea, Republic of 收起 << |
NCT01189890 | Type 2 Diabetes Mellitus | Phase 3 | Completed | - | - |
NCT02200991 | Type 2 Diabetes Mellitus | Phase 4 | Completed | - | Japan ... 展开 >> Investigational Site Number 392-107 Atsugi-shi, Japan Investigational Site Number 392-125 Chiyoda-ku, Japan Investigational Site Number 392-121 Chuoh-ku, Japan Investigational Site Number 392-102 Ichihara-shi, Japan Investigational Site Number 392-103 Kawaguchi-shi, Japan Investigational Site Number 392-114 Kitamoto-shi, Japan Investigational Site Number 392-122 Kobe-shi, Japan Investigational Site Number 392-126 Kumamoto-shi, Japan Investigational Site Number 392-127 Kumamoto-shi, Japan Investigational Site Number 392-101 Kyoto-shi, Japan Investigational Site Number 392-106 Matsudo-shi, Japan Investigational Site Number 392-124 Mitaka-shi, Japan Investigational Site Number 392-108 Mito-shi, Japan Investigational Site Number 392-119 Nerima-ku, Japan Investigational Site Number 392-117 Okayama-shi, Japan Investigational Site Number 392-111 Sagamihara-shi, Japan Investigational Site Number 392-110 Sapporo-shi, Japan Investigational Site Number 392-116 Satsumasendai-shi, Japan Investigational Site Number 392-105 Shizuoka-shi, Japan Investigational Site Number 392-118 Suita-shi, Japan 收起 << |
NCT00198146 | Newly Diagnosed With Type 1 Di... 展开 >>abetes 收起 << | Phase 2 | Completed | - | United States, Indiana ... 展开 >> Indiana University - Riley Hospital for Children Indianapolis, Indiana, United States, 46202 收起 << |
NCT01334229 | Type 2 Diabetes Mellitus | Phase 3 | Completed | - | Canada ... 展开 >> Laval University Quebec, Canada, G1V 0A6 收起 << |
NCT01334229 | - | Completed | - | - | |
NCT01128192 | - | Completed | - | - | |
NCT01048268 | Diabetes Mellitus | Phase 1 Phase 2 | Completed | - | Denmark ... 展开 >> Department of Internal Medicine F' laboratory Hellerup, Copenhagen County, Denmark, 2900 收起 << |
NCT02168218 | Obesity | Not Applicable | Completed | - | Switzerland ... 展开 >> CHUV-clinical research center Lausanne, VD, Switzerland, CH-1011 收起 << |
NCT02649465 | Non-alcoholic Fatty Liver Dise... 展开 >>ase 收起 << | Phase 4 | Recruiting | September 2020 | Japan ... 展开 >> Department of Disease Control and Homeostasis, Kanazawa University Hospital Recruiting Kanazawa, Ishikawa, Japan, 920-8641 Contact: Toshinari Takamura, MD, PhD +81-76-265-2234 ttakamura@m-kanazawa.jp Principal Investigator: Yumie Takeshita, MD, PhD 收起 << |
NCT01189890 | - | Completed | - | - | |
NCT02127047 | Diabetes Mellitus Type 1 | Phase 2 | Completed | - | Switzerland ... 展开 >> University Hospital Basel Basel, Switzerland, 4031 收起 << |
NCT01596504 | - | Completed | - | - | |
NCT02087124 | Metabolic Syndrome | Not Applicable | Completed | - | Denmark ... 展开 >> Aarhus University Hospital Aarhus, Aarhus C., Denmark, 8000 收起 << |
NCT03728959 | Hypoparathyroidism | Not Applicable | Enrolling by invitation | April 12, 2019 | Denmark ... 展开 >> Hvidovre University Hospital Hvidovre, Denmark, 2650 收起 << |
NCT02343471 | Healthy Type ... 展开 >>2 Diabetes 收起 << | Not Applicable | Completed | - | - |
NCT02228252 | Metabolic Syndrome | Not Applicable | Completed | - | Denmark ... 展开 >> Aarhus University Hospital Aarhus, Aarhus C, Denmark, 8000 收起 << |
NCT01254123 | Patients With a First Acute My... 展开 >>ocardial Infarction to be Treated With Primary Percutaneous Coronary Intervention (PCI). 收起 << | Phase 3 | Unknown | - | Netherlands ... 展开 >> VU Medical Center Recruiting Amsterdam, Netherlands, 1081 HV Contact: Yolande Appelman, Dr. 0031204442441 Y.Appelman@vumc.nl Principal Investigator: Yolande Appelman, Dr. 收起 << |
NCT02694575 | - | Recruiting | September 1, 2018 | United Kingdom ... 展开 >> Leicester Diabetes Centre Recruiting Leicester, Leicestershire, United Kingdom, LE5 4PW Contact: Zin Zin Hitke, MBBS MRCP 0116 258 8602 ext 8602 zin.hitke@uhl-tr.nhs.uk Principal Investigator: Melanie J Davies, MbChB, MRCP 收起 << | |
NCT02201550 | - | Completed | - | Denmark ... 展开 >> Hvidovre University Hospital Hvidovre, Denmark, 2650 收起 << | |
NCT01676116 | Diabetes Diab... 展开 >>etes Mellitus, Type 2 收起 << | Phase 3 | Completed | - | - |
NCT02386943 | Type 2 Diabetes | Phase 4 | Unknown | March 2015 | China ... 展开 >> Shanghai Jiao Tong University School of Medicine Recruiting Shanghai, China Contact: Ning Guang, MD,PHD 收起 << |
NCT02343380 | Diet-induced Thermogenesis | Not Applicable | Completed | - | - |
NCT01633762 | Diabetes Obes... 展开 >>ity Osteoporosis Inflammation 收起 << | Early Phase 1 | Completed | - | Denmark ... 展开 >> Gentofte University Hospital Hellerup, Denmark, 2900 收起 << |
NCT02343380 | - | Completed | - | - | |
NCT02077062 | - | Unknown | March 2015 | India ... 展开 >> G B Pant Hospital Recruiting New Delhi, Delhi, India, 110002 Contact: hirdaya h nag, ms 91 11 23234242 ext 5220 hirdayanag@gmail.com Principal Investigator: hirdaya h nag, ms Sub-Investigator: john m mathew, ms Sub-Investigator: puja sahuja, md Sub-Investigator: bhawana singh, md Sub-Investigator: v k gupta, md Sub-Investigator: a k sharma, md 收起 << | |
NCT01694173 | Type 2 Diabetes Mellitus | Phase 2 Phase 3 | Unknown | February 2013 | India ... 展开 >> PGIMER Recruiting Chandigarh, India Contact: Vikas Sood, MBBS, DRM 009779737349 vikasvineeta@rediffmail.com Contact: Anil Bhansali, MBBS,MD,DM 001722756583 anilbhansali_endocrine@rediffmail.com 收起 << |
NCT00572689 | Gestational Diabetes | Phase 4 | Withdrawn | - | United States, District of Col... 展开 >>umbia Georgetown University Medical Center Washington, District of Columbia, United States, 20007 Washington Hospital Center Washington, District of Columbia, United States, 20010 收起 << |
NCT01789307 | Focus of Study: Oral Tolerance... 展开 >> Test With Glucose, Lactose, Sucrose 收起 << | Not Applicable | Completed | - | Canada, British Columbia ... 展开 >> Child & Family Research Institute Vancouver, British Columbia, Canada, V5Z4H4 收起 << |
NCT02496221 | Diabetes Mellitus, Type 2 | Phase 4 | Completed | - | United States, Maryland ... 展开 >> GSK Investigational Site Baltimore, Maryland, United States, 21225 收起 << |
NCT01596504 | Type 2 Diabetes Mellitus | Phase 2 | Completed | - | Germany ... 展开 >> Investigational Site Number 276008 Berlin, Germany, 10117 Investigational Site Number 276006 Berlin, Germany, 14050 Investigational Site Number 276004 Kiel, Germany, 24105 Investigational Site Number 276002 Mainz, Germany, 55116 Investigational Site Number 276005 Mönchengladbach, Germany, 41061 Investigational Site Number 276007 München, Germany, 80636 Investigational Site Number 276003 Neu-Ulm, Germany, 89231 Investigational Site Number 276001 Neuss, Germany, 41460 收起 << |
NCT00694122 | Type 1 Diabetes ... 展开 >> Dawn Phenomenon 收起 << | Phase 3 | Completed | - | United States, Massachusetts ... 展开 >> Massachusettes General Hospital/ Diabetes Research Center Boston, Massachusetts, United States, 02114 收起 << |
NCT01337440 | Type 2 Diabetes Mellitus ... 展开 >> Chronic Liver Disease 收起 << | Phase 4 | Unknown | March 2013 | Japan ... 展开 >> Internal medicine, Kanazawa university hospital Recruiting Kanazawa, Ishikawa, Japan, 920-8641 Contact: Toshinari Takamura, MD, PhD +81-76-265-2233 ttakamura@m-kanazawa.jp Sub-Investigator: Kosuke R Shima, MD 收起 << |
NCT02577848 | Myocardial Infarction | Not Applicable | Unknown | October 2016 | China, Beijing ... 展开 >> PLA General Hospital Recruiting Beijing, Beijing, China, 100853 Contact: Yang Shi, M.D. +8610-66876231 ggyyong@sina.com Principal Investigator: Yu Tang Wang, M.D. 收起 << |
NCT00694122 | - | Completed | - | - | |
NCT01175473 | Type 2 Diabetes Mellitus | Phase 2 | Completed | - | Germany ... 展开 >> Sanofi-Aventis Investigational Site Number 276006 Berlin, Germany, 14050 Sanofi-Aventis Investigational Site Number 276004 Kiel, Germany, 24105 Sanofi-Aventis Investigational Site Number 276002 Mainz, Germany, 55116 Sanofi-Aventis Investigational Site Number 276003 Mannheim, Germany, 68167 Sanofi-Aventis Investigational Site Number 276005 Mönchengladbach, Germany, 41061 Sanofi-Aventis Investigational Site Number 276007 München, Germany, 80636 Sanofi-Aventis Investigational Site Number 276001 Neuss, Germany, 41460 收起 << |
NCT02518932 | Insulin Resistance | Phase 1 | Unknown | March 2016 | United States, Texas ... 展开 >> ICON PLC Recruiting San Antonio, Texas, United States, 78209 Contact: Rita Flusche 210-283-4123 Rita.flusche@iconplc.com 收起 << |
NCT03703141 | Healthy | Not Applicable | Completed | - | - |
NCT02496221 | - | Completed | - | - | |
NCT01175473 | - | Completed | - | - | |
NCT02130778 | Sodium Excretion by Urination | Early Phase 1 | Completed | - | Croatia ... 展开 >> University Hospital Centre Zagreb, Croatia, 10 000 University hospital Centre Zagreb Zagreb, Croatia, 10000 收起 << |
NCT03197662 | Prader-Willi Syndrome ... 展开 >> Hyperphagia 收起 << | Phase 2 | Recruiting | August 2020 | United States, New York ... 展开 >> Montefiore Medical Center, Albert Einstein College of Medicine Recruiting Bronx, New York, United States, 10461 Contact: Danya Schlussel, BA 718-839-7501 dschluss@montefiore.org Contact: Bonnie Taylor, PhD 718-839-7530 botaylor@montefiore.org Principal Investigator: Eric Hollander, MD 收起 << |
NCT01248663 | Pancreatic Cancer ... 展开 >> Surgery Improvement of Perioperative Outcome 收起 << | Not Applicable | Completed | - | Austria ... 展开 >> Medical University of Vienna Vienna, Austria, 1090 收起 << |
NCT02723110 | - | Unknown | July 2016 | United Kingdom ... 展开 >> OCDEM, University of Oxford Recruiting Oxford, Oxfordshire, United Kingdom, OX3 7LE Contact: Fredrik Karpe 01865 857222 fredrik.karpe@ocdem.ox.ac.uk Contact: Mahesh M Umapathysivam mahesh.umapathysivam@spc.ox.ac.uk Principal Investigator: Fredrik Karpe Sub-Investigator: Mahesh Umapathysivam Sub-Investigator: Anna Gloyn Sub-Investigator: Mark McCarthy Sub-Investigator: Patrik Rorsman 收起 << | |
NCT01673646 | Acromegaly, Pituitary Gigantis... 展开 >>m 收起 << | Phase 2 | Completed | - | Japan ... 展开 >> Novartis Investigative Site Nagoya, Aichi, Japan, 466-8560 Novartis Investigative Site Toyoake-city, Aichi, Japan, 470-1192 Novartis Investigative Site Fukuoka city, Fukuoka, Japan, 812-8582 Novartis Investigative Site Kitakyushu-city, Fukuoka, Japan, 807-8556 Novartis Investigative Site Fukushima-city, Fukushima, Japan, 960-1295 Novartis Investigative Site Sapporo-city, Hokkaido, Japan, 060-8648 Novartis Investigative Site Kobe-city, Hyogo, Japan, 650-0017 Novartis Investigative Site Morioka-city, Iwate, Japan, 020-8505 Novartis Investigative Site Kagoshima-city, Kagoshima, Japan, 890-8520 Novartis Investigative Site Isehara-city, Kanagawa, Japan, 259-1193 Novartis Investigative Site Kawasaki, Kanagawa, Japan, 211-8510 Novartis Investigative Site Yokohama, Kanagawa, Japan, 222-0036 Novartis Investigative Site Kyoto-city, Kyoto, Japan, 612-8555 Novartis Investigative Site Sendai-city, Miyagi, Japan, 980-8574 Novartis Investigative Site Okayama-city, Okayama, Japan, 700-8558 Novartis Investigative Site Osaka-city, Osaka, Japan, 530-8480 Novartis Investigative Site Osaka-city, Osaka, Japan, 534-0021 Novartis Investigative Site Suita-city, Osaka, Japan, 565-0871 Novartis Investigative Site Tokorozawa-city, Saitama, Japan, 359-8513 Novartis Investigative Site Shizuoka-city, Shizuoka, Japan, 420-8527 Novartis Investigative Site Bunkyo-ku, Tokyo, Japan, 113-8603 Novartis Investigative Site Bunkyo-ku, Tokyo, Japan, 113-8655 Novartis Investigative Site Itabashi-ku, Tokyo, Japan, 173-8610 Novartis Investigative Site Minato-ku, Tokyo, Japan, 105-8470 Novartis Investigative Site Shinjuku-ku, Tokyo, Japan, 162-8666 Novartis Investigative Site Chiba, Japan, 260-8677 Novartis Investigative Site Yamagata, Japan, 990-9585 收起 << |
NCT01503112 | - | Completed | - | United Kingdom ... 展开 >> Cornwall and Isles of Scilly NHS Primary Care Trust Truro, Cornwall, United Kingdom, TR13HD North Devon NHS Trust Barnstaple, Devon, United Kingdom, EX314JB Royal Devon and Exeter NHS Foundation Trust Exeter, Devon, United Kingdom, EX25DW Plymouth Hospitals NHS Trust Plymouth, Devon, United Kingdom, PL68DH South Devon Healthcare NHS Foundation Trust Torbay, Devon, United Kingdom, TQ27AA Taunton and Somerset NHS Foundation Trust. Taunton, Somerset, United Kingdom, BA228HR Yeovil Disctrict Hospital NHS Foundation Trust Yeovil, Somerset, United Kingdom, BA21 4AT The Royal Bournmouth and Christchurch Hospitals NHS Trust Bournmouth, United Kingdom, BH7 7DW North Bristol NHS Trust Bristol, United Kingdom, BS10 5NB Ipswich Hospital NHS Trust Ipswich, United Kingdom, IP4 5PD Northampton General Hospital NHS Trust Northampton, United Kingdom, NN15BD Oxford Radcliffe Hospitals NHS Trust Oxford, United Kingdom, OX3 9DU Portsmouth Hospitals NHS Trust Portsmouth, United Kingdom, PO6 3LY Surrey and Sussex Healthcare NHS trust Redhill, United Kingdom, RH1 5RH East Sussex Healthcare NHS Trust St Leonards-on-Sea, United Kingdom, TN37 7RD University Hospitls North Staffordshire NHS Trust Stoke on Trent, United Kingdom, ST4 7LN South Warwickshire NHS Foundation Trust Warwick, United Kingdom, CV34 5BW West Hertfordshire Hospitals NHS Trust Watford, United Kingdom, WD18 0HB 收起 << | |
NCT02585427 | Healthy | Not Applicable | Completed | - | Singapore ... 展开 >> Clinical Nutrition Research Centre Singapore, Singapore, 117599 收起 << |
NCT03019510 | Type2 Diabetes | Not Applicable | Recruiting | September 2021 | United States, Missouri ... 展开 >> University of Missouri Recruiting Columbia, Missouri, United States, 65211 Contact: Becky Shafer, MS 573-882-4517 munepkanaleylab@missouri.edu Contact: Jay Porter, MS munepkanaleylab@missouri.edu 收起 << |
NCT00712673 | Diabetes Mellitus, Type 2 | Phase 3 | Completed | - | United States, New Jersey ... 展开 >> Sanofi-Aventis Administrative Office Bridgewater, New Jersey, United States, 08807 Australia sanofi-aventis Australia & New Zealand administrative office Macquarie Park, Australia Canada Sanofi-Aventis Administrative Office Laval, Canada Chile Sanofi-Aventis Administrative Office Santiago, Chile Croatia Sanofi-Aventis Administrative Office Zagreb, Croatia Czech Republic Sanofi-Aventis Administrative Office Praha, Czech Republic Germany Sanofi-Aventis Administrative Office Berlin, Germany Mexico Sanofi-Aventis Administrative Office Mexico, Mexico Morocco Sanofi-Aventis Administrative Office Casablanca, Morocco Philippines Sanofi-Aventis Administrative Office Makati City, Philippines Romania Sanofi-Aventis Administrative Office Bucuresti, Romania Russian Federation Sanofi-Aventis Administrative Office Moscow, Russian Federation South Africa Sanofi-Aventis Administrative Office Midrand, South Africa Spain Sanofi-Aventis Administrative Office Barcelona, Spain Ukraine Sanofi-Aventis Administrative Office Kiev, Ukraine Venezuela Sanofi-Aventis Administrative Office Caracas, Venezuela 收起 << |
NCT00713830 | Diabetes Mellitus, Type 2 | Phase 3 | Completed | - | United States, New Jersey ... 展开 >> Sanofi-Aventis Administrative Office Bridgewater, New Jersey, United States, 08807 Bulgaria Sanofi-Aventis Administrative Office Sofia, Bulgaria Czech Republic Sanofi-Aventis Administrative Office Praha, Czech Republic Egypt Sanofi-Aventis Administrative Office Cairo, Egypt Germany Sanofi-Aventis Administrative Office Berlin, Germany India Sanofi-Aventis Administrative Office Mumbai, India Israel Sanofi-Aventis Administrative Office Natanya, Israel Japan Sanofi-Aventis Administrative Office Tokyo, Japan Korea, Republic of Sanofi-Aventis Administrative Office Seoul, Korea, Republic of Netherlands Sanofi-Aventis Administrative Office Gouda, Netherlands Romania Sanofi-Aventis Administrative Office Bucuresti, Romania Russian Federation Sanofi-Aventis Administrative Office Moscow, Russian Federation Taiwan Sanofi-Aventis Administrative Office Taipei, Taiwan Thailand Sanofi-Aventis Administrative Office Bangkok, Thailand Tunisia Sanofi-Aventis Administrative Office Megrine, Tunisia Turkey Sanofi-Aventis Administrative Office Istanbul, Turkey 收起 << |
NCT02683187 | Healthy | Phase 1 | Completed | - | United States, North Carolina ... 展开 >> Leslie Willis Durham, North Carolina, United States, 27707 收起 << |
NCT02634164 | Hyperglycemia | Not Applicable | Completed | - | - |
NCT01891955 | Type 2 Diabetes | Not Applicable | Completed | - | Spain ... 展开 >> Hospital Insular de Lanzarote Arrecife, Las Palmas, Spain, 35500 收起 << |
NCT02496611 | Severe Obesity | Phase 2 | Recruiting | January 2025 | United States, Minnesota ... 展开 >> University of Minnesota Recruiting Minneapolis, Minnesota, United States, 55455 Contact: Ann E Sheldon, B.S. 612-626-3813 shel0230@umn.edu Principal Investigator: Aaron S Kelly, Ph.D. 收起 << |
NCT03739268 | Type 2 Diabetes Mellitus | Not Applicable | Recruiting | September 1, 2020 | Denmark ... 展开 >> Steno Diabetes Center Copenhagen, Gentofte Hospital Recruiting Hellerup, Denmark, 2900 Contact: Henriette H Nerild, M.D. +45 3867 4264 henriette.holst.nerild@regionh.dk 收起 << |
NCT02053025 | Appetite Ener... 展开 >>gy Intake 收起 << | Not Applicable | Completed | - | United Kingdom ... 展开 >> Imperial College NIHR CRF London, United Kingdom, W12 0NN 收起 << |
NCT00713830 | - | Completed | - | - | |
NCT02120677 | Basal Cell Carcinoma | Early Phase 1 | Recruiting | December 2018 | United States, Maryland ... 展开 >> Johns Hopkins School of Medicine, Department of Dermatology Recruiting Baltimore, Maryland, United States, 21287 Contact: Nikki Tang, MD 410-502-7546 ctrep@jhmi.edu Contact: Bao Chau Ly, MS 410-502-7547 Baochau.Ly@jhmi.edu 收起 << |
NCT00976937 | - | Completed | - | - | |
NCT02640118 | Diabetes After Total Pancreate... 展开 >>ctomy 收起 << | Not Applicable | Completed | - | - |
NCT01414556 | Type 2 Diabetes Mellitus | Early Phase 1 | Completed | - | Denmark ... 展开 >> Gentofte Hospital Hellerup, Denmark, 2900 收起 << |
NCT00976937 | Type 2 Diabetes Mellitus | Phase 3 | Completed | - | - |
NCT00712673 | - | Completed | - | - | |
NCT02284009 | Diabetes Mellitus, Type 1 | Phase 2 | Completed | - | France ... 展开 >> GSK Investigational Site Amiens Cedex 1, France, 80054 GSK Investigational Site Bois-Guillaume, France, 76230 GSK Investigational Site Caen Cedex 9, France, 14033 GSK Investigational Site Lille Cedex, France, 59037 GSK Investigational Site Strasbourg cedex, France, 67091 Germany GSK Investigational Site Muenchen, Bayern, Germany, 80804 GSK Investigational Site Frankfurt, Hessen, Germany, 60590 GSK Investigational Site Duesseldorf, Nordrhein-Westfalen, Germany, 40225 GSK Investigational Site Dresden, Sachsen, Germany, 01307 Italy GSK Investigational Site Latina, Lazio, Italy, 04100 GSK Investigational Site Milano, Lombardia, Italy, 20132 GSK Investigational Site Roma, Italy, 00128 Spain GSK Investigational Site Alzira/Valencia, Spain, 46600 GSK Investigational Site Badalona, Spain, 08916 GSK Investigational Site Barcelona, Spain, 08036 GSK Investigational Site Granada, Spain, 18012 GSK Investigational Site Hospitalet de Llobregat, Spain, 08907 GSK Investigational Site Lleida, Spain, 25198 GSK Investigational Site Madrid, Spain, 28006 GSK Investigational Site Málaga, Spain, 29010 GSK Investigational Site Pama de Mallorca, Spain, 07010 GSK Investigational Site San Juan (Alicante), Spain, 03550 GSK Investigational Site Sevilla, Spain, 41014 United Kingdom GSK Investigational Site Ayr, United Kingdom, KA6 6DX GSK Investigational Site Birmingham, United Kingdom, B9 5SS GSK Investigational Site Bristol, United Kingdom, BS2 8HW GSK Investigational Site Cardiff, United Kingdom, CF14 4XN GSK Investigational Site Darlington, United Kingdom, DL3 6HX GSK Investigational Site Dundee, United Kingdom, DD1 9SY GSK Investigational Site Durham, United Kingdom, DH1 5TW GSK Investigational Site Glasgow, United Kingdom, G31 2ER GSK Investigational Site Liverpool, United Kingdom, L7 8XP GSK Investigational Site London, United Kingdom, E1 2AT GSK Investigational Site Newcastle upon Tyne, United Kingdom, NE1 4LP GSK Investigational Site Sheffield, United Kingdom, S5 7AU 收起 << |
NCT03573258 | Bariatric Surgery Candidate | Early Phase 1 | Recruiting | December 2022 | Switzerland ... 展开 >> University Hospital Zurich Recruiting Zürich, Zurich, Switzerland, 8091 Contact: Marco Bueter, MD, PhD +41 44 255 8895 marco.bueter@usz.ch 收起 << |
NCT01761318 | Diabetes Mellitus Type 2 ... 展开 >> Metabolic Syndrome Cardiovascular Disease Diastolic Dysfunction Fatty Liver 收起 << | Phase 4 | Completed | - | Netherlands ... 展开 >> Leiden University Medical Center Leiden, Netherlands, 2333 ZA 收起 << |
NCT01548729 | Cystic Fibrosis ... 展开 >> Diabetes Related Cystic Fibrosis 收起 << | Phase 1 Phase 2 | Unknown | March 2018 | France ... 展开 >> GAYET Jean-Brice Recruiting Service d'imagerie - Hôpital Foch, Suresnes, France, 92150 GRENET Dominique Recruiting Service de Pneumologie - Hôpital Foch, Suresnes, France, 92151 CRCM AdulteCHU de Grenoble, Hôpital A. Michallon Recruiting Grenoble, France, 38 043 Contact: Sébastien QUETANT, MD 04 76 76 75 93 squetant@chu-grenoble.fr Nephrologie, CHU Grenoble Recruiting Grenoble, France, 38043 Contact: François Bayle, MD 04 76 76 54 60 FBayle@chu-grenoble.fr Réanimation Cardiovasculaire et Thoracique, Hôpital Michallon Recruiting Grenoble, France, 38043 Contact: Michel Durand, MD 04 76 76 55 10 MDurand@chu-grenoble.fr Service d'Endocrinologie, CHU de Grenoble Recruiting Grenoble, France, 38043 Contact: Pierre.Yves Benhamou, MD, PhD 04 76 76 88 56 PYBenhamou@chu-grenoble.fr Service de Chirurgie Cardiaque, CHU Grenoble Recruiting Grenoble, France, 38043 Contact: Olivier Chavanon, MD, PhD 04 76 76 54 62 ochavanon@chu-grenoble.fr Service de Radiologie Interventionnelle, CHU de Grenoble Recruiting Grenoble, France, 38043 Contact: Frédéric Thony, MD 04 76 76 89 09 fthony@chu-grenoble.fr Contact: Christophe Sengel, MD 04 76 76 89 09 csengel@chu-grenoble.fr Service de Pneumologie, Hôpital A. MICHALLON , CHU de Grenoble Recruiting Grenoble, France, 38700 Contact: Christophe Pison, MD, PhD 04 76 76 58 98 CPison@chu-grenoble.fr Contact: Sébastien QUETANT, MD 04 76 76 75 93 squetant@chu-grenoble.fr Service d'Urologie et chirurgie de la Transplantation, Groupement Hospitalier Edouard Herriot Not yet recruiting Lyon, France, 69 437 Contact: Lionel Badet, MD, PhD 04 72 11 05 87 lionel.badet@chu-lyon.fr Service de médecine de la transplantation et immunologie clinique, Hôpital Edouard Herriot Not yet recruiting Lyon, France, 69437 Contact: Emmanuel Morelon, MD, PhD 04 72 11 01 51 emmanuel.morelon@chu-lyon.fr CRCM adulte, Centre Hospitalier Lyon-Sud Not yet recruiting Lyon, France, 69495 Contact: Isabelle Durieu, MD, PhD 04 78 86 13 52 isabelle.durieu@chu-lyon.fr Service d'Endocrinologie, Pavillon médical Not yet recruiting Lyon, France, 69495 Contact: Charles Thivolet, MD, PhD 04 78 86 14 87 charles.thivolet@chu-lyon.fr Service d'imagerie radiologique et de médecine nucléaire, Centre Hospitalier Lyon-Sud Not yet recruiting Lyon, France, 69495 Contact: Pierre-Jean Valette, MD, PhD 04 78 86 21 37 pierre-jean.valette@chu-lyon.fr Contact: Capucine Mucol, MD 04 72 11 75 43 capucine.micol@chu-lyon.fr Service de Chirurgie Thoracique, HOPITAL LOUIS PRADEL Not yet recruiting Lyon, France, 69677 Contact: François TRONC, MD, PhD 04 72 35 74 64 francois.tronc@chu-lyon.fr Service de Chirurgie Thoracique, HOPITAL LOUIS PRADEL Not yet recruiting Lyon, France, 69677 Contact: Olivier BASTIEN, MD, PhD 04 72 11 89 44 olivier.bastien@chu-lyon.fr Service de pneumologie, Hôpital Louis Pradel Not yet recruiting Lyon, France, 69677 Contact: François Philit, MD, PhD 04 72 35 58 36 francois.philit@chu-lyon.fr Service d'endocrinologie, diabète et maladies métaboliques Recruiting Strasbourg, France, 67 091 Contact: Laurence Kessler, MD, PhD 03 88 11 62 67 laurence.kessler@chru-strasbourg.fr Principal Investigator: Laurence Kessler, MD, PhD Service d'Anesthésie-Réanimations chirurgicales, Nouvel Hôpital Civil Recruiting Strasbourg, France, 67091 Contact: Philippe Wolf, Md, PhD 03 88 12 72 78 philippe.wolf@chru-strasbourg.fr Service d'Anesthésie-Réanimations Chirurgicales Recruiting Strasbourg, France, 67091 Contact: Annick Steib, MD, PhD 03.69.55.04.45 annick.steib@chru-strasbourg.fr Service de chirurgie, Nouvel Hôpital Civil Recruiting Strasbourg, France, 67091 Contact: Gilbert Massard, MD, PhD 03 69 55 07 98 Gilbert.Massard@chru-strasbourg.fr Service de pneumologie, Nouvel Hôpital Civil Recruiting Strasbourg, France, 67091 Contact: Romain Kessler, MD, PhD 03 69 55 06 46 romain.kessler@chru-strasbourg.fr Service de Radiologie, Hôpital de Hautepierre Recruiting Strasbourg, France, 67098 Contact: Michel Greget, MD, PhD 03 88 12 78 72 michel.greget@chru-strasbourg.fr 收起 << |
NCT02589028 | Diabetes Mellitus | Not Applicable | Completed | - | Korea, Republic of ... 展开 >> Seoul National University Hospital Seoul, Korea, Republic of, 110-744 收起 << |
NCT01997281 | Diabetes Mellitus | Not Applicable | Unknown | July 2014 | Korea, Republic of ... 展开 >> Seoul National University Hospital Seoul, Korea, Republic of, 110-744 收起 << |
NCT02683746 | Diabetes Mellitus, Type 2 | Phase 3 | Completed | - | - |
NCT01449747 | Type 2 Diabetes Mellitus | Phase 4 | Completed | - | Korea, Republic of ... 展开 >> The Catholic University of Korea; St.Paul's Hospital Seoul, Korea, Republic of, 130-709 The Catholic University of Korea; Seoul St. Mary's Hospital Seoul, Korea, Republic of, 137-701 收起 << |
NCT01449747 | - | Completed | - | - | |
NCT01833988 | Type 1 Diabetes | Not Applicable | Completed | - | United States, Massachusetts ... 展开 >> Massachusetts General Hospital Boston, Massachusetts, United States, 02114 收起 << |
NCT01833988 | - | Completed | - | - | |
NCT01473147 | Type 2 Diabetes Mellitus | Not Applicable | Completed | - | Taiwan ... 展开 >> Chang Gung Memorial Hospital Taoyuan, Taiwan, 333 收起 << |
NCT02683746 | - | Completed | - | - | |
NCT02315495 | Type 2 Diabetes | Phase 3 | Completed | - | China, Jiangsu ... 展开 >> Department of Endocrinology, Zhongda Hospital. Institute of Diabetes, Southeast University Nanjing, Jiangsu, China 收起 << |
NCT02082496 | Obesity | Phase 2 | Active, not recruiting | April 2019 | Denmark ... 展开 >> Department of Biomedical Sciences Copenhagen, Denmark, 2200 收起 << |
NCT03157063 | - | Recruiting | May 15, 2019 | United States, Missouri ... 展开 >> Children's Mercy Kansas City Recruiting Kansas City, Missouri, United States, 64108 Contact: Amy Papa 816-234-9230 aepapa@cmh.edu Contact energybalance@cmh.edu 收起 << | |
NCT01298830 | Intracerebral Hemorrhage (ICH) | Phase 1 Phase 2 | Terminated(Need for improvemen... 展开 >>t of study medication. Safety data collected sufficient. No further gain in knowledge expected.) 收起 << | - | Germany ... 展开 >> Neurochirurgische Klinik und Neurologische Klinik des Universitätsklinikums Heidelberg Heidelberg, Baden-Württemberg, Germany, 69120 Neurochirurgische Klinik der Universität Erlangen-Nürnberg Erlangen, Bavaria, Germany, 91054 Klinik für Neurochirurgie Klinikum Bogenhausen Akademisches Lehrkrankenhaus der Technischen Universität München München, Bavaria, Germany, 81925 Klinikum Region Hannover Krankenhaus Nordstadt, Klinik für Neurologie Hannover, Lower Saxony, Germany, 30167 International Neuroscience Institute Hannover, Lower Saxony, Germany, 30625 Klinik für Neurochirurgie Medizinische Hochschule Hannover Hannover, Lower Saxony, Germany, 30625 收起 << |
NCT03005951 | Insulin Resistance | Not Applicable | Recruiting | March 2019 | United States, New York ... 展开 >> Montefiore Medical Center of Albert Einstein College of Medicine Recruiting Bronx, New York, United States, 10467 Contact: Rubina Heptulla, MD 718-920-4664 rheptull@montefiore.org Sub-Investigator: Sophie Molholm, Ph.D Principal Investigator: Rubina Heptulla, MD Sub-Investigator: John Foxe, MD 收起 << |
NCT01739283 | Hypoglycemia | Not Applicable | Completed | - | Denmark ... 展开 >> Gentofte Hospital Hellerup, Denmark, 2900 收起 << |
NCT01666223 | Type 2 Diabetes ... 展开 >> Obesity 收起 << | Not Applicable | Completed | - | Denmark ... 展开 >> Diabetes Research Division, Department of Internal Medicine, Gentofte Hospital, University of Copenhagen Hellerup, Copenhagen, Denmark 收起 << |
NCT01073826 | Diabetes Mellitus, Type 2 ... 展开 >> Obesity 收起 << | Not Applicable | Completed | - | Switzerland ... 展开 >> University Hospital Zurich Zurich, Switzerland 收起 << |
NCT03755323 | - | Recruiting | December 31, 2022 | France ... 展开 >> Uhmontpellier Recruiting Montpellier, France, 34295 Contact: Ariane SULTAN, PR 467338402 ext 33 a-sultan@chu-montpellier.fr 收起 << | |
NCT01194479 | Type 1 Diabetes | Not Applicable | Completed | - | United States, Connecticut ... 展开 >> Yale University School of Medicine New Haven, Connecticut, United States, 06520 收起 << |
NCT03015519 | Diabetes Mellitus, Type 2 | Phase 3 | Withdrawn(The study was stoppe... 展开 >>d as the asset will be withdrawn from the market prior to study end.) 收起 << | April 20, 2020 | United States, Illinois ... 展开 >> GSK Investigational Site Chicago, Illinois, United States, 60634 United States, North Carolina GSK Investigational Site Morehead City, North Carolina, United States, 28557 United States, Texas GSK Investigational Site El Paso, Texas, United States, 79935 收起 << |
NCT01584232 | Type 2 Diabetes Mellitus | Phase 3 | Completed | - | Japan ... 展开 >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Aichi, Japan, 448-0852 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Chiba, Japan, 286-0048 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Ehime, Japan, 790-0024 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Fukuoka, Japan, 819-0168 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Hokkaido, Japan, 0530018 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Kagoshima, Japan, 8910401 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Kanagawa, Japan, 247-0055 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Kumamoto, Japan, 860-0811 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Kyoto, Japan, 606-8397 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Nagano, Japan, 385-0022 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Nagasaki, Japan, 857-1195 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Ooita, Japan, 8700039 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Osaka, Japan, 598-0048 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Tokyo, Japan, 103-0028 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Yamaguchi, Japan, 754-0002 收起 << |
NCT01584232 | - | Completed | - | - | |
NCT01157780 | Parenteral Nutrition Associate... 展开 >>d Liver Disease 收起 << | Not Applicable | Unknown | December 2014 | United States, Tennessee ... 展开 >> Le Bonheur Children's Medical Center Recruiting Memphis, Tennessee, United States, 38103 Contact: Emma M Tillman, PharmD 901-287-5349 etillman@uthsc.edu Principal Investigator: Emma M Tillman, PharmD Sub-Investigator: Catherine M Crill, PharmD Sub-Investigator: Dennis D Black, MD Sub-Investigator: Richard A Helms, PharmD 收起 << |
NCT02660736 | Diabetes Mellitus, Type 2 | Phase 1 | Completed | - | United States, Texas ... 展开 >> GSK Investigational Site Austin, Texas, United States, 78744 收起 << |
NCT01194479 | - | Completed | - | - | |
NCT02598791 | Obesity Adipo... 展开 >>sity Type 2 Diabetes 收起 << | Not Applicable | Completed | - | Denmark ... 展开 >> Center for Diabetesresearch, Gentofte hospital Hellerup, Denmark, 2900 收起 << |
NCT01930097 | Type 1 Diabetes | Phase 2 | Completed | - | Canada, Quebec ... 展开 >> Institut de recherches cliniques de Montréal Montreal, Quebec, Canada, H2W1R7 收起 << |
NCT00001229 | - | Completed | - | United States, Maryland ... 展开 >> National Heart, Lung and Blood Institute (NHLBI) Bethesda, Maryland, United States, 20892 收起 << | |
NCT00830076 | - | Completed | - | - | |
NCT02003274 | Type 1 Diabetes Mellitus | Not Applicable | Active, not recruiting | October 31, 2017 | Italy ... 展开 >> Clinical Research Center-University Hospital of Verona c/o Policlinico G.B. Rossi - Piazzale L.A. Scuro, 10, Verona, Italy, 37134 Division of Endocrinology and Metabolic Diseases - University Hospital of Verona Piazzale Stefani 1-Pad. 22, Verona, Italy, 37126 收起 << |
NCT00830076 | Type 2 Diabetes Mellitus | Phase 1 | Completed | - | - |
NCT00468091 | Digestive Physiology ... 展开 >> Gastrointestinal Motility Gastrointestinal Hormones Glucagon-like Peptide 1 Exendin (9-39) 收起 << | Phase 1 | Completed | - | Germany ... 展开 >> Clinical Research unit, Dept. of Internal Medicine II - Großhadern, University of Munich Munich, Germany, 81377 收起 << |
NCT02962492 | Evaluate Ketogenic Stress | Phase 4 | Unknown | October 2018 | United States, New York ... 展开 >> ECMC Ambulatory Center, 3rd Floor Buffalo, New York, United States, 14215 收起 << |
NCT02180334 | Diabetes Mellitus, Type 2 | Phase 4 | Completed | - | Korea, Republic of ... 展开 >> Seoul National University Hospital Seoul, Korea, Republic of, 110-744 收起 << |
NCT02987348 | - | Completed | - | United Kingdom ... 展开 >> Pharmatelligence Cardiff, United Kingdom, CF14 3QZ 收起 << | |
NCT02497651 | Diabetes Mellitus | Not Applicable | Completed | - | Denmark ... 展开 >> Center for Diabetes Research, Department of Medicine, Gentofte Hospital Hellerup, Copenhagen, Denmark, 2900 收起 << |
NCT02075567 | Blood Glucose Decrease During ... 展开 >>and After Defined Individual Exercise in T1DM 收起 << | Not Applicable | Completed | - | - |
NCT03361098 | Type 2 Diabetes Mellitus ... 展开 >> Obesity 收起 << | Phase 4 | Recruiting | January 31, 2020 | Netherlands ... 展开 >> VU Medical Center Recruiting Amsterdam, Noord-Holland, Netherlands, 1081 HV Contact: Charlotte C van Ruiten, MD +31204443287 c.ruiten@vumc.nl 收起 << |
NCT00795275 | Obesity | Not Applicable | Completed | - | United States, Colorado ... 展开 >> University of Colorado Denver Aurora, Colorado, United States, 80045 收起 << |
NCT00475371 | Diabetes Mellitus, Type 2 ... 展开 >> Healthy Males 收起 << | Phase 1 | Completed | - | Netherlands ... 展开 >> University Medical Centre Groningen Zuidlaren, Netherlands, 9470 AE 收起 << |
NCT02759926 | Healthy Obesi... 展开 >>ty 收起 << | Not Applicable | Unknown | - | - |
NCT02089256 | Healthy | Phase 4 | Completed | - | Estonia ... 展开 >> Tartu University Hospital Tartu, Estonia 收起 << |
NCT01664676 | Type 2 Diabetes Mellitus | Phase 4 | Completed | - | Denmark ... 展开 >> Aarhus University Hospital, Department of Endocrinology and Diabetes Aarhus, Denmark, 8000 收起 << |
NCT02026024 | - | Completed | - | Taiwan ... 展开 >> Chang Gung Memorial Hospital Taoyuan, Taiwan, 333 收起 << | |
NCT03715010 | Pre-diabetes ... 展开 >>Obese Glucose Intolerance 收起 << | Not Applicable | Completed | - | United States, California ... 展开 >> UCLA Center for Human Nutriiton Los Angeles, California, United States, 90095 收起 << |
NCT03565666 | Type1diabetes | Phase 2 Phase 3 | Completed | - | United States, California ... 展开 >> Stanford University Palo Alto, California, United States, 94305 United States, Colorado Barbara Davis Center for Childhood Diabetes Aurora, Colorado, United States, 80045 United States, Florida Nemours Children's Specialty Care Jacksonville, Florida, United States, 32207 收起 << |
NCT01762657 | Type 1 Diabetes | Phase 3 | Withdrawn(Study stopped prior ... 展开 >>to Patient Enrollment) 收起 << | September 2015 | - |
NCT01856790 | Type 1 Diabetes | Early Phase 1 | Completed | - | United States, Connecticut ... 展开 >> Yale University School of Medicine New Haven, Connecticut, United States, 06520 收起 << |
NCT02276677 | Overweight and Obesity | Early Phase 1 | Completed | - | United States, Massachusetts ... 展开 >> Massachusetts General Hospital Boston, Massachusetts, United States, 02114 收起 << |
NCT02048501 | Obesity Weigh... 展开 >>t Loss 收起 << | Not Applicable | Completed | - | United States, North Carolina ... 展开 >> Duke Center for Metabolic and Weight Loss Surgery Durham, North Carolina, United States, 27704 收起 << |
NCT00423501 | Diabetes Mellitus Type 2 | Phase 2 | Completed | - | - |
NCT02624817 | Permanent Neonatal Diabetes Me... 展开 >>llitus 收起 << | Phase 4 | Completed | - | Norway ... 展开 >> Haukeland University Hospital Bergen, Norway, 5021 收起 << |
NCT01524705 | Type 2 Diabetes | Phase 4 | Completed | - | United States, California ... 展开 >> So Calif. Permanente Medical Group San Diego, California, United States, 92109 United States, Florida University of Miami Miami, Florida, United States, 33136 United States, Georgia Atlanta Diabetes Associates Atlanta, Georgia, United States, 30309 United States, Massachusetts Joslin Diabetes Center Boston, Massachusetts, United States, 02215 United States, Minnesota International Diabetes Center Minneapolis, Minnesota, United States, 55416 United States, Missouri Washington University St. Louis, Missouri, United States, 63110 United States, New York Kaledia Health of Western New York Buffalo, New York, United States, 14209 United States, North Carolina Diabetes Care Center Durham, North Carolina, United States, 27713 United States, Oregon Oregon Health and Science University Portland, Oregon, United States, 97239 United States, Vermont University of Vermont Colchester, Vermont, United States, 05446 United States, Washington University of Washington Seattle, Washington, United States, 98105 Washington State University Spokane, College of Pharmacy Spokane WA 99202 USA Spokane, Washington, United States, 99202 收起 << |
NCT02624830 | Permanent Neonatal Diabetes Me... 展开 >>llitus 收起 << | Phase 4 | Unknown | February 2016 | Norway ... 展开 >> Haukeland University Hospital Bergen, Norway, 5021 收起 << |
NCT01179945 | Overweight | Not Applicable | Completed | - | United States, Massachusetts ... 展开 >> Massachusetts General Hospital Boston, Massachusetts, United States, 02101 Children's Hospital Boston, Massachusetts, United States, 02115 收起 << |
NCT00566189 | Diabetes Mellitus, Type 2 ... 展开 >> Insulin Resistance Obesity 收起 << | Phase 2 Phase 3 | Completed | - | Brazil ... 展开 >> LIMED (Laboratory of Investigation of Metabolism and Diabetes)/GASTROCENTRO/Univeristy of Campinas (UNICAMP) Campinas, SP, Brazil 收起 << |
NCT00497133 | - | Completed | - | Denmark ... 展开 >> Gentofte Hostital, Dep. og Internal Medicin F Gentofte, Hellerup, Denmark, DK-2900 收起 << | |
NCT00716092 | Diabetes Mellitus, Type 2 | Phase 2 | Completed | - | Germany ... 展开 >> 1218.37.49003 Boehringer Ingelheim Investigational Site Berlin, Germany 1218.37.49002 Boehringer Ingelheim Investigational Site Mainz, Germany 1218.37.49001 Boehringer Ingelheim Investigational Site Neuss, Germany 收起 << |
NCT01858909 | Severe Sepsis ... 展开 >> Septic Shock 收起 << | Phase 3 | Unknown | December 2013 | Spain ... 展开 >> Hospital Clínico Universitario Lozano Blesa Zaragoza, Spain, 50009 收起 << |
NCT00716092 | - | Completed | - | - | |
NCT02075281 | Obesity | Phase 2 | Completed | - | United States, California ... 展开 >> Hanmi pharmaceutical Los angeles, California, United States 收起 << |
NCT01096277 | Type 2 Diabetes Mellitus | Phase 4 | Unknown | December 2012 | Germany ... 展开 >> Hannover Medical School Not yet recruiting Hannover, Germany, 30625 Contact: Sajoscha A. Sorrentino, MD sorrentino.sajoscha@mh-hannover.de Principal Investigator: Sajoscha A. Sorrentino, MD 收起 << |
NCT02715193 | Type 1 Diabetes Mellitus ... 展开 >> Diabetes 收起 << | Phase 1 | Completed | - | United States, California ... 展开 >> San Diego, California, United States United States, Missouri St. Louis, Missouri, United States 收起 << |
NCT03650712 | Cystic Fibrosis-related Diabet... 展开 >>es 收起 << | Not Applicable | Not yet recruiting | August 31, 2021 | United States, Colorado ... 展开 >> University of Colorado Not yet recruiting Aurora, Colorado, United States, 80045 Contact: Christine L Chan, MD United States, Iowa University of Iowa Not yet recruiting Iowa City, Iowa, United States, 52242 Contact: Julie Coffey, ARNP United States, Minnesota University of Minnesota Not yet recruiting Minneapolis, Minnesota, United States, 55455 Contact: Amir Moheet, MD United States, Missouri Washington University St. Louis Not yet recruiting Saint Louis, Missouri, United States, 63110 Contact: Andrea Granados, MD 收起 << |
NCT01843881 | Type 2 Diabetes Mellitus | Early Phase 1 | Completed | - | United States, Minnesota ... 展开 >> Mayo Clinic Rochester, Minnesota, United States, 55905 收起 << |
NCT01843855 | Type 2 Diabetes Mellitus | Early Phase 1 | Completed | - | United States, Minnesota ... 展开 >> Mayo Clinic Rochester, Minnesota, United States, 55905-0001 收起 << |
NCT02889510 | Type 2 Diabetes | Phase 3 | Unknown | September 2018 | Spain ... 展开 >> Hospital Universitari Germans Trias i Pujol Not yet recruiting Badalona, Barcelona, Spain, 08916 Contact: Manuel Puig-Domingo +34 934978653 mpuig.germanstrias@gencat.cat Contact: Silvia Pellitero +34 625391561 spellitero.germanstrias@gencat.cat Sub-Investigator: Silvia Pellitero Clínica Universidad de Navarra Not yet recruiting Pamplona, Navarra, Spain, 31008 Contact: Javier Salvador +34 660597980 jsalvador@unav.es Hospital Universitari Vall d´Hebrón Not yet recruiting Barcelona, Spain, 08035 Contact: Rafael Simó rafael.simo@vhir.org Contact: Lorena Ramos +34 934894198 lorena.ramos@vhir.org Sub-Investigator: Andrea Ciudín Hospital Universitari Arnau de Vilanova de Lleida Recruiting Lleida, Spain, 25198 Contact: Albert Lecube, PhD +34 973705183 alecube@gmail.com Contact: Raquel Martí rmarti@irblleida.cat Sub-Investigator: Carolina López Sub-Investigator: Cecilia Turino Sub-Investigator: Asunción Seminario Hospital Universitario Virgen de la Victoria Not yet recruiting Málaga, Spain, 29010 Contact: Francisco Tinahones +34 951034016 fjtinahones@hotmail.com Contact: Inmaculada Picón +34 638430738 ipiconcesar@gmail.com Sub-Investigator: Baldomera Martínez Sub-Investigator: Paloma Romero Hospital Universitario Virgen del Rocío Not yet recruiting Sevilla, Spain, 41013 Contact: Pedro Pablo García +34 607686901 garcialunapp@yahoo.es Sub-Investigator: Francisco Ortega Sub-Investigator: Antonio Jesús Martínez 收起 << |
NCT02891525 | Healthy | Not Applicable | Completed | - | - |
NCT03414151 | - | Recruiting | July 2019 | Canada, Ontario ... 展开 >> Centre For Addiction and Mental Health Recruiting Toronto, Ontario, Canada, M5T1R8 Contact: Nicole MacKenzie, M.Ed 416-535-8501 ext 34719 nicole.mackenzie@camh.ca Principal Investigator: Margaret Hahn, MD, PhD 收起 << | |
NCT02589613 | Exploratory Behavior | Not Applicable | Completed | - | - |
NCT02446834 | Polycystic Ovary Syndrome | Not Applicable | Unknown | August 2017 | China, Shanghai ... 展开 >> Renji Hospital Department of Endocrinology and Metabolism Recruiting Shanghai, Shanghai, China, 200127 Contact: Wei Liu, MD +86-18918358342 sue_liuwei@163.com Contact: Jing Ma, MD +86-15800983436 cherry1996@live.cn 收起 << |
NCT01994135 | Hyperglycaemia | Not Applicable | Completed | - | United Kingdom ... 展开 >> School of Food Science and Nutrition Leeds, West Yorkshire, United Kingdom, LS2 9JT 收起 << |
NCT02187250 | PCOS Obesity | Phase 4 | Completed | - | Slovenia ... 展开 >> University Medical Center Ljubljana Ljubljana, Slovenia, 1000 收起 << |
NCT01162772 | - | Unknown | - | Austria ... 展开 >> Medical University of Viemma Recruiting Vienna, Austria, 1090 Contact: Jeanette Strametz-Juranek, MD 0043140400 ext 4618 jeanette.strametz-juranek@meduniwien.ac.at Contact: Alexandra Kautzky-Willer, MD 0140400 ext 4316 alexandra.kautzky-willer@meduniwien.ac.at Principal Investigator: Jeanette Strametz-Juranek, MD Principal Investigator: Alexandra Kautzky-Willer, MD Sub-Investigator: Alia Sabri, MD Sub-Investigator: Lana Kosi, MD 收起 << | |
NCT02770885 | Primary Polydipsia | Phase 2 | Recruiting | November 2019 | Switzerland ... 展开 >> University Hospital Basel Recruiting Basel, Switzerland Contact: Winzeler F Bettina 061 556 50 75 ext 0041 bettina.winzeler@usb.ch Contact: Julie Refardt 061 328 76 08 julie.refardt@usb.ch 收起 << |
NCT02981069 | Diabetes Mellitus, Type 2 | Phase 4 | Recruiting | January 31, 2020 | United States, Texas ... 展开 >> University of Texas Health Science Center Recruiting San Antonio, Texas, United States, 78229 Contact: Eugenio Cersosimo, MD 210-358-7200 cersosimo@uthscsa.edu Contact: Ralph A DeFronzo, MD 210-567-6691 defronzo@uthscsa.edu Principal Investigator: Eugenio Cersosimo, MD, PhD 收起 << |
NCT01580514 | Myocardial Infarction | Phase 4 | Completed | - | Korea, Republic of ... 展开 >> Kyung Hee University Hospital Seoul, Korea, Republic of, 130-872 收起 << |
NCT02902224 | Exploratory Behavior | Not Applicable | Completed | - | Switzerland ... 展开 >> University Hospital Basel Basel, Switzerland 收起 << |
NCT03573934 | Healthy | Not Applicable | Completed | - | Denmark ... 展开 >> Hvidovre University Hospital Hvidovre, Denmark, 2650 收起 << |
NCT01965509 | Type 2 Diabetes | Phase 2 | Completed | - | China ... 展开 >> China-Japan Friendship Hospital Beijing, China 收起 << |
NCT01965496 | Type 2 Diabetes | Phase 1 | Completed | - | China ... 展开 >> People's Liberation Army General Hospital of Chengdu Military Region Chengdu, China 收起 << |
NCT00678145 | Diabetes Mellitus ... 展开 >> Hypoglycemia Autonomic Failure 收起 << | Phase 2 | Recruiting | August 2022 | United States, New York ... 展开 >> Albert Einstein College of Medicine / General Clinical Research Center Recruiting Bronx, New York, United States, 10461 收起 << |
NCT01906359 | Type 2 Diabetes Mellitus | Not Applicable | Completed | - | Malaysia ... 展开 >> Malaysian Palm Oil Board (MPOB) Kajang, Selangor, Malaysia, 43000 Hulu Langat District Health Office Kajang, Selangor, Malaysia, 43100 Sepang District Health Office Sepang, Selangor, Malaysia, 43900 Universiti Putra Malaysia Serdang, Selangor, Malaysia, 43400 Selangor State Health Office Shah Alam, Selangor, Malaysia, 40100 收起 << |
NCT02360878 | - | Completed | - | Denmark ... 展开 >> Center for Diabetes Research, Gentofte Hospital, University of Copenhagen Hellerup, Denmark, 2900 收起 << | |
NCT02560376 | Insulinoma Ne... 展开 >>sidioblastosis 收起 << | Early Phase 1 | Unknown | December 2016 | China, Beijing ... 展开 >> Peking Union Medical College Hospital Recruiting Beijing, Beijing, China, 100730 Contact: Fang Li, MD +86 10 69155502 lifang@pumch.cn Contact: Yaping Luo, MD +86 10 69157033 luoyaping@live.com Principal Investigator: Fang Li, MD Principal Investigator: Shawn Chen, PHD 收起 << |
NCT01281228 | Diabetes Mellitus ... 展开 >> Diabetes Mellitus, Type 2 Obesity 收起 << | Not Applicable | Completed | - | Netherlands ... 展开 >> VU University Medical Center Amsterdam, De Boelelaan 1117, Netherlands, 1007MB 收起 << |
NCT00566215 | Diabetes Mellitus, Type 2 ... 展开 >> Insulin Resistance Obesity 收起 << | Phase 1 Phase 2 | Terminated(Benefit of duodenal... 展开 >> exclusion alone less than expected for treatment of type 2 diabetes; an additional effect of combination with omentectomy not observed) 收起 << | - | Brazil ... 展开 >> LIMED (Laboratory of Investigation of Metabolism and Diabetes)/GASTROCENTRO/Univeristy of Campinas (UNICAMP) Campinas, SP, Brazil 收起 << |
NCT02913703 | Type 2 Diabetes | Phase 1 | Active, not recruiting | December 2019 | United States, North Carolina ... 展开 >> Duke Center For Living Durham, North Carolina, United States, 27705 收起 << |
NCT03167411 | Type2 Diabetes Mellitus | Phase 1 | Completed | - | United States, Indiana ... 展开 >> Clinical Research Site Evansville, Indiana, United States, 47710 收起 << |
NCT01729299 | Diabetes | Not Applicable | Unknown | April 2014 | United States, Ohio ... 展开 >> University of Cincinnati Recruiting Cincinnati, Ohio, United States, 45267 Contact: Jenny Tong, MD, MPH 513-558-4446 jenny.tong@uc.edu Contact: Ahrar Haque, MD 513-558-3923 haqueau@uc.edu Principal Investigator: Jenny Tong, MD, MPH Cincinnati Children's Hospital and Medical Center Recruiting Cincinnati, Ohio, United States Contact: Ahrar Haque, MD 513-558-3923 收起 << |
NCT03359590 | Pharmacological Action | Phase 2 | Enrolling by invitation | July 30, 2019 | Germany ... 展开 >> Profil Institut für Stoffwechselforschung GmbH Neuss, Germany 收起 << |
NCT01976858 | Type 2 Diabetes | Phase 1 | Completed | - | China, Beijing ... 展开 >> Beijing tongren hospital Beijing, Beijing, China 收起 << |
NCT02849899 | Disorder Related to Renal Tran... 展开 >>splantation Diabetes 收起 << | Phase 3 | Not yet recruiting | January 2020 | - |
NCT00438503 | Renal Failure, Chronic ... 展开 >> Diabetic Nephropathies 收起 << | Phase 4 | Completed | - | Denmark ... 展开 >> Holstebro Hospital Holstebro, Denmark, 7500 收起 << |
NCT01919489 | Type 2 Diabetes | Phase 4 | Recruiting | June 2019 | United States, Florida ... 展开 >> University of Miami Recruiting Miami, Florida, United States Contact: Gianluca Iacobellis, MD GIacobellis@med.miami.edu Principal Investigator: Gianluca Iacobellis, MD United States, Georgia Grady Memorial Hospital Recruiting Atlanta, Georgia, United States, 30303 Contact: Guillermo E Umpierrez, MD 404-778-1665 geumpie@emory.edu Contact: Francisco J Pasquel, MD 404 778 1697 fpasque@emory.edu Principal Investigator: Guillermo Umpierrez, MD Sub-Investigator: Francisco J Pasquel, MD Sub-Investigator: Priya Vellanki, MD Emory University Hospital Recruiting Atlanta, Georgia, United States, 30324 Contact: Francisco Pasquel, MD fpasque@emory.edu Sub-Investigator: Francisco Pasquel, MD Emory Universtiy Hospital at MIdtown Recruiting Atlanta, Georgia, United States Contact: Francisco Pasquel, MD Sub-Investigator: Rodolfo J Galindo, MD United States, New York State University of NY at Buffalo Recruiting New York, New York, United States Contact: Ajay Chaudhuri, MD AChaudhuri@KaleidaHealth.Org Principal Investigator: Ajay Chaudhuri, MD 收起 << |
NCT00006068 | Diabetes Mellitus | Not Applicable | Unknown | - | - |
NCT00206297 | Type 1 Diabetes | Phase 3 | Completed | - | United States, Texas ... 展开 >> Baylor College of Medicine Houston, Texas, United States, 77030 收起 << |
NCT02971722 | Healthy | Phase 1 | Unknown | March 2018 | - |
NCT02750930 | Diabetes Mellitus, Type 2 | Phase 4 | Terminated(The termination was... 展开 >> result of GSK business considerations and not due to quality, safety or efficacy concerns with any albiglutide formulations or study conduct) 收起 << | - | - |
NCT01638260 | Type 2 Diabetes Mellitus | Phase 4 | Terminated(Terminated because ... 展开 >>of insufficient number of subjects included.) 收起 << | - | Netherlands ... 展开 >> Maastricht University Medical Center Maastricht, Netherlands, 6229HX 收起 << |
NCT02606617 | Type 2 Diabetes | Phase 4 | Unknown | December 2016 | - |
NCT02160379 | - | Completed | - | Switzerland ... 展开 >> CHUV-clinical research center Lausanne, VD, Switzerland, CH-1001 收起 << | |
NCT02750930 | - | Terminated(The termination was... 展开 >> result of GSK business considerations and not due to quality, safety or efficacy concerns with any albiglutide formulations or study conduct) 收起 << | - | - | |
NCT00992901 | Post Bariatricsurgery ... 展开 >> Hypoglycemia 收起 << | Early Phase 1 | Recruiting | July 2020 | United States, Texas ... 展开 >> South Texas Veterans Health Care System Recruiting San Antonio, Texas, United States, 78229 Contact: Marzieh Salehi 210-567-6691 salehi@uthscsa.edu Contact: Andrea Hansis-Diarte 210-567-6691 hansisdiarte@uthscsa.edu Principal Investigator: Marzieh Salehi, MD, MS 收起 << |
NCT03412149 | Obesity (Disorder) | Not Applicable | Recruiting | December 19, 2019 | Italy ... 展开 >> ICOT Hospital Recruiting Latina, Italy, 04100 Contact: Marcello Avallone +393384856243 marcello_avallone@libero.it 收起 << |
NCT02287285 | Type 2 Diabetes Mellitus | Early Phase 1 | Active, not recruiting | October 2018 | United States, New York ... 展开 >> New York Obesity Research Center, Columbia University New York, New York, United States, 10032 收起 << |
NCT01612468 | Diabetes Mellitus, Type 1 ... 展开 >> Overweight 收起 << | Phase 4 | Completed | - | Denmark ... 展开 >> Steno Diabetes Center Gentofte, Denmark, 2820 收起 << |
NCT00834626 | Diabetes | Not Applicable | Completed | - | India ... 展开 >> Kirloskar Hospital Hyderabad, AP, India, 500063 收起 << |
NCT02558270 | Type 2 Diabetes ... 展开 >> Metabolically Healthy Controls 收起 << | Phase 2 | Unknown | June 2018 | Austria ... 展开 >> Medical University Of Vienna, Department of Internal Medicine III Recruiting Vienna, Austria, 1090 Contact: Peter Wolf, MD 004314040043110 peter.wolf@meduniwien.ac.at 收起 << |
NCT00834626 | - | Completed | - | - | |
NCT02315001 | Ischaemic Heart Disease ... 展开 >> Coronary Heart Disease Chronic Stable Angina 收起 << | Phase 2 | Completed | - | United Kingdom ... 展开 >> Guy's and St Thomas' NHS Foundation Trust London, Greater London, United Kingdom, SE17EH 收起 << |
NCT03765008 | Glucose Metabolism Disorders ... 展开 >> Dehydration (Physiology) Water Deprivation 收起 << | Not Applicable | Not yet recruiting | July 29, 2019 | - |
NCT01592279 | Uncontrolled Type 1 Diabetic P... 展开 >>atients 收起 << | Phase 4 | Unknown | - | - |
NCT02987335 | - | Not yet recruiting | December 2022 | - | |
NCT03520153 | - | Recruiting | August 2021 | United States, Connecticut ... 展开 >> Yale New Haven Hospital Recruiting New Haven, Connecticut, United States, 06510 Contact: Cemre Robinson, M.D. 203-785-5809 cemre.robinson@yale.edu 收起 << | |
NCT00291772 | Type 1 Diabetes | Phase 4 | Completed | - | United States, Texas ... 展开 >> Texas Children's Hospital Houston, Texas, United States, 77030 收起 << |
NCT02408705 | Type 1 Diabetes Mellitus | Phase 2 | Completed | - | Austria ... 展开 >> Medical University Graz Graz, Austria, 8036 收起 << |
NCT01724736 | Pre Diabetic | Not Applicable | Completed | - | United States, Louisiana ... 展开 >> Pennington Biomedical Research Center Baton Rouge, Louisiana, United States, 70808 收起 << |
NCT01552018 | Coronary Artery Disease ... 展开 >> Diabetes Mellitus Type 2 收起 << | Phase 4 | Completed | - | Norway ... 展开 >> Center for Clinical Heart Research, Dept. of Cardiology, Oslo University Hospital Ullevaal Oslo, Norway, N-0424 收起 << |
NCT03101930 | Obesity PreDi... 展开 >>abetes 收起 << | Phase 4 | Recruiting | September 1, 2021 | United States, Tennessee ... 展开 >> Vanderbilt University Medical Center Recruiting Nashville, Tennessee, United States, 37232 Contact: Dustin Mayfield, RN 615-343-8701 Contact: Nancy J Brown, MD 6153438701 nancy.j.brown@vanderbilt.edu 收起 << |
NCT01771445 | Type 2 Diabetes | Not Applicable | Completed | - | Switzerland ... 展开 >> University Hospital of Basel, Division of Endocrinology Basel, Switzerland 收起 << |
NCT01572649 | Type 2 Diabetes Mellitus | Phase 1 | Completed | - | United States, California ... 展开 >> Investigational Site Number 840005 Chula Vista, California, United States, 91911 United States, Kansas Investigational Site Number 840001 Overland Park, Kansas, United States, 66212 United States, Kentucky Investigational Site Number 840003 Louisville, Kentucky, United States, 40202 Mexico Investigational Site Number 484001 Puebla, Mexico, 72190 South Africa Investigational Site Number 710002 Cape Town, South Africa, 7530 United Kingdom Investigational Site Number 826001 Leeds, United Kingdom, LS2 9LH 收起 << |
NCT01875575 | Endocrine System Diseases | Not Applicable | Completed | - | Switzerland ... 展开 >> University Hospital Basel Basel, Switzerland, CH-4031 收起 << |
NCT00807729 | Choleclithiasis ... 展开 >> Common Bile Duct Stones 收起 << | Not Applicable | Completed | - | United States, California ... 展开 >> San Francisco General Hospital San Francisco, California, United States, 94110 收起 << |
NCT01722240 | Type 1 Diabetes | Phase 3 | Recruiting | November 2019 | United States, New York ... 展开 >> Diabetes-Endocrinology Center of WNY Recruiting Buffalo, New York, United States, 14215 Contact: Jeanne Hejna, LPN 716-898-1950 jeannehe@buffalo.edu Principal Investigator: Paresh Dandona, MBBS,PhD 收起 << |
NCT03168295 | Diabetes Mellitus, Type 2 | Phase 4 | Recruiting | October 2019 | United States, Texas ... 展开 >> The University of Texas Health Science Center at San Antonio Recruiting San Antonio, Texas, United States, 78229 Contact: Ralph A DeFronzo, MD 210-567-6691 defronzo@uthscsa.edu Principal Investigator: Ralph A DeFronzo, MD 收起 << |
NCT01196728 | Type II Diabetes Mellitus | Phase 1 | Completed | - | Germany ... 展开 >> Parexel International GmbH Berlin, Germany, 14050 收起 << |
NCT02472717 | Psoriatic Arthritis ... 展开 >> Psoriasis Impaired Glucose Tolerance Type 2 Diabetes 收起 << | Phase 2 | Withdrawn | - | Canada, Ontario ... 展开 >> Toronto Western Hospital, The Centre for Prognosis Studies in the Rheumatic Diseases (CPSRD), University of Toronto Toronto, Ontario, Canada, M5T 2S8 收起 << |
NCT00744926 | Diabetes Mellitus Type 2 | Phase 3 | Completed | - | - |
NCT00712010 | - | Completed | - | - | |
NCT01727583 | Healthy | Not Applicable | Completed | - | Switzerland ... 展开 >> Nestlé CDU / Metabolic Unit Lausanne, Switzerland, 1000 收起 << |
NCT01550653 | Healthy | Phase 1 | Completed | - | Germany ... 展开 >> University of Luebeck, Department of Neuroendocrinology Luebeck, Germany, 23538 收起 << |
NCT01922817 | Type 1 Diabetes ... 展开 >> Hypoglycaemia 收起 << | Phase 3 | Completed | - | United Kingdom ... 展开 >> Clinical research centre, Ninewells Hospital and Medical School Dundee, United Kingdom, DD1 9SY 收起 << |
NCT02527993 | Hypoglycemia ... 展开 >>Obesity Surgery 收起 << | Phase 4 | Completed | - | - |
NCT03671733 | Obesity | Phase 3 | Recruiting | September 1, 2020 | China, Hunan ... 展开 >> Xiangya Hospital of Central South University Recruiting Changsha, Hunan, China, 410008 Contact: Jing Wu +86-13574120508 wujing0731@163.com 收起 << |
NCT02307695 | Type 1 Diabetes | Phase 4 | Unknown | March 2017 | China, Jiangsu ... 展开 >> First Affiliated Hospital, Nanjing Medical University Recruiting Nanjing, Jiangsu, China, 210029 Contact: Tao Yang, PhD 86-25-83718836 ext 6466 yangt@njmu.edu.cn Principal Investigator: Tao Yang, PhD 收起 << |
NCT02020395 | Endocrine System Diseases | Phase 1 | Completed | - | Switzerland ... 展开 >> University Hospital Basel, Division of Gastroenterology and Hepatology Basel, Switzerland, 4031 收起 << |
NCT02042664 | Obesity Diabe... 展开 >>tes 收起 << | Phase 3 | Completed | - | France ... 展开 >> Assistance Publique Hopitaux de Marseille Marseille, France, 13354 收起 << |
NCT00740012 | Stress Type 1... 展开 >> Diabetes 收起 << | Not Applicable | Completed | - | Germany ... 展开 >> Diabeteszentrum Bad Lauterberg im Harz Bad Lauterberg, Lower Saxony, Germany, 37431 收起 << |
NCT01917760 | - | Completed | - | China, Shanghai ... 展开 >> Department of Endocrinology and Metabolism,Huashan hospital Shanghai, Shanghai, China, 200040 收起 << | |
NCT01722227 | Type 1 Diabetes | Phase 3 | Withdrawn(No Funding Received ... 展开 >>from ADA) 收起 << | May 2018 | United States, New York ... 展开 >> Diabetes-Endocrinology Center of WNY Williamsville, New York, United States, 14221 收起 << |
NCT00712010 | Healthy | Not Applicable | Completed | - | Switzerland ... 展开 >> Nestec Clinical Development Unit / Metabolic Unit Lausanne, Switzerland, 1000 收起 << |
NCT03056677 | Metabolism Disorder, Glucose | Not Applicable | Completed | - | United Kingdom ... 展开 >> University of Aberdeen, The Rowett Institute Aberdeen, United Kingdom, AB25 2ZD 收起 << |
NCT01509001 | Type 2 Diabetes | Phase 4 | Completed | - | Brazil ... 展开 >> Clinical Hospital of São Paulo Medical School são Paulo, SP, Brazil 收起 << |
NCT00742339 | Cirrhosis Hep... 展开 >>atorenal Syndrome 收起 << | Phase 2 Phase 3 | Terminated(Decision of indepen... 展开 >>dent monitoring committee Risk of non-response to treatment significantly higher in midodrine group than in terlipressin group.) 收起 << | - | Italy ... 展开 >> Dept. of Clinical and Experimental Medicine, University of Padova Padova, Italy, 35100 收起 << |
NCT03230123 | Diabetes Mellitus ... 展开 >> Pre-diabetes 收起 << | Not Applicable | Recruiting | June 2018 | Brazil ... 展开 >> Federal University of Sao Paulo Recruiting Sao Paulo, SP, Brazil, 04039030 Contact: Maria C Izar, M.D.; Ph.D. 55-11-55499395 mcoizar@terra.com.br Contact: Francisco A Fonseca, M.D.; Ph.D. 55-11-55499395 fahfonseca@terra.com.br Principal Investigator: Maria C Izar, M.D.; Ph.D. Sub-Investigator: Edna S Costa, N.D.; M.Sc. Sub-Investigator: Francisco A Fonseca, M.D.; Ph.D. Sub-Investigator: Henrique T Bianco, M.D., Ph.D. Sub-Investigator: Juliana T Kato, N.D., M.Sc. Sub-Investigator: Thiago T Freitas, N.D., M.Sc. Sub-Investigator: Carolina N Franca, Ph.D. Sub-Investigator: Henrique A Fonseca, Ph.D. 收起 << |
NCT01607944 | - | Completed | - | Denmark ... 展开 >> Rigshospitalet Copenhagen, Denmark 收起 << | |
NCT02773927 | Metabolic Syndrome | Phase 3 | Completed | - | Mexico ... 展开 >> Universidad de Guadalajara Guadalajara, Jalisco, México, Mexico, 44100 收起 << |
NCT03225209 | Type 2 Diabetes Mellitus | Phase 2 | Active, not recruiting | August 15, 2018 | United States, North Carolina ... 展开 >> Department of Veteran Affairs, Greenville Health Care Center Greenville, North Carolina, United States, 27834 收起 << |
NCT02414893 | - | Completed | - | Spain ... 展开 >> Consorci Sanitari del Maresme Mataró, Barcelona, Spain, 08304 收起 << | |
NCT03665350 | Heart Failure ... 展开 >> Diabetes Mellitus, Type 2 收起 << | Phase 2 | Not yet recruiting | October 30, 2020 | Italy ... 展开 >> Ospedale Treviglio Not yet recruiting Treviglio, BG, Italy, 24047 Contact: Paolo Sganzerla, MD 0363424269 paolo.sganzerla@asst-bgovest.it Ospedale di Passirana Not yet recruiting Passirana, MI, Italy, 20017 Contact: Elena Martinoli, MD 02994304471 martinolielena@hotmail.com Ospedale di Saronno Not yet recruiting Saronno, VA, Italy, 21047 Contact: Daniele Nassiacos, MD 029613459 daniele.nassiacos@asst-valleolona.it 收起 << |
NCT03194945 | Type 2 Diabetes Mellitus | Phase 4 | Not yet recruiting | December 31, 2020 | China, Guangdong ... 展开 >> endocrinology department of the first affiliated hospital of Sun Yat-sen University Guangzhou, Guangdong, China, 510080 收起 << |
NCT00229658 | - | Completed | - | - | |
NCT00229658 | - | Completed | - | - | |
NCT02660047 | Diabetes Mellitus Type 2 ... 展开 >> Metabolic Syndrome Cardiovascular Disease Diastolic Dysfunction Fatty Liver 收起 << | Phase 4 | Completed | - | Netherlands ... 展开 >> Leiden University Medical Center Leiden, Albinusdreef 2, Netherlands, 2333 ZA 收起 << |
NCT00364377 | Pre-diabetes | Phase 4 | Completed | - | United States, Minnesota ... 展开 >> Mayo Clinic Rochester, Minnesota, United States, 55905 收起 << |
NCT03223389 | Overweight and Obesity ... 展开 >> Type 2 Diabetes Bariatric Surgery Gut Hormones Dietary Fat 收起 << | Not Applicable | Not yet recruiting | December 2018 | Denmark ... 展开 >> Dept. of Endocrinology Recruiting Hvidovre, Denmark, 2650 Contact: Christoffer Martinussen, MD +4538623032 christoffer.martinussen@regionh.dk Principal Investigator: Christoffer Martinussen, MD 收起 << |
NCT01122641 | Insulin Resistance ... 展开 >> Microvascular Disease 收起 << | Phase 3 | Completed | - | United Kingdom ... 展开 >> Diabetes and Vascular Research Department Exeter, Devon, United Kingdom, EX2 5AX 收起 << |
NCT00364377 | - | Completed | - | - | |
NCT03017352 | Diabetes Mellitus, Type 1 | Phase 2 | Recruiting | July 2018 | Denmark ... 展开 >> Steno Diabetes Center Recruiting Gentofte, Capital Region, Denmark, 2820 Sub-Investigator: Nicklas J Johansen, MD Sub-Investigator: Thomas F Dejgaard, MD Sub-Investigator: Asger Lund, MD, PhD Principal Investigator: Henrik U Andersen, MD, Dmsc Principal Investigator: Filip K Knop, Professor, MD, PhD 收起 << |
NCT01501084 | Obesity | Phase 1 | Completed | - | United States, California ... 展开 >> UCLA Gail and Gerald Oppenheimer Family Center for Neurobiology of Stress Los Angeles, California, United States, 90095 收起 << |
NCT02199587 | Precocious Puberty ... 展开 >> Growth Hormone Tests 收起 << | Not Applicable | Completed | - | Israel ... 展开 >> Meir Medical Center endocrine unit Kfar Saba, Israel 收起 << |
NCT02366624 | - | Completed | - | Chile ... 展开 >> Pontificia Universidad Catolica de Chile Santiago, Region Metropolitana, Chile 收起 << | |
NCT03713060 | Hypoglycemia Non-Diabetic ... 展开 >> Gastric Bypass Complicating Pregnancy/Birth/Puerperium Antepartum Condition 收起 << | Not Applicable | Not yet recruiting | September 30, 2021 | - |
NCT02917057 | - | Completed | - | United States, Massachusetts ... 展开 >> Optum Epidemiology Boston, Massachusetts, United States, 02215 收起 << | |
NCT02503943 | Type 2 Diabetes ... 展开 >> Overweight Obesity Masked Hypertension 收起 << | Phase 4 | Unknown | September 2016 | - |
NCT02688218 | Type 1 Diabetes | Not Applicable | Active, not recruiting | September 2018 | United States, Oregon ... 展开 >> Oregon Health and Science University Portland, Oregon, United States, 97239 收起 << |
NCT02411825 | Type 2 Diabetes Mellitus | Phase 1 | Completed | - | Germany ... 展开 >> Investigational Site Number 276001 Berlin, Germany, 10117 收起 << |
NCT03671928 | Ischemia Bowel | Not Applicable | Not yet recruiting | January 15, 2021 | France ... 展开 >> University Nice Hospital Not yet recruiting Nice, France, 06000 Contact: Damien MASSALOU 33492038614 massalou.d@chu-nice.fr Principal Investigator: Damien MASSALOU 收起 << |
NCT01701973 | Obesity | Phase 4 | Completed | - | United States, Tennessee ... 展开 >> Vanderbilt University Medical Center Nashville, Tennessee, United States, 37232 收起 << |
NCT01100125 | Diabetes | Phase 4 | Completed | - | Korea, Republic of ... 展开 >> Seoul National University Bundang Hospital Seongnam, Gyeonggi, Korea, Republic of, 463-707 Seoul National University Bundang Hospital Seongnam, Korea, Republic of 收起 << |
NCT02974244 | - | Completed | - | United States, Massachusetts ... 展开 >> Optum Epidemiology Boston, Massachusetts, United States, 02215 收起 << | |
NCT01392898 | Type 2 Diabetes Mellitus | Not Applicable | Unknown | May 2014 | Netherlands ... 展开 >> Radboud University Nijmegen Medical Centre Nijmegen, Netherlands 收起 << |
NCT02650830 | - | Unknown | December 2016 | Korea, Republic of ... 展开 >> Yonsei University College of Medicine Recruiting Seoul, Korea, Republic of, 03722 Contact: Jeong-Ho Kim, MD +82 02-2228-2455 收起 << | |
NCT03458715 | Type2 Diabetes | Phase 4 | Recruiting | November 21, 2018 | Taiwan ... 展开 >> Division of Endocrinology and Metabolism, Department of Internal Medicine, Mackay Memorial Hospital Recruiting Taipei, Taiwan, 10449 Contact: Yi-Hong Zeng, MD +886-2-25433535 ext 2174 starrydouchain@yahoo.com.tw Sub-Investigator: Sung-Chen Liu, MD Sub-Investigator: Chun-Chuan Lee, MD 收起 << |
NCT03498001 | Type II Diabetes | Not Applicable | Recruiting | December 2020 | France ... 展开 >> Chu Dijon Bourgogne Recruiting Dijon, France, 21000 Contact: Charles GUENANCIA 03.80.29.56.23 charles.guenancia@chu-dijon.fr 收起 << |
NCT01000688 | Type 2 Diabetes ... 展开 >> Endothelial Dysfunction 收起 << | Phase 3 | Completed | - | Netherlands ... 展开 >> Radboud University Nijmegen Medical Centre Nijmegen, Netherlands, 6500 HB 收起 << |
NCT01767441 | - | Unknown | June 2016 | Italy ... 展开 >> AOUI Verona Recruiting Verona, Italy, 37126 Contact: Riccardo C Bonadonna, MD, PHD +390458123115 riccardo.bonadonna@univr.it Contact: Maria Grazia Zenti, MD +390458123110 mariagrazia.zenti@univr.it Principal Investigator: Maria Grazia Zenti, MD 收起 << | |
NCT00968006 | Type 2 Diabetes Mellitus | Phase 4 | Completed | - | Italy ... 展开 >> University of Padova, Medical School Padova, Italy, 35100 收起 << |
NCT01701973 | - | Completed | - | - | |
NCT00975052 | Type 2 Diabetes | Phase 1 | Completed | - | - |
NCT00473356 | Obesity Post-... 展开 >>gastric Bypass 收起 << | Not Applicable | Completed | - | United States, Alabama ... 展开 >> UAB Kirklin Clinic Birmingham, Alabama, United States, 35294 收起 << |
NCT01779362 | Prediabetes T... 展开 >>ype 2 Diabetes 收起 << | Phase 3 | Active, not recruiting | August 2019 | United States, Illinois ... 展开 >> Jesse Brown VA Medical Center Chicago, Illinois, United States, 60612 University of Chicago Chicago, Illinois, United States, 60637 United States, Indiana Indiana University Indianapolis, Indiana, United States, 46202 United States, Washington VA Puget Sound Health Care System Seattle, Washington, United States, 98108 收起 << |
NCT00190502 | Diabetes Mellitus, Type 1 | Not Applicable | Unknown | - | Czech Republic ... 展开 >> Institute for Clinical and Experimental Medicine, Department of Diabetes Recruiting Prague, Czech Republic, 14021 Contact: Frantisek Saudek, MD. frsa@medicon.cz Principal Investigator: Frantisek Saudek, MD Sub-Investigator: Petr Boucek, MD. Sub-Investigator: Tereza Havrdova 收起 << |
NCT00849576 | Type 2 Diabetes | Phase 3 | Completed | - | Germany ... 展开 >> IKFE Parcusstrasse 8, Mainz, Germany, 55116 收起 << |
NCT02145611 | Type 2 Diabetes Mellitus ... 展开 >> Hypertension Endothelial Dysfunction 收起 << | Phase 4 | Completed | - | Brazil ... 展开 >> Fundação Faculdade Regional de Medicina de São José do Rio Preto São José do Rio Preto, São Paulo, Brazil, 15090-000 收起 << |
NCT01234155 | Diabetes Mellitus, Type 2 | Not Applicable | Completed | - | Denmark ... 展开 >> Rigshospitalet Copenhagen, Denmark, 2100 收起 << |
NCT01787916 | - | Completed | - | - | |
NCT01787916 | Type 1 Diabetes | Phase 4 | Completed | - | Canada ... 展开 >> CHU de Québec Quebec, Canada, G1V 4G2 收起 << |
NCT02800668 | - | Completed | - | Germany ... 展开 >> Herz- und Diabeteszentrum Bad Oeynhausen, Germany, 32545 收起 << | |
NCT03668470 | Adult Subjects With Type1Diabe... 展开 >>tes and Insulin Microsecretion 收起 << | Phase 2 | Not yet recruiting | June 2020 | France ... 展开 >> Service d'Endocrinologie, Maladies Métaboliques et Nutrition, CHU Grenoble, Hopital de la Tronche Not yet recruiting La Tronche, France, 38700 Contact: Pierre-Yves BENHAMOU +33 4 76 76 55 09 PYBenhamou@chu-grenoble.fr Principal Investigator: Pierre-Yves BENHAMOU Sub-Investigator: Sandrine LABLANCHE Département d''Endocrinologie, Diabétologie, Nutrition ; CHU Montpellier ; Hôpital Lapeyronie, Avenue du Doyen Giraud Not yet recruiting Montpellier 5, France, 34295 Contact: Eric RENARD +33 4 67 33 83 82 e-renard@chu-montpellier.fr Principal Investigator: Eric RENARD Sub-Investigator: Anne WOJTUSCISZYN Service d'Endocrinologie, Maladies Métaboliques et Nutrition,CHU Nantes,Hôpital Nord Laennec,Bd Jacques-Monod,Saint-Herblain Not yet recruiting NANTES cedex 1, France, 44093 Contact: Bertrand CARIOU +33 2 53 48 27 01 bertrand.cariou@univ-nantes.fr Principal Investigator: Bertrand CARIOU Sub-Investigator: Lucy CHAILLOUS Service de Diabétologie et Maladies Métaboliques, Assistance Publique des Hôpitaux de Paris ;Hôpital Cochin, 27 rue du Faubourg Saint-Jacques Not yet recruiting Paris, France, 75014 Contact: Etienne LARGER +33 1 58 41 19 19 etienne.larger@cch.aphp.fr Principal Investigator: Etienne LARGER Service d'Endocrinologie, Diabétologie, Maladies de la Nutrition, Hospices Civils de Lyon, Centre hospitalier Lyon-Sud Not yet recruiting Pierre-Bénite, France, 69495 Contact: Charles THIVOLET +33 4 78 86 14 87 charles.thivolet@chu-lyon.fr Principal Investigator: Charles THIVOLET Sub-Investigator: Lucien MARCHAND Service de Diabétologie Maladies Métaboliques et Nutrition ; CHU Toulouse, Pôle cardiovasculaire et métabolique, Hôpital Rangueil ; 1, avenue du Professeur Jean Poulhès - TSA 50032 Not yet recruiting TOULOUSE cedex 9, France, 31059 Contact: Hélène HANAIRE : +33 5 61 32 30 18 hanaire.h@chu-toulouse.fr Principal Investigator: Hélène HANAIRE Service de Diabétologie, Maladies Métaboliques, Nutrition ; CHU Nancy ; Technopôle Nancy-Brabois ; Rue du Morvan, Not yet recruiting Vandœuvre-lès-Nancy, France, 54500 Contact: Bruno GUERCI +33 3 83 65 65 28 b.guerci@chu-nancy.fr Principal Investigator: Bruno GUERCI 收起 << |
NCT00740363 | Glucose Intolerance | Phase 4 | Completed | - | Norway ... 展开 >> Rikshospitalet Medical Center Oslo, Norway, 0027 收起 << |
NCT03455049 | Increased Insulin | Not Applicable | Recruiting | May 30, 2018 | Indonesia ... 展开 >> Faculty of Medicine, Universitas Indonesia Recruiting Jakarta Pusat, DKI Jakarta, Indonesia, 10430 Contact: Tri Juli Edi Tarigan, MD +62 813 15 483 293 tje_tar@yahoo.com Contact: Nida Amalina, PH +62 856 9703 6895 amalinanida@gmail.com 收起 << |
NCT02127541 | Endogenous Hyperinsulinaemic H... 展开 >>ypoglycaemia 收起 << | Not Applicable | Completed | - | Switzerland ... 展开 >> University Hospital Basel Basel, Switzerland, 4031 收起 << |
NCT03642600 | PCOS Obesity ... 展开 >> Metabolic Syndrome 收起 << | Phase 4 | Not yet recruiting | December 30, 2019 | - |
NCT02274740 | Type II Diabetes Mellitus | Phase 2 | Terminated(Sponsor decision no... 展开 >>t related to safety reasons) 收起 << | - | - |
NCT00467649 | Type 2 Diabetes Mellitus | Phase 4 | Completed | - | - |
NCT00467649 | - | Completed | - | - | |
NCT00551590 | Type 2 Diabetes Mellitus | Phase 1 | Completed | - | Germany ... 展开 >> Clinical Research unit, Dept. of Internal Medicine II - Großhadern, University of Munich Munich, Germany, 81377 收起 << |
NCT03543423 | Healthy | Not Applicable | Recruiting | June 30, 2019 | Denmark ... 展开 >> Department of Gastrointestinal Surgery, Righospitalet Recruiting Copenhagen, Capital, Denmark, 2100 Contact: Lars Bo Svendsen, DMSci lars.bo.svendsen@regionh.dk Contact: Simon Veedfald, MD +4541102595 Simon.veedfald@regionh.dk Principal Investigator: Simon Veedfald, MD Principal Investigator: Jens J Holst, DMsci Principal Investigator: Lars Bo Svendsen 收起 << |
NCT01824680 | Obesity | Not Applicable | Suspended | July 2014 | France ... 展开 >> CHU Clermont-Ferrand Clermont-Ferrand, France, 63003 收起 << |
NCT01573988 | Volunteers | Not Applicable | Terminated(Difficulties in rec... 展开 >>ruiting of volunteers with a BMI (Body Mass Index) between 30 and 35 kg/m2) 收起 << | - | France ... 展开 >> Centre Hospitalier Lyon Sud - Centre de Recherche en Nutrition Humaine Pierre Bénite, France, 69495 收起 << |
NCT00631293 | Healthy | Phase 1 Phase 2 | Completed | - | Belgium ... 展开 >> University Hospital Ghent Ghent, Belgium, 9000 收起 << |
NCT01488136 | Type 1 Diabetes | Phase 4 | Unknown | December 2012 | United Kingdom ... 展开 >> NHS Tayside Recruiting Dundee, United Kingdom, DD1 9SY Principal Investigator: Priya S George, MRCP 收起 << |
NCT00361946 | - | Completed | - | United States, Texas ... 展开 >> Baylor College of Medicine Houston, Texas, United States, 77030 收起 << | |
NCT02250872 | Cancer Cispla... 展开 >>tin Adverse Reaction 收起 << | Phase 2 Phase 3 | Unknown | June 2018 | Korea, Republic of ... 展开 >> Seoul National University Bundang Hospital Recruiting Seongnam-si, Gyeonggi-do, Korea, Republic of, 463-707 Contact: Hyunjin Cho 82 31 787 7030 Principal Investigator: Ki Young Na, MD PhD 收起 << |
NCT01135472 | Healthy | Phase 1 | Completed | - | United States, California ... 展开 >> City of Hope Medical Center Duarte, California, United States, 91010 收起 << |
NCT01681550 | Type 2 Diabetes Mellitus | Not Applicable | Unknown | October 2018 | Japan ... 展开 >> Nagaoka Red Cross Hospital Not yet recruiting Nagaoka, Niigata, Japan, 940-2085 Contact: Kyuzi Kamoi, MD -81-0256-28-3600 kkam-int@echigo.ne.jp 收起 << |
NCT01845259 | Impaired Glucose Tolerance Ass... 展开 >>ociated With Drugs 收起 << | Phase 2 | Unknown | March 2017 | Denmark ... 展开 >> Psychiatric Centre Rigshospitalet Copenhagen, København Ø, Denmark, 2100 收起 << |
NCT02941445 | Polycystic Ovary Syndrome ... 展开 >> Body Weight 收起 << | Phase 4 | Completed | - | - |
NCT01682343 | Nutritional and Metabolic Dise... 展开 >>ases 收起 << | Not Applicable | Completed | - | United Kingdom ... 展开 >> Northumbria University Newcastle upon Tyne, Tyne on Wear, United Kingdom, NE1 8ST 收起 << |
NCT00856609 | Weight Loss O... 展开 >>besity 收起 << | Phase 3 | Completed | - | United States, Arizona ... 展开 >> NIDDK, Phoenix Phoenix, Arizona, United States, 85014 收起 << |
NCT01695109 | Healthy Human Male Subjects | Phase 4 | Completed | - | Austria ... 展开 >> Division of Endocrinology and Metabolism, Medical University of Vienna Vienna, Austria, 1090 收起 << |
NCT03325569 | Incretin Hormones in PCOS With... 展开 >> Prediabetes 收起 << | Not Applicable | Completed | - | Slovenia ... 展开 >> UMC Ljubljana Ljubljana, Slovenia, 1000 收起 << |
NCT00663312 | Idiopathic Parkinson's Disease | Not Applicable | Terminated | - | France ... 展开 >> CHU Clermont-Ferrand, France, 63000 收起 << |
NCT00867594 | Brittle Type I Diabetes Mellit... 展开 >>us 收起 << | Phase 2 | Completed | - | Israel ... 展开 >> Hadassah University Hospital Jerusalem, Israel, 91120 收起 << |
NCT00835848 | Myocardial Infarction | Phase 4 | Completed | - | Denmark ... 展开 >> Heart Center, Rigshospitalet Copenhagen, Denmark, 2100 收起 << |
NCT01309698 | Type 2 Diabetes | Phase 4 | Completed | - | Japan ... 展开 >> Novartis Investigative Site Tokyo, Japan 收起 << |
NCT02022007 | Polycystic Ovary Syndrome ... 展开 >> Disorder of Glucose Regulation 收起 << | Phase 3 | Completed | - | United States, Louisiana ... 展开 >> Woman's Hospital Baton Rouge, Louisiana, United States, 70817 收起 << |
NCT02022007 | - | Completed | - | - | |
NCT03454152 | - | Not yet recruiting | June 2020 | - | |
NCT02692781 | Obesity | Phase 1 | Completed | - | Israel ... 展开 >> Tel Aviv Sourasky Medical Center Tel Aviv, Israel, 64239 收起 << |
NCT00558740 | - | Completed | - | Switzerland ... 展开 >> Centre Hospitalier Universitaire Vaudois Lausanne, Vaud, Switzerland, CH-1011 收起 << | |
NCT01666665 | Insulin Resistance ... 展开 >> Hypermetabolism Hyperglycemia 收起 << | Phase 2 Phase 3 | Recruiting | August 2020 | United States, Texas ... 展开 >> Shriners Hospitals for Children Recruiting Galveston, Texas, United States, 77551 Contact: Cathy Reed, BSN 409-770-6987 ca2reed@utmb.edu Contact: Deb Benjamin, MSN 409-770-6731 dbenjami@utmb.edu Principal Investigator: David N Herndon, MD Sub-Investigator: Oscar Suman, PhD 收起 << |
NCT03534661 | Hyperlipidemias | Phase 2 Phase 3 | Recruiting | December 31, 2018 | Canada, Ontario ... 展开 >> Tornto General Hospital, UHN Recruiting Toronto, Ontario, Canada, M5G 1L7 Contact: Brenda Hughes, RN 416-340-8886 brenda.hughes@uhn.ca Principal Investigator: Gary F Lewis, MD 收起 << |
NCT02157298 | Type 2 Diabetes Mellitus | Phase 4 | Completed | - | Japan ... 展开 >> Research Site Adachi-ku, Japan Research Site Chitose-shi, Japan Research Site Chiyoda-ku, Japan Research Site Chuo-ku, Japan Research Site Fukuoka-shi, Japan Research Site Hirosaki-shi, Japan Research Site Kamakura-shi, Japan Research Site Koriyama-shi, Japan Research Site Mitaka-shi, Japan Research Site Oita-Shi, Japan Research Site Osaka-shi, Japan Research Site Sendai-shi, Japan Research Site Shizuoka-shi, Japan Research Site Yokohama-shi, Japan 收起 << |
NCT02157298 | - | Completed | - | - | |
NCT02783196 | Type 2 Diabetes | Not Applicable | Unknown | June 2017 | Israel ... 展开 >> Diabetes Unit E. Wolfson Hospital Holon, Tel Aviv, Israel, 58100 收起 << |
NCT00974831 | Overweight | Phase 2 | Completed | - | United States, Texas ... 展开 >> University of Texas Austin, Texas, United States, 78712 收起 << |
NCT00856609 | - | Completed | - | - | |
NCT03189953 | Insulinoma | Phase 1 Phase 2 | Enrolling by invitation | February 2019 | - |
NCT00299871 | Type 2 Diabetes | Phase 2 | Completed | - | United States, New Jersey ... 展开 >> Sanofi-Aventis Administrative Office Bridgewater, New Jersey, United States, 08807 Brazil Sanofi-Aventis Administrative Office Sao Paulo, Brazil Canada Sanofi-Aventis Administrative Office Laval, Canada Poland Sanofi-Aventis Administrative Office Warszawa, Poland Romania Sanofi-Aventis Administrative Office Bucuresti, Romania Russian Federation Sanofi-Aventis Administrative Office Moscow, Russian Federation Ukraine Sanofi-Aventis Administrative Office Kiev, Ukraine 收起 << |
NCT02128581 | Obesity Diabe... 展开 >>tes Roux-en-Y Gastric Bypass 收起 << | Phase 1 | Active, not recruiting | December 2018 | United States, Minnesota ... 展开 >> Mayo Clinic in Rochester Rochester, Minnesota, United States, 55905 收起 << |
NCT01425580 | Congestive Heart Failure ... 展开 >> Type 2 Diabetes Mellitus 收起 << | Phase 2 | Completed | - | Sweden ... 展开 >> Karolinska Institutet, Department of Clinical Science and Education, Södersjukhuset Stockholm, Sweden, 118 83 Karolinska Institutet, Division of Internal Medicine Södersjukhuset AB Stockholm, Sweden, 118 83 收起 << |
NCT03500900 | Healthy | Not Applicable | Completed | - | - |
NCT01531907 | - | Unknown | September 2014 | United Kingdom ... 展开 >> Academic Unit of Bone Metabolism Sheffield, South Yorkshire, United Kingdom, S5 7AU 收起 << | |
NCT02049034 | Type 2 Diabetes | Phase 4 | Completed | - | United Kingdom ... 展开 >> University of Surrey FHMS Diabetes and Metabolic Medicine Guildford, Surrey, United Kingdom, GU2 7WG 收起 << |
NCT02380521 | Type 2 Diabetes Mellitus | Phase 4 | Completed | - | Italy ... 展开 >> University Hospital of Palermo Palermo, Italy, 90127 收起 << |
NCT01542242 | Diabetes Mellitus Type 2 ... 展开 >> Prader Willi Syndrome 收起 << | Phase 4 | Terminated(Subject withdrew) | - | Canada, British Columbia ... 展开 >> Vancouver General Hospital - Diamond Center Vancouver, British Columbia, Canada, V5Z 1M9 收起 << |
NCT03235804 | Dietary Modification | Not Applicable | Not yet recruiting | December 31, 2020 | - |
NCT02608372 | High Blood Glucose | Not Applicable | Completed | - | Denmark ... 展开 >> Department of Nutrition, Exercise and Sports, University of Copenhagen Frederiksberg, Denmark, 1958 收起 << |
NCT01600703 | Hyperlipidemia | Phase 2 Phase 3 | Completed | - | Canada, Ontario ... 展开 >> Toronto General Hospital Toronto, Ontario, Canada, M5G 2C4 收起 << |
NCT01794429 | Obesity Metab... 展开 >>olic Syndrome X Drug-induced Obesity Schizophrenia 收起 << | Phase 3 | Completed | - | Denmark ... 展开 >> Cnsr/Cins Glostrup, Denmark, 2600 收起 << |
NCT03554265 | Traumatic Brain Injury ... 展开 >> Fatigue Cognitive Impairment 收起 << | Phase 3 | Recruiting | July 1, 2021 | United States, Texas ... 展开 >> University of Texas Medical Branch Recruiting Galveston, Texas, United States, 77555 Contact: Kate M Randolph, BS 409-772-8126 kmrandol@utmb.edu Contact: Christopher P Danesi, MS 409-772-8126 cpdanesi@utmb.edu Principal Investigator: Randall J Urban, MD Sub-Investigator: Edgar L Dillon, PhD 收起 << |
NCT01600703 | - | Completed | - | - | |
NCT00909701 | Starvation | Not Applicable | Completed | - | United Kingdom ... 展开 >> Nottingham Digestive Diseases Centre Biomedical Research Unit Nottingham, Nottinghamshire, United Kingdom, NG7 2UH 收起 << |
NCT02691481 | Type 2 Diabetes Mellitus ... 展开 >> Obesity 收起 << | Not Applicable | Completed | - | - |
NCT03645421 | Type 2 Diabetes | Phase 2 | Recruiting | December 6, 2018 | Japan ... 展开 >> Research Site Recruiting Chuo-ku, Japan, 103-0027 Research Site Recruiting Shinjuku-ku, Japan, 160-0008 Research Site Recruiting Shinjuku-ku, Japan, 162-0053 Research Site Recruiting Suita-shi, Japan, 565-0853 收起 << |
NCT01342939 | - | Completed | - | Denmark ... 展开 >> Diabetes Research Division, Gentofte University Hospital, Niels Andersens vej 65, opgang 40, 2. Hellerup, Denmark, 2900 收起 << | |
NCT00439023 | Renal Failure, Chronic | Phase 4 | Completed | - | Denmark ... 展开 >> Holstebro Hospital Holstebro, Denmark, 7500 收起 << |
NCT03566693 | Diabetes Mellitus, Type 2 | Not Applicable | Recruiting | May 31, 2022 | United States, California ... 展开 >> Scripps Whittier Diabetes Institute Recruiting San Diego, California, United States, 92121 Contact: Cherri Rosario Rosal.Rosario@scrippshealth.org Principal Investigator: Athena Philis-Tsimikas, M.D. United States, Georgia Atlanta Diabetes Associates Recruiting Atlanta, Georgia, United States, 30318 Contact: Nitin Rastogi Nrastogi@atlantadiabetes.com Principal Investigator: Bruce W. Bode, M.D. United States, Idaho Rocky Mountain Diabetes & Osteoporosis Center, P.A. Recruiting Idaho Falls, Idaho, United States, 83404-7596 Contact: Nikki McGraw, MA, CCRC 208-528-9648 nikki.mcgraw@idahomed.com Principal Investigator: David Liljenquist, M.D. United States, Iowa Iowa Diabetes and Endocrinology Research Center Recruiting West Des Moines, Iowa, United States, 50265 Contact: Kristie Stifel 515-329-6804 kstifel@iderc.com Principal Investigator: Anuj Bhargava, M.D. United States, Maryland MODEL Clinical Research Recruiting Baltimore, Maryland, United States, 21204 Contact: Karen Klein 443-524-1789 karenklein99@hotmail.com Principal Investigator: Philip Levin, M.D. United States, Minnesota Park Nicollet International Diabetes Center Recruiting Minneapolis, Minnesota, United States, 55416 Contact: Kathy McCann 952-993-3705 Kathleen.mccann@parknicollet.com Principal Investigator: Thomas Martens, M.D. United States, Nevada Las Vegas Endocrinology Recruiting Henderson, Nevada, United States, 89052 Contact: Alejandra Martinez zillah725@gmail.com Principal Investigator: Quang Nguyen, D.O. United States, Texas Texas Diabetes & Endocrinology, P.A. Recruiting Austin, Texas, United States, 78731 Contact: Rachel Barosh 512-334-3505 rbarosh@texasdiabetes.com Principal Investigator: Thomas Blevins, M.D. Texas Diabetes & Endocrinology, P.A. Recruiting Austin, Texas, United States, 78749 Contact: Emmanuel Lopez 512-334-3505 elopez@texasdiabetes.com Principal Investigator: Lindsay Harrison, M.D. Research Institute of Dallas Recruiting Dallas, Texas, United States, 75231 Contact: Veronica Almanza 214-265-2157 valmanza@researchdallas.com Principal Investigator: Stephen Aronoff, M.D. United States, Utah Advanced Research Institute Recruiting Ogden, Utah, United States, 84405 Contact: Hilary Wahlen hilary@advresearch.org Principal Investigator: Jack Wahlen, M.D., Ph.D. 收起 << |
NCT00571220 | - | Completed | - | United States, New York ... 展开 >> St Luke's Roosevelt Hospital Center New York, New York, United States, 10025 收起 << | |
NCT00755287 | Diabetes Mellitus Type 2 | Phase 3 | Completed | - | - |
NCT01835964 | Diabetes Mellitus, Type 1 | Not Applicable | Completed | - | United States, Virginia ... 展开 >> University of Virginia Charlottesville, Virginia, United States, 22904 收起 << |
NCT02366767 | - | Completed | - | - | |
NCT02366767 | Diabetes Mellitus, Type 1 | Not Applicable | Completed | - | United States, California ... 展开 >> Camp Conrad-Chinnock Angelus Oaks, California, United States, 92305 Packard El Camino Hospital Mountain View, California, United States, 94040 Lucile Packard Children's Hospital Palo Alto, California, United States, 94304 收起 << |
NCT02411682 | Type 2 Diabetes | Not Applicable | Unknown | April 2015 | - |
NCT02738151 | Diabetes Mellitus, Type 2 | Phase 4 | Completed | - | - |
NCT02480985 | Pituitary Disorders ... 展开 >> Traumatic Brain Injury 收起 << | Not Applicable | Active, not recruiting | March 2018 | Canada, Ontario ... 展开 >> The Ottawa Hospital Ottawa, Ontario, Canada Sunnybrook Health Sciences Centre Toronto, Ontario, Canada Canada, Quebec Hôpital du Sacré-Coeur de Montréal Montreal, Quebec, Canada CHU de Sherbrooke - Hôpital Fleurimont Sherbrooke, Quebec, Canada Canada CHU de Québec - Hôpital de l'Enfant-Jésus Quebec, Canada 收起 << |
NCT01733758 | - | Completed | - | - | |
NCT02738151 | - | Completed | - | - | |
NCT01733758 | Diabetes Mellitus, Type 2 | Phase 3 | Completed | - | - |
NCT01137695 | Type 2 Diabetes Mellitus | Phase 3 | Unknown | April 2012 | United States, New Jersey ... 展开 >> North Jersey Endocrine Consultants Denville, New Jersey, United States, 07834 United States, New York University Physicians Group Staten Island, New York, United States, 10301 United States, Pennsylvania St. Mary Medical Center Langhorne, Pennsylvania, United States, 19047 收起 << |
NCT02310009 | Type 2 Diabetes Mellitus | Not Applicable | Withdrawn(PI relocated to a di... 展开 >>fferent country and coI moved to a different lab.) 收起 << | - | Denmark ... 展开 >> Rigshospitalet Copenhagen, Denmark 收起 << |
NCT01771614 | Type 1 Diabetes ... 展开 >> Type 2 Diabetes 收起 << | Not Applicable | Withdrawn(PI relocated to a di... 展开 >>fferent country.) 收起 << | January 2017 | United Kingdom ... 展开 >> University of Birmingham Birmingham, West Midlands, United Kingdom, B15 2TT 收起 << |
NCT02662400 | Diabetes Mellitus, Non-Insulin... 展开 >>-Dependent 收起 << | Phase 2 Phase 3 | Completed | - | - |
NCT00993304 | Diabetes Diab... 展开 >>etes Mellitus, Type 2 收起 << | Phase 1 | Completed | - | Denmark ... 展开 >> Novo Nordisk Investigational Site Aarhus C, Denmark, 8000 收起 << |
NCT02374632 | Bariatric Surgery (Gastric Byp... 展开 >>ass) Severe Obesity 收起 << | Phase 4 | Active, not recruiting | June 2017 | Denmark ... 展开 >> Department of Endocrinology, Hvidovre Hospital Hvidovre, Denmark, DK-2650 收起 << |
NCT00633763 | - | Completed | - | United States, California ... 展开 >> University of California Irvine Medical Center Orange, California, United States, 92868 收起 << | |
NCT02963662 | Obesity Chron... 展开 >>ic Inflammation Type 2 Diabetes 收起 << | Not Applicable | Completed | - | - |
NCT00631488 | Diabetes Mellitus, Type 2 | Phase 2 | Completed | - | - |
NCT02148978 | Cystic Fibrosis | Not Applicable | Unknown | - | Israel ... 展开 >> Hadassah Har Hazofim Recruiting Jerusalem, Israel Contact: Ram Weiss, MD PhD ramw@ekmd.huji.ac.il 收起 << |
NCT02014740 | - | Completed | - | - | |
NCT02921906 | Neonatal Diabetes | Not Applicable | Recruiting | August 2018 | United Kingdom ... 展开 >> Exeter Clinical Research Facility Recruiting Exeter, Devon, United Kingdom, EX25DW Contact: Pamela Bowman, MBBS MA 01392408325 P.Bowman@exeter.ac.uk Contact: Bea A Knight, PhD 01392408172 B.A.Knight@exeter.ac.uk 收起 << |
NCT00631488 | - | Completed | - | - | |
NCT01345734 | - | Completed | - | Philippines ... 展开 >> Novo Nordisk Investigational Site Manilla, Philippines, 1605 收起 << | |
NCT01006603 | Type 2 Diabetes Mellitus | Phase 4 | Completed | - | - |
NCT02147925 | Non-alcoholic Fatty Liver Dise... 展开 >>ase 收起 << | Phase 4 | Completed | - | China, Guangdong ... 展开 >> The Third Affiliated Hospital of Sun Yat-sen University Guangzhou, Guangdong, China, 510630 收起 << |
NCT01914133 | Other Specified Hypotension ... 展开 >> Syncope 收起 << | Phase 2 | Recruiting | August 2018 | Canada, British Columbia ... 展开 >> Vancouver Coastal Health Research Institute, VGH Research Pavilion Room 186 Recruiting Vancouver, British Columbia, Canada, V5Z 1M9 Contact: Boris Feldman 604-875-5115 boris.feldman@vch.ca Principal Investigator: Kenneth M Madden, MD MSc FRCPC Sub-Investigator: Graydon Meneilly, MD, FRCPC 收起 << |
NCT01006603 | - | Completed | - | - | |
NCT02005978 | - | Unknown | December 2017 | Denmark ... 展开 >> National University Hospital, Department of Medical Endocrinology Copenhagen, Denmark, DK-2100 收起 << | |
NCT01978990 | - | Withdrawn(financial issues) | October 2019 | - | |
NCT01467063 | Type I Diabetes Mellitus | Not Applicable | Unknown | July 2013 | United States, Florida ... 展开 >> Nemours Children's Clinic Jacksonville, Florida, United States, 32207 收起 << |
NCT01957098 | Insulin Resistance | Not Applicable | Completed | - | Denmark ... 展开 >> Institute of Human Nutrition, The Royal Veterinary and Agricultural University Frederiksberg, Denmark, DK-1958 收起 << |
NCT02014740 | Type 2 Diabetes ... 展开 >> Overweight Obesity 收起 << | Phase 4 | Completed | - | United States, Florida ... 展开 >> University of Miami Miami, Florida, United States, 33136 收起 << |
NCT02097342 | Type 2 Diabetes Mellitus ... 展开 >> Insulin Sensitivity/Resistance 收起 << | Phase 4 | Unknown | January 2015 | India ... 展开 >> Postgraduate Institute of Medical Education & Research Recruiting Chandigarh, India, 160012 Contact: Anil Bhansali, MD DM anilbhansaliendocrine@gmail.com 收起 << |
NCT01840189 | Addison Disease ... 展开 >> Type 1 Diabetes 收起 << | Phase 2 | Completed | - | Norway ... 展开 >> Haukeland University Hospiatl Bergen, Norway, 5021 收起 << |
NCT01812590 | Type 2 Diabetes | Not Applicable | Completed | - | Denmark ... 展开 >> Rigshospitalet Copenhagen, Denmark 收起 << |
NCT02229240 | Diabetes Mellitus, Type 2 | Phase 3 | Withdrawn(Study was cancelled ... 展开 >>prior to enrolling any patients) 收起 << | December 2015 | - |
NCT02324842 | Type 2 Diabetes Mellitus | Not Applicable | Recruiting | December 2018 | United States, Texas ... 展开 >> University of Texas Health Science Center at San Antonio Recruiting San Antonio, Texas, United States, 78229 Contact: Ralph A DeFronzo, MD 210-567-6691 defronzo@uthscsa.edu Contact: Monica Palomo, BS 210-567-6710 palomom@uthscsa.edu Principal Investigator: Ralph A DeFronzo, MD 收起 << |
NCT02902198 | Obesity | Not Applicable | Recruiting | July 2019 | Switzerland ... 展开 >> University Hopital Basel Recruiting Basel, Switzerland Contact: Bettina Wölnerhanssen, Dr bettina.woelnerhanssen@usb.ch 收起 << |
NCT01388192 | - | Unknown | December 2016 | Taiwan ... 展开 >> National Taiwan University Hospital Recruiting Taipei, Taiwan, 100 Contact: Yu-Wen Tien, Ph.D. +886-972651427 kptkptkpt@yahoo.com.tw Principal Investigator: Yu-Wen Tien, Ph.D. 收起 << | |
NCT03263819 | - | Recruiting | December 30, 2019 | United States, Tennessee ... 展开 >> Vanderbilt University Medical Center Recruiting Nashville, Tennessee, United States, 37232 Contact: Cyndya Shibao, MD, MSCI cyndya.shibao@vanderbilt.edu Contact: Cyndya A Shibao, MD, MSCI 6155120956 cyndya.shibao@vanderbilt.edu Principal Investigator: Cyndya Shibao, MD, MSCI Sub-Investigator: Emily Garland, PhD Sub-Investigator: Amanda Peltier, MD 收起 << | |
NCT02969863 | Type1diabetes | Not Applicable | Completed | - | United States, Massachusetts ... 展开 >> MGH Diabetes Research Center Boston, Massachusetts, United States, 02114 收起 << |
NCT02692040 | Diabetes Mellitus ... 展开 >> Obesity 收起 << | Phase 1 | Unknown | December 2016 | United Kingdom ... 展开 >> Covance Clinical Research Unit Recruiting Leeds, United Kingdom, LS2 9LH Contact: Jim Bush, PhD MRCS +44 113 301 3500 Jim.bush@covance.com Contact: Catherine Laing +44 113 301 3725 Catherine.Laing@covance.com Principal Investigator: Jim Bush, PhD MRCS 收起 << |
NCT03690206 | Short Bowel Syndrome | Phase 3 | Recruiting | October 23, 2020 | - |
NCT01578928 | Renal Impairment | Phase 1 | Completed | - | Germany ... 展开 >> Novartis Investigative Site Berlin, Germany, 14050 South Africa Novartis Investigative Site Bloemfontein, Free State, South Africa, 9300 收起 << |
NCT01140438 | Diabetes | Not Applicable | Active, not recruiting | December 2018 | Norway ... 展开 >> Valdemar Grill Trondheim, Norway, 7006 收起 << |
NCT01930448 | - | Withdrawn(PI relocated to anot... 展开 >>her Institution) 收起 << | - | United States, New York ... 展开 >> St. Luke's Roosevelt Hospital-New York Obesity Nutrition Research Center New York, New York, United States, 10025 收起 << | |
NCT00006278 | - | Completed | - | United States, Maryland ... 展开 >> National Institute of Child Health and Human Development (NICHD) Bethesda, Maryland, United States, 20892 收起 << | |
NCT02161666 | - | Completed | - | Denmark ... 展开 >> Hvidovre University Hospital Hvidovre, Danmark, Denmark, 2650 收起 << | |
NCT02775513 | - | Unknown | - | - | |
NCT03025347 | Appetitive Behavior | Not Applicable | Completed | - | United Kingdom ... 展开 >> Loughborough University Loughborough, United Kingdom, LE11 3TU 收起 << |
NCT01462227 | Hypoglycemia | Not Applicable | Completed | - | United States, Connecticut ... 展开 >> Yale School of Medicine New Haven, Connecticut, United States, 06520 收起 << |
NCT00359346 | - | Completed | - | United States, Maryland ... 展开 >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 收起 << | |
NCT02969863 | - | Completed | - | - | |
NCT01462227 | - | Completed | - | - | |
NCT00064714 | Diabetes Mellitus | Phase 2 | Completed | - | United States, Maryland ... 展开 >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 收起 << |
NCT02953834 | Impaired Glucose Tolerance ... 展开 >> Hypogonadism 收起 << | Phase 1 | Recruiting | December 2023 | United States, Massachusetts ... 展开 >> Massachusetts General Hospital Recruiting Boston, Massachusetts, United States, 02114 Contact: Margaret Lippincott, MD 617-726-8434 mlippincott@partners.org Principal Investigator: Margaret Lippincott, MD Sub-Investigator: Stephanie Seminara, MD 收起 << |
NCT02569762 | Impaired Glucose Tolerance | Not Applicable | Active, not recruiting | August 2018 | Canada, Manitoba ... 展开 >> Richardson Centre for Functional Foods & Nutraceuticals Winnipeg, Manitoba, Canada, R3T 2E1 收起 << |
NCT00005889 | Infant, Low Birth Weight ... 展开 >> Hyperglycemia 收起 << | Not Applicable | Unknown | - | United States, Texas ... 展开 >> Baylor College of Medicine Recruiting Houston, Texas, United States, 77030 Contact: Agneta L. Sunehag 713-798-6725 asunehag@bcm.tmc.edu 收起 << |
NCT01951729 | Pre-diabetes | Phase 1 | Completed | - | United States, Missouri ... 展开 >> Washington University School of Medicine Saint Louis, Missouri, United States, 63110 收起 << |
NCT02185638 | Obesity | Not Applicable | Completed | - | Denmark ... 展开 >> Department Of Human Nutrition, Faculty of Science, University of Copenhagen Frederiksberg, Denmark, 1958 收起 << |
NCT00775684 | - | Completed | - | - | |
NCT01851694 | Cystic Fibrosis ... 展开 >> Pancreatic Insufficiency 收起 << | Not Applicable | Recruiting | September 2019 | United States, Pennsylvania ... 展开 >> Children's Hospital of Philadelphia and University of Pennsylvania Recruiting Philadelphia, Pennsylvania, United States, 19060 Contact: Christina Kubrak 267-426-5135 kubrak@email.chop.edu Principal Investigator: Michael Rickels, M.D., M.S Principal Investigator: Andrea Kelly, M.D, M.S. 收起 << |
NCT01835678 | Type 2-diabetes | Phase 3 | Completed | - | Germany ... 展开 >> Clinical Research Unit, Department of Nephrology and Hypertension, University of Erlangen-Nürnberg Erlangen, Germany, 91054 Clinical Research Unit, Department of Nephrology and Hypertension, University of Erlangen-Nürnberg Nuremberg, Germany, 90471 收起 << |
NCT02653131 | Short Bowel Syndrome | Phase 4 | Unknown | December 2017 | Poland ... 展开 >> Stanley Dudrick's Memorial Hospital Recruiting Skawina, Poland, 32-050 Contact: Stanislaw Klek, Assoc. Prof. +48604293566 klek@poczta.onet.pl Principal Investigator: Stanislaw Klek, Assoc. Prof. 收起 << |
NCT00565526 | - | Completed | - | United States, Maryland ... 展开 >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 收起 << | |
NCT03232034 | Obesity Diabe... 展开 >>tes 收起 << | Not Applicable | Completed | - | United Kingdom ... 展开 >> University of Bath Bath, United Kingdom 收起 << |
NCT00775684 | Pre-diabetes ... 展开 >>Type 2 Diabetes 收起 << | Not Applicable | Completed | - | United States, Pennsylvania ... 展开 >> Clinical and Translational Research Center, Hospital of University of Pennsylvania Philadelphia, Pennsylvania, United States, 19104 Rodebaugh Diabetes Center, Hospital of the University of Pennsylvania Philadelphia, Pennsylvania, United States, 19104 Pennsylvania Hospital Philadelphia, Pennsylvania, United States, 19107 收起 << |
NCT01601561 | Cardiac Surgery | Not Applicable | Unknown | - | Canada, Quebec ... 展开 >> Royal Victoria Hospital, McGill University Health Centre Recruiting Montreal, Quebec, Canada, H3A 1A1 Contact: Roupen Hatzakorzian, MD 514 934 1934 ext 31104 roupenhatz@hotmail.com Contact: Thomas Schricker, MD PhD 514 934 1934 ext 36057 thomas.schricker@mcgill.ca 收起 << |
NCT01765894 | - | Completed | - | Denmark ... 展开 >> XLab, Center for Healthy Aging, Department of Biomedical Sciences, University of Copenhagen Copenhagen, Denmark, 2200 收起 << | |
NCT00813228 | Diabetes Mellitus Type 1 ... 展开 >> Diabetes Mellitus Type 2 收起 << | Phase 1 | Completed | - | United States, Maryland ... 展开 >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 收起 << |
NCT02697253 | Obesity | Phase 2 | Active, not recruiting | December 2020 | United States, New York ... 展开 >> Columbia University Medical Center - Russ Berrie Building New York, New York, United States, 10032 收起 << |
NCT01316354 | Metabolic Syndrome | Not Applicable | Completed | - | Denmark ... 展开 >> Aarhus University Hospital Aarhus, Denmark, 8000 收起 << |
NCT01739049 | Binge Eating Behaviour | Phase 4 | Completed | - | Malaysia ... 展开 >> University Kebangsaan Malaysia Medical Centre Kuala Lumpur, Wilayah Persekutuan, Malaysia, 56000 收起 << |
NCT03287076 | Acute Ischemic Stroke | Phase 2 | Recruiting | December 31, 2020 | Australia, Victoria ... 展开 >> Box Hill Hospital Recruiting Melbourne, Victoria, Australia, 3128 Contact: Christopher Bladin +61 3 9035 7338 chris.bladin@unimelb.edu.au Principal Investigator: Christopher Bladin 收起 << |
NCT00834938 | - | Completed | - | Brazil ... 展开 >> LIMED (Laboratory of Investigation of Metabolism and Diabetes)/GASTROCENTRO/Univeristy of Campinas (UNICAMP) Campinas, São Paulo, Brazil 收起 << | |
NCT02794402 | Obesity | Phase 2 | Unknown | November 2016 | Austria ... 展开 >> Department of Pediatrics, Salzburg State Hospital, Paracelsus Medical University Salzburg, Austria, 5020 Sweden Uppsala University Hospital Uppsala, Sweden, 75185 收起 << |
NCT02863276 | Diabetes Mellitus Type 2 ... 展开 >> Insulin Resistance 收起 << | Not Applicable | Completed | - | - |
NCT02229500 | Optimum Propionate Delivery to... 展开 >> the Large Intestine 收起 << | Not Applicable | Completed | - | United Kingdom ... 展开 >> Glasgow Clinical Research Facility Glasgow, Lanarkshire, United Kingdom, G4 0SF 收起 << |
NCT02302677 | - | Completed | - | - | |
NCT03777176 | Congenital Hyperinsulinism | Phase 3 | Not yet recruiting | February 2020 | United States, California ... 展开 >> Rady Children's Hospital San Diego Not yet recruiting San Diego, California, United States, 92093 United States, Colorado Children's Hospital of Colorado Not yet recruiting Aurora, Colorado, United States, 13123 United States, Pennsylvania Children's Hospital of Philadelphia Not yet recruiting Philadelphia, Pennsylvania, United States, 19104 United States, Texas Cook Children's Medical Center Not yet recruiting Fort Worth, Texas, United States, 76104 United Kingdom NHS Greater Glasgow and Clyde Not yet recruiting Glasgow, United Kingdom Great Osmond Street Hospital for Children NHS Foundation Trust Not yet recruiting London, United Kingdom Central Manchester University Hospital NHS Foundation Trust Not yet recruiting Manchester, United Kingdom 收起 << |
NCT03267758 | Cardiovascular Disease | Not Applicable | Recruiting | December 2019 | United States, Wisconsin ... 展开 >> Medical College of Wisconsin Recruiting Milwaukee, Wisconsin, United States, 53226 Principal Investigator: Michael E Widlansky 收起 << |
NCT02012842 | Metabolic Syndrome ... 展开 >> Periodontal Disease Inflammatory Response 收起 << | Not Applicable | Active, not recruiting | December 2017 | Brazil ... 展开 >> Faculty of Dentistry, Federal University of Rio Grande do Sul and Hospital de Clinicas de Porto Alegre Porto Alegre, RS, Brazil, 90035-003 Faculdade de Odontologia da UFRGS Porto Alegre, RS, Brazil, 90035003 收起 << |
NCT01342042 | Type 2 Diabetes | Phase 2 | Unknown | December 2011 | China, Beijing ... 展开 >> Peking University First Hospital Recruiting Peking, Beijing, China, 010 Contact: Cui Yi Min, MD 86-10-88325988 Principal Investigator: Cui Yi Min, MD 收起 << |
NCT03260881 | Type2 Diabetes ... 展开 >> Coronary Artery Disease 收起 << | Phase 4 | Recruiting | June 30, 2020 | United States, Florida ... 展开 >> University of Miami Recruiting Miami, Florida, United States, 33136 Contact: Gianluca Iacobellis, MD PhD 305-243-3636 giacobellis@med.miami.edu Principal Investigator: Gianluca Iacobellis, MD PhD University of Miami Recruiting Miami, Florida, United States, 33136 Contact: Gianluca Iacobellis, MD, PhD 305-243-3636 giacobellis@med.miami.edu 收起 << |
NCT03002675 | Obesity | Phase 4 | Unknown | - | Netherlands ... 展开 >> Leiden University Medical Center Recruiting Leiden, Zuid-Holland, Netherlands, 2333 ZA Contact: Ingrid Jazet, MD, PhD +33-715268161 i.m.jazet@lumc.nl Contact: Mariëtte Boon, PhD +31-715265462 m.r.boon@lumc.nl 收起 << |
NCT02451189 | Obesity Overw... 展开 >>eight 收起 << | Not Applicable | Completed | - | United Kingdom ... 展开 >> Glasgow Clinical Research Facility Glasgow, Lanarkshire, United Kingdom, G4 0SF 收起 << |
NCT01444898 | Prader-Willi Syndrome | Not Applicable | Completed | - | United States, California ... 展开 >> Children's Hospital of Los Angeles Los Angeles, California, United States, 90027 收起 << |
NCT02338193 | Diabetes Prevention in Women A... 展开 >>fter GDM Who Are at High-risk 收起 << | Phase 3 | Active, not recruiting | March 2019 | United States, Louisiana ... 展开 >> Woman's Hospital Baton Rouge, Louisiana, United States, 70815 收起 << |
NCT01364584 | Type 2 Diabetes | Not Applicable | Completed | - | United States, Colorado ... 展开 >> University of Colorado Anschutz Medical Campus Aurora, Colorado, United States, 80045 收起 << |
NCT01364584 | - | Completed | - | - | |
NCT01391884 | - | Completed | - | Denmark ... 展开 >> Department of Nephrology P, Copenhagen University Hospital, Rigshospitalet Copenhagen, Denmark, 2100 收起 << | |
NCT01593137 | Type 2 Diabetes | Phase 4 | Withdrawn(Lack of patients wit... 展开 >>h the criteria established in the protocol.) 收起 << | December 2014 | Spain ... 展开 >> Hospital Clínico San Carlos Madrid, Spain, 28040 收起 << |
NCT02125656 | Insulin Resistance ... 展开 >> Sleep Deprivation 收起 << | Not Applicable | Unknown | May 2015 | - |
NCT01444898 | - | Completed | - | - | |
NCT02280174 | Type 2 Diabetes | Phase 4 | Unknown | October 2016 | Argentina ... 展开 >> National University of Formosa Recruiting Formosa, Argentina, 3600 Contact: Juan Pa Nogueira, MD/PhD 00543704425447 nogueirajuanpatricio@gmail.com 收起 << |
NCT01856907 | Disorder of Glucose Regulation | Phase 4 | Completed | - | United States, Louisiana ... 展开 >> Woman's Hospital Baton Rouge, Louisiana, United States, 70817 收起 << |
NCT02649907 | Hormonal Response to Different... 展开 >> Compositions of Macronutrients 收起 << | Not Applicable | Unknown | October 2017 | Germany ... 展开 >> Charite Campus Mitte Recruiting Berlin, Germany, 10117 Contact: Knut Mai, MD knut.mai@charite.de Contact: Joachim Spranger, Prof joachim.spranger@charite.de 收起 << |
NCT02654665 | Non-alcoholic Fatty Liver Dise... 展开 >>ase (NAFLD) Weight Loss Non-alcoholic Steatohepatitis (NASH) 收起 << | Phase 3 | Recruiting | December 2018 | Singapore ... 展开 >> Changi General Hospital Recruiting Singapore, Singapore, 529889 Contact: Joan Khoo, MRCP +658503807 收起 << |
NCT01792193 | - | Completed | - | Germany ... 展开 >> Saarland University Homburg / Saar, Saarland, Germany, 66421 收起 << | |
NCT01856907 | - | Completed | - | - | |
NCT02076880 | Severe Obesity ... 展开 >> Type 2 Diabetes 收起 << | Not Applicable | Unknown | November 2017 | France ... 展开 >> CHU Montpellier Recruiting Montpellier, France, 34295 Contact: GALTIER Florence f-galtier@chu-montpellier.fr Principal Investigator: GALTIER Florence, MD 收起 << |
NCT01530178 | Diabetes Mellitus, Type 1 | Phase 4 | Completed | - | United States, New York ... 展开 >> Albert Einstein College of Medicine CRC Bronx, New York, United States, 10461 收起 << |
NCT01561508 | Diabetes Mellitus | Phase 2 | Withdrawn(Unable to obtain IND... 展开 >> currently) 收起 << | - | United States, Alabama ... 展开 >> University of Alabama at Birmingham Birmingham, Alabama, United States, 35233 收起 << |
NCT02170324 | Obesity | Phase 4 | Completed | - | China, Hubei ... 展开 >> Wuhan General Hospital Wuhan, Hubei, China, 430070 收起 << |
NCT02846233 | Type 2 Diabetes Mellitus | Not Applicable | Recruiting | December 2018 | United States, California ... 展开 >> UCSF Fresno Recruiting Fresno, California, United States, 93701 Contact: SOE NAING snaing@fresno.ucsf.edu 收起 << |
NCT01530178 | - | Completed | - | - | |
NCT02673138 | Type 1 Diabetes | Not Applicable | Completed | - | United States, Connecticut ... 展开 >> Yale University School of Medicine New Haven, Connecticut, United States, 06520 收起 << |
NCT03062592 | Type2 Diabetes Mellitus ... 展开 >> Obesity 收起 << | Not Applicable | Completed | - | - |
NCT02176681 | Haemodialyzed, Type 2 Diabetes | Phase 4 | Completed | - | France ... 展开 >> CH d'Amiens Amiens, France, 80054 CH de Besançon Besancon, France, 25030 AURAL Colmar Colmar, France, 68000 Hospices civils de Colmar Colmar, France, 68024 CH de Dijon Dijon, France, 21079 AURAL Mulhouse Mulhouse, France, 68070 CH de Mulhouse Mulhouse, France, 68070 CH de Nancy Nancy, France, 54000 AURAL Clinique Sainte Anne Strasbourg, France, 67000 Clinique Sainte Anne Strasbourg, France, 67000 Hôpitaux Universitaires de Strasbourg Strasbourg, France, 67091 AURAL Strasbourg Strasbourg, France, 67200 CH de Valenciennes Valenciennes, France, 59300 收起 << |
NCT03305367 | Type 2 Diabetes Mellitus | Not Applicable | Completed | - | Denmark ... 展开 >> Department of Endocrinology Odense, Denmark, 5000 收起 << |
NCT02942056 | Diabetes Mellitus | Phase 2 | Not yet recruiting | January 2020 | - |
NCT02673138 | - | Completed | - | - | |
NCT00596427 | Diabetes | Not Applicable | Completed | - | United States, California ... 展开 >> Diablo Clinical Research, Inc Walnut Creek, California, United States, 94598 United States, Florida Clinical Pharmacology of Miami, Inc Miami, Florida, United States, 33014 United States, Texas Diabetes & Glandular Disease Research Associates San Antonio, Texas, United States, 78229 收起 << |
NCT01607450 | - | Completed | - | - | |
NCT03552315 | Postprandial Hyperglycemia ... 展开 >> Metabolic Syndrome Type 2 Diabetes Mellitus 收起 << | Not Applicable | Recruiting | November 30, 2018 | Sweden ... 展开 >> Dept Experimental Medical Science, Lund University Recruiting Lund, Sweden Contact: Kristina E Andersson, PhD +46 709 307357 kristina_e.andersson@med.lu.se 收起 << |
NCT00596427 | - | Completed | - | - | |
NCT01051011 | Diabetes Mellitus Type 2 | Phase 3 | Terminated(high discontinuatio... 展开 >>n rates mainly due to GI tolerability and implementation of risk mitigation plan to address hypersensitivity reactions) 收起 << | - | - |
NCT00042601 | Diabetes Mellitus, Type 1 ... 展开 >> Diabetes Mellitus, Type 2 收起 << | Phase 2 | Completed | - | Australia, South Australia ... 展开 >> Royal Adelaide Hospital Adelaide, South Australia, Australia, 5000 收起 << |
NCT03556098 | Diabetes Mellitus, Type 1 | Not Applicable | Recruiting | January 1, 2020 | Denmark ... 展开 >> Steno Diabetes Center Copenhagen, Clinical Metabolic Physiology Recruiting Hellerup, Denmark, 2900 Contact: Bjørn Hoe, MD 004553634340 bjoern.hoe@regionh.dk Contact: Filip K Knop, PhD, MD filip.krag.knop.01@regionh.dk 收起 << |
NCT01654120 | Diabetes Mellitus, Type II | Phase 4 | Completed | - | United States, North Carolina ... 展开 >> Mountain Diabetes and Endocrine Center Asheville, North Carolina, United States, 28803 收起 << |
NCT01856595 | Diabetes Mellitus, Type 2 | Phase 1 | Completed | - | United States, California ... 展开 >> Anaheim Clinical Trials Anaheim, California, United States, 92801 Profil Institute for Clinical Research, Inc. Chula Vista, California, United States, 91911 United States, Florida MRA Clinical Research, LLC South Miami, Florida, United States, 33143 收起 << |
NCT03680248 | Hepatic Fat Content | Not Applicable | Recruiting | December 2019 | Czechia ... 展开 >> Institute for Clinical and Experimental Medicine Recruiting Prague 4, Czechia, 14021 Contact: Jan Kovar, PhD +420 261363369 jan.kovar@ikem.cz Contact: Tereza Dusilova, MSc +420 261362728 tereza.dusilova@ikem.cz 收起 << |
NCT01952145 | Diabetes Diab... 展开 >>etes Mellitus, Type 2 收起 << | Phase 3 | Completed | - | - |
NCT01170715 | Psoriasis | Not Applicable | Completed | - | United States, New York ... 展开 >> The Rockefeller University New York, New York, United States, 10065 收起 << |
NCT01952145 | - | Completed | - | - | |
NCT01408628 | Type 2 Diabetes | Not Applicable | Completed | - | United States, Kansas ... 展开 >> The University of Kansas Medical Center Kansas City, Kansas, United States, 66160 收起 << |
NCT01408628 | - | Completed | - | - | |
NCT00950599 | Type 2 Diabetes Mellitus | Phase 2 | Completed | - | - |
NCT03279211 | Amino Acid | Not Applicable | Not yet recruiting | July 2019 | - |
NCT03415139 | - | Not yet recruiting | April 2025 | United States, Tennessee ... 展开 >> Vanderbilt University Medical Center Not yet recruiting Nashville, Tennessee, United States, 37232 Contact: VICC Clinical Trials Information Program 800-811-8480 Contact: Brian G Engelhardt, MD 615-936-0381 brian.engelhardt@vanderbilt.edu 收起 << | |
NCT03310476 | Overweight and Obesity | Not Applicable | Recruiting | January 2019 | United States, Texas ... 展开 >> Texas Woman's University Recruiting Houston, Texas, United States, 77030 Contact: Mindy A Patterson, PhD, RDN 713-794-2375 mmaziarz@twu.edu 收起 << |
NCT01856595 | - | Completed | - | - | |
NCT00950599 | - | Completed | - | - | |
NCT01092663 | Diabetes Mellitus, Type 2 | Not Applicable | Completed | - | United States, California ... 展开 >> University of California, San Francisco San Francisco, California, United States, 94110 United States, Florida Clinical Pharmacology of Miami Miami, Florida, United States, 33014 United States, Texas Healthcare Discoveries, LLC d/b/a ICON Development Solutions San Antonio, Texas, United States, 78209 收起 << |
NCT01841359 | Hypoglycemia ... 展开 >>Evidence of Previous Gastric Surgery 收起 << | Phase 4 | Active, not recruiting | October 2018 | United States, Massachusetts ... 展开 >> Joslin Diabetes Center Boston, Massachusetts, United States, 02215 收起 << |
NCT01469351 | Alzheimers Disease | Not Applicable | Completed | - | Denmark ... 展开 >> Aarhus University Aarhus, Denmark, 8000 收起 << |
NCT01505673 | Type 2 Diabetes Mellitus ... 展开 >> Obesity 收起 << | Phase 4 | Completed | - | United States, Texas ... 展开 >> UT Southwestern Dallas, Texas, United States, 75390 收起 << |
NCT01505673 | - | Completed | - | - | |
NCT01092663 | - | Completed | - | - | |
NCT02635386 | Polycystic Ovary Syndrome ... 展开 >> Obesity 收起 << | Phase 3 | Recruiting | August 2019 | United States, Louisiana ... 展开 >> Woman's Hospital Recruiting Baton Rouge, Louisiana, United States, 70815 Contact: Karen Elkind-Hirsch, PhD. 225-231-5278 Contact: Ericka Seidemann, MS 225-231-5275 ericka.seidemann@womans.org Principal Investigator: Karen Elkind-Hirsch, Ph.D. Sub-Investigator: Renee Harris, M.D. 收起 << |
NCT00957268 | Diabetes Mellitus, Type 2 | Phase 1 | Completed | - | United States, Florida ... 展开 >> Miami, Florida, United States Pineallas Park, Florida, United States United States, Kentucky Louisville, Kentucky, United States United States, North Carolina Durham, North Carolina, United States United States, Pennsylvania Philadelphia, Pennsylvania, United States United States, Tennessee Memphis, Tennessee, United States United States, Texas San Antonio, Texas, United States 收起 << |
NCT02621489 | Atherosclerosis ... 展开 >> Diabetes Restenosis 收起 << | Phase 4 | Recruiting | December 2019 | Sweden ... 展开 >> Dept of clinical science and education Karolinska Institutet Södersjukhuset Recruiting Stockholm, Other, Sweden, 11883 Contact: Thomas Nyström, MD, PhD +4686163211 thomas.nystrom@sodersjukhuset.se Contact: Nils Witt, Md, PhD +4686161000 Sub-Investigator: Nils Witt, MD, PhD Sub-Investigator: Irene Santos, MD 收起 << |
NCT02628392 | Type2 Diabetes Mellitus | Not Applicable | Completed | - | Japan ... 展开 >> Heishinkai Medical Group Incorporated OCROM Clinic Suita-shi, Osaka, Japan 收起 << |
NCT00254254 | Type 2 Diabetes Mellitus | Phase 2 | Completed | - | United States, Arkansas ... 展开 >> Research Site Little Rock, Arkansas, United States United States, California Research Site San Diego, California, United States United States, Colorado Research Site Denver, Colorado, United States United States, Kentucky Research Site Louisville, Kentucky, United States United States, Texas Research Site San Antonio, Texas, United States 收起 << |
NCT01721382 | Cystic Fibrosis | Phase 1 | Completed | - | United States, Florida ... 展开 >> Nemours Children's Clinic Jacksonville, Florida, United States, 32207 收起 << |
NCT01408667 | Metabolic Cardiovascular Syndr... 展开 >>ome 收起 << | Phase 1 Phase 2 | Completed | - | Netherlands ... 展开 >> Academic Medical Centre, Amsterdam, Netherlands, 1100 DD 收起 << |
NCT03514576 | Hypoglycemia, Reactive | Phase 4 | Enrolling by invitation | November 1, 2018 | Denmark ... 展开 >> Zealand University Hospital Køge, Denmark, 4600 收起 << |
NCT02589002 | Glucose Metabolism Disorders | Not Applicable | Completed | - | Mexico ... 展开 >> Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran Mexico City, Distrito Federal, Mexico, 14080 收起 << |
NCT01477567 | Diabetes Mellitus, Type 2 | Phase 1 | Completed | - | Singapore ... 展开 >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Singapore, Singapore 收起 << |
NCT01724411 | Overweight and Obesity | Not Applicable | Completed | - | United Kingdom ... 展开 >> Rowett Institute of Nutrition and Health. University of Aberdeen Aberdeen, United Kingdom, AB219SB 收起 << |
NCT01477567 | - | Completed | - | - | |
NCT02931630 | Abdominal Obesity ... 展开 >> Metabolic Syndrome Type 2 Diabetes Cardiovascular Disease 收起 << | Not Applicable | Completed | - | Denmark ... 展开 >> Aarhus University Hospital, Dep. of clinical nutrition research Aarhus, Denmark, 8000 收起 << |
NCT02650947 | Healthy | Not Applicable | Completed | - | Thailand ... 展开 >> Faculty of Medicine Ramathibodi Hospital, Mahidol University Bangkok, Thailand, 10400 收起 << |
NCT01496430 | Hypertension ... 展开 >>Diabetes 收起 << | Phase 3 | Terminated(Business Decision; ... 展开 >>No Safety Or Efficacy Concerns. (See below)) 收起 << | - | - |
NCT01263483 | Type 2 Diabetes Mellitus | Phase 2 Phase 3 | Completed | - | - |
NCT01496430 | - | Terminated(Business Decision; ... 展开 >>No Safety Or Efficacy Concerns. (See below)) 收起 << | - | - | |
NCT03183193 | Non-Alcoholic Fatty Liver Dise... 展开 >>ase Obese Overweight 收起 << | Not Applicable | Recruiting | December 2019 | Spain ... 展开 >> Centre for Nutrition Research, University of Navarra Recruiting Pamplona, Navarra, Spain, 31008 Contact: M. Angeles Zulet, PhD +34948425600 ext 806317 mazulet@unav.es Contact: Itziar Abete, PhD +34948425600 ext 806357 iabetego@unav.es 收起 << |
NCT01263470 | Diabetes Mellitus, Type 2 | Phase 2 | Completed | - | Japan ... 展开 >> Okayama, Japan, 701-0192 收起 << |
NCT01263483 | - | Completed | - | - | |
NCT03115424 | Obesity | Phase 3 | Recruiting | December 2020 | United States, Minnesota ... 展开 >> Mayo Clinic in Rochester Recruiting Rochester, Minnesota, United States, 55905 收起 << |
NCT03449251 | Cardiovascular Diseases ... 展开 >> Type 2 Diabetes Mellitus 收起 << | Phase 2 | Recruiting | February 2020 | United Kingdom ... 展开 >> Addenbrooke's Hospital Recruiting Cambridge, Cambridgeshire, United Kingdom, CB20QQ Contact: Joseph Cheriyan, MBChB, FRCP 01223 926590 jc403@medschl.cam.ac.uk Principal Investigator: Joseph Cheriyan, MBChB, FRCP 收起 << |
NCT01263470 | - | Completed | - | - | |
NCT02795559 | Obesity Diabe... 展开 >>tes 收起 << | Not Applicable | Completed | - | Canada, Ontario ... 展开 >> Glycemic Index Laboratories Toronto, Ontario, Canada, M5C 2X3 收起 << |
NCT03150030 | - | Enrolling by invitation | October 1, 2019 | Denmark ... 展开 >> Gentofte Hospital Hellerup, Denmark, 2900 收起 << | |
NCT01856881 | Diabetes Mellitus | Phase 1 | Terminated(This study was term... 展开 >>inated on August 29th, 2014 due to a business decision by the Sponsor. The study was not terminated due to a safety reason.) 收起 << | - | United States, California ... 展开 >> Research Site Chula Vista, California, United States, 91911 United States, Florida Research Site Miramar, Florida, United States, 33025 United States, Kansas Research Site Overland Park, Kansas, United States, 66212 United States, Ohio Research Site Cincinnati, Ohio, United States, 45255 United States, Texas Research Site San Antonio, Texas, United States, 78209 United States, Washington Research Site Renton, Washington, United States, 98057 收起 << |
NCT01643811 | - | Completed | - | Korea, Republic of ... 展开 >> National Cancer Center Goyang, Kyeonggi-do, Korea, Republic of, 410-769 收起 << | |
NCT01529216 | Type 2 Diabetes Mellitus | Not Applicable | Completed | - | France ... 展开 >> Hospital Georges Pompidou Paris, France Netherlands Atrium Medisch Centrum Heerlen, Netherlands 收起 << |
NCT00354536 | Diabetes Mellitus, Type 2 | Phase 2 | Completed | - | United States, Florida ... 展开 >> GSK Investigational Site Miramar, Florida, United States, 33025 GSK Investigational Site Orlando, Florida, United States, 32809 United States, Hawaii GSK Investigational Site Honolulu, Hawaii, United States, 96814-4224 United States, Oregon GSK Investigational Site Portland, Oregon, United States, 97239 United States, Texas GSK Investigational Site San Antonio, Texas, United States, 78229 收起 << |
NCT01094535 | Pancreatic Cancer | Not Applicable | Withdrawn(Poor enrollment) | - | United States, New York ... 展开 >> Columbia University Medical Center New York, New York, United States, 10032 收起 << |
NCT02713555 | Diabetes Mellitus, Type 2 ... 展开 >> Obesity 收起 << | Not Applicable | Recruiting | March 2020 | Denmark ... 展开 >> Hospital Unit Midt Recruiting Viborg, Region Midt, Denmark, 8800 Contact: katrine brodersen 29411259 katrine.brodersen@rm.dk Contact: Michael F. Nielsen michanls@rm.dk 收起 << |
NCT00909597 | Diabetes Mellitus Type 2 | Phase 3 | Completed | - | - |
NCT00938158 | Diabetes Mellitus, Type 2 | Phase 1 | Completed | - | United States, Alabama ... 展开 >> GSK Investigational Site Anniston, Alabama, United States, 36207 United States, Florida GSK Investigational Site Miami, Florida, United States, 33169 GSK Investigational Site Orlando, Florida, United States, 32809 United States, Louisiana GSK Investigational Site Baton Rouge, Louisiana, United States, 70806 United States, Minnesota GSK Investigational Site Minneapolis, Minnesota, United States, 55404 South Africa GSK Investigational Site Parktown, Gauteng, South Africa, 2193 GSK Investigational Site Somerset West, South Africa, 07129 收起 << |
NCT00849017 | - | Completed | - | - | |
NCT00747968 | Type 2 Diabetes | Phase 2 Phase 3 | Completed | - | Denmark ... 展开 >> Aarhus University Hospital, Investigational Dept. M of Endocrinology Aarhus, Aarhus C, Denmark, 8000 Aarhus University Hospital, Investigational Dept. M of Endocrinology Aarhus, Denmark, 8000 C Aarhus University Hospital, Investigational Dept. M of Endocrinology Aarhus, Denmark, 8000 收起 << |
NCT00849017 | Diabetes Mellitus, Type 2 | Phase 3 | Completed | - | - |
NCT02851849 | Type 2 Diabetes Mellitus | Phase 2 | Completed | - | - |
NCT00882492 | Hyperglycemia ... 展开 >> Hypoglycemia 收起 << | Phase 1 | Completed | - | United States, Pennsylvania ... 展开 >> University of Pennsylvania Philadelphia, Pennsylvania, United States, 19104 收起 << |
NCT01098461 | Diabetes Mellitus, Type 2 | Phase 2 | Completed | - | Japan ... 展开 >> GSK Investigational Site Aichi, Japan, 466-0815 GSK Investigational Site Ehime, Japan, 790-0067 GSK Investigational Site Fukuoka, Japan, 810-0001 GSK Investigational Site Fukuoka, Japan, 811-1346 GSK Investigational Site Fukuoka, Japan, 815-8555 GSK Investigational Site Fukuoka, Japan, 819-0168 GSK Investigational Site Hiroshima, Japan, 731-0103 GSK Investigational Site Hokkaido, Japan, 003-0023 GSK Investigational Site Hokkaido, Japan, 044-0053 GSK Investigational Site Hokkaido, Japan, 061-1395 GSK Investigational Site Hokkaido, Japan, 080-0010 GSK Investigational Site Hokkaido, Japan, 080-0016 GSK Investigational Site Ibaraki, Japan, 310-0826 GSK Investigational Site Ibaraki, Japan, 311-0113 GSK Investigational Site Kagoshima, Japan, 891-0401 GSK Investigational Site Kanagawa, Japan, 210-0852 GSK Investigational Site Kanagawa, Japan, 235-0045 GSK Investigational Site Kumamoto, Japan, 862-0976 GSK Investigational Site Kumamoto, Japan, 866-0862 GSK Investigational Site Miyagi, Japan, 980-0021 GSK Investigational Site Miyagi, Japan, 985-0852 GSK Investigational Site Nagasaki, Japan, 856-0831 GSK Investigational Site Saitama, Japan, 355-0321 GSK Investigational Site Saitama, Japan, 362-0021 GSK Investigational Site Tochigi, Japan, 329-0101 GSK Investigational Site Tochigi, Japan, 329-0433 GSK Investigational Site Tokyo, Japan, 125-0054 GSK Investigational Site Tokyo, Japan, 154-0015 GSK Investigational Site Tokyo, Japan, 177-0041 GSK Investigational Site Yamagata, Japan, 990-0885 收起 << |
NCT03714594 | Glucose, Low Blood | Phase 2 | Recruiting | September 2021 | Italy ... 展开 >> Department of Endocrinology and Metabolism, University of Pisa Recruiting Pisa, Italy, 56124 Contact: Stefano Del Prato, MD +39 050 995103 stefano.delprato@med.unipi.it Sub-Investigator: Giuseppe Daniele, MD 收起 << |
NCT01492465 | Diabetes Mellitus | Phase 1 | Terminated(Decision by Sponsor... 展开 >>) 收起 << | - | United States, Nebraska ... 展开 >> Research Site Omaha, Nebraska, United States, 68154 United States, Texas Research Site San Antonio, Texas, United States, 78209 San Antonio, Texas, United States, 78209 收起 << |
NCT01972542 | Diabetes Pred... 展开 >>iabetes 收起 << | Not Applicable | Completed | - | Korea, Republic of ... 展开 >> Seoul National University Bundang Hospital Seongnam, Korea, Republic of, 463-707 收起 << |
NCT02537314 | Obesity | Phase 1 | Enrolling by invitation | April 2019 | United States, Tennessee ... 展开 >> Vanderbilt University Medical Center Nashville, Tennessee, United States, 37232 收起 << |
NCT01357889 | Diabetes Mellitus, Type 2 | Phase 2 | Completed | - | - |
NCT02891954 | Diabetes Mellitus, Type 2 | Phase 1 | Enrolling by invitation | June 30, 2023 | - |
NCT02532855 | Type 2 Diabetes Mellitus | Phase 3 | Completed | - | - |
NCT01098461 | - | Completed | - | - | |
NCT01357889 | - | Completed | - | - | |
NCT01006291 | Diabetes Diab... 展开 >>etes Mellitus, Type 2 收起 << | Phase 3 | Completed | - | - |
NCT01009580 | Diabetes Diab... 展开 >>etes Mellitus, Type 2 收起 << | Phase 3 | Completed | - | - |
NCT01006291 | - | Completed | - | - | |
NCT01009580 | - | Completed | - | - | |
NCT01954147 | Type 2 Diabetes | Phase 1 Phase 2 | Unknown | October 2015 | China, Fujian ... 展开 >> Diabetes Care Center of Nanjing Military Command Fuzhou, Fujian, China, 350025 收起 << |
NCT02505334 | Diabetes Diab... 展开 >>etes Mellitus, Type 2 收起 << | Phase 3 | Completed | - | Japan ... 展开 >> Novo Nordisk Investigational Site Annaka-shi, Gunma, Japan, 379 0116 Novo Nordisk Investigational Site Chitose, Hokkaido, Japan, 066-0032 Novo Nordisk Investigational Site Chuo-ku Tokyo, Japan, 103-0027 Novo Nordisk Investigational Site Chuo-ku, Tokyo, Japan, 103 0002 Novo Nordisk Investigational Site Chuo-ku, Tokyo, Japan, 103 0027 Novo Nordisk Investigational Site Chuo-ku,, Japan, 104 0061 Novo Nordisk Investigational Site Fukuoka-shi, Fukuoka, Japan Novo Nordisk Investigational Site Higashiosaka-shi, Osaka, Japan Novo Nordisk Investigational Site Hokkaido, Japan, 078-8236 Novo Nordisk Investigational Site Ichikawa-shi, Chiba, Japan Novo Nordisk Investigational Site Iruma-shi, Saitama, Japan, 358 0011 Novo Nordisk Investigational Site Izumisano-shi, Japan, 598 0048 Novo Nordisk Investigational Site Kashiwara-shi, Osaka, Japan, 582 0005 Novo Nordisk Investigational Site Kawagoe-shi, Saitama, Japan, 350 0851 Novo Nordisk Investigational Site Kobe-shi, Hyogo, Japan Novo Nordisk Investigational Site Kumamoto-shi,Kumamoto, Japan, 862 0976 Novo Nordisk Investigational Site Mito-shi, Ibaraki, Japan, 310-0845 Novo Nordisk Investigational Site Mito-shi, Ibaraki, Japan Novo Nordisk Investigational Site Miyazaki-shi, Japan, 880 0034 Novo Nordisk Investigational Site Naka-shi, Ibaraki, Japan, 311 0113 Novo Nordisk Investigational Site Neyagawa-shi, Osaka, Japan Novo Nordisk Investigational Site Nishinomiya-shi, Hygo, Japan, 662 0971 Novo Nordisk Investigational Site Nishinomiya-shi, Hyogo, Japan, 663-8501 Novo Nordisk Investigational Site Oita-shi, Japan, 870 0039 Novo Nordisk Investigational Site Okawa-shi, Fukuoka, Japan, 831 0016 Novo Nordisk Investigational Site Osaka-shi, Osaka, Japan, 553 0003 Novo Nordisk Investigational Site Osaka-shi, Osaka, Japan, 5590012 Novo Nordisk Investigational Site Oyama-shi, Tochigi, Japan, 323 0022 Novo Nordisk Investigational Site Saga-shi,Saga, Japan, 849 0937 Novo Nordisk Investigational Site Sapporo-shi, Hokkaido, Japan, 060 0062 Novo Nordisk Investigational Site Sapporo-shi, Hokkaido, Japan, 060-0001 Novo Nordisk Investigational Site Sapporo-shi, Hokkaido, Japan, 062 0007 Novo Nordisk Investigational Site Sappro-shi, Hokkaido, Japan, 060 8648 Novo Nordisk Investigational Site Shimotsuke-shi, Tochigi, Japan, 329 0433 Novo Nordisk Investigational Site Shinjuku-ku, Tokyo, Japan, 160-0008 Novo Nordisk Investigational Site Shizuoka-shi, Japan, 424 0853 Novo Nordisk Investigational Site Suita-shi, Osaka, Japan, 565-0853 Novo Nordisk Investigational Site Takatsuki-shi, Osaka, Japan, 569 1096 Novo Nordisk Investigational Site Tokyo, Japan, 103-0028 Novo Nordisk Investigational Site Tokyo, Japan, 105-8471 Novo Nordisk Investigational Site Tokyo, Japan, 123-0845 Novo Nordisk Investigational Site Tokyo, Japan, 144-0051 Novo Nordisk Investigational Site Tokyo, Japan, 169-0073 Novo Nordisk Investigational Site Tokyo, Japan, 181-0013 Novo Nordisk Investigational Site Yokohama, Kanagawa, Japan, 236-0004 Novo Nordisk Investigational Site Yokohama-shi Kanagawa, Japan, 232-0064 Novo Nordisk Investigational Site Yokohama-shi, Japan, 235 0045 收起 << |
NCT01988545 | Healthy | Not Applicable | Unknown | December 2014 | Denmark ... 展开 >> Køge Hospital Recruiting Køge, State..., Denmark, 4600 Contact: lasse bremholm, MD, ph.d. 004560927874 lassebremholm@dadlnet.dk Principal Investigator: Lasse Bremholm, MD, ph.d. 收起 << |
NCT02442791 | Cardiac Arrest ... 展开 >> Coma 收起 << | Not Applicable | Completed | - | Denmark ... 展开 >> Kardiologisk Afdeling, Rigshospitalet Copenhagen, Denmark, DK-2100 收起 << |
NCT02505334 | - | Completed | - | - | |
NCT02650596 | Heart Failure | Not Applicable | Unknown | February 2018 | China, Beijing ... 展开 >> PLA General Hospital Recruiting Beijing, Beijing, China, 100853 Contact: Yang Shi, M.D. +8610-66876231 ggyyong@sina.com Principal Investigator: Yu Tang Wang, M.D. 收起 << |
NCT02500979 | Type 1 Diabetes Mellitus | Phase 1 | Completed | - | United States, California ... 展开 >> Research Site Chula Vista, California, United States, 91911 United States, Oregon Research Site Portland, Oregon, United States, 97239 United States, Tennessee Research Site Chattanooga, Tennessee, United States, 37411 收起 << |
NCT03249506 | - | Completed | - | United States, Pennsylvania ... 展开 >> Health ResearchTx, LLC Trevose, Pennsylvania, United States, 19053 收起 << | |
NCT02417103 | Obesity | Phase 3 | Terminated(Recruiting failure) | - | Germany ... 展开 >> University Medical Center Hamburg Hamburg, Germany, 20246 收起 << |
NCT02550548 | Insulin Secretion | Phase 1 | Active, not recruiting | August 2019 | United States, North Carolina ... 展开 >> Duke Center for Living Durham, North Carolina, United States, 27705 收起 << |
NCT02532855 | - | Completed | - | - | |
NCT01301833 | Type 2 Diabetes Mellitus | Phase 3 | Completed | - | Japan ... 展开 >> Chitose-shi, Hokkaidou, Japan 收起 << |
NCT01530061 | Appetite | Not Applicable | Unknown | April 2013 | United States, Louisiana ... 展开 >> Pennington Biomedical Research Center Baton Rouge, Louisiana, United States, 70808 收起 << |
NCT02520258 | Glucose Metabolism Disorder | Not Applicable | Recruiting | June 2020 | United States, New York ... 展开 >> The Rockefeller University Recruiting New York, New York, United States, 10065 Contact: Recruitment Specialist 800-782-2737 rucares@rockefeller.edu Contact: Thomas Huber, PhD 212 327 8283 hubert@rockefeller.edu Principal Investigator: Thomas Huber, PhD 收起 << |
NCT01301833 | - | Completed | - | - | |
NCT00982228 | - | Completed | - | - | |
NCT03478098 | Roux-en-Y Gastric Bypass ... 展开 >> Obesity 收起 << | Not Applicable | Recruiting | June 1, 2019 | Denmark ... 展开 >> Department of Endocrinology, Hvidovre Hospital Recruiting Hvidovre, Denmark, DK-2650 Contact: Kirstine N Bojsen-Moller, MD, PHD +4538626371 kirstine.bojsen-moeller@regionh.dk 收起 << |
NCT02015780 | Type 2 Diabetes Mellitus ... 展开 >> Chronic Kidney Disease 收起 << | Phase 3 | Withdrawn(Due to potential con... 展开 >>cerns about liver safety (See Detailed Description)) 收起 << | January 2016 | - |
NCT02682680 | Type 2 Diabetes Mellitus | Phase 4 | Unknown | December 2017 | Canada, Alberta ... 展开 >> LMC Calgary Not yet recruiting Calgary, Alberta, Canada Contact: Akshay Jain, MD 403-288-3224 calgaryresearch@lmc.ca Canada, Ontario LMC Barrie Recruiting Barrie, Ontario, Canada Contact: Hani Alasaad, MBBS 705-737-0830 barrieresearch@lmc.ca LMC Brampton Recruiting Brampton, Ontario, Canada, L6S 0C9 Contact: Harpreet Bajaj, MBBS, MPH 905-595-0560 bramptonresearch@lmc.ca LMC Etobicoke Recruiting Etobicoke, Ontario, Canada Contact: Hasnain Khandwala, MBBS 416-645-1035 etobicokeresearch@lmc.ca LMC Markham Recruiting Markham, Ontario, Canada Contact: Nikhil Gupta, MBBS, MPH 905-294-0800 markhamresearch@lmc.ca LMC Oakville Recruiting Oakville, Ontario, Canada Contact: David Twum-Barima, MB ChB, MSc 905-337-0040 oakvilleresearch@lmc.ca LMC Thornhill Recruiting Thornhill, Ontario, Canada Contact: Ronald Goldenberg, MD 905-763-8660 thornhillresearch@lmc.ca LMC Bayview Recruiting Toronto, Ontario, Canada Contact: Ronnie Aronson, MD 416-645-2929 torontoresearch@lmc.ca 收起 << |
NCT02500979 | - | Completed | - | - | |
NCT02227849 | Type 2 Diabetes Mellitus | Phase 4 | Completed | - | Japan ... 展开 >> Reserch site Chubu, Japan Reserch site Hokkaido, Japan Reserch site Kanto, Japan Reserch site Kinki, Japan 收起 << |
NCT00982228 | Diabetes Diab... 展开 >>etes Mellitus, Type 1 收起 << | Phase 3 | Completed | - | - |
NCT01087372 | - | Completed | - | Spain ... 展开 >> Hospital Universitari Son Dureta. Intensive Care Unit Palma de Mallorca, Illes Balears, Spain, 07014 收起 << | |
NCT01386541 | Type 2 Diabetes Mellitus | Phase 1 | Completed | - | Germany ... 展开 >> Nycomed Investigational site Mannheim, Germany, 68167 收起 << |
NCT02505958 | Obesity | Not Applicable | Unknown | July 2016 | United States, Pennsylvania ... 展开 >> Temple University Hospital Philadelphia, Pennsylvania, United States, 19140 收起 << |
NCT03769883 | Type 2 Diabetes Mellitus ... 展开 >> Type2 Diabetes Diabetes Mellitus, Type 2 Type2 Diabetes Mellitus 收起 << | Not Applicable | Recruiting | August 2021 | Denmark ... 展开 >> Center for Physical Activity Research, Copenhagen University Hospital Recruiting Copenhagen, Denmark, 2100 Contact: Mathias Ried-larsen, PhD 0045 35 45 06 99 mathias.ried-larsen@regionh.dk Contact: Inge Holm 0045 35 45 76 21 inge.holm@regionh.dk 收起 << |
NCT01059799 | Diabetes Diab... 展开 >>etes Mellitus, Type 2 收起 << | Phase 3 | Completed | - | - |
NCT02204813 | Bypass, Gastric ... 展开 >> Roux-en-Y Gastric Bypass Vertical Sleeve Gastrectomy Gastric Banding Bariatric Surgery 收起 << | Phase 1 | Completed | - | United States, Missouri ... 展开 >> Washington University School of Medicine Saint Louis, Missouri, United States, 63110 收起 << |
NCT02745470 | Diabetes Mellitus | Not Applicable | Completed | - | Korea, Republic of ... 展开 >> Seoul National University Hospital Seoul, Korea, Republic of, 110-744 收起 << |
NCT01593605 | Impaired Glucose Tolerance | Not Applicable | Completed | - | United States, Tennessee ... 展开 >> Facility: Vanderbilt University Nashville, Tennessee, United States, 37232 收起 << |
NCT01059799 | - | Completed | - | - | |
NCT01678742 | Diabetes Mellitus ... 展开 >> Obesity 收起 << | Not Applicable | Completed | - | Korea, Republic of ... 展开 >> Jeju National University Hospital Jeju, Korea, Republic of, 690-767 收起 << |
NCT02098395 | - | Completed | - | - | |
NCT00729326 | Type 2 Diabetes Mellitus | Phase 4 | Completed | - | United States, Texas ... 展开 >> Research Site San Antonio, Texas, United States 收起 << |
NCT02255812 | Exploratory Behavior | Not Applicable | Completed | - | Switzerland ... 展开 >> University Hospital Basel, Switzerland, CH-4031 收起 << |
NCT02098395 | Diabetes Diab... 展开 >>etes Mellitus, Type 1 收起 << | Phase 3 | Completed | - | - |
NCT03034226 | Hypoglycemia ... 展开 >>Diabetes Mellitus, Type 1 收起 << | Not Applicable | Active, not recruiting | October 2019 | Denmark ... 展开 >> Department of Clinical Medicine Aarhus, Denmark, 8000 收起 << |
NCT00566813 | - | Completed | - | - | |
NCT00566813 | Diabetes Mellitus, Type 1 | Phase 1 Phase 2 | Completed | - | United States, Illinois ... 展开 >> University of Illinois at Chicago Chicago, Illinois, United States, 60612 收起 << |
NCT00729326 | - | Completed | - | - | |
NCT02254291 | Diabetes Diab... 展开 >>etes Mellitus, Type 2 收起 << | Phase 3 | Completed | - | Japan ... 展开 >> Novo Nordisk Investigational Site Asahikawa-shi, Hokkaido, Japan, 070 0002 Novo Nordisk Investigational Site Chitose, Hokkaido, Japan, 066-0032 Novo Nordisk Investigational Site Chuo-ku Tokyo, Japan, 103-0027 Novo Nordisk Investigational Site Chuo-ku Tokyo, Japan, 104-0031 Novo Nordisk Investigational Site Chuo-ku, Tokyo, Japan, 103 0027 Novo Nordisk Investigational Site Ebina-shi, Japan, 243 0432 Novo Nordisk Investigational Site Izumisano-shi, Japan, 598 0048 Novo Nordisk Investigational Site Kashiwara-shi, Osaka, Japan, 582 0005 Novo Nordisk Investigational Site Katsushika-ku, Tokyo, Japan, 125 0054 Novo Nordisk Investigational Site Kumamoto-shi,Kumamoto, Japan, 862 0976 Novo Nordisk Investigational Site Naka-shi, Ibaraki, Japan, 311 0113 Novo Nordisk Investigational Site Nishinomiya-shi, Hygo, Japan, 662 0971 Novo Nordisk Investigational Site Oita-shi, Japan, 870 0039 Novo Nordisk Investigational Site Osaka-shi, Osaka, Japan, 553 0003 Novo Nordisk Investigational Site Ota-ku, Tokyo, Japan, 144 0035 Novo Nordisk Investigational Site Ota-ku, Tokyo, Japan Novo Nordisk Investigational Site Sapporo-shi, Hokkaido, Japan, 060 0062 Novo Nordisk Investigational Site Sapporo-shi, Hokkaido, Japan, 060-0001 Novo Nordisk Investigational Site Shimotsuke-shi, Tochigi, Japan, 329 0433 Novo Nordisk Investigational Site Shinjuku-ku, Tokyo, Japan, 160-0008 Novo Nordisk Investigational Site Suita-shi, Osaka, Japan, 565-0853 Novo Nordisk Investigational Site Takatsuki-shi, Osaka, Japan, 569 1096 Novo Nordisk Investigational Site Tokyo, Japan, 181-0013 Novo Nordisk Investigational Site Yokohama, Kanagawa, Japan, 236-0004 Novo Nordisk Investigational Site Yokohama-shi, Japan, 235 0045 收起 << |
NCT00883558 | - | Completed | - | - | |
NCT02254291 | - | Completed | - | - | |
NCT01959529 | Diabetes Diab... 展开 >>etes Mellitus, Type 2 收起 << | Phase 3 | Completed | - | - |
NCT02722200 | Obesity | Phase 1 | Active, not recruiting | November 2018 | United States, Connecticut ... 展开 >> Yale University New Haven, Connecticut, United States, 06511 收起 << |
NCT00372957 | - | Completed | - | - | |
NCT02637388 | Obesity | Not Applicable | Unknown | December 2016 | United Kingdom ... 展开 >> Queen Margaret University, Edinburgh Musselburgh, East Lothain, United Kingdom, EH21 6UU 收起 << |
NCT00883558 | Diabetes Mellitus, Type 1 | Phase 2 | Completed | - | United States, Colorado ... 展开 >> Barbara Davis Center for Childhood Diabetes Aurora, Colorado, United States, 80045 United States, Florida Diabetes Research Institute Miami, Florida, United States, 33136 United States, Michigan Henry Ford Health System Detroit, Michigan, United States, 48202 United States, Montana Mercury Street Medical Butte, Montana, United States, 59701 United States, North Carolina UNC Diabetes Care Center/Highgate Specialty Center Durham, North Carolina, United States, 27713 United States, Ohio Cleveland Clinic Cleveland, Ohio, United States, 44195 United States, Texas Texas Diabetes and Endocrinology Austin, Texas, United States, 78731 United States, Washington West Olympia Internal Medicine Olympia, Washington, United States, 98502 收起 << |
NCT00823992 | Diabetes Mellitus Type 2 | Phase 3 | Completed | - | - |
NCT01959529 | - | Completed | - | - | |
NCT01871844 | Healthy Male Volunteers | Phase 1 | Completed | - | Italy ... 展开 >> Centro Ricerche Cliniche Verona, Italy United Kingdom Quotient Clinical Ruddington, Nottingham, United Kingdom, NG116JS 收起 << |
NCT01119846 | Diabetes Mellitus, Type 2 | Phase 2 | Completed | - | United States, Arizona ... 展开 >> GSK Investigational Site Phoenix, Arizona, United States, 85013 United States, California GSK Investigational Site Chula Vista, California, United States, 91910 United States, Florida GSK Investigational Site Miami, Florida, United States, 33169 United States, North Carolina GSK Investigational Site Durham, North Carolina, United States, 27705 United States, Ohio GSK Investigational Site Columbus, Ohio, United States, 43212 United States, Texas GSK Investigational Site San Antonio, Texas, United States, 78209 United States, Washington GSK Investigational Site Tacoma, Washington, United States, 98418 收起 << |
NCT00372957 | Diabetes Mellitus, Type 2 | Phase 2 | Completed | - | - |
NCT00853151 | Diabetes Mellitus, Type 2 | Phase 1 | Completed | - | - |
NCT01119846 | - | Completed | - | - | |
NCT01079234 | Diabetes Diab... 展开 >>etes Mellitus, Type 1 收起 << | Phase 3 | Completed | - | - |
NCT02607410 | Type 2 Diabetes Mellitus | Phase 4 | Completed | - | Brazil ... 展开 >> University of Sao Paulo General Hospital Sao Paulo, Brazil, 05403-000 收起 << |
NCT01541215 | Diabetes Diab... 展开 >>etes Mellitus, Type 2 收起 << | Phase 3 | Completed | - | - |
NCT01749163 | Extra-pancreatic Incretin Effe... 展开 >>ct Glucose Effectiveness 收起 << | Not Applicable | Completed | - | Denmark ... 展开 >> Rigshospitalet Copenhagen, Capital Region, Denmark, 2100 收起 << |
NCT01079234 | - | Completed | - | - | |
NCT00753896 | Type 2 Diabetes | Phase 3 | Completed | - | United States, Arizona ... 展开 >> Research Site Mesa, Arizona, United States Research Site Tempe, Arizona, United States United States, California Research Site Concord, California, United States Research Site Fresno, California, United States Research Site La Mesa, California, United States United States, Georgia Research Site Atlanta, Georgia, United States United States, Idaho Research Site Idaho Falls, Idaho, United States United States, Kentucky Research Site Bowling Green, Kentucky, United States United States, Oregon Research Site Corvallis, Oregon, United States United States, Tennessee Research Site Chattanooga, Tennessee, United States Research Site Memphis, Tennessee, United States Canada, British Columbia Research Site New Westminister, British Columbia, Canada Canada, Ontario Research Site Ajax, Ontario, Canada Research Site Cambridge, Ontario, Canada Research Site Windsor, Ontario, Canada Mexico Research Site Chihuahua, Chiuahua, Mexico Research Site Monterrey, Nuevo Leon, Mexico Research Site Distrito Federal, Mexico Romania Research Site Baia Mare, Romania Research Site Brasov, Romania Research Site Bucharesti, Romania Research Site Craiova, Romania Research Site Iasi, Romania Research Site Suceava, Romania South Africa Research Site Johannesburg, South Africa Research Site Pretoria, South Africa 收起 << |
NCT00733577 | Diabetes Mellitus, Type 2 | Phase 1 | Completed | - | United States, Florida ... 展开 >> GSK Investigational Site Miami, Florida, United States, 33169 GSK Investigational Site Orlando, Florida, United States, 32809 United States, New Jersey GSK Investigational Site Hackensack, New Jersey, United States, 07601 United States, Texas GSK Investigational Site San Antonio, Texas, United States, 78209 收起 << |
NCT00853151 | - | Completed | - | - | |
NCT00476879 | Metabolism Fa... 展开 >>tty Liver 收起 << | Not Applicable | Completed | - | Denmark ... 展开 >> Medical department M, Arhus Sygehus, Region midtjylland Aarhus, Denmark, 8000 收起 << |
NCT02077452 | Type 2 Diabetes Mellitus | Phase 1 | Completed | - | - |
NCT02204397 | Type 1 Diabetes Mellitus | Phase 2 | Completed | - | Canada, Quebec ... 展开 >> Montreal General Hospital Montreal, Quebec, Canada, H3G 1A4 收起 << |
NCT01527747 | Type 2 Diabetes ... 展开 >> Hypertriglyceridemia 收起 << | Phase 4 | Enrolling by invitation | December 2020 | United States, Oregon ... 展开 >> Oregon Health & Science University Portland, Oregon, United States, 97239 收起 << |
NCT00753896 | - | Completed | - | - | |
NCT03358745 | Metabolic Syndrome X ... 展开 >> Insulin Resistance Hyperinsulinism Glucose Metabolism Disorders Metabolic Diseases 收起 << | Not Applicable | Active, not recruiting | January 30, 2019 | Sweden ... 展开 >> Antidiabetic Food Centre, Chemical Centre. Lund University Lund, Skane, Sweden, 221 00 Food for Health Science Centre. Lund University Medicon Village Lund, Sweden, SE 223 81 收起 << |
NCT02686177 | Type 2 Diabetes | Phase 4 | Recruiting | June 18, 2019 | France ... 展开 >> Nutrition department, pole ENDO - Assistance Publique Hôpitaux Marseille Recruiting Marseille, France, 13005 Contact: Anne DUTOUR, MD, PhD 33 4 91 38 29 63 anne.dutour@ap-hm.fr 收起 << |
NCT02933788 | Type 2 Diabetes Mellitus | Phase 4 | Unknown | December 2018 | - |
NCT01637272 | Dumping Syndrome | Phase 2 | Completed | - | United States, California ... 展开 >> Ximed Center for Weight Management Ximed Research La Jolla, California, United States, 92037 Stanford University Medical Center SC - SOM230X2203 Stanford, California, United States, 94304 United States, Minnesota Mayo Clinic - Rochester Mayo MN Rochester, Minnesota, United States, 55905 United States, New York Montefiore Medical Center CLCZ696B2320 Bronx, New York, United States, 10467 United States, Texas Texas Tech University Health Science Center El Paso, Texas, United States, 79905 United States, Virginia Virginia Endocrinology Research SC Chesapeake, Virginia, United States, 23321 Belgium Novartis Investigative Site Brugge, Belgium, 8310 Novartis Investigative Site Bruxelles, Belgium, 1200 Novartis Investigative Site Gent, Belgium, 9000 Novartis Investigative Site Leuven, Belgium, 3000 France Novartis Investigative Site Paris Cedex 13, France, 75651 Novartis Investigative Site Pessac Cedex, France, 33604 Novartis Investigative Site Pierre-Benite Cedex, France, 69495 Germany Novartis Investigative Site Hamburg, Germany, 20246 Novartis Investigative Site Würzburg, Germany, 97080 Netherlands Novartis Investigative Site Groningen, Netherlands, 9713 GZ Novartis Investigative Site Utrecht, Netherlands, 3584CX 收起 << |
NCT01367106 | 21-hydroxylase; Defect | Not Applicable | Active, not recruiting | June 2018 | France ... 展开 >> Hôpital saint Louis Paris, France, 75010 Professor GAUTIER Paris, France 收起 << |
NCT00351585 | Diabetes Mellitus, Type 2 | Phase 3 | Completed | - | - |
NCT00997152 | Type II Diabetes Mellitus | Phase 2 | Terminated | - | - |
NCT01397942 | Type 2 Diabetes | Not Applicable | Completed | - | Denmark ... 展开 >> Hospital Vendsyssel, Center for Clinical Research Hjørring, Nordjylland, Denmark, 9800 收起 << |
NCT01520454 | Obesity Lepti... 展开 >>n Resistance 收起 << | Not Applicable | Completed | - | United States, Massachusetts ... 展开 >> Beth Israel Deaconess Medical Center Boston, Massachusetts, United States, 02215 收起 << |
NCT01637272 | - | Completed | - | - | |
NCT01520454 | - | Completed | - | - | |
NCT01541215 | - | Completed | - | - | |
NCT01708044 | Type 1 Diabetes | Phase 1 | Completed | - | United States, Oregon ... 展开 >> Research Site Portland, Oregon, United States 收起 << |
NCT00957268 | - | Completed | - | - | |
NCT02093221 | Type 1 Diabetes Mellitus | Phase 2 | Terminated(Wk 52 primary endpo... 展开 >>int results would be unaffected by follow-up data so trial was discontinued prior to wk 104. No safety data was collected after wk 52.) 收起 << | - | - |
NCT02860923 | Craniopharyngiomas ... 展开 >> Hypothalamic Obesity 收起 << | Phase 3 | Completed | - | France ... 展开 >> CHU d'Angers Angers, France CHU de Brest Brest, France CHU de Grenoble Grenoble, France CHU de Lyon Lyon, France APHM Marseille, France Hôpital Bicêtre Paris, France Hôpital Cochin Paris, France Hôpital Européen Georges Pompidou Paris, France Hôpital Pitié Salpétrière (APHP) Paris, France Hôpital Haut-Lévêque Pessac, France CHU de Toulouse Toulouse, France 收起 << |
NCT02093221 | - | Terminated(Wk 52 primary endpo... 展开 >>int results would be unaffected by follow-up data so trial was discontinued prior to wk 104. No safety data was collected after wk 52.) 收起 << | - | - | |
NCT00286455 | Diabetes Mellitus | Phase 3 | Completed | - | - |
NCT01836523 | Diabetes Diab... 展开 >>etes Mellitus, Type 1 收起 << | Phase 3 | Completed | - | - |
NCT00286455 | - | Completed | - | - | |
NCT03461068 | Ketones Dieta... 展开 >>ry Supplements 收起 << | Phase 1 | Recruiting | December 2018 | Canada, British Columbia ... 展开 >> University of British Columbia, Okanagan. Recruiting Kelowna, British Columbia, Canada, V1V 1V7 Contact: Jonathan P Little, PHD +12508786893 jonathan.little@ubc.ca Contact: Étienne Myette-Côté, MSC 250 807 9122 myettect@ualberta.ca 收起 << |
NCT03046927 | Type 1 Diabetes | Phase 2 Phase 3 | Recruiting | July 31, 2020 | United States, Massachusetts ... 展开 >> University of Massachusetts Medical School Recruiting Worcester, Massachusetts, United States, 01655 Contact: Deepa Patel, MPH Deepa.Patel@umassmed.edu Contact: Antonio Villalobos-Ortiz, MS Antonio.Villalobos-Ortiz@umassmed.edu 收起 << |
NCT01836523 | - | Completed | - | - | |
NCT03057509 | Small Bowel Carcinoid Tumor | Phase 1 | Recruiting | September 30, 2021 | United States, Massachusetts ... 展开 >> Massachusetts general Hospital Recruiting Boston, Massachusetts, United States, 02114 Contact: Umar Mahmood, MD, PhD 617-726-6477 umahmood@mgh.harvard.edu Principal Investigator: Umar mahmood, MD, PhD Dana Farber Cancer Institute Recruiting Boston, Massachusetts, United States, 02115 Contact: Matthew Kulke, MD 617-632-5136 Mathew_kulke@dfci.harvard.edu Principal Investigator: Matthew Kulke, MD 收起 << |
NCT02505893 | Diabetes Mellitus, Type 1 | Phase 2 | Recruiting | May 2018 | Italy ... 展开 >> IRCCS San Raffaele Scientific Institute Recruiting Milan, Italy, 20132 Contact: Lorenzo Piemonti, MD piemonti.lorenzo@hsr.it Contact: Paola Maffi, MD paola.maffi@hsr.it Sub-Investigator: Paola Maffi, MD Principal Investigator: Emanuele Bosi, MD Sub-Investigator: Andrea Bolla, MD 收起 << |
NCT02535715 | Type 1 Diabetes | Phase 2 | Completed | - | United States, Texas ... 展开 >> The University of Texas Health Science Center at San Antonio San Antonio, Texas, United States, 78229 收起 << |
NCT00145353 | Type 1 Diabetes Mellitus | Phase 4 | Unknown | - | Denmark ... 展开 >> Diabetes Research Center Odense, Funen, Denmark, 5000 收起 << |
NCT03585920 | Appetitive Behavior ... 展开 >> Individual Difference Food Sensitivity Food Preferences 收起 << | Not Applicable | Recruiting | December 31, 2018 | United Kingdom ... 展开 >> Sensory Science Centre, Department of Food and Nutritional Science, University of Reading Recruiting Reading, Berkshire, United Kingdom, RG6 6UR Contact: Lisa Methven Contact: Xirui Zhou 收起 << |
NCT00259727 | - | Completed | - | United States, California ... 展开 >> VA Medical Center, San Francisco San Francisco, California, United States, 94121 收起 << | |
NCT03144271 | Diabetes Diab... 展开 >>etes Mellitus, Type 2 Healthy 收起 << | Phase 1 | Completed | - | Germany ... 展开 >> Novo Nordisk Investigational Site Neuss, Germany, 41460 收起 << |
NCT01610934 | Maturity-onset Diabetes of the... 展开 >> Young 收起 << | Phase 2 Phase 3 | Completed | - | Denmark ... 展开 >> Diabetes research Division, University Hospital Gentofte Hellerup, Denmark, 2900 收起 << |
NCT01440439 | Diabetes Mellitus, Type 1 | Phase 4 | Unknown | June 2012 | United Kingdom ... 展开 >> Wycombe Hospital Recruiting High Wycombe, Buckinghamshire, United Kingdom, HP11 2TT 收起 << |
NCT03295968 | Appetitive Behavior ... 展开 >> Pediatric Obesity 收起 << | Not Applicable | Completed | - | Canada, Ontario ... 展开 >> University of Toronto Toronto, Ontario, Canada, M5S 3E2 收起 << |
NCT03347890 | Obesity | Phase 4 | Recruiting | March 1, 2020 | Switzerland ... 展开 >> University Hospitals of Geneva Recruiting Geneva, Switzerland, 1206 Contact: Zoltan Pataky, MD zoltan.pataky@hcuge.ch Principal Investigator: Zoltan Pataky, MD Sub-Investigator: Loic Locatelli, MD 收起 << |
NCT01507311 | Diabetes Diab... 展开 >>etes Mellitus, Type 2 收起 << | Phase 1 | Completed | - | Denmark ... 展开 >> Novo Nordisk Investigational Site Århus C, Denmark, 8000 收起 << |
NCT03721991 | Type 1 Diabetes Mellitus | Not Applicable | Recruiting | July 1, 2019 | Denmark ... 展开 >> Steno Diabetes Center Copenhagen Recruiting Gentofte, Denmark, 2820 Contact: Peter Rossing, MD peter.rossing@regionh.dk Principal Investigator: Peter Rossing, MD 收起 << |
NCT02620592 | Diabetes Mellitus | Phase 1 | Completed | - | United States, California ... 展开 >> Profil Institute for Clinical Research Chula Vista, California, United States, 91911 收起 << |
NCT02770833 | Overweight | Not Applicable | Completed | - | Denmark ... 展开 >> Department of Nutrition, Exercise and Sports Copenhagen, Frederiksberg, Denmark, 1958 收起 << |
NCT00558571 | Diabetes Mellitus, Type 2 | Phase 1 | Completed | - | Germany ... 展开 >> 1245.4.49003 Boehringer Ingelheim Investigational Site Berlin, Germany 1245.4.49002 Boehringer Ingelheim Investigational Site Mainz, Germany 1245.4.49001 Boehringer Ingelheim Investigational Site Neuss, Germany 收起 << |
NCT02175459 | - | Recruiting | December 2018 | Italy ... 展开 >> Endocrinology - Catholic University Recruiting Rome, RM, Italy, 00168 Principal Investigator: ANDREA GIACCARI, MD, PHD 收起 << | |
NCT00558571 | - | Completed | - | - | |
NCT01956305 | Type 2 Diabetes Mellitus | Phase 1 | Completed | - | United States, Texas ... 展开 >> Worldwide Clinical Trials San Antonio, Texas, United States, 78217 收起 << |
NCT01088711 | Type 2 Diabetes (T2D) | Phase 1 | Completed | - | - |
NCT01241448 | - | Completed | - | - | |
NCT01088711 | - | Completed | - | - | |
NCT00754988 | Diabetes Mellitus Type 2 | Phase 3 | Completed | - | - |
NCT00744367 | Diabetes Mellitus Type 2 | Phase 3 | Completed | - | - |
NCT01098539 | Diabetes Mellitus, Type 2 | Phase 3 | Completed | - | - |
NCT01098539 | - | Completed | - | - | |
NCT01147692 | Diabetes Mellitus, Type 2 | Phase 1 | Completed | - | United States, Texas ... 展开 >> GSK Investigational Site Austin, Texas, United States, 78744 收起 << |
NCT01241448 | Diabetes Mellitus, Type 2 | Phase 2 | Completed | - | - |
NCT01128894 | - | Completed | - | - | |
NCT01147718 | Diabetes Mellitus, Type 2 | Phase 1 | Completed | - | United States, Texas ... 展开 >> GSK Investigational Site Austin, Texas, United States, 78744 收起 << |
NCT01147731 | Diabetes Mellitus, Type 2 | Phase 1 | Completed | - | United States, Texas ... 展开 >> GSK Investigational Site Austin, Texas, United States, 78744 收起 << |
NCT02234349 | Pancreas-kidney Transplantatio... 展开 >>n Kidney Transplantation 收起 << | Not Applicable | Completed | - | France ... 展开 >> Hôpital Edourad Herriot - Pavillon P LYON cedex 03, France, 69437 收起 << |
NCT01128894 | Diabetes Mellitus, Type 2 | Phase 3 | Completed | - | - |
NCT00859079 | Diabetes Mellitus Type 2 ... 展开 >> Hyperglycemia 收起 << | Phase 4 | Completed | - | Austria ... 展开 >> Medical University of Graz, Department for Internal Medicine Graz, Austria, 8036 收起 << |
NCT02367066 | Type 2 Diabetes Mellitus | Phase 1 | Completed | - | United States, California ... 展开 >> Research Site Chula Vista, California, United States 收起 << |
NCT02367066 | - | Completed | - | - | |
NCT02535299 | GLP-1;Metformin;Telomere-telom... 展开 >>erase System;Par-4 收起 << | Phase 4 | Recruiting | December 2019 | China, Chongqing ... 展开 >> Southwest Hospital of the Third Military Medical University Recruiting Chongqing, Chongqing, China, 400038 Contact: wu qi nan, doctor 13452867542 ext +86 wqn11@126.com Contact: chen bing, doctor 68754138 ext +86 chenbing3@medmail.com.cn 收起 << |
NCT01326026 | - | Completed | - | - | |
NCT01365507 | - | Completed | - | - | |
NCT02927600 | Healthy | Not Applicable | Completed | - | Singapore ... 展开 >> Clinical Nutrition Research Center Singapore, Singapore, 117599 收起 << |
NCT01364428 | Diabetes Diab... 展开 >>etes Mellitus, Type 2 收起 << | Phase 3 | Completed | - | - |
NCT01365507 | Diabetes Diab... 展开 >>etes Mellitus, Type 2 收起 << | Phase 3 | Completed | - | - |
NCT00605475 | Type 2 Diabetes Mellitus | Phase 2 | Completed | - | United States, Arkansas ... 展开 >> Arkansas Research Medical Testing Little Rock, Arkansas, United States, 72202 United States, Florida Allied Research International - Cetero Research Miami Miami, Florida, United States, 33169 Elite Research Institute Miami Miami, Florida, United States, 33169 United States, Maryland International Research Center Towson MD, Maryland, United States, 21286 United States, Oregon Covance Clinical Research Unit Inc Portland, Oregon, United States, 97239 United States, Washington Charles River Clinical Services NW Tacoma, Washington, United States, 98418 Germany Novartis Investigator Site Berlin, Germany Novartis Investigator Site Kiel, Germany Novartis Investigator Site Moenchengladbach, Germany Novartis Investigator Site Munich, Germany Novartis Investigative Site Neuss, Germany Russian Federation Novartis Investigative Site Moscow, Russian Federation Novartis Investigative Site St. Petersberg, Russian Federation 收起 << |
NCT00605475 | - | Completed | - | - | |
NCT01326026 | Diabetes Diab... 展开 >>etes Mellitus, Type 2 收起 << | Phase 3 | Completed | - | - |
NCT02793154 | Diabetes Mellitus, Type 2 | Phase 4 | Terminated(Early termination d... 展开 >>ue to insufficient enrollment.) 收起 << | - | United States, Kentucky ... 展开 >> GSK Investigational Site Louisville, Kentucky, United States, 40213 United States, Texas GSK Investigational Site Dallas, Texas, United States, 75230 收起 << |
NCT03117998 | Type1 Diabetes Mellitus | Phase 2 | Recruiting | June 30, 2019 | United States, California ... 展开 >> Altman Clinical and Translational Research Institute Recruiting San Diego, California, United States, 92037 Contact: Todd May 858-657-7039 tmay@ucsd.edu Diablo Clinical Research Recruiting Walnut Creek, California, United States, 94598 Contact: Caitlin Sheets 925-930-7267 csheets@Diabloclinical.com Contact: Mark Christiansen, MD United States, Missouri Washington University School of Medicine Recruiting Saint Louis, Missouri, United States, 63110 Contact: Karen Flavin 314-747-8592 flavinkarens@wustl.edu 收起 << |
NCT03141710 | Diabetes Mellitus, Type 2 | Not Applicable | Recruiting | August 2018 | United Kingdom ... 展开 >> The Rowett Institute, Human Nutrition Unit Recruiting Aberdeen, United Kingdom, AB25 2ZD Contact: Alexandra M Johnstone, PhD 00441224438614 alex.johnstone@abdn.ac.uk 收起 << |
NCT01426399 | Healthy | Phase 1 | Completed | - | Korea, Republic of ... 展开 >> Seoul National University Hospital Seoul, Korea, Republic of 收起 << |
NCT02793154 | - | Terminated(Early termination d... 展开 >>ue to insufficient enrollment.) 收起 << | - | - | |
NCT01687582 | Type 2 Diabetes ... 展开 >> Psoriasis 收起 << | Not Applicable | Unknown | March 2013 | Belgium ... 展开 >> Cliniques universitaires Saint-Luc Recruiting Brussels, Belgium, 1200 Contact: Martin Buysschaert, PhD +3227645475 martin.buysschaert@uclouvain.be Contact: Vanessa Preumont, MD +3227645475 vanessa.preumont@uclouvain.be Principal Investigator: Martin Buysschaert, PhD 收起 << |
NCT03772067 | Type2 Diabetes ... 展开 >> Healthy Obesity, Metabolically 收起 << | Not Applicable | Not yet recruiting | October 20, 2019 | Israel ... 展开 >> Diabetes Unit E. Wolfson Hospital Holon, Tel Aviv, Israel, 58100 Daniela Jakubowicz Holon, Wolfson Medical Center, Israel, 58100 收起 << |
NCT01059812 | Diabetes Diab... 展开 >>etes Mellitus, Type 2 收起 << | Phase 3 | Completed | - | - |
NCT01059812 | - | Completed | - | - | |
NCT01845064 | Diabetes Type 2 | Phase 1 Phase 2 | Completed | - | Netherlands ... 展开 >> PRA Zuidlaren, Netherlands, 9471 GP 收起 << |
NCT01364428 | - | Completed | - | - | |
NCT02180646 | Type 2 Diabetes | Not Applicable | Completed | - | - |
NCT00885118 | - | Completed | - | - | |
NCT01726764 | Type 2 Diabetes ... 展开 >> Depression 收起 << | Phase 1 | Completed | - | Denmark ... 展开 >> Department of Clinical Pharmacology, Institute of Public Health, University of Southern Denmark Odense, Denmark, DK-5000 收起 << |
NCT03698396 | Diabetes Mellitus, Type 1 | Phase 1 Phase 2 | Not yet recruiting | December 1, 2023 | - |
NCT00885118 | Diabetes Mellitus, Type 2 | Phase 2 | Completed | - | Japan ... 展开 >> 1245.15.003 Boehringer Ingelheim Investigational Site Hachioji, Tokyo, Japan 1245.15.002 Boehringer Ingelheim Investigational Site Koganei, Tokyo, Japan 1245.15.001 Boehringer Ingelheim Investigational Site Nakano-ku, Tokyo, Japan 1245.15.005 Boehringer Ingelheim Investigational Site Suita, Osaka, Japan 1245.15.004 Boehringer Ingelheim Investigational Site Yokohama, Kanagawa, Japan 收起 << |
NCT02219295 | Disorder of Glucose Regulation | Not Applicable | Completed | - | Germany ... 展开 >> Department of Clinical Nutrition Nuthetal, Brandenburg, Germany, D-14558 收起 << |
NCT02358668 | Pre-Diabetes | Phase 2 | Completed | - | Hong Kong ... 展开 >> The Chinese University of Hong Kong Shatin, Hong Kong 收起 << |
NCT02478190 | Hyperglycemia ... 展开 >> Diabetes Mellitus Complications of Diabetes Mellitus Diabetes-Related Complications Diabetes Mellitus, Type 2 收起 << | Not Applicable | Completed | - | United States, Minnesota ... 展开 >> Hennepin County Medical Center Minneapolis, Minnesota, United States, 55415 收起 << |
NCT02180646 | - | Completed | - | - | |
NCT02363335 | Healthy Volunteers | Phase 1 | Completed | - | United States, Maryland ... 展开 >> National Institute of Aging, Clinical Research Unit Baltimore, Maryland, United States, 21224 收起 << |
NCT02772679 | Type 1 Diabetes Mellitus | Phase 1 | Suspended(New enrollment suspe... 展开 >>nded to allow time for additional analyses) 收起 << | December 2021 | United States, California ... 展开 >> University of California, San Francisco Medical Center San Francisco, California, United States, 94143 United States, Connecticut Yale University New Haven, Connecticut, United States, 06519 收起 << |
NCT02358668 | - | Completed | - | - | |
NCT02349152 | Heart Diseases ... 展开 >> Hyperglycemia 收起 << | Phase 4 | Completed | - | United States, Pennsylvania ... 展开 >> UPMC Presbyterian Hospital Pittsburgh, Pennsylvania, United States, 15213 收起 << |
NCT02349152 | - | Completed | - | - | |
NCT02597049 | Type 2 Diabetes Mellitus | Phase 3 | Completed | - | - |
NCT02599272 | Cardiometabolic Risk | Not Applicable | Completed | - | Singapore ... 展开 >> Clinical Nutrition Research Centre Singapore, Singapore, 117599 收起 << |
NCT00518115 | Diabetes Mellitus, Type 2 | Phase 2 | Completed | - | - |
NCT02597049 | - | Completed | - | - | |
NCT03538015 | Hypoglycemia Unawareness | Phase 2 | Not yet recruiting | June 2020 | United States, Utah ... 展开 >> University of Utah Not yet recruiting Salt Lake City, Utah, United States, 84132 收起 << |
NCT00518115 | - | Completed | - | - | |
NCT02111096 | Diabetes Mellitus, Type 2 | Phase 2 | Terminated(The overall benefit... 展开 >>-risk profile did not support continued development of LY2409021 for type 2 diabetes.) 收起 << | - | - |
NCT03447561 | Healthy Food ... 展开 >>Reward 收起 << | Not Applicable | Recruiting | June 2019 | Belgium ... 展开 >> Universitaire ziekenhuizen Leuven Recruiting Leuven, Belgium, 3000 收起 << |
NCT01297738 | Obesity Diabe... 展开 >>tes Mellitus Type 2 收起 << | Not Applicable | Completed | - | Netherlands ... 展开 >> Academic Medical Center Amsterdam, Noord-Holland, Netherlands, 1105 AZ 收起 << |
NCT02250222 | Type 2 Diabetes Mellitus | Phase 1 | Completed | - | United States, Arizona ... 展开 >> Celerion, Inc Tempe, Arizona, United States, 85283 United States, Florida Clinical Pharmacology of Miami, Inc Miami, Florida, United States, 33014 United States, Ohio Medpace Clinical Pharmacology Cincinnati, Ohio, United States, 45227 收起 << |
NCT02011217 | Appetite Regulation | Not Applicable | Completed | - | Sweden ... 展开 >> Paediatric Research Facility; The Children's Hospital at Uppsala University Hospital Uppsala, Sweden, SE-751 85 收起 << |
NCT03383614 | Filariasis | Phase 1 | Recruiting | October 1, 2018 | United Kingdom ... 展开 >> Hammersmith Medicines Research Limited Recruiting London, United Kingdom, NW10 7EW Contact: Jeremy Dennison, BSc MSc PhD MBChB +44 20 89 63 45 46 jdennison@hmrlondon.com Contact: Frans van den Berg +44 20 89 61 41 30 fvandenberg@hmrlondon.com 收起 << |
NCT02312427 | Heart Failure ... 展开 >> Diabetes Mellitus 收起 << | Phase 4 | Completed | - | Japan ... 展开 >> Mitsui Memorial Hospital Taito-ku, Tokyo, Japan 收起 << |
NCT01819129 | Diabetes Diab... 展开 >>etes Mellitus, Type 2 收起 << | Phase 3 | Completed | - | - |
NCT02111096 | - | Terminated(The overall benefit... 展开 >>-risk profile did not support continued development of LY2409021 for type 2 diabetes.) 收起 << | - | - | |
NCT03139864 | Type 1 Diabetes | Not Applicable | Not yet recruiting | December 2018 | France ... 展开 >> CHU Clermont-Ferrand Not yet recruiting Clermont-Ferrand, France, 63003 Contact: Patrick LACARIN 04 73 75 11 95 placarin@chu-clermontferrand.fr Principal Investigator: Daniel TERRAL 收起 << |
NCT01819129 | - | Completed | - | - | |
NCT03200782 | Postprandial Hypoglycemia ... 展开 >> Bariatric Surgery Late Dumping Syndrome 收起 << | Not Applicable | Completed | - | Switzerland ... 展开 >> University Hospital Basel, Department of Endocrinology, Diabetes and Metabolism Basel, Switzerland, 4056 Basel 收起 << |
NCT02003586 | Healthy | Not Applicable | Completed | - | France ... 展开 >> Eurofins Optimed Clinical research Gieres, France 收起 << |
NCT03734718 | Diabetes Mellitus, Type 1 ... 展开 >> Hypoglycemia 收起 << | Not Applicable | Recruiting | June 1, 2019 | Denmark ... 展开 >> Steno Diabetes Center CopenhagenSteno Diabetes Center Copenhagen, Clinical Metabolic Physiology Recruiting Hellerup, Denmark, 2800 Contact: Sebastian M heimbürger, Msc. +45 38673407 sebastian.moeller.heimbuerger@regionh.dk Contact: Filip K Knop, Prof, MD Principal Investigator: Filip K Knop, Prof, MD 收起 << |
NCT03046186 | - | Recruiting | June 2017 | Denmark ... 展开 >> Hvidovre University Hospital Recruiting Hvidovre, Please Select, Denmark, 2650 Contact: Maria S Svane 38626357 Maria.Saur.Svane@regionh.dk Principal Investigator: Sten Madsbad, MD, DMSc 收起 << | |
NCT00393705 | - | Completed | - | - | |
NCT02684396 | Healthy Volunteers | Phase 1 | Completed | - | - |
NCT00393705 | Diabetes Mellitus, Type 2 | Phase 4 | Completed | - | Croatia ... 展开 >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Zagreb, Croatia, HR-10000 Poland For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Bialystok, Poland, 15-276 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Rzeszow, Poland, 35-0723 Romania For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Bucharest, Romania, 020475 South Africa For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Kempton Park, South Africa, 1619 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Kenilworth, South Africa, 7708 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Kuilsriver, South Africa, 7580 Turkey For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Istanbul, Turkey, 34662 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Konya, Turkey, 42075 收起 << |
NCT02684396 | - | Completed | - | - | |
NCT00861809 | Gastroparesis | Phase 2 | Completed | - | Belgium ... 展开 >> GSK Investigational Site Leuven, Belgium, 3000 Sweden GSK Investigational Site Stockholm, Sweden, SE-171 76 收起 << |
NCT02163278 | Diabetes Mellitus, Type 2 | Phase 1 | Completed | - | Taiwan ... 展开 >> Taipei Medical University - Taipei Medical University Hospital Taipei, Taiwan, 11031 收起 << |
NCT00881530 | Diabetes Mellitus, Type 2 | Phase 2 | Completed | - | - |
NCT02507167 | Gastrointestinal Hormones | Phase 1 | Completed | - | Germany ... 展开 >> Department of Clinical Pharmacology Greifswald, Germany, 17489 收起 << |
NCT03729934 | Obesity Overw... 展开 >>eight and Obesity Overweight Triglycerides High 收起 << | Not Applicable | Not yet recruiting | December 1, 2019 | - |
NCT02320721 | - | Completed | - | - | |
NCT03255876 | Hyperglycemia, Postprandial ... 展开 >> Healthy 收起 << | Not Applicable | Recruiting | September 1, 2018 | United Kingdom ... 展开 >> School of Food Science and Nutrition, University of Leeds Recruiting Leeds, West Yorkshire, United Kingdom, LS2 9JT Contact: Gary Williamson, PhD +441133438380 G.Williamson@leeds.ac.uk Contact: Aleksandra Konic Ristic, PhD +441133432979 a.konicristic@leeds.ac.uk Principal Investigator: Aleksandra Konic Ristic, PhD Sub-Investigator: Hilda Nyambe, PhD Sub-Investigator: Asimina Kerimi, PhD Sub-Investigator: Sarka Tumova, PhD 收起 << |
NCT02320721 | Type 2 Diabetes Mellitus | Phase 3 | Completed | - | - |
NCT01468181 | Type 2 Diabetes Mellitus | Phase 3 | Completed | - | Japan ... 展开 >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Aichi, Japan, 466-0815 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Chiba, Japan, 277-0825 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Hokkaido, Japan, 050-0073 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Hyogo, Japan, 662-0971 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Ibaraki, Japan, 300-0053 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Kanagawa, Japan, 231-0023 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Kyoto, Japan, 615-8125 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Nagano, Japan, 390-1401 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Okayama, Japan, 700-8558 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Osaka, Japan, 560-0082 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Saitama, Japan, 3438577 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Tokyo, Japan, 1030002 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Toyama, Japan, 930-0859 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Wakayama, Japan, 644-0011 收起 << |
NCT00958399 | Healthy | Not Applicable | Completed | - | United States, Minnesota ... 展开 >> University of Minnesota - General Clinical Research Center Minneapolis, Minnesota, United States, 55455 收起 << |
NCT03424187 | Obesity | Not Applicable | Active, not recruiting | April 2019 | - |
NCT00881530 | - | Completed | - | - | |
NCT02673554 | Type 2 Diabetes | Phase 1 | Completed | - | - |
NCT02084004 | Type 2 Diabetes Mellitus | Phase 2 Phase 3 | Withdrawn(The sponsor have not... 展开 >> enough money to support this trial) 收起 << | April 2018 | China, Shaanxi ... 展开 >> Second Affiliated Hospital of Xi'an Jiaotong University Xi'an, Shaanxi, China, 710004 The 323rd Hospital of People's Liberation Army Xi'an, Shaanxi, China, 710054 First Affiliated Hospital of Xi'an Jiaotong University Xi'an, Shaanxi, China, 710061 Shaanxi Provincial People's Hospital Xi'an, Shaanxi, China, 710068 收起 << |
NCT01468181 | - | Completed | - | - | |
NCT00847080 | Reactive Hypoglycemia | Phase 4 | Completed | - | Mexico ... 展开 >> Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran Mexico, DF, Mexico, 14000 收起 << |
NCT01154582 | Physiology Nu... 展开 >>trition 收起 << | Not Applicable | Completed | - | France ... 展开 >> Centre de recherche sur volontaires Bobigny, France, 93 Centre de recherche sur Volontaires Nantes, France, 44 收起 << |
NCT01555008 | Type 2 Diabetes Mellitus ... 展开 >> Renal Impairment 收起 << | Phase 1 | Completed | - | United States, Alabama ... 展开 >> Lexicon Investigational Site Anniston, Alabama, United States, 36207 United States, California Lexicon Investigational Site Chula Vista, California, United States, 91911 United States, Florida Lexicon Investigational Site Edgewater, Florida, United States, 32132 United States, Minnesota Lexicon Investigational Site Minneapolis, Minnesota, United States, 55404 United States, Texas Lexicon Investigational Site San Antonio, Texas, United States, 78209 United States, Washington Lexicon Investigational Site Renton, Washington, United States, 98057 收起 << |
NCT00832741 | - | Completed | - | Denmark ... 展开 >> Hvidovre University Hospital Hvidovre, Denmark, 2650 收起 << | |
NCT03635437 | Type 1 Diabetes Mellitus | Phase 1 Phase 2 | Recruiting | April 30, 2020 | Sweden ... 展开 >> Uppsala University Hospital Recruiting Uppsala, Sweden, 75185 Contact: Per-Ola P Carlsson, MD, PhD +46702721167 per-ola.carlsson@mcb.uu.se 收起 << |
NCT02685345 | Type 2 Diabetes Mellitus | Phase 2 | Completed | - | Japan ... 展开 >> Yodogawaku, Osaka, Japan, 565-0853 收起 << |
NCT01045707 | - | Completed | - | - | |
NCT01073566 | Diabetes Mellitus | Phase 2 | Completed | - | United States, California ... 展开 >> California Pacific Medical Center San Francisco, California, United States, 94110 United States, Illinois Northwestern University Chicago, Illinois, United States, 60611 United States, Michigan Henry Ford Health System Detroit, Michigan, United States, 48202 United States, Minnesota International Diabetes Center at Park Nicollet Minneapolis, Minnesota, United States, 55416 United States, Texas University of Texas Southwestern Medical Center Dallas, Texas, United States, 75390 收起 << |
NCT02810691 | Cystic Fibrosis-related Diabet... 展开 >>es Cystic Fibrosis 收起 << | Not Applicable | Completed | - | Canada, Quebec ... 展开 >> Institut de recherches cliniques de Montréal Montréal, Quebec, Canada, H2W 1R7 收起 << |
NCT01073566 | - | Completed | - | - | |
NCT02613897 | Diabetes Mellitus, Type 2 | Not Applicable | Completed | - | United States, Texas ... 展开 >> The University of Texas Health Science Center at San Antonio San Antonio, Texas, United States, 78229 收起 << |
NCT02049814 | Type 2 Diabetes Mellitus | Phase 4 | Completed | - | China, Anhui ... 展开 >> Hefei, Anhui, China Maanshan, Anhui, China China, Beijing Beijing, Beijing, China China, Guangdong Guangzhou, Guangdong, China Shenzhen, Guangdong, China Taishan, Guangdong, China China, Hunan Zhuzhou, Hunan, China China, Jiangsu Nanjing, Jiangsu, China Xuzhou, Jiangsu, China China, Jilin Changchun, Jilin, China Jilin, Jilin, China China, Liaoning Shenyang, Liaoning, China China, Shandong Qingdao, Shandong, China China, Shanghai Shanghai, Shanghai, China China, Shanxi Yan An, Shanxi, China Yanan, Shanxi, China China, Tianjin Tianjin, Tianjin, China China, Zhejiang Wenzhou, Zhejiang, China 收起 << |
NCT02395003 | - | Recruiting | November 2020 | United States, Connecticut ... 展开 >> Yale Recruiting New Haven, Connecticut, United States, 06511 Contact: Bridget Pierpont 收起 << | |
NCT00517465 | Diabetes Mellitus Type 2 | Phase 1 | Completed | - | Germany ... 展开 >> Berlin, Germany, 14050 Neuss, Germany, 41460 Hungary Balatonfuered, Hungary, 8230 Budapest, Hungary, 1027 Slovakia Bratislava, Slovakia, 82108 Bratislava, Slovakia, 833 05 United Kingdom Slough, United Kingdom, SL1 4AA Welwyn Garden City, United Kingdom, AL7 1TW 收起 << |
NCT01263496 | Type 2 Diabetes Mellitus | Phase 2 | Completed | - | - |
NCT01588366 | Diabetes Mellitus, Type 2 | Phase 1 | Completed | - | Singapore ... 展开 >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST) or speak with your personal physician. Singapore, Singapore 收起 << |
NCT01263509 | Type 2 Diabetes Mellitus | Phase 2 Phase 3 | Completed | - | - |
NCT01263509 | - | Completed | - | - | |
NCT02043054 | Type 2 Diabetes Mellitus ... 展开 >> Cardiovascular Disease 收起 << | Phase 3 | Completed | - | United Kingdom ... 展开 >> University Hospitals of Leicester NHS Trust, Diabetes Research Centre Leicester, Leicestershire, United Kingdom, LE5 4PW 收起 << |
NCT01263496 | - | Completed | - | - | |
NCT01045707 | Diabetes Diab... 展开 >>etes Mellitus, Type 2 收起 << | Phase 3 | Completed | - | - |
NCT03279731 | Binge-Eating Disorder | Phase 3 | Recruiting | April 20, 2020 | United States, Pennsylvania ... 展开 >> University of Pennyslvania Recruiting Philadelphia, Pennsylvania, United States, 19140 Contact: Kelly C Allison, PhD 215-898-2823 kca@pennmedicine.upenn.edu Contact: Madelyn Ruggieri, MS 215-573-5502 mrugg@pennmedicine.upenn.edu Principal Investigator: Kelly C Allison, PhD Sub-Investigator: Thomas A Wadden, PhD Sub-Investigator: Robert Berkowitz, MD 收起 << |
NCT00468884 | Healthy | Phase 1 | Completed | - | Switzerland ... 展开 >> Clinical Research Centre, University Hospital Basel, Switzerland, CH-4031 收起 << |
NCT00477581 | Type 2 Diabetes Mellitus | Phase 4 | Completed | - | United States, California ... 展开 >> Research Site Los Angeles, California, United States Research Site Spring Valley, California, United States United States, Florida Research Site Miami, Florida, United States Research Site Pembroke Pines, Florida, United States United States, Illinois Research Site Chicago, Illinois, United States United States, Indiana Research Site Indianapolis, Indiana, United States, 46260 Research Site Indianapolis, Indiana, United States United States, Michigan Research Site Detroit, Michigan, United States United States, Montana Research Site Butte, Montana, United States United States, North Carolina Research Site Winston-Salem, North Carolina, United States United States, Ohio Research Site Cincinatti, Ohio, United States Research Site Marion, Ohio, United States United States, Oregon Research Site Eugene, Oregon, United States Research Site Portland, Oregon, United States United States, South Carolina Research Site Charleston, South Carolina, United States Research Site Greer, South Carolina, United States United States, Texas Research Site Austin, Texas, United States Research Site Corpus Christi, Texas, United States Research Site San Antonio, Texas, United States 收起 << |
NCT02072096 | Diabetes Mellitus, Type 2 | Phase 4 | Terminated(The trial was termi... 展开 >>nated per protocol because of lack of feasibility.) 收起 << | - | - |
NCT01156779 | Diabetes Mellitus | Phase 1 | Completed | - | Korea, Republic of ... 展开 >> Clinical Trial center, Clinical Research institute, Seoul National University Hospital Seoul, Korea, Republic of 收起 << |
NCT00811460 | Diabetes Mellitus Type 2 | Phase 1 | Completed | - | Germany ... 展开 >> Neuss, Germany, 41460 收起 << |
NCT02072096 | - | Terminated(The trial was termi... 展开 >>nated per protocol because of lack of feasibility.) 收起 << | - | - | |
NCT00809705 | Diabetes Mellitus Type 2 | Phase 3 | Completed | - | Germany ... 展开 >> Berlin, Germany, 14050 Neuss, Germany, 41460 United Kingdom London, United Kingdom, HA1 3UJ 收起 << |
NCT00822705 | Anti Obesity Agent | Phase 1 Phase 2 | Completed | - | Switzerland ... 展开 >> Clinical Research Center, University Hospital Basel Basel, Basel-Stadt, Switzerland, 4031 收起 << |
NCT02092896 | Diabetes Diab... 展开 >>etes Mellitus, Type 1 收起 << | Phase 3 | Completed | - | Denmark ... 展开 >> Dept. of Endocrinology, Hvidovre University Hospital Hvidovre, Copenhagen, Denmark, 2650 收起 << |
NCT02881684 | Obesity | Not Applicable | Recruiting | December 2018 | Hong Kong ... 展开 >> The University of Hong Kong Recruiting Hong Kong, Hong Kong Contact: Michele MA Yuen, MBBS (852) 6073 2211 micheleyuen@hotmail.com Contact: Carol HY Fong, MSc Stat (852) 2255 3711 kalofong@gmail.com 收起 << |
NCT00972283 | - | Completed | - | - | |
NCT00537719 | Diabetes Mellitus, Type 2 | Phase 1 | Completed | - | United States, Kentucky ... 展开 >> GSK Investigational Site Lexington, Kentucky, United States, 40503 收起 << |
NCT02385630 | Esophageal Neoplasms ... 展开 >> Stomach Neoplasms Weight Loss Malnutrition 收起 << | Not Applicable | Unknown | January 2017 | Ireland ... 展开 >> Wellcome Trust-Health Research Board Clinical Research Facility, St. James's Hospital Dublin, Ireland, D8 收起 << |
NCT02962089 | Undernutrition | Not Applicable | Recruiting | August 2019 | Switzerland ... 展开 >> Hôpital du Valais Recruiting Sion, Valais, Switzerland, 1951 Contact: Daniel Teta, MD, PhD 0041 27 603 42 40 daniel.teta@hopitalvs.ch Lausanne University Hospital Recruiting Lausanne, Vaud, Switzerland, 1011 Contact: Menno Pruijm, PD, MER1 0041 21 314 13 58 menno.pruijm@chuv.ch Geneva University Hospital Recruiting Geneva, Switzerland, 1205 Contact: Laurence Genton, MD 0041 22 37 29 344 laurence.genton@hcuge.ch 收起 << |
NCT02497859 | Obesity | Not Applicable | Completed | - | United States, Texas ... 展开 >> Texas Tech University - Department of Nutritional Sciences Lubbock, Texas, United States, 79409 收起 << |
NCT01606397 | Diabetes Mellitus, Type 2 | Phase 1 | Completed | - | Singapore ... 展开 >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Singapore, Singapore United Kingdom For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Plymouth, United Kingdom 收起 << |
NCT02994420 | - | Recruiting | December 2018 | Switzerland ... 展开 >> Clinic for Reproductive Endocrinology, University Hospital Zurich Recruiting Zurich, Switzerland, 8091 Contact: Brigitte Leeners, MD +41 44 255 5001 brigitte.leeners@usz.ch 收起 << | |
NCT01606371 | Diabetes Mellitus, Type 2 | Phase 1 | Completed | - | Singapore ... 展开 >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Singapore, Singapore 收起 << |
NCT02381249 | Esophageal Neoplasms ... 展开 >> Stomach Neoplasms Weight Loss Malnutrition Pancreatic Neoplasms Duodenal Neoplasms 收起 << | Not Applicable | Completed | - | Ireland ... 展开 >> Wellcome Trust-Health Research Board Clinical Research Facility, St. James's Hospital Dublin, Ireland, D8 Sweden Gastrosurgical Laboratory, Sahlgrenska Academy, University of Gothenburg Gothenburg, Sweden 收起 << |
NCT00849056 | - | Completed | - | - | |
NCT00972283 | Diabetes Diab... 展开 >>etes Mellitus, Type 2 收起 << | Phase 3 | Completed | - | - |
NCT00112684 | Unspecified Adult Solid Tumor,... 展开 >> Protocol Specific 收起 << | Phase 1 | Terminated | - | United States, Ohio ... 展开 >> Ohio State University Medical Center Columbus, Ohio, United States, 43210 收起 << |
NCT00589888 | Endothelial Dysfunction ... 展开 >> Hypertension 收起 << | Not Applicable | Completed | - | United States, Georgia ... 展开 >> Grady Memorial Hospital Atlanta, Georgia, United States, 30303 收起 << |
NCT00849056 | Diabetes Mellitus, Type 2 | Phase 3 | Completed | - | - |
NCT00589888 | - | Completed | - | - | |
NCT03085511 | Obesity | Not Applicable | Recruiting | May 2019 | United States, Texas ... 展开 >> Texas Tech University - Department of Nutritional Sciences Recruiting Lubbock, Texas, United States, 79409 Contact: Nikhil Dhurandhar, Ph.D. 806-834-6446 nikhil.dhurandhar@ttu.edu 收起 << |
NCT02563847 | Endocrine System Diseases | Not Applicable | Completed | - | Switzerland ... 展开 >> University Hospital Basel, Phase 1 Research Unit Basel, Switzerland 收起 << |
NCT03522792 | Physiology - Regulation of App... 展开 >>etite and Food Intake 收起 << | Not Applicable | Recruiting | July 1, 2019 | Denmark ... 展开 >> Hvidovre University Hospital Recruiting Hvidovre, Capital, Denmark, 2650 Contact: Simon Veedfald, MD +45 41 10 25 95 veedfald@sund.ku.dk Contact: Steen Madsbad, Dr.Med.Sci sten.madsbad@regionh.dk 收起 << |
NCT01966978 | Diabetes Mellitus, Type 2 ... 展开 >> Diabetes 收起 << | Phase 4 | Completed | - | United States, Texas ... 展开 >> UT Southwestern Medical Center Dallas, Texas, United States, 02720 收起 << |
NCT01561131 | Prevention of Obesity | Not Applicable | Completed | - | Denmark ... 展开 >> Department of Human Nutrition, University of Copenhagen Frederiksberg, Copenhagen, Denmark, 1958 收起 << |
NCT01677104 | Type 2 Diabetes ... 展开 >> Obesity 收起 << | Not Applicable | Completed | - | United Kingdom ... 展开 >> Diabetes and Vascular Center Exeter, United Kingdom, EX2 5AX 收起 << |
NCT00475475 | Overweight Ob... 展开 >>esity 收起 << | Not Applicable | Completed | - | United States, Washington ... 展开 >> University of Washington General Clinical Research Center Seattle, Washington, United States, 98195 收起 << |
NCT02035241 | Healthy | Not Applicable | Completed | - | Sweden ... 展开 >> Antidiabetic Food Centre (Medicon Village) - Lund University Lund, Skane, Sweden, 22381 收起 << |
NCT01769404 | Diabetes Mellitus, Type 1 | Phase 1 | Completed | - | Germany ... 展开 >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Neuss, Germany, 41460 收起 << |
NCT02385617 | Esophageal Neoplasms ... 展开 >> Stomach Neoplasms Weight Loss Malnutrition 收起 << | Not Applicable | Completed | - | Ireland ... 展开 >> Wellcome Trust-Health Research Board Clinical Research Facility, St. James's Hospital Dublin, Ireland, D8 Sweden Gastrosurgical Laboratory, Sahlgrenska Academy, University of Gothenburg Gothenburg, Sweden 收起 << |
NCT01514942 | PCOS | Phase 4 | Completed | - | Italy ... 展开 >> Istituto di Patologia Ostetrica e Ginecologica Catania, Italy 收起 << |
NCT01272193 | - | Completed | - | - | |
NCT00631046 | Obesity Growt... 展开 >>h Metabolic Syndrome Cardiovascular Disease 收起 << | Not Applicable | Completed | - | Denmark ... 展开 >> Dept. of Human Nutrition Copenhagen, Frederiksberg C, Denmark, DK-1958 收起 << |
NCT01272193 | Diabetes Diab... 展开 >>etes Mellitus, Type 2 收起 << | Phase 3 | Completed | - | - |
NCT02512523 | Type 2 Diabetes Mellitus | Phase 4 | Unknown | - | Korea, Republic of ... 展开 >> HANDOK Inc. Recruiting Seoul, Korea, Republic of Contact: Sejin Kim, CRM SeJin.Kim@handok.com Contact: Sojung Park, CPL SoJung.Park@handok.com 收起 << |
NCT02131272 | Diabetes Diab... 展开 >>etes Mellitus, Type 2 收起 << | Phase 3 | Terminated | - | - |
NCT01937598 | - | Completed | - | - | |
NCT02544321 | Type 1 Diabetes | Phase 2 | Recruiting | December 2018 | United States, Colorado ... 展开 >> University of Colorado-Denver, Anshutz Medical Campus Recruiting Aurora, Colorado, United States, 80045 Contact: Ellen Lyon, MS 720-848-6690 ellen.lyon@ucdenver.edu Contact: Amy Baumgartner, MS 720-777-5774 amy.baumgartner@childrenscolorado.org 收起 << |
NCT01937598 | Type 2 Diabetes | Phase 3 | Completed | - | Germany ... 展开 >> Diabeteszentrum Bad Lauterberg Bad Lauterberg, Germany, 37431 收起 << |
NCT01739127 | - | Completed | - | Canada, British Columbia ... 展开 >> BC Mental Health & Addictions Research Institute Vancouver, British Columbia, Canada, V5Z 4H4 收起 << | |
NCT02529449 | Type 1 Diabetes Mellitus | Phase 2 | Completed | - | Japan ... 展开 >> Site JP00006 Aichi, Japan Site JP00002 Fukuoka, Japan Site JP00009 Gunma, Japan Site JP00001 Ibaraki, Japan Site JP00005 Kanagawa, Japan Site JP00008 Kanagawa, Japan Site JP00003 Okayama, Japan Site JP00004 Osaka, Japan Site JP00010 Osaka, Japan Site JP00011 Osaka, Japan Site JP00007 Tokyo, Japan 收起 << |
NCT00672386 | Diabetes Mellitus, Type 2 ... 展开 >> Diabetes Mellitus Endocrine System Diseases Nutritional and Metabolic Diseases 收起 << | Phase 2 | Completed | - | - |
NCT02131272 | - | Terminated | - | - | |
NCT02906891 | Hypoglycemia ... 展开 >>Diabetes Mellitus, Type 1 收起 << | Not Applicable | Terminated(Insufficient resour... 展开 >>ces to complete study) 收起 << | - | United States, North Carolina ... 展开 >> East Carolina University Greenville, North Carolina, United States, 27834 收起 << |
NCT02365740 | Diabetes Mellitus, Type 1 | Not Applicable | Unknown | November 2016 | Italy ... 展开 >> Dept. of "Medicina Clinica e Chirurgia" of Federico II University Recruiting Naples, Italy, 80131 Contact: Brunella Capaldo, MD 0817462311 bcapaldo@unina.it Contact: Roberta Lupoli, MD 0817462427 sereroby@yahoo.it Principal Investigator: Brunella Capaldo, MD Sub-Investigator: Roberta Lupoli, MD Sub-Investigator: Lutgarda Bozzetto, MD Sub-Investigator: Giovanni Annuzzi, MD 收起 << |
NCT01788033 | Diabetes Mellitus Type 1 | Phase 2 | Completed | - | Switzerland ... 展开 >> University Hospital Basel Basel, Switzerland, 4031 收起 << |
NCT02871960 | Surgical Stress and Immune Fun... 展开 >>ction 收起 << | Not Applicable | Unknown | September 2018 | - |
NCT02682940 | Diabetes Mellitus, Type 1 ... 展开 >> Hypoglycemia 收起 << | Not Applicable | Terminated(Insufficient Resour... 展开 >>ces) 收起 << | - | United States, Georgia ... 展开 >> Atlanta Diabetes Associates Atlanta, Georgia, United States, 30318 收起 << |
NCT01140542 | Diabetes Mellitus Type 2 | Phase 2 | Completed | - | - |
NCT03422588 | Laparoscopic Right Colectomy | Not Applicable | Recruiting | November 1, 2018 | Italy ... 展开 >> University of Naples Federico II Recruiting Naples, Italy, 80131 Contact: Marco Milone, MD milone.marco.md@gmail.com 收起 << |
NCT02245906 | Healthy | Phase 1 Phase 2 | Completed | - | Sweden ... 展开 >> Antidiabetic Food Centre (Medicon Village) - Lund University Lund, Skåne, Sweden, 221 00 收起 << |
NCT01122979 | Diabetes Mellitus, Type 2 | Phase 4 | Completed | - | Brazil ... 展开 >> Investigational Site Number 076-007 Curitiba, Brazil, 80060-900 Investigational Site Number 076-010 Fortaleza, Brazil, 60015-052 Investigational Site Number 076-001 Fortaleza, Brazil, 60115-282 Investigational Site Number 076-003 Porto Alegre, Brazil, 91350-250 Investigational Site Number 076-005 São Paulo, Brazil, 01244-030 Investigational Site Number 076-013 São Paulo, Brazil, 01308-050 Investigational Site Number 076-004 São Paulo, Brazil, 01323-001 Investigational Site Number 076-002 São Paulo, Brazil, 04024-002 Investigational Site Number 076-009 São Paulo, Brazil, o4039-000 Investigational Site Number 076-006 Taguatinga, Brazil, 72155000 收起 << |
NCT01986036 | Healthy | Not Applicable | Unknown | May 2014 | United Kingdom ... 展开 >> Northumbria University Newcastle upon Tyne, Tyne and Wear, United Kingdom, NE1 8ST 收起 << |
NCT03663530 | Obesity | Not Applicable | Not yet recruiting | June 30, 2023 | United States, New York ... 展开 >> New York Obesity Nutrition Research Center Not yet recruiting New York, New York, United States, 10032 Contact: Theresa Pizinger, MS 212-851-5583 tmp2125@cumc.columbia.edu Contact: Ismel Salazar, MS 212-851-5578 is2527@cumc.columbia.edu Principal Investigator: Marie-Pierre St-Onge, PhD 收起 << |
NCT02405260 | Diabetes Mellitus, Type 2 | Phase 2 | Completed | - | United States, Arizona ... 展开 >> Mesa, Arizona, United States, 85213 Tuscon, Arizona, United States, 85741 United States, California Canoga Park, California, United States, 91303 Huntington Park, California, United States, 90255 Los Angeles, California, United States, 90056 West Hills, California, United States, 91307 United States, Colorado Centennial, Colorado, United States, 80112 Littleton, Colorado, United States, 80127 United States, Connecticut Waterbury, Connecticut, United States, 06708 United States, Florida West Palm Beach, Florida, United States, 33409 United States, Illinois Gurnee, Illinois, United States, 60031 United States, Indiana Evansville, Indiana, United States, 47725 United States, Minnesota Rochester, Minnesota, United States, 55905 United States, North Carolina Greensboro, North Carolina, United States, 27408 United States, South Carolina Moncks Corner, South Carolina, United States, 29461 United States, Texas San Antonio, Texas, United States, 78209 San Antonio, Texas, United States, 78229 Schertz, Texas, United States, 78154 United States, Virginia Norfolk, Virginia, United States, 23507 United States, Washington Richland, Washington, United States, 99352 收起 << |
NCT00309244 | Diabetes Type 2 | Phase 3 | Completed | - | - |
NCT02009488 | Diabetes Mellitus, Type 2 | Phase 1 | Completed | - | United States, California ... 展开 >> San Diego, La Jolla, California, United States United States, Florida Gainesville, Florida, United States 收起 << |
NCT01814137 | - | Completed | - | - | |
NCT00949091 | Diabetes Mellitus, Type 2 | Phase 1 | Completed | - | - |
NCT01305291 | Lack of Satiety | Not Applicable | Completed | - | United States, Iowa ... 展开 >> Nutrition and Wellness Research Center Ames, Iowa, United States, 50011 收起 << |
NCT00309244 | - | Completed | - | - | |
NCT01814137 | Diabetes Diab... 展开 >>etes Mellitus, Type 2 收起 << | Phase 3 | Completed | - | - |
NCT02430870 | Type 2 Diabetes Mellitus | Phase 1 | Completed | - | United States, California ... 展开 >> Anaheim, California, United States Chula Vista, California, United States 收起 << |
NCT01334242 | Healthy | Phase 1 | Completed | - | United States, Texas ... 展开 >> Lexicon Investigational Site San Antonio, Texas, United States, 78209 收起 << |
NCT02430870 | - | Completed | - | - | |
NCT03230786 | Type 2 Diabetes Mellitus | Phase 2 | Completed | - | Czechia ... 展开 >> Vdoviak Miroslav MUDr. - Interní Ambulance Karlovy Vary, Czechia, 360 17 General University Hospital Prague 2, Czechia, 128 00 Institute for Clinical and experimental Medicine Praha 4, Czechia, 140 21 Interní a Diabetologická ambulance, Clintrial s.r.o Praha, Czechia, 100 00 Endokrinologicky Ústav Praha, Czechia, 113 94 Diabet2 s.r.o Praha, Czechia Interní a Diabetologická ambulance Uherské Hradiště, Czechia, 68 601 Diabetologická a Obezitologická ambulance České Budějovice, Czechia Denmark Bispebjerg Hospital, Endokrinologisk Afdeling Bispebjerg, Copenhagen NV, Denmark, 2400 Bioclinica Ballerup, Copenhagen, Denmark, 2750 Bioclinica Aalborg, Jutland, Denmark, 9000 Aarhus University Hospital, Endocrinlogy Department Aarhus, Jutland, Denmark, 8000 Sydvestjysk Sygehus Esbjerg, Jutland, Denmark, 6700 Bioclinica Vejle, Jutland, Denmark, 7100 Holbæk Sygehus Holbæk, Denmark, 4300 Moldova, Republic of Rtl Sm Srl/Scr Chisinau, Moldova, Republic of, MD2025 Rtl Sm Srl Chisinau, Moldova, Republic of, MD2025 Poland Centrum Badań Klinicznych PI-House sp. z o.o. Gdańsk, Poland, 80-546 Specjalistyczna Praktyka Lekarska Piotr Kubalski Grudziądz, Poland, 86-302 Medyczne Centrum Diabetologiczno Endokrynologiczno Metaboliczno Kraków, Poland, 31-261 Prywatny Gabinet Lekarski M. Horodecki (budynek Medicus) Opole, Poland, 45-367 Centrum Medyczne Hygea Tychy, Poland, 43-100 Centrum Medyczne AMED Warsaw, Poland, 01-518 Prywatny Gabinet Lekarski i Wizyty Lekarskie Jan Ruxer Łódź, Poland, 90-074 Romania S.C. Policlinica CCBR S.R.L. Bucharest, Romania, 030463 Institutului Național de Diabet, Nutriție și Boli Metabolice "Prof.Dr. N.C. Paulescu" Bucharest, Romania S.C Nicodiab S.R.L. Bucharest, Romania S.C. Sfinx Medica S.R.L. Constanţa, Romania, 900412 S.C. Mediab S.R.L. Targu Mures, Romania S.C. Mediab S.R.L. Târgu-Mureş, Romania United Kingdom St. Pancras London, United Kingdom, WC1X 8QD 收起 << |
NCT01511185 | Diabetes Diab... 展开 >>etes Mellitus, Type 2 收起 << | Phase 1 | Completed | - | United States, Michigan ... 展开 >> Novo Nordisk Investigational Site Ann Arbor, Michigan, United States, 48109-0926 收起 << |
NCT01938469 | Gastric Bypass Surgery ... 展开 >> Obesity 收起 << | Not Applicable | Completed | - | United States, New York ... 展开 >> St. Lukes- Roosevelt Hospital- New York Obesity Research Center New York, New York, United States, 10025 收起 << |
NCT02357550 | Ketone Body Metabolism ... 展开 >> Brain Metabolism 收起 << | Not Applicable | Completed | - | Denmark ... 展开 >> Aarhus University Hospital Aarhus, Denmark, 8000 收起 << |
NCT03235219 | Diabetes Mellitus, Type 2 | Phase 1 | Completed | - | United States, California ... 展开 >> ProSciento, Inc. Chula Vista, California, United States, 91911 United States, Florida Advanced Pharma CR, LLC Miami, Florida, United States, 33147 收起 << |
NCT01824264 | Type 2 Diabetes Mellitus | Phase 2 | Withdrawn | November 2016 | - |
NCT00353834 | Type 2 Diabetes Mellitus | Phase 4 | Completed | - | United States, Massachusetts ... 展开 >> Joslin Diabetes Center Boston, Massachusetts, United States, 02215 收起 << |
NCT02544568 | Diabetes Mellitus | Not Applicable | Completed | - | Sweden ... 展开 >> Karolinska University Hospital Stockholm, Sweden, 17176 收起 << |
NCT01762644 | Type 1 Diabetes | Phase 3 | Withdrawn(This study was withd... 展开 >>rawn prior to enrollment.) 收起 << | August 2016 | - |
NCT01174576 | Health | Not Applicable | Completed | - | Greece ... 展开 >> Metabolic Unit of the Department of Nutrition and Dietetics, Harokopio University Athens, Greece, 17671 收起 << |
NCT03526744 | Healthy Volunteers | Not Applicable | Recruiting | December 2018 | Norway ... 展开 >> Haukeland University Hospital Recruiting Bergen, Norway Contact: Hanna Fjeldheim Dale +47 98088495 hanna.fjeldheim.dale@helse-bergen.no Contact: Caroline Jensen +47 97078964 caroline.jensen@helse-bergen.no Ålesund Hospital, Helse Møre og Romsdal HF Recruiting Ålesund, Norway Contact: Caroline Jensen +47 97078964 caroline.jensen@helse-mr.no Contact: Hanna Fjeldheim Dale +4798088495 hanna.fjeldheim.dale@helse-mr.no 收起 << |
NCT03669796 | Healthy Volunteers | Not Applicable | Completed | - | Norway ... 展开 >> Haukeland University Hospital Bergen, Norway Ålesund Hospital, Helse Møre og Romsdal HF Ålesund, Norway 收起 << |
NCT01174576 | - | Completed | - | - | |
NCT03013764 | Physical Inactivity ... 展开 >> Dietary Protein 收起 << | Not Applicable | Completed | - | United States, Missouri ... 展开 >> University of Missouri Columbia, Missouri, United States, 65211 收起 << |
NCT01779245 | Lipid Metabolism | Not Applicable | Completed | - | United Kingdom ... 展开 >> Northumbria University Newcastle upon Tyne, Tyne and Wear, United Kingdom, NE1 8ST 收起 << |
NCT01713023 | Type 1 Diabetes | Not Applicable | Completed | - | Brazil ... 展开 >> University Hospital of Rio de Janeiro, Federal University of Rio de Janeiro Rio de Janeiro, Brazil, 21941-590 收起 << |
NCT01202526 | - | Completed | - | Denmark ... 展开 >> Hvidovre University Hospital Copenhagen, Hvidovre, Denmark, DK-2650 收起 << | |
NCT02438540 | Insulin Sensitivity ... 展开 >> Obesity 收起 << | Not Applicable | Completed | - | - |
NCT02403284 | Insulin Resistance | Phase 4 | Active, not recruiting | December 2018 | United States, Arizona ... 展开 >> Carl T. Hayden VA Medical Hospital Phoenix, Arizona, United States, 85012 收起 << |
NCT02438540 | - | Completed | - | - | |
NCT03261531 | Obesity | Not Applicable | Recruiting | November 2018 | United States, Minnesota ... 展开 >> Mayo Clinic in Rochester Recruiting Rochester, Minnesota, United States, 55905 Contact: Deb Eckert 507-538-5860 eckert.deborah@mayo.edu Contact: Kayla Arndt 507-538-6599 arndt.kayla@mayo.edu Principal Investigator: Michael Camilleri, M.D. Sub-Investigator: Andres Acosta, M.D Sub-Investigator: Hoda Kadouh, Ph.D 收起 << |
NCT01406886 | Appetite | Not Applicable | Completed | - | United States, Massachusetts ... 展开 >> USARIEM Natick, Massachusetts, United States, 01760 收起 << |
NCT00396071 | Diabetes Mellitus, Type 2 | Phase 3 | Completed | - | Germany ... 展开 >> Diabetes Zentrum Bad Lauterberg Bad Lauterberg, Germany, 37431 Switzerland Novartis Pharmaceuticals Basel, Switzerland 收起 << |
NCT02812615 | Malnutrition ... 展开 >>Infection 收起 << | Not Applicable | Recruiting | October 31, 2019 | Bangladesh ... 展开 >> Mirpur Recruiting Dhaka, Bangladesh, 1216 Contact: Tahmeed Ahmed, Ph.D +88029827001-10 ext 2300 tahmeed@icddrb.org Contact: Mustafa Mustafa, MPH 9840523-32 ext 2304 mustafa@icddrb.org Principal Investigator: Mustafa Mustafa, MPH 收起 << |
NCT01375270 | Type 2 Diabetes Mellitus | Not Applicable | Completed | - | Denmark ... 展开 >> Centre of Inflammation and Metabolism, Rigshospitalet Copenhagen, Denmark, 2100 收起 << |
NCT03569852 | Fasting Inter... 展开 >>mittent Fasting Athletic Performance Cardiovascular Risk Factor Resting Energy Expenditure 收起 << | Not Applicable | Recruiting | July 15, 2020 | United States, California ... 展开 >> UC Davis, Western Human Nutrition Research Center Recruiting Davis, California, United States, 95616 收起 << |
NCT02653599 | Type 2 Diabetes Mellitus | Phase 2 | Completed | - | - |
NCT03009695 | Obesity Food ... 展开 >>Craving Appetite and General Nutritional Disorders 收起 << | Not Applicable | Recruiting | December 2018 | Italy ... 展开 >> San Donato Hospital Recruiting San Donato Milanese, MI, Italy, 20097 Contact: Anna Ferrulli, MD anna.ferrulli@grupposandonato.it 收起 << |
NCT03024983 | Dietary Modification | Not Applicable | Completed | - | Italy ... 展开 >> Department of Food Science, University of Parma Parma, Italy, 43125 收起 << |
NCT01806506 | Morbid Obesity ... 展开 >> Metabolic Syndrome X Diabetes Mellitus Dyslipidemia Hypertension 收起 << | Not Applicable | Unknown | - | Poland ... 展开 >> Department of General, Transplant and Liver Surgery, Public Central Teaching Hospital, Medical University of Warsaaw Warsaw, Poland, 02-097 收起 << |
NCT01402037 | Type 1 Diabetes | Not Applicable | Unknown | July 2016 | Belgium ... 展开 >> UZ Brussels Recruiting Brussels, Belgium, 1090 Contact: Bart Keymeulen, MD PhD +32 2 477 61 11 bart.keymeulen@uzbrussel.be Principal Investigator: Katelijn Decochez, MD PhD UZ Antwerpen Recruiting Edegem, Belgium, 2650 Contact: Christophe Deblock, MD. PhD. Principal Investigator: Christophe Deblock, MD PhD UZ Gent Recruiting Gent, Belgium, 9000 Contact: Johannes Ruige, MD PhD johannes.Ruige@uzgent.be Principal Investigator: Johannes Ruige, MD PhD 收起 << |
NCT03184064 | Postprandial Period | Not Applicable | Completed | - | United Kingdom ... 展开 >> Metabolic Research Unit London, England, United Kingdom, SE1 9NH 收起 << |
NCT02490085 | Type 2 Diabetes | Phase 2 | Recruiting | September 2018 | Canada, Quebec ... 展开 >> Institut de recherches cliniques de Montréal Recruiting Montreal, Quebec, Canada, H2W 1R7 Contact: Virginie Messier 514-987-5500 ext 3227 virginie.messier@ircm.qc.ca Principal Investigator: Rémi Rabasa-Lhoret Centre hospitalier universitaire de Sherbrooke Not yet recruiting Sherbrooke, Quebec, Canada, J1H 5N4 Contact: André Carpentier 819-564-5241 andre.carpentier@usherbrooke.ca Principal Investigator: André Carpentier 收起 << |
NCT03344133 | Overweight and Obesity | Not Applicable | Recruiting | November 30, 2017 | United Kingdom ... 展开 >> School of Medicine, University of Glasgow / New Lister Building, Glasgow Royal Infirmary Recruiting Glasgow, United Kingdom, G312ER Contact: Eleni Rizou, BSc MSc e.rizou.1@research.gla.ac.uk Contact: Konstantinos Gerasimidis, BSc MSc PhD Konstantinos.Gerasimidis@glasgow.ac.uk 收起 << |
NCT00655863 | Diabetes Mellitus | Phase 3 | Completed | - | Netherlands ... 展开 >> Amsterdam, Netherlands Sweden Gothenburg, Sweden 收起 << |
NCT00353834 | - | Completed | - | - | |
NCT00871572 | Diabetes Mellitus, Type 2 | Phase 2 | Completed | - | United States, California ... 展开 >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Buena Park, California, United States, 90620 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Huntington Park, California, United States, 90255 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Westlake Village, California, United States, 91361 United States, Florida For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Fort Lauderdale, Florida, United States, 33306 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Jupiter, Florida, United States, 33458 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. New Port Richey, Florida, United States, 34652 United States, Idaho For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Idaho Falls, Idaho, United States, 83404 United States, Kansas For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Topeka, Kansas, United States, 66606 United States, Kentucky For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Madisonville, Kentucky, United States, 42431 United States, Nevada For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Las Vegas, Nevada, United States, 89101 United States, South Dakota For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Rapid City, South Dakota, United States, 57702 United States, Texas For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. San Antonio, Texas, United States, 78229 United States, Virginia For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Norfolk, Virginia, United States, 23502 Germany For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Aschaffenburg, Germany, 63739 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Mainz, Germany, 55116 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Munchen, Germany, 80336 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Saarlouis, Germany, 66740 Lithuania For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Kaunas, Lithuania, LT-51270 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Vilnius, Lithuania, LT-08661 收起 << |
NCT00655863 | - | Completed | - | - | |
NCT03482895 | - | Recruiting | December 20, 2018 | France ... 展开 >> AP-HP - Hôpital Européen Georges-Pompidou Recruiting Paris, Île-de-France, France, 75015 Contact: Claire Carette, MD claire.carette@aphp.fr 收起 << | |
NCT00871572 | - | Completed | - | - | |
NCT01897844 | Healthy | Phase 1 | Completed | - | Italy ... 展开 >> Centro Ricerche Cliniche Verona, Italy, 37134 收起 << |
NCT03418415 | Type 2 Diabetes Mellitus ... 展开 >> Renal Denervation 收起 << | Not Applicable | Recruiting | January 2022 | China, Jiangsu ... 展开 >> Zhongda Hospital, Southeast University Recruiting Nanjing, Jiangsu, China, 210009 Contact: Gao-Jun Teng, MD +86 25 83272121 gjteng@seu.edu.cn Contact: Tao Pan, PhD +86-15850651223 15850651223@126.com 收起 << |
NCT00530023 | Type 1 Diabetes | Phase 4 | Completed | - | United States, California ... 展开 >> Diabetes Treatment Center, Loma Linda University Loma Linda, California, United States, 92354 United States, Oregon Portland Diabetes & Endocrinology Portland, Oregon, United States, 97210 收起 << |
NCT02192853 | Type 2 Diabetes Mellitus | Phase 4 | Completed | - | Denmark ... 展开 >> Diabetes Research Division, Department of Endocrinology, Gentofte Hospital Hellerup, Denmark, 2900 收起 << |
NCT01456572 | Endocrine System Diseases | Phase 1 | Completed | - | Switzerland ... 展开 >> University Hospital Basel, Phase 1 Research Unit Basel, Basel-Stadt, Switzerland, 4031 收起 << |
NCT01720589 | Childhood Obesity | Not Applicable | Completed | - | United States, New York ... 展开 >> St. Luke's/Roosevelt Hospital New York, New York, United States, 10025 收起 << |
NCT03510624 | Type 2 Diabetes Mellitus | Phase 1 | Not yet recruiting | June 1, 2019 | - |
NCT01188863 | Type 2 Diabetes Mellitus | Phase 1 | Completed | - | United States, Texas ... 展开 >> Lexicon Investigational Site San Antonio, Texas, United States, 78209 收起 << |
NCT03315780 | Type 2 Diabetes | Phase 4 | Completed | - | Japan ... 展开 >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Fukuoka, Japan, 812-0025 收起 << |
NCT00530023 | - | Completed | - | - | |
NCT03412136 | Appetitive Behavior ... 展开 >> Pediatric Obesity 收起 << | Not Applicable | Completed | - | Canada, Ontario ... 展开 >> University of Toronto Toronto, Ontario, Canada, M5S 3E2 收起 << |
NCT01951716 | Does the Vagus Nerve Mediate t... 展开 >>he Effects of Xenin-25 收起 << | Phase 1 | Withdrawn | July 2018 | United States, Missouri ... 展开 >> Washington University School of Medicine Saint Louis, Missouri, United States, 63110 收起 << |
NCT02993562 | - | Completed | - | Denmark ... 展开 >> Center for Diabetes Research, Herlev and Gentofte Hospitals Copenhagen, Region Hovedstaden, Denmark, 2900 收起 << | |
NCT01162876 | Diabetes | Phase 3 | Completed | - | Japan ... 展开 >> Kyushu Clinical Pharmacology Reserch Clinic Fukuoka, Japan 收起 << |
NCT01369979 | - | Completed | - | Denmark ... 展开 >> Aarhus University Hospital, PET-centre Aarhus C, Denmark, 8000 收起 << | |
NCT00978627 | Diabetes Diab... 展开 >>etes Mellitus, Type 1 收起 << | Phase 3 | Completed | - | - |
NCT01511393 | - | Enrolling by invitation | December 2035 | United States, West Virginia ... 展开 >> United BioSource Corporation Morgantown, West Virginia, United States, 26505-8065 收起 << | |
NCT00982644 | - | Completed | - | - | |
NCT02259933 | Healthy | Phase 1 | Completed | - | - |
NCT00978627 | - | Completed | - | - | |
NCT01785043 | DIABETES Mellitus Type 2 Not W... 展开 >>ell Controlled 收起 << | Phase 4 | Completed | - | Spain ... 展开 >> Hospital Clínic de Barcelona Barcelona, Spain, 08036 收起 << |
NCT00982644 | Diabetes Diab... 展开 >>etes Mellitus, Type 2 收起 << | Phase 3 | Completed | - | - |
NCT01209351 | Healthy Volunteers | Phase 1 | Completed | - | United States, Texas ... 展开 >> Cetero Clinical Research San Antonio, Texas, United States, 78229 收起 << |
NCT01215370 | Metabolic Syndrome | Not Applicable | Completed | - | Netherlands ... 展开 >> Wageningen University, Division of Human Nutrition Wageningen, Gelderland, Netherlands 收起 << |
NCT02333591 | Coronary Microvascular Dysfunc... 展开 >>tion 收起 << | Phase 4 | Recruiting | November 2018 | Denmark ... 展开 >> Department of Research in Endocrinology, Bispebjerg University Hospital Recruiting Copenhagen, Denmark, 2400 Contact: Malin Nilsson, MD +4540259871 mnil0028@regionh.dk Contact: Mette Zander, associated prof. +4551543686 m.zander@dadlnet.dk 收起 << |
NCT03492580 | - | Completed | - | United States, New Jersey ... 展开 >> Janssen Investigative Site Titusville, New Jersey, United States, 08560 收起 << | |
NCT03038295 | Retinopathy of Prematurity | Phase 2 | Not yet recruiting | December 2019 | - |
NCT03013296 | Glucose Metabolism Disorders | Not Applicable | Completed | - | Denmark ... 展开 >> Center for Diabetes Research Copenhagen, Gentofte, Denmark, 2900 收起 << |
NCT02259764 | Healthy | Phase 1 | Completed | - | - |
NCT00211536 | - | Completed | - | - | |
NCT00717457 | Diabetes Mellitus Type 2 | Phase 3 | Completed | - | - |
NCT02459496 | Type 2 Diabetes ... 展开 >> NAFLD Obesity Dyslipoproteinaemia Hypertension 收起 << | Not Applicable | Recruiting | December 2020 | Germany ... 展开 >> German Institut for Human Nutrition; Department for Clinical Nutrition Not yet recruiting Nuthetal, Brandenburg, Germany, 14458 Contact: Margrit Kemper, Dr. med. 033200 88 2775 margrit.kemper@dife.de Contact: Silke Hornemann 033200 88 2779 silke.hornemann@dife.de Sub-Investigator: Margrit Kemper, Dr. med. Sub-Investigator: Silke Hornemann Sub-Investigator: Christiana Gerbracht, Dr. German Institute for Human Nutrition, Department for Clinical Nutrition Recruiting Berlin, Germany, 12203 Contact: Stefan Kabisch, Dr. med. 030 450 514 ext 429 stefan.kabisch@charite.de Contact: Ulrike Kaiser, M.sc. 030 450 514 ext 428 ulrike.kaiser@charite.de Sub-Investigator: Stefan Kabisch, Dr. med. Sub-Investigator: Ulrike Kaiser, M.sc. 收起 << |
NCT00211536 | Type 1 Diabetes | Phase 3 | Completed | - | United States, California ... 展开 >> Sansum Medical Research Institute Santa Barbara, California, United States, 93105 United States, Colorado University of Colorado Health Sciences Center Aurora, Colorado, United States, 80010 United States, Missouri Hellman & Rosen Endocrine Associates North Kansas City, Missouri, United States, 64116 United States, Ohio Cleveland Clinic Wooser, Ohio, United States, 44195 United States, Texas Diabetes & Glandular Disease Clinic San Antonio, Texas, United States, 78229 收起 << |
NCT01686945 | Diabetes Diab... 展开 >>etes Mellitus, Type 2 Healthy 收起 << | Phase 1 | Completed | - | Germany ... 展开 >> Novo Nordisk Investigational Site Berlin, Germany, 14050 收起 << |
NCT02648191 | Obesity Baria... 展开 >>tric Surgery 收起 << | Not Applicable | Terminated(Lack of inclusion a... 展开 >>nd departure of the investigator) 收起 << | - | France ... 展开 >> CHU de Saint-Etienne St Etienne, France, 42000 收起 << |
NCT01554293 | Diabetes Mellitus | Phase 1 | Unknown | September 2013 | India ... 展开 >> Fortis Clinical Research Ltd Recruiting Faridabad, Haryana, India, 121 002 Contact: Dr Deepak C Chilkoti +91-129-4090 900 Deepak.chilkoti@fortis-cro.com Principal Investigator: Dr Deepak C Chilkoti 收起 << |
NCT00763815 | Diabetes Mellitus Type 2 | Phase 3 | Completed | - | - |
NCT00763451 | - | Completed | - | - | |
NCT02940249 | Prevention of Hyperglycaemia | Not Applicable | Completed | - | United Kingdom ... 展开 >> Metabolic Research Unit at King's College London Waterloo Campus, London, United Kingdom, SE1 9NH 收起 << |
NCT02825251 | Diabetes Diab... 展开 >>etes Mellitus, Type 1 收起 << | Phase 3 | Completed | - | - |
NCT00975286 | Type 2 Diabetes Mellitus | Phase 3 | Completed | - | - |
NCT00763815 | - | Completed | - | - | |
NCT00975286 | - | Completed | - | - | |
NCT02713477 | Type 2 Diabetes Mellitus | Phase 1 | Completed | - | Japan ... 展开 >> Investigational Site Number 392001 Fukuoka-Shi, Japan 收起 << |
NCT01169779 | Type 2 Diabetes Mellitus | Phase 3 | Completed | - | China ... 展开 >> Investigational Site Number 156011 Beijing, China, 100034 Investigational Site Number 156012 Beijing, China, 100101 Investigational Site Number 156019 Beijing, China, 100191 Investigational Site Number 156002 Beijing, China, 100700 Investigational Site Number 156003 Beijing, China, 100730 Investigational Site Number 156009 Beijing, China, 100730 Investigational Site Number 156001 Beijing, China, 100853 Investigational Site Number 156036 Changchun, China, 130041 Investigational Site Number 156016 Changsha, China, 410008 Investigational Site Number 156015 Changsha, China, 410011 Investigational Site Number 156006 Chengdu, China, 610041 Investigational Site Number 156032 Chengdu, China, 610072 Investigational Site Number 156010 Dalian, China, 116027 Investigational Site Number 156004 Guangzhou, China, 510080 Investigational Site Number 156008 Guangzhou, China, 510080 Investigational Site Number 156025 Guangzhou, China, 510630 Investigational Site Number 156031 Haikou, China, 57028 Investigational Site Number 156014 Harbin, China, 150001 Investigational Site Number 156029 Hefei, China, 230022 Investigational Site Number 156013 Qingdao, China, 266003 Investigational Site Number 156007 Shanghai, China, 200003 Investigational Site Number 156030 Shanghai, China, 200065 Investigational Site Number 156020 Shenyang, China, 110004 Investigational Site Number 156035 Suzhou, China, 215004 Investigational Site Number 156033 Taiyuan, China, 030001 Investigational Site Number 156037 Tianjin, China, 300052 Investigational Site Number 156022 Xi'An, China, 710032 Investigational Site Number 156023 Xi'An, China, 710061 Hong Kong Investigational Site Number 344001 Hong Kong, Hong Kong Investigational Site Number 344003 Hong Kong, Hong Kong Investigational Site Number 344002 Shatin, Nt, Hong Kong Malaysia Investigational Site Number 458001 Kelantan, Malaysia, 16150 Investigational Site Number 458003 Kuala Lumpur, Malaysia, 59100 Investigational Site Number 458002 Putrajaya, Malaysia, 62250 Thailand Investigational Site Number 764002 Bangkok, Thailand, 10400 收起 << |
NCT01169779 | - | Completed | - | - | |
NCT02380833 | Healthy | Not Applicable | Completed | - | United States, South Carolina ... 展开 >> Clemson University Clemson, South Carolina, United States, 29631 收起 << |
NCT01569841 | - | Completed | - | - | |
NCT01569841 | Diabetes Diab... 展开 >>etes Mellitus, Type 1 收起 << | Phase 3 | Completed | - | United States, Minnesota ... 展开 >> Novo Nordisk Clinical Trial Call Center Minneapolis, Minnesota, United States, 55416-2699 收起 << |
NCT00763451 | Diabetes Mellitus, Type 2 | Phase 3 | Completed | - | United States, New Jersey ... 展开 >> Sanofi-Aventis Administrative Office Bridgewater, New Jersey, United States, 08807 Brazil Sanofi-Aventis Administrative Office Sao Paulo, Brazil Chile Sanofi-Aventis Administrative Office Santiago, Chile Colombia Sanofi-Aventis Administrative Office Santafe de Bogota, Colombia Estonia Sanofi-Aventis Administrative Office Tallinn, Estonia Germany Sanofi-Aventis Administrative Office Berlin, Germany Italy Sanofi-Aventis Administrative Office Milano, Italy Lithuania Sanofi-Aventis Administrative Office Vilnius, Lithuania Malaysia Sanofi-Aventis Administrative Office Kuala Lumpur, Malaysia Mexico Sanofi-Aventis Administrative Office Mexico, Mexico Philippines Sanofi-Aventis Administrative Office Makati City, Philippines Poland Sanofi-Aventis Administrative Office Warszawa, Poland Romania Sanofi-Aventis Administrative Office Bucuresti, Romania Slovakia Sanofi-Aventis Administrative Office Brastislava, Slovakia Ukraine Sanofi-Aventis Administrative Office Kiev, Ukraine 收起 << |
NCT03411395 | Healthy | Not Applicable | Completed | - | - |
NCT02825251 | - | Completed | - | - | |
NCT02582606 | Insulin Resistance | Not Applicable | Completed | - | United Kingdom ... 展开 >> David Greenfield Human Physiology Unit, University of Nottingham Medical School Nottingham, Notts, United Kingdom, NG72UH 收起 << |
NCT03337971 | Bone and Bones ... 展开 >> Osteoporosis Risk Osteoporosis, Postmenopausal 收起 << | Not Applicable | Recruiting | April 4, 2019 | Ireland ... 展开 >> University of Limerick Recruiting Limerick, Co Limerick, Ireland Contact: Philip Jakeman, PhD +35361202800 ext 2800 phil.jakeman@ul.ie Contact: Catherine Norton, PhD +35361204780 ext 4780 catherine.norton@ul.ie Principal Investigator: Philip Jakeman, PhD Sub-Investigator: Catherine Norton, PhD 收起 << |
NCT02340247 | Severe Obesity | Phase 4 | Completed | - | Denmark ... 展开 >> Hvidovre University Hospital Hvidovre, Denmark, DK-2650 收起 << |
NCT00905255 | Diabetes Mellitus, Type 2 | Phase 3 | Completed | - | Japan ... 展开 >> Sanofi-Aventis Administrative Office Tokyo, Japan 收起 << |
NCT01830686 | Insulin Resistance | Not Applicable | Completed | - | United States, Louisiana ... 展开 >> Pennington Biomedical Research Center Baton Rouge, Louisiana, United States, 70808 收起 << |
NCT00905255 | - | Completed | - | - | |
NCT01074268 | Diabetes Diab... 展开 >>etes Mellitus, Type 1 收起 << | Phase 3 | Completed | - | - |
NCT02097277 | Diabetes Mellitus Type 2 | Phase 2 | Completed | - | United States, Arkansas ... 展开 >> Arkansas Clinical Research Little Rock, Arkansas, United States, 72205 United States, California Anaheim Clinical Trials Llc Anaheim, California, United States, 92801 National Research Institute Los Angeles, California, United States, 90057 Encompass Clinical Research Spring Valley, California, United States, 91978 United States, Florida All Medical Research, Llc Cooper City, Florida, United States, 33024 United States, Kentucky Central Kentucky Research Associates, Inc. Lexington, Kentucky, United States, 40509 United States, New Jersey Premier Research Trenton, New Jersey, United States, 08611 United States, North Carolina Metrolina Internal Medicine Charlotte, North Carolina, United States, 28204 United States, Ohio Sterling Research Grp, Ltd. Cincinnati, Ohio, United States, 45219 Canada, British Columbia Manna Research Vancouver Vancouver, British Columbia, Canada, V6J 1S3 Canada, Ontario Aggarwal And Associates Brampton, Ontario, Canada, L6T 0G1 Canada, Quebec Rhodin Recherche Clinique Drummondville, Quebec, Canada, J2B 7T1 Recherche Gcp Research Montreal, Quebec, Canada, H1M 1B1 Medexa Recherche Victoriaville, Quebec, Canada, G6P 6P6 Canada Alpha-Recherche Clinique Quebec, Canada, G3K 2P8 收起 << |
NCT01965210 | Appetite Regulation | Not Applicable | Completed | - | Sweden ... 展开 >> Paediatric Research Facility; The Children's Hospital at Uppsala University Hospital Uppsala, Sweden, SE-751 85 收起 << |
NCT02648217 | - | Completed | - | - | |
NCT00560417 | Diabetes Mellitus, Type 2 | Phase 3 | Completed | - | - |
NCT03708419 | Obesity Pre-d... 展开 >>iabetic Type 2 Diabetes Mellitus 收起 << | Not Applicable | Recruiting | July 1, 2020 | Netherlands ... 展开 >> Department of Human Biology, Maastricht University Medical Centre Recruiting Maastricht, Netherlands, 6200MD Contact: Ellen Blaak, Prof. +31(0)43-3881503 e.blaak@maastrichtuniversity.nl Wageningen University and Research Recruiting Wageningen, Netherlands, 6700AA Contact: Edith JM Feskens, Prof. +31(0)317482567 edith.feskens@wur.nl 收起 << |
NCT00560417 | - | Completed | - | - | |
NCT00069784 | Diabetes Mellitus, Non-Insulin... 展开 >>-Dependent 收起 << | Phase 3 | Completed | - | - |
NCT02648217 | Diabetes Diab... 展开 >>etes Mellitus, Type 2 收起 << | Phase 3 | Completed | - | Algeria ... 展开 >> Novo Nordisk Investigational Site Algiers, Algeria Novo Nordisk Investigational Site Oran, Algeria, 31000 Novo Nordisk Investigational Site Setif, Algeria, 19000 Novo Nordisk Investigational Site Sidi Bel abbes, Algeria, 22000 India Novo Nordisk Investigational Site Hyderabad, Andhra Pradesh, India, 500 001 Novo Nordisk Investigational Site Hyderabad, Andhra Pradesh, India, 500058 Novo Nordisk Investigational Site Mysore, Karnataka, India, 570001 Novo Nordisk Investigational Site Kozhikode, Kerala, India, 673017 Novo Nordisk Investigational Site Mumbai, Maharashtra, India, 400010 Novo Nordisk Investigational Site Mumbai, Maharashtra, India, 400058 Novo Nordisk Investigational Site Pune, Maharashtra, India, 411001 Novo Nordisk Investigational Site Kolkatta, West Bengal, India, 700073 Novo Nordisk Investigational Site New Delhi, India, 110001 Lebanon Novo Nordisk Investigational Site Beirut, Lebanon Novo Nordisk Investigational Site Hazmieh, Lebanon Novo Nordisk Investigational Site Lebanon - Beirut, Lebanon, 9611 Malaysia Novo Nordisk Investigational Site Cheras, Malaysia, 56000 Novo Nordisk Investigational Site Kota Bharu, Kelantan, Malaysia, 16150 Novo Nordisk Investigational Site Seremban, Negeri Sembilan, Malaysia, 70400 South Africa Novo Nordisk Investigational Site Benoni, Gauteng, South Africa, 1501 Novo Nordisk Investigational Site Johannesburg, Gauteng, South Africa, 1812 Novo Nordisk Investigational Site Johannesburg, Gauteng, South Africa, 1827 Novo Nordisk Investigational Site Lenasia, Gauteng, South Africa, 1827 Novo Nordisk Investigational Site Pretoria, Gauteng, South Africa, 0181 Novo Nordisk Investigational Site Durban, KwaZulu-Natal, South Africa, 4091 Novo Nordisk Investigational Site Durban, KwaZulu-Natal, South Africa, 4092 Novo Nordisk Investigational Site Durban, KwaZulu-Natal, South Africa, 4450 Novo Nordisk Investigational Site Cape Town, Western Cape, South Africa, 7925 United Arab Emirates Novo Nordisk Investigational Site Ajman, United Arab Emirates, 21499 Novo Nordisk Investigational Site Ajman, United Arab Emirates, 4184 Novo Nordisk Investigational Site Dubai, United Arab Emirates, 7272 Novo Nordisk Investigational Site Umm Al Quwain, United Arab Emirates, 24 收起 << |
NCT00069784 | - | Completed | - | - | |
NCT02384551 | Gastroesophageal Reflux Diseas... 展开 >>e Obesity 收起 << | Early Phase 1 | Recruiting | December 31, 2020 | United States, Tennessee ... 展开 >> Tennessee Valley Healthcare System Nashville Campus, Nashville, TN Recruiting Nashville, Tennessee, United States, 37212-2637 Contact: Kevin D Niswender, MD PhD 615-936-0500 Kevin.Niswender@va.gov Contact: Heidi J Silver, PhD (615) 593-1299 heidi.j.silver@vanderbilt.edu Principal Investigator: Kevin D Niswender, MD PhD 收起 << |
NCT00688701 | Diabetes Mellitus, Type 2 | Phase 3 | Completed | - | United States, New Jersey ... 展开 >> Sanofi-Aventis Administrative Office Bridgewater, New Jersey, United States, 08807 Belgium Sanofi-Aventis Administrative Office Diegem, Belgium India Sanofi-Aventis Administrative Office Mumbai, India Israel Sanofi-Aventis Administrative Office Natanya, Israel Japan Sanofi-Aventis Administrative Office Tokyo, Japan Korea, Republic of Sanofi-Aventis Administrative Office Seoul, Korea, Republic of Mexico Sanofi-Aventis Administrative Office Mexico, Mexico Poland Sanofi-Aventis Administrative Office Warszawa, Poland Romania Sanofi-Aventis Administrative Office Bucuresti, Romania Russian Federation Sanofi-Aventis Administrative Office Moscow, Russian Federation Tunisia Sanofi-Aventis Administrative Office Megrine, Tunisia Ukraine Sanofi-Aventis Administrative Office Kiev, Ukraine 收起 << |
NCT02033499 | - | Completed | - | - | |
NCT01617434 | - | Completed | - | - | |
NCT02033499 | DIABETES MELLITUS, NONINSULIN-... 展开 >>DEPENDENT, 2 (Disorder) 收起 << | Not Applicable | Completed | - | United States, North Carolina ... 展开 >> The University of North Carolina at Chapel Hill Chapel Hill, North Carolina, United States, 27599 收起 << |
NCT00715624 | Diabetes Mellitus, Type 2 | Phase 3 | Completed | - | United States, New Jersey ... 展开 >> Sanofi-Aventis Administrative Office Bridgewater, New Jersey, United States, 08807 Brazil Sanofi-Aventis Administrative Office Sao Paulo, Brazil Canada Sanofi-Aventis Administrative Office Laval, Canada Chile Sanofi-Aventis Administrative Office Santiago, Chile Egypt Sanofi-Aventis Administrative Office Cairo, Egypt France Sanofi-Aventis Administrative Office Paris, France Germany Sanofi-Aventis Administrative Office Berlin, Germany India Sanofi-Aventis Administrative Office Mumbai, India Italy Sanofi-Aventis Administrative Office Milano, Italy Korea, Republic of Sanofi-Aventis Administrative Office Seoul, Korea, Republic of Mexico Sanofi-Aventis Administrative Office Mexico, Mexico Puerto Rico Sanofi-Aventis Administrative Office Puerto Rico, Puerto Rico Russian Federation Sanofi-Aventis Administrative Office Moscow, Russian Federation Turkey Sanofi-Aventis Administrative Office Istanbul, Turkey United Kingdom Sanofi-Aventis Administrative Office Guildford Surrey, United Kingdom 收起 << |
NCT01617434 | Diabetes Diab... 展开 >>etes Mellitus, Type 2 收起 << | Phase 3 | Completed | - | - |
NCT00866658 | Diabetes Mellitus, Type 2 | Phase 3 | Completed | - | Japan ... 展开 >> Sanofi-Aventis Administrative Office Tokyo, Japan Korea, Republic of Sanofi-Aventis Administrative Office Seoul, Korea, Republic of Philippines Sanofi-Aventis Administrative Office Makati City, Philippines Taiwan Sanofi-Aventis Administrative Office Taipei, Taiwan 收起 << |
NCT00715624 | - | Completed | - | - | |
NCT00688701 | - | Completed | - | - | |
NCT02621502 | Overweight | Not Applicable | Completed | - | Spain ... 展开 >> Hospital Universitairo La Paz Madrid, Spain, 28046 收起 << |
NCT01835431 | Diabetes Diab... 展开 >>etes Mellitus, Type 1 收起 << | Phase 3 | Completed | - | - |
NCT01835431 | - | Completed | - | - | |
NCT00707031 | - | Completed | - | - | |
NCT00707031 | Diabetes Mellitus, Type 2 | Phase 3 | Completed | - | - |
NCT01798706 | Type 2 Diabetes | Phase 3 | Completed | - | - |
NCT03462069 | Diabetes Mellitus | Phase 2 | Recruiting | August 7, 2019 | Germany ... 展开 >> Investigational Site Number 2760001 Recruiting Berlin, Germany, 13353 收起 << |
NCT00866658 | - | Completed | - | - | |
NCT01798706 | - | Completed | - | - | |
NCT02322112 | Overweight and Obesity | Not Applicable | Recruiting | December 2020 | Canada, Alberta ... 展开 >> Alberta Diabetes Institute Clinical Research Unit Recruiting Edmonton, Alberta, Canada, T6G 2E1 收起 << |
NCT02894112 | Oral Glucose Tolerance Test ... 展开 >> High Fat Tolerance Test 收起 << | Not Applicable | Completed | - | United States, Texas ... 展开 >> Cardiovascular Aging Research Laboratory Austin, Texas, United States, 78702 收起 << |
NCT02976688 | Endstage Renal Disease | Phase 2 Phase 3 | Unknown | December 2017 | - |
NCT01658579 | Type 1 Diabetes Mellitus | Phase 2 | Completed | - | United States, California ... 展开 >> Investigational Site Number 840002 Temecula, California, United States, 92591 United States, Minnesota Investigational Site Number 840001 Minneapolis, Minnesota, United States, 55416 United States, Oregon Investigational Site Number 840003 Portland, Oregon, United States, 97201-3098 收起 << |
NCT03175120 | Diabetes Diab... 展开 >>etes Mellitus, Type 2 收起 << | Phase 3 | Active, not recruiting | April 8, 2019 | - |
NCT01658579 | - | Completed | - | - | |
NCT02292433 | Type 2 Diabetes Mellitus | Phase 1 | Completed | - | Japan ... 展开 >> P-one Clinic, Keikokai Medical Corporation Hachioji-shi, Tokyo, Japan, 192-0071 收起 << |
NCT02025595 | - | Completed | - | Netherlands ... 展开 >> VU University Medical Center Amsterdam, Netherlands, 1081HV 收起 << | |
NCT02542631 | Diabetes Mellitus, Type 2 | Not Applicable | Completed | - | - |
NCT00673309 | Burns | Phase 2 Phase 3 | Completed | - | United States, Texas ... 展开 >> University of Texas Medical Branch Galveston, Texas, United States, 77550 收起 << |
NCT02152124 | - | Unknown | August 2017 | Belgium ... 展开 >> Ghent University Hospital, Department of Endocrinology, 9K12IE Ghent, Belgium, 9000 收起 << | |
NCT00768651 | Type 1 Diabetes | Phase 2 | Completed | - | Canada, Alberta ... 展开 >> University of Alberta - Clinical Islet Transplant Program Edmonton, Alberta, Canada, T6G2C8 收起 << |
NCT02542631 | - | Completed | - | - | |
NCT00949286 | - | Completed | - | - | |
NCT00768651 | - | Completed | - | - | |
NCT03151005 | Polycystic Ovary Syndrome (PCO... 展开 >>S) Overweight Obesity 收起 << | Phase 4 | Recruiting | December 31, 2018 | China, Chongqing ... 展开 >> The Second Affiliated Hospital, Third Military Medical University Recruiting Chongqing, Chongqing, China, 400037 Principal Investigator: Min Long, MD 收起 << |
NCT01421147 | Diabetes Mellitus, Type 1 | Phase 3 | Completed | - | - |
NCT01617304 | Obesity Type ... 展开 >>2 Diabetes Insulin Resistance Cardiovascular Disease 收起 << | Not Applicable | Completed | - | Denmark ... 展开 >> Department of Human Nutrition, University of Copenhagen Frederiksberg, Denmark 收起 << |
NCT02302716 | - | Completed | - | - | |
NCT01421147 | - | Completed | - | - | |
NCT02302716 | Diabetes Mellitus, Type 2 | Phase 3 | Completed | - | - |
NCT01854723 | Diabetes | Phase 4 | Unknown | December 2015 | United States, Oregon ... 展开 >> Providence Medical Group Northeast Clinic Portland, Oregon, United States, 97213 收起 << |
NCT02764021 | Type 2 Diabetes Mellitus | Not Applicable | Completed | - | Denmark ... 展开 >> Bispebjerg Hospital Copenhagen, Copenhagen NV, Denmark, 2400 收起 << |
NCT01708668 | Labor Pain Pa... 展开 >>in Neurologic Manifestations Signs and Symptoms Pathological Conditions, Signs and Symptoms 收起 << | Not Applicable | Unknown | June 2017 | China, Jiangsu ... 展开 >> Nanjing Maternal and Child Health Care Hospital Affiliated to Nanjing Medical University Recruiting Nanjing, Jiangsu, China, 210004 Contact: Shanwu Feng, M.D. +86 25 52226112 shanwufeng@163.com Principal Investigator: Shanwu Feng, M.D. 收起 << |
NCT01421459 | Diabetes Mellitus, Type 2 | Phase 3 | Completed | - | - |
NCT00666718 | - | Completed | - | - | |
NCT01123083 | Diabetes Mellitus, Type 1 | Phase 3 | Completed | - | Italy ... 展开 >> GSK Investigational Site Roma, Italy, 00155 收起 << |
NCT02292433 | - | Completed | - | - | |
NCT01123083 | - | Completed | - | - | |
NCT03027336 | Dyslipidemias | Phase 2 | Completed | - | Italy ... 展开 >> Endocrinology Unit Parma, Italy, 43126 收起 << |
NCT00666718 | Diabetes Mellitus, Type 2 | Phase 3 | Completed | - | - |
NCT01290250 | Overweight Ob... 展开 >>esity 收起 << | Not Applicable | Completed | - | Spain ... 展开 >> Department of Biochemistry and Molecular Biology II, Institute of Nutrition and Food Technology, Center for Biomedical Research, University of Granada, Spain, 18071 收起 << |
NCT00529191 | Type 1 Diabetes | Phase 2 | Completed | - | United States, Pennsylvania ... 展开 >> Diabetes Center for Children & Clinical Translational Research Center Philadelphia, Pennsylvania, United States, 19104 收起 << |
NCT01847690 | Addison Disease | Phase 2 | Unknown | March 2014 | Norway ... 展开 >> Haukeland Universitetessykehus, Department of Medicine Bergen, Norway, 5021 收起 << |
NCT00529191 | - | Completed | - | - | |
NCT02662738 | Healthy | Not Applicable | Completed | - | Netherlands ... 展开 >> QPS Groningen, Hanzeplein 1, Netherlands, 9713 GZ 收起 << |
NCT01421459 | - | Completed | - | - | |
NCT02961179 | Insulin Sensitivity ... 展开 >> Type2 Diabetes 收起 << | Not Applicable | Recruiting | January 2019 | Canada ... 展开 >> Research Center CHU de Quebec-Université Laval Recruiting Quebec, Canada, G1V 4G2 Contact: Sarah Chouinard-Castonguay, MSc 418-525-4444 ext 48729 Sarah.Chouinard-Castonguay@crchudequebec.ulaval.ca Principal Investigator: Iwona Rudkowska, PhD 收起 << |
NCT02956369 | Obesity | Not Applicable | Recruiting | August 2019 | Switzerland ... 展开 >> St Claraspital Recruiting Basel, Switzerland, 4016 Contact: Bettina Woelnerhanssen, MD bettina.woelnerhanssen@usb.ch Principal Investigator: Bettina Woelnerhanssen, MD 收起 << |
NCT01790438 | Diabetes Mellitus, Type 2 | Phase 3 | Completed | - | - |
NCT01938521 | Type 2 Diabetes | Not Applicable | Completed | - | Israel ... 展开 >> Daniela Jakubowicz MD Holon,, Tel Aviv, Israel, 58100 收起 << |
NCT00487240 | Diabetes Mellitus, Type 1 | Phase 3 | Completed | - | - |
NCT01790438 | - | Completed | - | - | |
NCT02330406 | Dipeptidyl-Peptidase 4 Inhibit... 展开 >>ors LDL Cholesterol Glycosylated Hemoglobin Diabetes Mellitus Coronary Disease 收起 << | Phase 4 | Active, not recruiting | December 2018 | Japan ... 展开 >> Department of Cardiovascular Medicine, Tomishiro Central Hospital Tomishiro, Okinawa, Japan, 901-0243 收起 << |
NCT00487240 | - | Completed | - | - | |
NCT00139659 | Asthma Diabet... 展开 >>es Mellitus 收起 << | Phase 3 | Completed | - | - |
NCT03404700 | Diabetes Mellitus, Type 2 ... 展开 >> Insulin Resistance 收起 << | Not Applicable | Recruiting | January 2019 | United States, Texas ... 展开 >> Texas Tech University - Department of Nutritional Sciences Recruiting Lubbock, Texas, United States, 79409 Contact: Nikhil V Dhurandhar, PhD 806-834-6446 nikhil.dhurandhar@ttu.edu 收起 << |
NCT00139659 | - | Completed | - | - | |
NCT03029364 | - | Recruiting | June 30, 2024 | United Kingdom ... 展开 >> Department for Health, University of Bath Recruiting Bath, United Kingdom, BA2 7AY Contact: Oliver J Chrzanowski-Smith, MSc +44 (0) 1225384654 o.j.chrzanowski-smith@bath.ac.uk Contact: Javier T Gonzalez, PhD +44 (0) 1225 38 5518 J.T.Gonzalez@bath.ac.uk 收起 << | |
NCT02750007 | Diabetes Mellitus, Type 2 | Phase 1 | Unknown | - | China, Hunan ... 展开 >> The Second Xiangya Hospital of Central South University Recruiting Changsha, Hunan, China, 410011 Contact: Zhiguang Zhou, Professor 0731-85292097 zhouzg@hotmail.com 收起 << |
NCT02699372 | Healthy Volunteer | Phase 1 | Completed | - | Netherlands ... 展开 >> PRA Health Sciences Early Development Services Zuidlaren, Netherlands, 9471 GP 收起 << |
NCT00391027 | Diabetes Mellitus, Type 2 | Phase 4 | Completed | - | - |
NCT00850629 | Obesity Weigh... 展开 >>t Loss Weight Gain Hormone Disturbance Adipose Tissue Insulin Resistance Skeletal Muscle 收起 << | Not Applicable | Completed | - | Germany ... 展开 >> Charite Berlin, Germany, 12200 收起 << |
NCT02500186 | Diabetes Melltius, Type 2 | Not Applicable | Completed | - | - |
NCT01812967 | Glycemic Control ... 展开 >> Gastrointestinal Hormone Response Healthy Young Men 收起 << | Not Applicable | Completed | - | Canada, Ontario ... 展开 >> University of Toronto Toronto, Ontario, Canada, M5S 3E2 收起 << |
NCT00970528 | Diabetes Mellitus, Type 2 | Phase 4 | Completed | - | Korea, Republic of ... 展开 >> Wonju-si, Gang''weondo, Korea, Republic of, 220-701 Busan, Korea, Korea, Republic of, 602-714 Gyeonggi-do, Korea, Korea, Republic of, 463-500 Gyeonggi-do, Korea, Korea, Republic of, 471-701 Pusan, Korea, Korea, Republic of, 602-739 Seoul, Korea, Korea, Republic of, 150-713 Daegu, Korea, Republic of, 705-717 Jeonju-si, Korea, Republic of, 456-712 Seongbuk-gu Seoul, Korea, Republic of, 136-705 Seoul, Korea, Republic of, 134-701 Seoul, Korea, Republic of, 135-710 收起 << |
NCT02845622 | Cardiovascular Diseases ... 展开 >> Glucose Metabolism Disorders 收起 << | Not Applicable | Completed | - | Italy ... 展开 >> San Donato Hospital San Donato Milanese, Italy, 20097 收起 << |
NCT02916355 | Adiposity | Not Applicable | Completed | - | Switzerland ... 展开 >> University Hospital Basel, Department of Endocrinology, Diabetes and Metabolism Basel, Switzerland, CH-4031 Basel 收起 << |
NCT00359762 | Type 2 Diabetes Mellitus | Phase 3 | Completed | - | - |
NCT00391027 | - | Completed | - | - | |
NCT01848990 | Type 1 Diabetes Mellitus | Phase 4 | Completed | - | - |
NCT01621178 | - | Completed | - | - | |
NCT01455441 | Type 2 Diabetes | Phase 4 | Completed | - | Denmark ... 展开 >> Department of Internal Medicine, Gentofte Hospital Hellerup, Denmark, 2900 收起 << |
NCT02033473 | Healthy | Phase 1 | Completed | - | France ... 展开 >> University Hospital of Toulouse Toulouse, France, 31059 收起 << |
NCT00359762 | - | Completed | - | - | |
NCT00308139 | Type 2 Diabetes Mellitus | Phase 3 | Completed | - | - |
NCT01848990 | - | Completed | - | - | |
NCT00838903 | Diabetes Mellitus, Type 2 | Phase 3 | Completed | - | - |
NCT00308139 | - | Completed | - | - | |
NCT01620476 | Diabetes Heal... 展开 >>thy 收起 << | Phase 1 | Completed | - | Japan ... 展开 >> Novo Nordisk Investigational Site Tokyo, Japan, 1000005 收起 << |
NCT01621178 | Type 2 Diabetes ... 展开 >> Chronic Kidney Disease 收起 << | Phase 3 | Completed | - | - |
NCT00838916 | Diabetes Mellitus, Type 2 | Phase 3 | Completed | - | - |
NCT00838916 | - | Completed | - | - | |
NCT00838903 | - | Completed | - | - | |
NCT00839527 | - | Completed | - | - | |
NCT02119819 | Diabetes Mellitus, Type 2 | Phase 2 | Completed | - | - |
NCT02364869 | Chronic Kidney Disease | Not Applicable | Completed | - | Brazil ... 展开 >> Federal University of São Paulo São Paulo, Brazil 收起 << |
NCT02799849 | Narcolepsy | Not Applicable | Unknown | January 2017 | France ... 展开 >> Service d'Exploration et pathologie du sommeil, Hôpital Femme Mère Enfant Recruiting Bron, France, 69677 Contact: Patricia Franco, MD 04 27 85 60 52 ext +33 patricia.franco@chu-lyon.fr Contact: Sonia GALLETTI 04 27 85 77 39 ext +33 sonia.galletti@chu-lyon.fr 收起 << |
NCT03423381 | Glucose Tolerance | Not Applicable | Enrolling by invitation | October 30, 2019 | Sweden ... 展开 >> Food Technology, engineering and Nutrition, LTH, Lund University Lund, Sweden, 22100 收起 << |
NCT01874366 | Overweight Di... 展开 >>abetes Mellitus Type 2 in Obese 收起 << | Phase 1 | Unknown | December 2015 | United States, Florida ... 展开 >> Phase I clinic: MRA Clinical Research Recruiting Miami, Florida, United States, 33143 Contact: Patricia Pardo, MD 305-722-0970 ext 5110 ppardo@miamiresearch.com 收起 << |
NCT00998699 | Type 1 Diabetes | Phase 2 | Completed | - | Switzerland ... 展开 >> Basel, Switzerland Zurich, Switzerland 收起 << |
NCT00839527 | Diabetes Mellitus, Type 2 | Phase 3 | Completed | - | - |
NCT01620463 | Diabetes Diab... 展开 >>etes Mellitus, Type 2 收起 << | Phase 1 | Completed | - | Japan ... 展开 >> Novo Nordisk Investigational Site Tokyo, Japan, 1000005 收起 << |
NCT01508923 | Diabetes Diab... 展开 >>etes Mellitus, Type 2 收起 << | Phase 2 | Completed | - | Denmark ... 展开 >> Novo Nordisk Investigational Site Århus C, Denmark, 8000 收起 << |
NCT01253278 | Diabetes Mellitus, Type 2 | Phase 1 | Completed | - | Germany ... 展开 >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Neuss, Germany, D-41460 收起 << |
NCT01619332 | Type II Diabetes | Phase 1 Phase 2 | Completed | - | United States, California ... 展开 >> Novartis Investigative Site Chula Vista, California, United States, 91910 United States, Florida Novartis Investigative Site Miami, Florida, United States, 33126 Novartis Investigative Site Orlando, Florida, United States, 32809 United States, Ohio Novartis Investigative Site Cincinnati, Ohio, United States, 45227 United States, Tennessee Novartis Investigative Site Knoxville, Tennessee, United States, 37920 United States, Texas Novartis Investigative Site San Antonio, Texas, United States, 78209 收起 << |
NCT01406262 | Diabetes Mellitus, Type 2 | Phase 1 | Completed | - | - |
NCT00678886 | Diabetes Mellitus, Type 1 | Phase 3 | Completed | - | - |
NCT01676220 | Type 2 Diabetes Mellitus | Phase 3 | Completed | - | - |
NCT01499095 | Type 2 Diabetes Mellitus | Phase 3 | Completed | - | - |
NCT00678886 | - | Completed | - | - | |
NCT02951624 | Sedentary Lifestyle ... 展开 >> Overweight and Obesity Metabolic Disease 收起 << | Not Applicable | Completed | - | Denmark ... 展开 >> Center for Physical Activity Research, Copenhagen University Hospital Copenhagen, Denmark, 2100 收起 << |
NCT01306838 | Short Bowel Syndrome ... 展开 >> Necrotizing Enterocolitis Small Intestine Perforation 收起 << | Early Phase 1 | Completed | - | United States, North Carolina ... 展开 >> WFUHS Brenner Children's Hospital NICU Winston-Salem, North Carolina, United States, 27157 收起 << |
NCT02862431 | Diabetes Mellitus, Type 2 | Phase 1 | Terminated(manufacturing-relat... 展开 >>ed issues) 收起 << | - | Germany ... 展开 >> Neuss, Germany 收起 << |
NCT01499095 | - | Completed | - | - | |
NCT02897219 | Type 1 Diabetes Mellitus | Phase 3 | Completed | - | Japan ... 展开 >> Site JP00005 Aichi, Japan Site JP00028 Aichi, Japan Site JP00003 Chiba, Japan Site JP00013 Chiba, Japan Site JP00035 Chiba, Japan Site JP00022 Fukuoka, Japan Site JP00023 Fukuoka, Japan Site JP00031 Fukuoka, Japan Site JP00002 Gunma, Japan Site JP00011 Gunma, Japan Site JP00006 Hiroshima, Japan Site JP00033 Hokkaido, Japan Site JP00034 Hokkaido, Japan Site JP00021 Hyogo, Japan Site JP00009 Ibaraki, Japan Site JP00010 Ibaraki, Japan Site JP00004 Kanagawa, Japan Site JP00015 Kanagawa, Japan Site JP00016 Kanagawa, Japan Site JP00019 Mie, Japan Site JP00008 Nagasaki, Japan Site JP00024 Nagasaki, Japan Site JP00025 Nagasaki, Japan Site JP00032 Nagasaki, Japan Site JP00026 Niigata, Japan Site JP00020 Osaka, Japan Site JP00029 Osaka, Japan Site JP00036 Osaka, Japan Site JP00012 Saitama, Japan Site JP00017 Shizuoka, Japan Site JP00018 Shizuoka, Japan Site JP00001 Tochigi, Japan Site JP00030 Tokushima, Japan Site JP00014 Tokyo, Japan Site JP00027 Toyama, Japan Site JP00007 Yamaguchi, Japan 收起 << |
NCT02847091 | Type 2 Diabetes Mellitus | Phase 4 | Completed | - | Japan ... 展开 >> Site JP00007 Gunma, Japan Site JP00008 Hiroshima, Japan Site JP00009 Hyogo, Japan Site JP00010 Kanagawa, Japan Site JP00003 Mie, Japan Site JP00004 Osaka, Japan Site JP00015 Shiga, Japan Site JP00002 Tochigi, Japan Site JP00005 Tochigi, Japan Site JP00013 Tochigi, Japan Site JP00001 Tokyo, Japan Site JP00006 Tokyo, Japan Site JP00011 Tokyo, Japan Site JP00012 Tokyo, Japan Site JP00014 Tokyo, Japan 收起 << |
NCT01676220 | - | Completed | - | - | |
NCT02405806 | Obesity Diet ... 展开 >>Modification 收起 << | Not Applicable | Completed | - | - |
NCT02844907 | Insulin Secretion | Phase 4 | Recruiting | December 2020 | United States, North Carolina ... 展开 >> VA Health Care System Recruiting Durham, North Carolina, United States, 27705 Contact: Leslie S Kelly 910-782-9771 leslie.kelly@va.gov Contact: Lucy W Piner, MS 919-660-6781 lucy.piner@va.gov Principal Investigator: David D'Alessio, MD 收起 << |
NCT00143247 | Diabetes Mellitus | Phase 2 | Terminated(See termination rea... 展开 >>son in detailed description.) 收起 << | - | United States, California ... 展开 >> Pfizer Investigational Site San Diego, California, United States, 92123 United States, Connecticut Pfizer Investigational Site New Haven, Connecticut, United States, 06504 United States, Florida Pfizer Investigational Site Miami, Florida, United States, 33136 United States, Illinois Pfizer Investigational Site Chicago, Illinois, United States, 60610 United States, New Mexico Pfizer Investigational Site Albuquerque, New Mexico, United States, 87131-5666 United States, North Carolina Pfizer Investigational Site Durham, North Carolina, United States, 27710 Pfizer Investigational Site Winston Salem, North Carolina, United States, 27157 United States, Texas Pfizer Investigational Site Austin, Texas, United States, 78752 Pfizer Investigational Site Austin, Texas, United States, 78758 Pfizer Investigational Site Dallas, Texas, United States, 75230 Pfizer Investigational Site Dallas, Texas, United States, 75243 Pfizer Investigational Site San Antonio, Texas, United States, 78229 收起 << |
NCT01944020 | Sleep Apnea Syndromes | Not Applicable | Recruiting | March 2018 | United States, New York ... 展开 >> Columbia University Medical Center Recruiting New York, New York, United States, 10032 Contact: Ari Shechter, Ph.D. 212-851-5584 as4874@columbia.edu Principal Investigator: Ari Shechter, Ph.D. 收起 << |
NCT01446068 | Nutritional Intervention ... 展开 >> Nutritional and Metabolic Diseases Obesity 收起 << | Early Phase 1 | Completed | - | Switzerland ... 展开 >> Agroscope Liebefeld-Posieux ALP Research Station Berne, Switzerland, 3003 University Hospital Inselspital, Berne Berne, Switzerland, 3010 收起 << |
NCT02054650 | Chronic Low Back Pain ... 展开 >> Type 2 Diabetes Mellitus 收起 << | Not Applicable | Terminated(Scheduling and recr... 展开 >>uitment difficulties) 收起 << | - | United States, Texas ... 展开 >> University of North Texas Health Science Center Fort Worth, Texas, United States, 76107 收起 << |
NCT00510952 | Diabetes Mellitus, Type 2 | Phase 3 | Completed | - | United States, Arkansas ... 展开 >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Jonesboro, Arkansas, United States, 72401 United States, California For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Huntington Park, California, United States, 90255 United States, Florida For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Miami, Florida, United States, 33145 United States, Georgia For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Atlanta, Georgia, United States, 30312 United States, Indiana For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Indianapolis, Indiana, United States, 46222 United States, Kansas For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Wichita, Kansas, United States, 67208 United States, Kentucky For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Lexington, Kentucky, United States, 40502 United States, Louisiana For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Slidell, Louisiana, United States, 70458 United States, New Jersey For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Toms River, New Jersey, United States, 08755 United States, New York For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Brooklyn, New York, United States, 11203 United States, Washington For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Tacoma, Washington, United States, 98405 Brazil For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Brasilia, Brazil, 71625-009 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Fortaleza, Brazil, 60430-350 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Joinville, Brazil, 89201-260 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Sao Paulo, Brazil, 01244-030 Canada, British Columbia For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Victoria, British Columbia, Canada, V8R 6V4 Puerto Rico For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Ponce, Puerto Rico, 00716 收起 << |
NCT02340039 | Postprandial Hyperglycemia | Not Applicable | Completed | - | United Kingdom ... 展开 >> Metabolic Research Unit at King's College London. Franklin-Wilkins Buiding. Waterloo Campus London, England, United Kingdom, W3 7LR 收起 << |
NCT01292993 | Type 2 Diabetes Mellitus | Phase 1 | Completed | - | United States, Texas ... 展开 >> Lexicon Investigational Site San Antonio, Texas, United States, 78209 收起 << |
NCT02903199 | Type II Diabetes Mellitus ... 展开 >> Glucose Metabolism Disorders Metabolic Diseases 收起 << | Not Applicable | Unknown | October 2016 | United Kingdom ... 展开 >> Northumbria University Newcastle-upon-Tyne, Tyne & Wear, United Kingdom, NE1 8ST 收起 << |
NCT01074268 | - | Completed | - | - | |
NCT00510952 | - | Completed | - | - | |
NCT03761186 | Type1diabetes | Not Applicable | Not yet recruiting | December 2021 | - |
NCT02144545 | Obesity, Morbid | Not Applicable | Unknown | October 2017 | Spain ... 展开 >> Hospital de la Santa Creu i Sant Pau Recruiting Barcelona, Spain, 08025 Contact: Maria Carmen Balagué Ponz, MD +34 93 556 56 71 cbalague@santpau.cat Contact: Eduardo Maria Targarona Soler, MD PhD +34 93 556 56 71 etargarona@santpau.cat Sub-Investigator: Eduardo Maria Targarona Soler, MD PhD 收起 << |
NCT01934816 | Healthy Subjects | Not Applicable | Terminated(Technical Issues wi... 展开 >>th intervention) 收起 << | - | United Kingdom ... 展开 >> Royal Devon and Exeter NHS Foundation Trust Exeter, United Kingdom, EX25DW 收起 << |
NCT02814123 | Diabetes Mellitus, Type 1 | Phase 2 | Recruiting | June 30, 2018 | Canada, Quebec ... 展开 >> McGill University Health Centre Recruiting Montréal, Quebec, Canada Contact: Natalia Strauss 514-398-4491 natalia.strauss@mcgill.ca Contact: Sarah Twardy sarah.bernier-twardy@mail.mcgill.ca Sub-Investigator: Ahmad Haidar Principal Investigator: Laurent Legault 收起 << |
NCT02240680 | Diabetes Mellitus, Type 2 | Phase 4 | Completed | - | - |
NCT01117350 | Diabetes Mellitus, Type 2 | Phase 4 | Completed | - | - |
NCT02240680 | - | Completed | - | - | |
NCT01427920 | Diabetes Diab... 展开 >>etes Mellitus, Type 2 收起 << | Phase 4 | Completed | - | - |
NCT00143247 | - | Terminated(See termination rea... 展开 >>son in detailed description.) 收起 << | - | - | |
NCT01117350 | - | Completed | - | - | |
NCT03624569 | Cardiovascular Diseases ... 展开 >> Endotoxemia Endothelial Dysfunction Postprandial Hyperglycemia Gut Health 收起 << | Not Applicable | Recruiting | September 2020 | United States, Ohio ... 展开 >> Ohio State University Recruiting Columbus, Ohio, United States, 43210 Contact: Richard Bruno, PhD, RD 收起 << |
NCT03338855 | Diabetes Mellitus, Type 2 ... 展开 >> Skeletal Muscle Insulin Sensitivity 收起 << | Phase 4 | Recruiting | December 16, 2019 | Netherlands ... 展开 >> Research Site Recruiting Maastricht, Netherlands, 6229 HX 收起 << |
NCT02823808 | Diabetes | Phase 4 | Recruiting | December 2021 | Korea, Republic of ... 展开 >> Kyunghee University Medical Center Recruiting Seoul, Korea, Republic of Contact: Sang Youl Rhee 收起 << |
NCT00437489 | Diabetes Mellitus, Type 2 | Phase 4 | Terminated(This protocol was t... 展开 >>erminated not for safety reasons, but because Pfizer decided to return the worldwide rights for Exubera to Nektar, on 18 October 2007.) 收起 << | - | Hong Kong ... 展开 >> Pfizer Investigational Site Hong Kong, Hong Kong Pakistan Pfizer Investigational Site Karachi, Sindh, Pakistan, 74600 Philippines Pfizer Investigational Site Makati, Philippines, 1218 Pfizer Investigational Site Marikina City, Philippines, 1810 Pfizer Investigational Site Pasay City, Philippines, 1300 Pfizer Investigational Site Pasig City, Philippines, 1605 Pfizer Investigational Site Quezon City, Philippines, 1102 Singapore Pfizer Investigational Site Singapore, Singapore, 119074 Pfizer Investigational Site Singapore, Singapore, 159964 收起 << |
NCT02218333 | Healthy | Not Applicable | Completed | - | Norway ... 展开 >> University of Oslo Oslo, Post box 1046, Blindern, Norway, 0317 收起 << |
NCT03203915 | Dyslipidemia ... 展开 >>Obesity 收起 << | Not Applicable | Recruiting | August 2019 | United States, California ... 展开 >> Western Human Nutrition Research Center Recruiting Davis, California, United States, 95616 Contact: Ellen L Bonnel, PhD 530-752-4184 ellen.bonnel@ars.usda.gov Principal Investigator: Nancy L Keim, PhD 收起 << |
NCT02482558 | Healthy | Not Applicable | Completed | - | United Kingdom ... 展开 >> Sir Peter Mansfield Magnetic Resonance Centre, University of Nottingham Nottingham, Nottinghamshire, United Kingdom, NG7 2QX 收起 << |
NCT03565510 | Dietary Modification | Not Applicable | Recruiting | September 1, 2020 | Canada, Alberta ... 展开 >> University of Alberta Recruiting Edmonton, Alberta, Canada, T6G 2E1 Contact: Camila Oliveira, MSc 7804924182 camila@ualberta.ca 收起 << |
NCT02953587 | Obesity | Phase 1 | Active, not recruiting | September 2019 | United States, Tennessee ... 展开 >> Vanderbilt University Medical Center Nashville, Tennessee, United States, 37232 收起 << |
NCT01427920 | - | Completed | - | - | |
NCT00732173 | Endometrial Cancer | Not Applicable | Completed | - | United States, Ohio ... 展开 >> Case Medical Center, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center Cleveland, Ohio, United States, 44106-5065 收起 << |
NCT03686293 | Blood Glucose, High | Not Applicable | Completed | - | Denmark ... 展开 >> Department of Nutrition, Exercise and Sports, University of Copenhagen Frederiksberg, Denmark, 1958 收起 << |
NCT02562014 | Obesity | Not Applicable | Completed | - | - |
NCT01561235 | Obesity | Not Applicable | Completed | - | Denmark ... 展开 >> Department of human Nutrition Frederiksberg, Denmark, 1958 收起 << |
NCT02901496 | Adiposity | Not Applicable | Recruiting | November 2017 | Denmark ... 展开 >> Rigshospitalet, Centre of Inflammation and Metabolism (CIM) Centre for Physical Activity Research (CFAS) Recruiting Copenhagen, Denmark, 2100 Contact: Louise L Lehrskov, MD +45 35457190 louise.lang.lehrskov@regionh.dk Principal Investigator: Louise L Lehrskov, MD Principal Investigator: Regitse H Christensen, MD Principal Investigator: Anne-Sophie Wedel-Neergard, MD 收起 << |
NCT01472666 | Metabolic Syndrome ... 展开 >> Type 2 Diabetes Cardiovascular Disease Abdominal Obesity 收起 << | Not Applicable | Completed | - | Denmark ... 展开 >> Aarhus University Hospital Aarhus, Aarhus C, Denmark, 8000 收起 << |
NCT00437489 | - | Terminated(This protocol was t... 展开 >>erminated not for safety reasons, but because Pfizer decided to return the worldwide rights for Exubera to Nektar, on 18 October 2007.) 收起 << | - | - | |
NCT02856113 | Diabetes Mellitus, Type 2 | Phase 3 | Recruiting | June 11, 2021 | - |
NCT03380546 | Gestational Diabetes Mellitus ... 展开 >>in Pregnancy 收起 << | Phase 3 | Recruiting | March 30, 2022 | France ... 展开 >> Jean Verdier Hospital Recruiting Bondy, France, 93140 Contact: Emmanuel COSSON, MD-PhD 01 48 02 65 94 ext +33 emmanuel.cosson@aphp.fr 收起 << |
NCT02144597 | Morbid Obesity ... 展开 >> Liver Fat 收起 << | Not Applicable | Completed | - | United Kingdom ... 展开 >> Imperial Clinical research facility London, greater London, United Kingdom, W12 0NN 收起 << |
NCT01648218 | Post-Transplant Glucocorticoid... 展开 >> Induced Diabetes 收起 << | Phase 4 | Terminated(Poor enrollment) | - | Canada, British Columbia ... 展开 >> Vancouver General Hospital - Jim Pattison Pavilion Vancouver, British Columbia, Canada, V5Z 1M9 收起 << |
NCT03112538 | Type 2 Diabetes Mellitus | Phase 4 | Recruiting | December 2018 | Malaysia ... 展开 >> Hospital Putrajaya Recruiting Putrajaya, Wilayah Persekutuan, Malaysia, 62250 Contact: Zanariah Hussein, MBBS,MRCP 0122907136 ppzana@hpj.gov.my Contact: Nurain Mohd Noor, MBBS,MMed 0122051570 ppnurain@hpj.gov.my Principal Investigator: Noor Rafhati Adyani Abdullah, MBBS,MRCP 收起 << |
NCT02883127 | - | Recruiting | March 2019 | Denmark ... 展开 >> Center for Pregnant Women with Diabetes Recruiting Copenhagen, Østerbro, Denmark, 2100 Contact: Björg Ásbjörnsdóttir, MD +45 2285 6797 bjoerg.asbjoernsdottir.01@regionh.dk 收起 << | |
NCT03291249 | NASH - Nonalcoholic Steatohepa... 展开 >>titis NAFLD T2DM (Type 2 Diabetes Mellitus) 收起 << | Phase 2 | Not yet recruiting | June 1, 2019 | - |
NCT01619215 | - | Recruiting | July 2018 | Saudi Arabia ... 展开 >> King Khalid University Hospital Recruiting Riyadh, Saudi Arabia, 7805 Contact: Tamader AlDoheyan, (MBBSc) +966500083720 AlDoheyan.Tamader@gmail.com Contact: Maram AlKhamash +966548327049 Malkhamash.c@KSU.EDU.SA Sub-Investigator: Fahad Bamehriz, MBBS Sub-Investigator: Hisham Al-Khalidi, MBBS Sub-Investigator: Talal Al-Tuwaijri, MBBS Sub-Investigator: Amna Al-Mulhim, MBBS Sub-Investigator: Atheer Al-Sabhan, MBBS Sub-Investigator: Shaden Al-Amro, MBBS Sub-Investigator: Tamader AlDoheyan, (MBBSc) King Khalid University Hospital Recruiting Riyadh, Saudi Arabia, 7805 Contact: Tamader Al-Doheyan, (MBBSc) +966500083720 AlDoheyan.Tamader@gmail.com Contact: Maram AlKhamash +966548327049 Malkhamash.c@KSU.EDU.SA 收起 << | |
NCT02160275 | Diabetes Mellitus, Type 1 | Not Applicable | Completed | - | Netherlands ... 展开 >> Rijnstate Hospital Arnhem, Gelderland, Netherlands, 6815 AD Academic Medical Center Amsterdam, Noord-Holland, Netherlands, 1105 AZ 收起 << |
NCT02924454 | Drug Overdose ... 展开 >> Overdose of Beta-adrenergic Blocking Drug Blood Pressure 收起 << | Phase 4 | Completed | - | Denmark ... 展开 >> Bispebjerg University Hospital Copenhagen Copenhagen NW, Capital Region of Denmark, Denmark, 2400 收起 << |
NCT01077505 | Diabetes Mellitus, Type 2 | Phase 1 | Completed | - | United States, Texas ... 展开 >> GSK Investigational Site Austin, Texas, United States, 78744 收起 << |
NCT02787551 | Type 2 Diabetes Mellitus | Phase 3 | Active, not recruiting | November 20, 2018 | - |
NCT03223844 | Schizophrenia ... 展开 >> Psychosis Sensitisation 收起 << | Not Applicable | Recruiting | December 2021 | Austria ... 展开 >> Medical University of Vienna Recruiting Vienna, Austria, 1090 Contact: Ana Weidenauer, MD 0043140400 ext 35470 ana.weidenauer@meduniwien.ac.at 收起 << |
NCT02651987 | Pancreatic Tumours ... 展开 >> Midgut Neuroendocrine Tumours 收起 << | Phase 2 | Recruiting | October 2019 | - |
NCT01967888 | Pancreatectomy for Chronic Pan... 展开 >>creatitis 收起 << | Phase 2 Phase 3 | Completed | - | United States, California ... 展开 >> University of California. Department of Surgery, Division of Transplantation San Francisco, California, United States, 94143 United States, Illinois The University of Chicago Medical Center Chicago, Illinois, United States, 60637 United States, Minnesota Schulze Diabetes Institute University of Minnesota Medical School Minneapolis, Minnesota, United States, 55455 United States, New Hampshire Dartmouth-Hitchcock Medical Center Lebanon, New Hampshire, United States, 03756 United States, Ohio The University of Cincinnati Medical Center Cincinnati, Ohio, United States, 45219 United States, Pennsylvania Thomas E. Starzl Transplantation Institute University of Pittsburgh Medical Center Pittsburgh, Pennsylvania, United States, 15213 United States, South Carolina Medical University of South Carolina Charleston, South Carolina, United States, 29425 United States, Texas Baylor University Medical Center Dallas, Texas, United States, 75246 Canada, Alberta University of Alberta, Clinical Islet Transplant Program Edmonton, Alberta, Canada, T6G 2C8 收起 << |
NCT03720197 | - | Not yet recruiting | March 31, 2022 | Canada, Quebec ... 展开 >> Institut de recherches cliniques de Montréal Not yet recruiting Montreal, Quebec, Canada, H7K3Y8 Contact: Virginie Messier 514-987-5500 ext 3227 virginie.messier@ircm.qc.ca Principal Investigator: Remi Rabasa-Lhoret Canada Centre Hospitalier de l'Université de Montréal Not yet recruiting Montreal, Canada Contact: Remi Rabasa-Lhoret 514-987-5500 ext 3227 remi.rabasa-lhoret@ircm.qc.ca Principal Investigator: Remi Rabasa-Lhoret Centre Hospitalier Universitaire Sainte-Justine Not yet recruiting Montreal, Canada Contact: Catherine Pelletier catherine.pelletier@recherche-ste-justine.qc.ca Principal Investigator: Melanie Henderson McGill University Health Centre Montreal, Canada Centre Hospitalier Universitaire de Québec-Université Laval Not yet recruiting Quebec, Canada Contact: Claudia Gagnon claudia.gagnon@crchudequebec.ulaval.ca Principal Investigator: Claudia Gagnon Centre hospitalier universitaire de Sherbrooke Not yet recruiting Sherbrooke, Canada Contact: Andre Carpentier andre.carpentier@usherbrooke.ca Principal Investigator: Andre Carpentier 收起 << | |
NCT02325960 | Type 2 Diabetes | Phase 4 | Completed | - | China, Jiangsu ... 展开 >> at Division of Endocrinology, the Affiliated Drum Tower Hospital of Nanjing University Nanjing, Jiangsu, China, 210008 收起 << |
NCT03510000 | Type1diabetes | Not Applicable | Recruiting | August 31, 2019 | Canada, Ontario ... 展开 >> Sinai Health System Recruiting Toronto, Ontario, Canada, M5T 3L9 Contact: Andrej Orszag 416-586-4800 class15@lunenfeld.ca Principal Investigator: Bruce A. Perkins, MD Canada, Quebec Institut de recherches cliniques de Montréal Recruiting Montréal, Quebec, Canada, H2W 1R7 Contact: Virginie Messier, B.Sc. 514 987-5500 promd@ircm.qc.ca Principal Investigator: Rémi Rabasa-Lhoret, MD, PhD McGill University Health Center Recruiting Montréal, Quebec, Canada, H3A 2B4 Contact 514-398-4491 haidarlab.dmc@mcgill.ca Principal Investigator: Ahmad Haidar 收起 << |
NCT01409330 | Type 2 Diabetes | Phase 4 | Unknown | December 2013 | Germany ... 展开 >> German Diabetes Center Recruiting Duesseldorf, NRW, Germany, 40225 Contact: Lejla Zahiragic, MD 00492118104819 lejla.zahiragic@med.uni-duesseldorf.de Contact: Bettina Nowotny, MD 00492113382-0 ext -575 bettina.nowotny@ddz.uni-duesseldorf.de Sub-Investigator: Lejla Zahiragic, MD Sub-Investigator: Bettina Nowotny, MD, M.Sc. Principal Investigator: Michael Roden, Professor, MD Charite, Department of Internal Medicine Active, not recruiting Berlin, Germany University Hospital, Department of Internal Medicine III Not yet recruiting Dresden, Germany Contact: Ulrike Schatz, MD Sub-Investigator: Ulrike Schatz, MD Principal Investigator: Stefan Bornstein, Professor, MD University Hospital, Department of Internal Medicine I Recruiting Heidelberg, Germany Contact: Jan Groener, MD jan.groener@med.uni-heidelberg.de Sub-Investigator: Jan Groener, MD Principal Investigator: Peter Nawroth, Professor, MD Klinikum der Universität München (KUM) Active, not recruiting Munich, Germany University Hospital, Department of Internal Medicine IV Active, not recruiting Tübingen, Germany 收起 << |
NCT02130687 | Type 2 Diabetes Mellitus ... 展开 >> Hypertension 收起 << | Not Applicable | Recruiting | June 2020 | United States, Tennessee ... 展开 >> Vanderbilt University Recruiting Nashville, Tennessee, United States, 37232 Contact: Jessica R Wilson, M.D. jessica.r.wilson@vanderbilt.edu Contact: Scott Hubers, M.D. scott.hubers@vanderbilt.edu Principal Investigator: Nancy J Brown, M.D. Sub-Investigator: Jessica Devin, M.D. Sub-Investigator: Jessica R Wilson, M.D. Sub-Investigator: Claudia E Ramirez, M.D. Sub-Investigator: Scott Hubers, M.D. 收起 << |
NCT00922649 | Type 2 Diabetes | Not Applicable | Completed | - | United States, California ... 展开 >> The Regents of the University of California on behalf of its San Diego campus La Jolla, California, United States, 92093 AMCR Institute, Inc. San Diego, California, United States, 92026 United States, Georgia Atlanta Diabetes Associates, Inc. Atlanta, Georgia, United States, 30309 United States, Idaho Rocky Mountain Diabetes and Osteoporosis Center, PA Idaho Falls, Idaho, United States, 83404 United States, Kentucky Kentucky Diabetes Endocrinology Center Lexington, Kentucky, United States, 40503 United States, Texas dgd Research, Inc. San Antonio, Texas, United States, 78229 收起 << |
NCT02888691 | Type 1 Diabetes | Not Applicable | Completed | - | Denmark ... 展开 >> Hvidovre University Hospital Hvidovre, Denmark, 2650 收起 << |
NCT03224234 | Diabetes | Not Applicable | Recruiting | December 30, 2019 | United States, Georgia ... 展开 >> Emory Clinic, Emory University Hospital (non-CRN), Emory University Hospital Clinical Research Network, Emory University Hospital Midtown, Grady Health System (non-CRN) Recruiting Atlanta, Georgia, United States, 30322 Contact: Guillermo Umpierrez, MD 404-778-1665 geumpie@emory.edu Contact: Saumeth Cardona Bolivar, MD 404-616-4827 scardon@emory.edu 收起 << |
NCT02568605 | Non-alcoholic Fatty Liver Dise... 展开 >>ase 收起 << | Not Applicable | Recruiting | August 2020 | Canada, Alberta ... 展开 >> University of Calgary Recruiting Calgary, Alberta, Canada, T2N 1N4 Contact: Raylene A Reimer, PhD, RD 403-220-8218 reimer@ucalgary.ca 收起 << |
NCT03369548 | Healthy | Not Applicable | Recruiting | December 23, 2019 | United Kingdom ... 展开 >> Hugh Sinclair Unit of Human Nutrition, Department of Food and Nutritional Sciences, University of Reading Recruiting Reading, Berkshire, United Kingdom, RG6 6AP Contact: Julie A Lovegrove, Professor 0044(0)1183786418 ext 6418 j.a.lovegrove@reading.ac.uk Contact: Camilla Pedersen, PhD +44 (0)797 617 6090 C.Pedersen@reading.ac.uk Principal Investigator: Julie A Lovegrove, Professor Sub-Investigator: Camilla Pedersen, PhD Sub-Investigator: Kim Jackson, PhD Sub-Investigator: Jeremy Spencer, Professor 收起 << |
NCT01902394 | Digestive Health and Immune Fu... 展开 >>nction 收起 << | Not Applicable | Completed | - | United States, Massachusetts ... 展开 >> HNCRA at Tufts University Boston, Massachusetts, United States, 02111 收起 << |
NCT03721874 | Prediabetic State ... 展开 >> Substrate Oxidation 收起 << | Phase 4 | Not yet recruiting | January 2020 | Netherlands ... 展开 >> Maastricht University and Medical Centre Not yet recruiting Maastricht, Limburg, Netherlands, 6200 MD 收起 << |
NCT03544892 | Diabetes Mellitus, Type 1 | Not Applicable | Recruiting | May 1, 2019 | United States, Oklahoma ... 展开 >> University of Oklahoma Harold Hamm Diabetes Center Recruiting Tulsa, Oklahoma, United States, 74135 Contact: Julie Crawford, MS AHIP 918-619-4812 Julia-Crawford@ouhsc.edu 收起 << |
NCT02157974 | Hepatic Steatosis ... 展开 >> Polycystic Ovarian Syndrome Obesity 收起 << | Phase 2 Phase 3 | Recruiting | December 2018 | United States, Colorado ... 展开 >> University of Colorado Anshutz Medical Campus/Children's Hospital Colorado Recruiting Aurora, Colorado, United States, 80045 Contact: Yesenia Garcia 720-777-6984 yesenia.garciareyes@childrenscolorado.org 收起 << |
NCT03643315 | Obesity | Not Applicable | Not yet recruiting | September 2019 | - |
NCT01321905 | Cystic Fibrosis | Phase 2 | Unknown | - | Sweden ... 展开 >> Stockholm Cystic Fibrosis Center, Karolinska University Hospital Huddinge Recruiting Stockholm, Sweden, 141 86 Contact: Lena Hjelte, Professor 0046858587359 Lena.Hjelte@karolinska.se 收起 << |
NCT00308308 | - | Completed | - | - | |
NCT03761615 | - | Recruiting | July 31, 2021 | United States, California ... 展开 >> Sansum Diabetes Research Institute Recruiting Santa Barbara, California, United States, 93105 Contact: Camille Andre 805-682-7640 ext 217 candre@sansum.org United States, Minnesota Mayo Clinic Recruiting Rochester, Minnesota, United States, 55905 Contact: Shelly McCrady-Spitzer 507-255-0316 McCradySpitzer.Shelly@mayo.edu United States, New York Icahn School of Medicine at Mount Sinai Recruiting New York, New York, United States, 10029 Contact: Selassie Ogyaadu 212-241-9089 selassie.ogyaadu@icahn.mssm.edu 收起 << | |
NCT00308308 | Diabetes, Type I | Phase 3 | Completed | - | - |
NCT00736879 | Type 2 Diabetes Mellitus | Phase 3 | Completed | - | - |
NCT00736879 | - | Completed | - | - | |
NCT00620282 | Diabetes Diab... 展开 >>etes Mellitus, Type 2 收起 << | Phase 3 | Completed | - | United States, Minnesota ... 展开 >> Novo Nordisk Investigational Site Rochester, Minnesota, United States, 55905 收起 << |
NCT03672903 | Obesity | Phase 1 Phase 2 | Recruiting | December 2022 | Sweden ... 展开 >> Sahlgrenska University Hospital Recruiting Göteborg, Sweden, S-405 30 Contact: John-Olov Jansson, Professor, PhD, MD joj@neuro.gu.se Contact: Edwin Gidestrand, MD edwin.gidestrand@vgregion.se Principal Investigator: Per-Anders Jansson, Professor, PhD, MD Sub-Investigator: John-Olov Jansson, Professor, PhD, MD Sub-Investigator: Edwin Gidestrand, MD 收起 << |
NCT00859898 | Type 2 Diabetes Mellitus | Phase 3 | Completed | - | - |
NCT01719913 | Metabolic Diseases ... 展开 >> Injury of Gastrointestinal Tract 收起 << | Not Applicable | Completed | - | Denmark ... 展开 >> The Novo Nordisk Foundation of Basic Metabolic Health, Section for Metabolic Genetics Copenhagen, Denmark, 2100 收起 << |
NCT03587727 | - | Not yet recruiting | September 30, 2021 | United States, Colorado ... 展开 >> University of Colorado Anshutz Medical Campus/Children's Hospital Colorado Not yet recruiting Aurora, Colorado, United States, 80045 Contact: Yesenia Garcia Reyes 720-777-6984 yesenia.garciareyes@childrenscolorado.org 收起 << | |
NCT03097237 | Overweight Ob... 展开 >>esity 收起 << | Not Applicable | Unknown | August 2018 | Sweden ... 展开 >> Swedish University of Agricultural Sciences Recruiting Uppsala, Sweden Contact: Kia Nöhr Iversen, MSc +46702567405 kia.nohr.iversen@slu.se Contact: Rikard Landberg, Dr rikard.landberg@slu.se Principal Investigator: Rikard Landberg, Dr 收起 << |
NCT03071718 | Overweight Ob... 展开 >>esity 收起 << | Not Applicable | Active, not recruiting | March 2019 | Italy ... 展开 >> Federico II University Naples, Italy, 80131 收起 << |
NCT00859898 | - | Completed | - | - | |
NCT00960661 | Type 2 Diabetes Mellitus | Phase 3 | Completed | - | - |
NCT00960661 | - | Completed | - | - | |
NCT00620282 | - | Completed | - | - | |
NCT03556033 | Diabetes Mellitus, Type 1 ... 展开 >> Hypoglycemia Hypoglycemia Unawareness 收起 << | Phase 2 | Not yet recruiting | December 2019 | Netherlands ... 展开 >> Radboud university medical center Not yet recruiting Nijmegen, Netherlands, 6500HB Contact: L. van Meijel 收起 << |
NCT01644500 | Type 2 Diabetes Mellitus | Phase 3 | Completed | - | China ... 展开 >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Beijing, China, 100088 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Changsha, China, 410011 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Chengdu, China, 610041 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Chongqing, China For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Guang Zhou, China, 510120 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Guiyang, China, 550004 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Hangzhou, China, 310009 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Harbin, China, 150001 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Hefei, China, 230022 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Huai'An, China, 223300 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Jinan, China, 250001 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Nanjing, China, 210029 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Nanning, China, 530007 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Qingdao, China, 266003 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Shanghai, China, 200040 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Shenyang, China, 110004 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Shijiazhuang, China, 050000 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Wu Han, China, 430022 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Wuxi, China, 214023 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Xi'An, China, 710032 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Xiamen, China, 361003 Korea, Republic of For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Gangwon-Do, Korea, Republic of, 200-722 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Jeju Special Self-Governing Pr, Korea, Republic of, 690-767 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Seoul, Korea, Republic of, 134-090 Taiwan For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Changhua, Taiwan, 500 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Jhonghe City, Taiwan, 235 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Kaohsiung, Taiwan, 824 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Niao Sung Hsiang, Taiwan, 833 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Sindian City, Taiwan, 23148 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Yong Kung City, Taiwan, 71004 收起 << |
NCT02070081 | Obesity | Not Applicable | Completed | - | Denmark ... 展开 >> Faculty of Science, NEXS Frederiksberg, Denmark, 1958 收起 << |
NCT01369082 | - | Completed | - | United States, California ... 展开 >> University of California, San Francisco San Francisco, California, United States, 94143 United States, Florida University of Miami Miami, Florida, United States, 33136 United States, Georgia Emory University Atlanta, Georgia, United States, 30322 United States, Illinois Northwestern University Chicago, Illinois, United States, 60611 University of Illinois Chicago, Illinois, United States, 60612 United States, Massachusetts Massachusetts General Hospital Boston, Massachusetts, United States, 02493 United States, Minnesota University of Minnesota Minneapolis, Minnesota, United States, 55455 United States, Pennsylvania University of Pennsylvania Philadelphia, Pennsylvania, United States, 19104 收起 << | |
NCT01644500 | - | Completed | - | - | |
NCT01196104 | Type 2 Diabetes | Phase 3 | Terminated(For Business Reason... 展开 >>s) 收起 << | - | - |
NCT01513798 | Diabetes Mellitus, Type 2 | Not Applicable | Completed | - | Sweden ... 展开 >> Department of Public Health and Clinical Medicine, Medicine Umeå, Sweden, 90187 收起 << |
NCT00917267 | Type 2 Diabetes Mellitus | Phase 3 | Completed | - | - |
NCT00917267 | - | Completed | - | - | |
NCT01029886 | - | Completed | - | - | |
NCT00696657 | Diabetes Diab... 展开 >>etes Mellitus, Type 2 收起 << | Phase 2 | Completed | - | - |
NCT02284230 | Kidney Failure, Chronic ... 展开 >> Prediabetic State 收起 << | Phase 2 | Withdrawn(Inability to recruit... 展开 >> participants) 收起 << | - | Denmark ... 展开 >> Department of Nephrology, Rigshospitalet Copenhagen, Denmark, 2100 收起 << |
NCT00696657 | - | Completed | - | - | |
NCT02906917 | Diabetes Diab... 展开 >>etes Mellitus, Type 2 收起 << | Phase 3 | Completed | - | - |
NCT00607087 | Diabetes Mellitus, Type 1 | Phase 4 | Completed | - | United States, New Jersey ... 展开 >> Sanofi-Aventis Administrative Office Bridgewater, New Jersey, United States Australia Sanofi-Aventis Administrative Office Macquarie Park, Australia Austria Sanofi-Aventis Administrative Office Vienna, Austria France Sanofi-Aventis Administrative Office Paris, France Hungary Sanofi-Aventis Administrative Office Budapest, Hungary Israel Sanofi-Aventis Administrative Office Natanya, Israel Italy Sanofi-Aventis Administrative Office Milan, Italy Korea, Republic of Sanofi-Aventis Administrative Office Seoul, Korea, Republic of Netherlands Sanofi-Aventis Administrative Office PE Gouda, Netherlands Spain Sanofi-Aventis Administrative Office Barcelona, Spain Sweden Sanofi-Aventis Administrative Office Bromma, Sweden United Kingdom Sanofi-Aventis Administrative Office Guildford Surrey, United Kingdom 收起 << |
NCT02906917 | - | Completed | - | - | |
NCT02294474 | Type 2 Diabetes Mellitus | Phase 3 | Completed | - | - |
NCT00607087 | - | Completed | - | - | |
NCT02273180 | Type 1 Diabetes Mellitus | Phase 3 | Completed | - | - |
NCT00676338 | Type 2 Diabetes Mellitus | Phase 3 | Completed | - | - |
NCT01196104 | - | Terminated(For Business Reason... 展开 >>s) 收起 << | - | - | |
NCT02273180 | - | Completed | - | - | |
NCT00935532 | Type 2 Diabetes Mellitus | Phase 3 | Completed | - | Japan ... 展开 >> Research Site Aomori, Japan Research Site Chiba, Japan Research Site Ehime, Japan Research Site Fukuoka, Japan Research Site Gunma, Japan Research Site Hiroshima, Japan Research Site Hokkaido, Japan Research Site Hyogo, Japan Research Site Ibaragi, Japan Research Site Kagawa, Japan Research Site Kanagawa, Japan Research Site Kumamoto, Japan Research Site Kyoto, Japan Research Site Nagano, Japan Research Site Nagasaki, Japan Research Site Nara, Japan Research Site Oita, Japan Research Site Osaka, Japan Research Site Saitama, Japan Research Site Shizuoka, Japan Research Site Tokyo, Japan Research Site Toyama, Japan 收起 << |
NCT00676338 | - | Completed | - | - | |
NCT01029886 | Type 2 Diabetes Mellitus | Phase 3 | Completed | - | - |
NCT01831765 | Diabetes Diab... 展开 >>etes Mellitus, Type 1 收起 << | Phase 3 | Completed | - | - |
NCT01831765 | - | Completed | - | - | |
NCT01517373 | Diabetes Mellitus, Type 2 | Phase 2 | Completed | - | - |
NCT02294474 | - | Completed | - | - | |
NCT01475461 | - | Completed | - | - | |
NCT01867502 | Diabetes Mellitus, Type 2 ... 展开 >> Hypoglycemic Agents Diabetic Blood Glucose Monitoring Exercise 收起 << | Phase 4 | Unknown | August 2015 | Brazil ... 展开 >> Hospital de Clínicas de Porto Alegre Porto Alegre Recruiting Porto Alegre, Rio Grande do Sul, Brazil, 90035-903 Contact: Aline Fofonka, MSc 55-5192339191 alinefofonka@hotmail.com Principal Investigator: Beatriz D Schaan, PhD 收起 << |
NCT01475461 | Type 2 Diabetes Mellitus | Phase 2 | Completed | - | - |
NCT00935532 | - | Completed | - | - | |
NCT02773368 | - | Completed | - | - | |
NCT01476475 | - | Completed | - | - | |
NCT02773368 | Diabetes Diab... 展开 >>etes Mellitus, Type 2 收起 << | Phase 3 | Completed | - | - |
NCT01517373 | - | Completed | - | - | |
NCT02058147 | - | Completed | - | - | |
NCT01476475 | Type 2 Diabetes Mellitus | Phase 2 | Completed | - | - |
NCT02058160 | Type 2 Diabetes | Phase 3 | Completed | - | - |
NCT02058160 | - | Completed | - | - | |
NCT02058147 | Type 2 Diabetes | Phase 3 | Completed | - | - |
NCT01768559 | - | Completed | - | - | |
NCT01215955 | Diabetes Mellitus, Type 2 | Phase 4 | Completed | - | - |
NCT00879970 | Diabetes Mellitus, Type 2 | Phase 4 | Terminated(FDA has placed the ... 展开 >>trial on full clinical hold.) 收起 << | - | - |
NCT01215955 | - | Completed | - | - | |
NCT00637273 | Type 2 Diabetes Mellitus | Phase 3 | Completed | - | - |
NCT00641056 | Type 2 Diabetes Mellitus | Phase 3 | Completed | - | - |
NCT00637273 | - | Completed | - | - | |
NCT00879970 | - | Terminated(FDA has placed the ... 展开 >>trial on full clinical hold.) 收起 << | - | - | |
NCT01768559 | Type 2 Diabetes | Phase 3 | Completed | - | - |
NCT00641056 | - | Completed | - | - | |
NCT00976391 | - | Completed | - | - | |
NCT00976391 | Diabetes Mellitus, Type 2 | Phase 3 | Completed | - | - |
NCT02722655 | - | Recruiting | December 2030 | Mexico ... 展开 >> Hospital Regional de Alta Especialidad del Bajío Recruiting Leon, Guanajuato, Mexico, 37660 Contact: María L Evia-Viscarra +52 (477) 2672000 ext 1504 mlola.evia@hraeb.gob.mx Sub-Investigator: Edel R Rodea-Montero Sub-Investigator: Rodolfo Guardado-Mendoza 收起 << | |
NCT01175824 | Diabetes Mellitus, Type 2 | Phase 4 | Completed | - | Argentina ... 展开 >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Mar Del Plata, Argentina, B7600FZN For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Ramos Mejia, Argentina, B1704ETD Brazil For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Porto Alegre, Brazil, 90035-170 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. São Paulo, Brazil, 01244-030 China For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Changzhou, China, 213003 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Harbin, China, 150086 Egypt For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Alexandria, Egypt For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Cairo, Egypt, 11562 India For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Jaipur, India, 302018 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Vishakhapatnam, India, 530002 Korea, Republic of For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Daegu, Korea, Republic of, 700-712 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Goyang-Si, Korea, Republic of, 410-719 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Kyunggi-Do, Korea, Republic of, 425-020 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Seoul, Korea, Republic of, 134-090 Spain For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Málaga, Spain, 29010 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. San Boi De Llobregat, Spain, 08830 Turkey For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Antalya, Turkey, 07070 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Istanbul, Turkey, 34865 收起 << |
NCT01175811 | Diabetes Mellitus, Type 2 | Phase 4 | Completed | - | China ... 展开 >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Beijing, China, 100730 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Guang Zhou, China, 510515 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Kunming, China, 650032 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Nanjing, China, 210109 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Shanghai, China, 200080 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Xi'An, China, 710032 Korea, Republic of For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Daegu, Korea, Republic of, 705-718 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Goyang-Si, Korea, Republic of, 410-719 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Seoul, Korea, Republic of, 130-702 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Yeongdeungpo-Gu, Korea, Republic of, 150-950 Taiwan For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Changhua, Taiwan, 500 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Kuei Shan Hsiang, Taiwan, 33305 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Sindian City, Taiwan, 23148 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Yong Kung City, Taiwan, 71004 收起 << |
NCT01175824 | - | Completed | - | - | |
NCT03321227 | Nutrition Cog... 展开 >>nitive Performance Appetite 收起 << | Not Applicable | Recruiting | December 1, 2018 | Canada, Ontario ... 展开 >> School of Nutrition, Ryerson University Recruiting Toronto, Ontario, Canada, M5B 2K3 Contact: Nick Bellissimo, PhD 416 979 5000 ext 3026 nick.bellissimo@ryerson.ca Principal Investigator: Nick Bellissimo, PhD 收起 << |
NCT00993473 | - | Completed | - | - | |
NCT00993473 | Type 1 Diabetes Mellitus | Phase 3 | Completed | - | - |
NCT01851304 | Obesity Overw... 展开 >>eight 收起 << | Not Applicable | Completed | - | Italy ... 展开 >> Department of Agriculture and Food Science Portici, Italy, 80055 收起 << |
NCT03081832 | Prader-Willi Syndrome | Not Applicable | Recruiting | December 2018 | France ... 展开 >> Centre de référence du syndrome de Prader-Willi Hôpital des Enfants Recruiting Toulouse, France, 31059 Contact: Maïthé Tauber, Pr 5 34 55 85 51 ext 33 tauber.mt@chu-toulouse.fr Principal Investigator: Maïthé Tauber, Pr Sub-Investigator: Gwenaëlle Diene, Dr Sub-Investigator: Sophie Çabal-Berthoumieu, Dr Sub-Investigator: Pascale Fichaux-Bourin, Dr 收起 << |
NCT00701935 | Diabetes Mellitus | Phase 2 | Terminated(Enrollment was much... 展开 >> slower than anticipated, leading to a decision to terminate the study early for enrollment futility.) 收起 << | - | United States, Arizona ... 展开 >> Research Site Temple, Arizona, United States United States, Colorado Research Site Colorado Springs, Colorado, United States United States, Hawaii Research Site Honolulu, Hawaii, United States United States, Nebraska Research Site Bellevue, Nebraska, United States United States, Nevada Research Site Las Vegas, Nevada, United States Canada, Alberta Research Site Calgary, Alberta, Canada Canada, British Columbia Research Site Vancouver, British Columbia, Canada Research Site Victoria, British Columbia, Canada Canada, Manitoba Research Site Winnipeg, Manitoba, Canada Canada, New Brunswick Research Site Saint John, New Brunswick, Canada Canada, Ontario Research Site Brampton, Ontario, Canada Research Site London, Ontario, Canada Research Site Ottawa, Ontario, Canada Research Site Toronto, Ontario, Canada Canada, Quebec Research Site Chicoutimi, Quebec, Canada Research Site Pointe-Claire, Quebec, Canada Canada Research Site Quebec, Canada 收起 << |
NCT01175811 | - | Completed | - | - | |
NCT00701935 | - | Terminated(Enrollment was much... 展开 >> slower than anticipated, leading to a decision to terminate the study early for enrollment futility.) 收起 << | - | - | |
NCT03482830 | - | Recruiting | February 2019 | Denmark ... 展开 >> Department of Surgery, Zealand University Hospital Recruiting Køge, Denmark, 2300 Contact: Sarah Ekeloef +45 47323012 savb@regionsjaelland.dk 收起 << | |
NCT00877890 | Type 2 Diabetes Mellitus | Phase 3 | Completed | - | - |
NCT01003184 | Type 2 Diabetes Mellitus | Phase 3 | Completed | - | Ireland ... 展开 >> Research Site Dublin, Ireland United Kingdom Research Site Addlestone, England, United Kingdom Research Site Bath, England, United Kingdom Research Site Birmingham, England, United Kingdom Research Site Blackburn, England, United Kingdom Research Site Bournemouth, England, United Kingdom Research Site Chippenham, England, United Kingdom Research Site Derby, England, United Kingdom Research Site Exeter, England, United Kingdom Research Site High Wycombe, England, United Kingdom Research Site Hull, England, United Kingdom Research Site Leicester, England, United Kingdom Research Site Liverpool, England, United Kingdom Research Site London, England, United Kingdom Research Site Manchester, England, United Kingdom Research Site Merseyside, England, United Kingdom Research Site Middlesborough, England, United Kingdom Research Site Newcastle, England, United Kingdom Research Site Northampton, England, United Kingdom Research Site Oldham, England, United Kingdom Research Site Plymouth, England, United Kingdom Research Site Portsmouth, England, United Kingdom Research Site Sheffield, England, United Kingdom Research Site Stevenage, England, United Kingdom Research Site Suffolk, England, United Kingdom Research Site Wakefield, England, United Kingdom Research Site Wiltshire, England, United Kingdom Research Site Aberdeen, Scotland, United Kingdom Research Site Dundee, Scotland, United Kingdom Research Site Carmathen, Wales, United Kingdom Research Site Swansea, Wales, United Kingdom Research Site Wrexham, Wales, United Kingdom Research Site Leytonstone, United Kingdom Research Site Livingston, United Kingdom 收起 << |
NCT01003184 | - | Completed | - | - | |
NCT00877890 | - | Completed | - | - | |
NCT01773304 | Obesity Bone ... 展开 >>Metabolism 收起 << | Not Applicable | Completed | - | Denmark ... 展开 >> Department of Human Nutrition, University of Copenhagen Copenhagen, Frederiksberg C, Denmark, 1958 收起 << |
NCT03433248 | Type2 Diabetes | Phase 4 | Recruiting | December 1, 2020 | Netherlands ... 展开 >> VU University Medical Center Recruiting Amsterdam, Noord-Holland, Netherlands, 1081HV Contact: Michaël JB van Baar, MD +31 20 444 4709 m.vanbaar@vumc.nl Contact: Daniël H van Raalte, MD PhD +31 20 444 0534 d.vanraalte@vumc.nl Principal Investigator: Mark HH Kramer, MD PhD Principal Investigator: Daniël H van Raalte, MD PhD 收起 << |
NCT01285518 | Diabetes Mellitus, Type 2 | Phase 1 | Completed | - | United States, California ... 展开 >> Profil Institute for Clinical Research, Inc. Chula Vista, California, United States, 91911 United States, Florida Comprehensive Phase One (A Division of Comprehensive NeuroScience, Inc.) Ft. Meyers, Florida, United States, 33901 Elite Research Institute Miami, Florida, United States, 33169 Comprehensive Phase One (A Division of Comprehensive NeuroScience, Inc.) Miramar, Florida, United States, 33025 United States, Texas Cetero Research San Antonio, Texas, United States, 78229 收起 << |
NCT01875354 | Overweight | Not Applicable | Completed | - | United States, Utah ... 展开 >> Utah State University Logan, Utah, United States, 84322 收起 << |
NCT01618162 | - | Completed | - | - | |
NCT01285518 | - | Completed | - | - | |
NCT01064778 | Obesity | Not Applicable | Completed | - | United States, Massachusetts ... 展开 >> Children's Hospital Boston Boston, Massachusetts, United States, 02115 Beth Israel Deaconess Medical Center Boston, Massachusetts, United States, 02215 Brigham and Women's Hospital Boston, Massachusetts, United States, 02215 收起 << |
NCT03254368 | Type 2 Diabetes Mellitus ... 展开 >> Overweight and Obesity 收起 << | Phase 2 | Recruiting | April 2019 | Australia, New South Wales ... 展开 >> Coffs Harbour GP SuperClinic Recruiting Coffs Harbour, New South Wales, Australia, 2450 Contact: Melissa Hull-Moody +61266913573 melissah@coffsgpsc.com.au Northside Health Active, not recruiting Coffs Harbour, New South Wales, Australia, 2450 The Aim Centre Recruiting Merewether, New South Wales, Australia, 2291 Contact: Kate Bone +61249632323 kate@hunterdiabetes.com.au The Boden Institute Recruiting Sydney, New South Wales, Australia, 2006 Contact: Tegan Picone +61286270141 tegan.picone@sydney.edu.au Holdsworth House Medical Practice Recruiting Sydney, New South Wales, Australia, 2010 Contact: Trina Vincent +61280381044 trina.vincent@holdsworthhouse.com.au Pendlebury Research Recruiting Sydney, New South Wales, Australia, 2289 Contact: Paula Abrego +61249025162 paula@pendleburyresearch.com.au Australia, Queensland Q-Pharm Active, not recruiting Herston, Queensland, Australia, 4006 Griffith University, Gold Coast Campus Recruiting Southport, Queensland, Australia, 4222 Contact: Danielle O'Reilly +61755527260 d.oreilly@griffith.edu.au Australia, South Australia Southern Adelaide Diabetes & Endocrine Services Active, not recruiting Daw Park, South Australia, Australia, 5041 Australia, Victoria Eastern Clinical Research Unit (ECRU) Recruiting Box Hill, Victoria, Australia, 3128 Contact: Joanne Phillips +61390949509 joanne.phillips@monash.edu Barwon Health Recruiting Geelong, Victoria, Australia, 3218 Contact: Bree Sarah +61342152875 brees@barwonhealth.org.au Royal Melbourne Hospital Recruiting Parkville, Victoria, Australia, 3050 Contact: Marika Bjorasen +61393427344 marika.bjorasen@mh.org.au New Zealand Optimal Clinical Trials Recruiting Auckland, New Zealand, 1021 Contact: Liz Smaill +6493034987 liz@optimalclinicaltrials.com Middlemore Hospital Recruiting Auckland, New Zealand, 2025 Contact: Ruth Cammell +6492760044 ext 2976 ruth.cammell@mmclintrials.nz Christchurch Diabetes Centre Active, not recruiting Christchurch, New Zealand, 8011 Southern Clinical Trials Recruiting Christchurch, New Zealand, 8024 Contact: Julia Matheison +6433371979 julia@sctrials.co.nz Lipid and Diabetes Research Group Recruiting Christchurch, New Zealand, 8140 Contact: Zarnia Morrison +6433641375 zarnia.morrison@cdhb.health.nz Clinical Trials New Zealand Ltd Recruiting Hamilton, New Zealand, 3206 Contact: Eileen Bisley +6478430105 eileen@clinicaltrialsnz.com P3 Research Hawkes Bay Recruiting Hastings, New Zealand, 4130 Contact: Alison Strong +64 21 335693 alison.strong@p3research.co.nz P3 Research Wellington Recruiting Newtown, New Zealand, 6021 Contact: Mary McKay +616448010002 mary@p3research.co.nz Lakeland Clinical Trials Recruiting Rotorua, New Zealand, 3010 Contact: Philippa Williams +64 (0)7 3477 870 philippa@lakelandtrials.com P3 Research Tauranga Recruiting Tauranga, New Zealand, 3110 Contact: Katie Kennett +6475790453 katie@p3research.co.nz Wellington Hospital Recruiting Wellington, New Zealand, 6021 Contact: Cecilia Ross +6448062371 cecilia.ross@ccdhb.org.nz 收起 << |
NCT02235194 | Type 2 Diabetes, ... 展开 >> Prediabetes 收起 << | Not Applicable | Completed | - | Germany ... 展开 >> Stoffwechselzentrum Rhein Pfalz Mannheim, Germany, 68163 收起 << |
NCT01680341 | - | Completed | - | - | |
NCT01618162 | Diabetes Diab... 展开 >>etes Mellitus, Type 2 收起 << | Phase 3 | Completed | - | - |
NCT01680341 | Diabetes Diab... 展开 >>etes Mellitus, Type 2 收起 << | Phase 3 | Completed | - | - |
NCT02582242 | Diabetes Type... 展开 >> 2 Diabetes Mellitus 收起 << | Phase 4 | Completed | - | - |
NCT00384085 | - | Completed | - | - | |
NCT00384085 | Diabetes Mellitus, Type 2 | Phase 4 | Completed | - | United States, New Jersey ... 展开 >> Sanofi-Aventis Administrative Office Bridgewater, New Jersey, United States 收起 << |
NCT02230345 | Inflammation ... 展开 >>Dyslipidemia 收起 << | Not Applicable | Completed | - | Switzerland ... 展开 >> Clinical research center, Lausanne University hospital Lausanne, Vaud, Switzerland, 1011 收起 << |
NCT00138671 | Diabetes Mellitus ... 展开 >> Chronic Obstructive Pulmonary Disease 收起 << | Phase 3 | Terminated(See termination rea... 展开 >>son in detailed description.) 收起 << | - | - |
NCT01795248 | Gestational Diabetes Mellitus | Phase 4 | Active, not recruiting | August 2020 | Denmark ... 展开 >> Center for Diabetes Research Hellerup, Denmark, 2900 收起 << |
NCT00377858 | Diabetes Mellitus, Type 2 | Phase 4 | Completed | - | Australia, South Australia ... 展开 >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Keswick, South Australia, Australia, 5035 Australia, Victoria For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Fitzroy, Victoria, Australia, 3065 Australia, Western Australia For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Fremantle, Western Australia, Australia, 6160 Canada, Ontario For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. London, Ontario, Canada, N6A 4L2 Canada, Quebec For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Granby, Quebec, Canada, J2G 1T7 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Sherbrooke, Quebec, Canada, J1G 5K2 Canada, Saskatchewan For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Regina, Saskatchewan, Canada, S4P 0W5 France For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Mantes La Jolie, France, 78200 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Menton, France, 06500 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Pau, France, 64000 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Poitiers, France, 86000 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Toulouse, France, 31082 Korea, Republic of For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Goyang-Si/Kyunggi-Do, Korea, Republic of, 410-719 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Kwang Ju, Korea, Republic of, 501-757 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Seoul, Korea, Republic of, 110-746 Mexico For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Chihuahua, Mexico, 31238 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Guadalajara, Mexico, 44620 Russian Federation For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Arkhangelsk, Russian Federation, 163045 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Moscow, Russian Federation, 117036 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Saint Petersburg, Russian Federation, 193257 Spain For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Alicante, Spain, 03114 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Almeria, Spain, 04001 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Barcelona, Spain, 08017 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Bilbao, Spain, 48013 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Malaga, Spain, 29010 收起 << |
NCT03665207 | Critical Illness ... 展开 >> Hyperglycemia 收起 << | Phase 3 | Recruiting | September 2025 | Belgium ... 展开 >> Department of Intensive Care Medicine, University Hospital Antwerp Not yet recruiting Antwerp, Belgium, 2650 Contact: Philippe Jorens, MD, PhD +32 3 8213635 Philippe.Jorens@uza.be Principal Investigator: Philippe Jorens, MD, PhD Department of Intensive Care Medicine, University Hospital Ghent Not yet recruiting Ghent, Belgium, 9000 Contact: Dominique Benoit, MD, PhD +32 9 3322775 Dominique.Benoit@UGent.be Principal Investigator: Dominique Benoit, MD, PhD Sub-Investigator: Eric Hoste, MD, PhD Sub-Investigator: Harlinde Peperstraete, MD Sub-Investigator: Joris Vermassen, MD Department of Intensive Care Medicine, Jessa Hospital Hasselt Not yet recruiting Hasselt, Belgium, 3500 Contact: Jasperina Dubois, MD + 32 11 308971 jasperina.dubois@jessazh.be Principal Investigator: Jasperina Dubois, MD Department of Intensive Care Medicine, University Hospitals Leuven Recruiting Leuven, Belgium, 3000 Contact: Greet Van den Berghe, MD, PhD +32 16 344021 greet.vandenberghe@kuleuven.be Contact: Jan Gunst, MD, PhD +32 16 344021 jan.gunst@kuleuven.be Principal Investigator: Greet Van den Berghe, MD, PhD Principal Investigator: Jan Gunst, MD, PhD Medical Intensive Care Unit, University Hospitals Leuven Not yet recruiting Leuven, Belgium, 3000 Contact: Greet Hermans, MD, PhD +32 16 344275 greet.hermans@uzleuven.be Principal Investigator: Greet Hermans, MD, PhD Sub-Investigator: Alexander Wilmer, MD, PhD 收起 << |
NCT00138671 | - | Terminated(See termination rea... 展开 >>son in detailed description.) 收起 << | - | - | |
NCT00137046 | Diabetes Mellitus, Type 1 | Phase 3 | Terminated(See termination rea... 展开 >>son in detailed description.) 收起 << | - | - |
NCT00136916 | Diabetes Mellitus | Phase 3 | Terminated(See termination rea... 展开 >>son in detailed description.) 收起 << | - | - |
NCT00136916 | - | Terminated(See termination rea... 展开 >>son in detailed description.) 收起 << | - | - | |
NCT03418896 | Hypogonadism ... 展开 >>Calcium Disorder Renal Disease 收起 << | Not Applicable | Recruiting | December 31, 2019 | Denmark ... 展开 >> Department of Growth and Reproduction, Rigshospitalet Recruiting Copenhagen, Denmark, 2100 Contact: Li Juel Mortensen, MD +4535459456 Rigshospitalet Recruiting Copenhagen, Denmark, 2100 Contact: Martin Blomberg Jensen, MD +4535451865 blombergjensen@gmail.com Principal Investigator: Martin Blomberg Jensen, MD 收起 << |
NCT03028181 | - | Completed | - | - | |
NCT02051504 | - | Completed | - | France ... 展开 >> CHRU Lille Lille, France, 59037 收起 << | |
NCT00137046 | - | Terminated(See termination rea... 展开 >>son in detailed description.) 收起 << | - | - | |
NCT02052076 | Obesity Metab... 展开 >>olic Syndrome 收起 << | Not Applicable | Completed | - | United Kingdom ... 展开 >> David Greenfield Human Physiology Unit, University of Nottingham Medical School Nottingham, Notts, United Kingdom, NG72UH 收起 << |
NCT00494013 | Diabetes Mellitus Type 2 | Phase 3 | Completed | - | - |
NCT02137512 | Type 1 Diabetes | Not Applicable | Completed | - | United States, California ... 展开 >> Sansum Diabetes Research Institute Santa Barbara, California, United States, 93105 Stanford University Stanford, California, United States, 94305 United States, Virginia University of Virginia Charlottesville, Virginia, United States, 22908 France Montpellier University Hospital Montpellier, France, 34295 Israel National Center for Childhood Diabetes- Schneider Children's Medical Center Petah Tikva, Israel, 49202 Italy University of Padova Padova, Italy, 93106 收起 << |
NCT02553213 | Bariatric Surgery Candidate | Not Applicable | Recruiting | July 2019 | Germany ... 展开 >> University of Hohenheim Recruiting Stuttgart, Germany Contact: Anna Schweinlin +4971145924880+4970712986584 anna.schweinlin@uni-hohenheim.de 收起 << |
NCT02313220 | Obesity | Phase 2 | Completed | - | Sweden ... 展开 >> Dept of Medical Sciences, Clinical Diabetes and Metabolism, Uppsala University and Section for Diabetes and Endocrinology at the Uppsala University Hospital Uppsala, Sweden, 75185 收起 << |
NCT00377858 | - | Completed | - | - | |
NCT02137512 | - | Completed | - | - | |
NCT02448667 | Glycogen Storage Disease Type ... 展开 >>III 收起 << | Not Applicable | Recruiting | February 2018 | Denmark ... 展开 >> Copenhagen Neuromuscular Center, department 3342, Rigshospitalet Recruiting Copenhagen, Region hovedstaden, Denmark, 2100 Contact: Astrid E Buch, MD +45 35 45 61 35 astrid.emilie.buch.02@regionh.dk Contact: Nicolai Preisler, MD +45 35 45 61 26 nicolai.preisler@regionh.dk 收起 << |
NCT00494013 | - | Completed | - | - | |
NCT02582242 | - | Completed | - | - | |
NCT01826162 | Type 2 Diabetes Mellitus ... 展开 >> Obesity 收起 << | Not Applicable | Completed | - | Netherlands ... 展开 >> Maastricht University Maastricht, Limburg, Netherlands, 6200 MD Maastricht University Maastricht, Netherlands, 6200 收起 << |
NCT00766909 | Complications of Transplanted ... 展开 >>Organs and Tissue Diabetes Mellitus Nos New Onset 收起 << | Phase 4 | Completed | - | Denmark ... 展开 >> Department of Nephrology, Aarhus University Hospital, Skejby Aarhus, Jutland, Denmark, 8200 收起 << |
NCT02772783 | Diabetes Mellitus, Type 1 | Not Applicable | Completed | - | United States, Massachusetts ... 展开 >> Beth Israel Deaconess Medical Center Boston, Massachusetts, United States, 02115 收起 << |
NCT02500706 | - | Completed | - | - | |
NCT02500706 | Diabetes Diab... 展开 >>etes Mellitus, Type 1 收起 << | Phase 3 | Completed | - | - |
NCT01232491 | Diabetes Diab... 展开 >>etes Mellitus, Type 2 收起 << | Phase 4 | Completed | - | - |
NCT01232491 | - | Completed | - | - | |
NCT02030600 | Diabetes Diab... 展开 >>etes Mellitus, Type 2 收起 << | Phase 3 | Completed | - | - |
NCT01534442 | The Focus of This Study is to ... 展开 >>Evaluete the Significances of the Vagal Cholinerg Nervuos System for the Effect of GLP-1 by Using Atropin Administration. 收起 << | Not Applicable | Unknown | December 2012 | Denmark ... 展开 >> Diabetes research Division, Department of Internal Medicin, Gentofte Hospital Recruiting Hellerup, Denmark, 2900 Contact: Astrid Plamboeck, MD +45 26208174 astridp@sund.ku.dk Contact: Tina Vilsbøll, MD, Dr. med +45 40940825 t.vilsboll@dadlnet.dk Principal Investigator: Astrid Plamboeck, MD Diabetes Research Division, Department of Internal Medicine, Gentofte Hospital, Copenhagen Denmark Recruiting Hellerup, Denmark, 2900 Contact: Astrid Plamboeck, MD +45 26208174 astridp@sund.ku.dk Principal Investigator: Astrid Plamboeck, MD 收起 << |
NCT02030600 | - | Completed | - | - | |
NCT02034513 | - | Completed | - | - | |
NCT03609632 | Bariatric Surgery | Not Applicable | Completed | - | Switzerland ... 展开 >> Division of Endocrinology, Diabetes and Clinical Nutrition, Bern University Hospital Bern, Switzerland, 3010 收起 << |
NCT01136746 | Hyperglycemia | Phase 3 | Terminated(Low enrollment) | - | United States, Alabama ... 展开 >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Birmingham, Alabama, United States, 35294 United States, Florida For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Jacksonville, Florida, United States, 32209 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Miami, Florida, United States, 33136 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Weston, Florida, United States, 33331 United States, Georgia For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Atlanta, Georgia, United States, 30312 United States, Kansas For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Topeka, Kansas, United States, 66604 United States, Kentucky For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Hazard, Kentucky, United States, 41701 United States, Maine For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Bangor, Maine, United States, 04401 United States, Missouri For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Kansas City, Missouri, United States, 64111 United States, Ohio For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Cleveland, Ohio, United States, 44106 United States, South Carolina For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Charleston, South Carolina, United States, 29425 United States, Tennessee For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Memphis, Tennessee, United States, 38104 收起 << |
NCT02607306 | Diabetes Diab... 展开 >>etes Mellitus, Type 2 收起 << | Phase 3 | Completed | - | - |
NCT02342834 | Diabetes Mellitus, Type 2 | Not Applicable | Unknown | March 2015 | Italy ... 展开 >> Azienda Ospedaliero-Universitaria Pisana Pisa, PI, Italy, 56127 收起 << |
NCT01136746 | - | Terminated(Low enrollment) | - | - | |
NCT03389269 | - | Completed | - | Denmark ... 展开 >> Center for Diabetes Research Hellerup, Denmark, 2900 收起 << | |
NCT02876484 | Severe Obesity | Phase 4 | Recruiting | February 2019 | Denmark ... 展开 >> Hvidovre University Hospital Recruiting Hvidovre, Denmark, DK-2650 Contact: Maria S Svane, MD +45 38626357 Maria.Saur.Svane@regionh.dk Contact: Sten Madsbad, MD, DMSc Sub-Investigator: Isabella Jonsson 收起 << |
NCT01509469 | Obesity Overw... 展开 >>eight 收起 << | Not Applicable | Completed | - | Netherlands ... 展开 >> Maastricht University Medical Center Maastricht, Limburg, Netherlands 收起 << |
NCT02034513 | Diabetes Diab... 展开 >>etes Mellitus, Type 1 收起 << | Phase 3 | Completed | - | - |
NCT03526289 | Type 2 Diabetes Mellitus ... 展开 >> Overweight and Obesity 收起 << | Not Applicable | Completed | - | Denmark ... 展开 >> Center for diabetes research Hellerup, Denmark, DK-2900 收起 << |
NCT03172494 | Diabetes Diab... 展开 >>etes Mellitus, Type 2 收起 << | Phase 3 | Recruiting | July 29, 2019 | - |
NCT00211510 | Type 1 Diabetes | Not Applicable | Completed | - | United States, California ... 展开 >> Children's Hospital of Los Angeles Los Angeles, California, United States, 90027 Stanford University Stanford, California, United States, 94305 United States, Georgia Atlanta Diabetes Associates Atlanta, Georgia, United States, 30309 United States, Massachusetts Joslin Diabetes Center Boston, Massachusetts, United States, 02215 United States, New York The Endocrine Group Albany, New York, United States, 12206 United States, Texas Diabetes and Glandular Diabetes Research Associates San Antonio, Texas, United States, 78229 United States, Washington University of Washington Seattle, Washington, United States, 98195 收起 << |
NCT03674957 | - | Active, not recruiting | March 2019 | Canada, Manitoba ... 展开 >> University of Manitoba Winnipeg, Manitoba, Canada, R3T 6C5 收起 << | |
NCT02952963 | Severe Obesity | Phase 4 | Unknown | February 2017 | Denmark ... 展开 >> Hvidovre University Hospital Recruiting Hvidovre, DK, Denmark, 2650 Contact: Maria S Svane, MD +4538626357 maria.saur.svane@regionh.dk Contact: Sten Madsbad, MD Sub-Investigator: Isabella Jonsson, stud.med. 收起 << |
NCT02212067 | Diabetes Diab... 展开 >>etes Mellitus, Type 2 收起 << | Phase 1 | Completed | - | Germany ... 展开 >> Novo Nordisk Investigational Site Neuss, Germany, 41460 收起 << |
NCT02081118 | Type 2 Diabetes | Phase 2 | Completed | - | United States, Florida ... 展开 >> Hanmi pharmaceutical Miami, Florida, United States 收起 << |
NCT02291874 | Type 2 Diabetes Mellitus | Phase 4 | Completed | - | Japan ... 展开 >> Chubu, Japan Chugoku, Japan Hokkaido, Japan Kansai, Japan Kanto, Japan Kyushu, Japan 收起 << |
NCT02762578 | - | Completed | - | - | |
NCT00211510 | - | Completed | - | - | |
NCT02865486 | Healthy | Not Applicable | Completed | - | Switzerland ... 展开 >> Division of Gastroenterology and Hepatology, University Hopsital Zurich Zürich, Switzerland, 8091 收起 << |
NCT02762578 | Diabetes Diab... 展开 >>etes Mellitus, Type 2 收起 << | Phase 3 | Completed | - | - |
NCT01499082 | Type 2 Diabetes Mellitus | Phase 3 | Completed | - | - |
NCT01499082 | - | Completed | - | - | |
NCT01226043 | Diabetes Mellitus, Type 2 | Phase 4 | Completed | - | United States, New Jersey ... 展开 >> Sanofi-Aventis Administrative Office Bridgewater, New Jersey, United States, 08807 收起 << |
NCT01226043 | - | Completed | - | - | |
NCT01846702 | Healthy Volunteers | Phase 1 | Completed | - | Singapore ... 展开 >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Singapore, Singapore, 117597 收起 << |
NCT01846702 | - | Completed | - | - | |
NCT03305783 | - | Recruiting | January 1, 2019 | Denmark ... 展开 >> Clinical metabolic physiology, Steno Diabetes Center Copenhagen Recruiting Copenhagen, Hellerup, Denmark, 2900 Contact: Christina C Nexøe-Larsen, MD, Ph.D. student 收起 << | |
NCT01298518 | Type 2 Diabetes Patients | Phase 1 | Completed | - | United States, California ... 展开 >> Pfizer Investigational Site Chula Vista, California, United States, 91911 United States, Florida Pfizer Investigational Site DeLand, Florida, United States, 32720 Pfizer Investigational Site Miami Gardens, Florida, United States, 33169 收起 << |
NCT00751114 | - | Completed | - | - | |
NCT03307681 | Healthy | Not Applicable | Not yet recruiting | July 1, 2019 | Canada, Ontario ... 展开 >> School of Nutrition, Ryerson University Toronto, Ontario, Canada, M5B 2K3 收起 << |
NCT02798003 | - | Unknown | September 2018 | Netherlands ... 展开 >> Maastricht UMC Recruiting Maastricht, Limburg, Netherlands, 6200MD Contact: Karin Sanders, MD 0031433884597 k.sanders@maastrichtuniversity.nl 收起 << | |
NCT00751114 | Diabetes Mellitus, Type 2 | Phase 4 | Completed | - | - |
NCT03309124 | Healthy | Not Applicable | Recruiting | July 1, 2019 | Canada, Ontario ... 展开 >> School of Nutrition, Ryerson University Recruiting Toronto, Ontario, Canada, M5B 2K3 Contact: Nick Bellissimo, PhD 416 979 5000 ext 3026 nick.bellissimo@ryerson.ca Principal Investigator: Nick Bellissimo, PhD 收起 << |
NCT01358981 | Diabetes Mellitus, Type 2 | Phase 1 | Completed | - | Singapore ... 展开 >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Singapore, Singapore 收起 << |
NCT02823249 | Endocrine System Diseases | Not Applicable | Completed | - | Switzerland ... 展开 >> University Hospital Basel Basel, Basel-Stadt, Switzerland, 4031 收起 << |
NCT02529709 | Dyslipidemia | Not Applicable | Completed | - | United States, Texas ... 展开 >> Texas Christian University Fort Worth, Texas, United States, 76129 收起 << |
NCT01683266 | Type 1 Diabetes Mellitus | Phase 3 | Completed | - | - |
NCT01683266 | - | Completed | - | - | |
NCT02043886 | Type 2 Diabetes ... 展开 >> Postprandial Hypotension 收起 << | Phase 2 | Completed | - | Canada, British Columbia ... 展开 >> VITALiTY Research Centre Vancouver, British Columbia, Canada, V5Z1M9 收起 << |
NCT01075282 | Diabetes Mellitus, Type 2 | Phase 3 | Completed | - | - |
NCT02501889 | Overweight and Obesity | Not Applicable | Completed | - | United States, California ... 展开 >> UC San Diego La Jolla, California, United States, 92093-0901 收起 << |
NCT01347840 | - | Terminated(Study was terminate... 展开 >>d for business reasons.) 收起 << | - | United States, Ohio ... 展开 >> Veterans Affairs Medical Center Cincinnati, Ohio, United States, 45267 收起 << | |
NCT01347840 | - | Terminated(Study was terminate... 展开 >>d for business reasons.) 收起 << | - | - | |
NCT01298518 | - | Completed | - | - | |
NCT01834404 | - | Completed | - | - | |
NCT00380380 | Diabetes Mellitus, Type 2 | Phase 3 | Completed | - | Germany ... 展开 >> Munich, 81377, Germany Munich, Germany 收起 << |
NCT03057444 | Diabetes Mellitus, Type 2 ... 展开 >> Pre Diabetes 收起 << | Not Applicable | Completed | - | Germany ... 展开 >> Institute of Clinical Nutrition Stuttgart, Baden-Württemberg, Germany, 70599 收起 << |
NCT01890629 | Type 2 Diabetes Mellitus | Phase 4 | Completed | - | Korea, Republic of ... 展开 >> Severance hospital Seoul, Korea, Republic of, 120-752 收起 << |
NCT01513590 | Diabetes Diab... 展开 >>etes Mellitus, Type 2 收起 << | Phase 3 | Completed | - | - |
NCT01075282 | - | Completed | - | - | |
NCT01513590 | - | Completed | - | - | |
NCT02857764 | - | Completed | - | - | |
NCT02040571 | Type 1 Diabetes | Not Applicable | Completed | - | Australia, Victoria ... 展开 >> St Vincent's Hospital Melbourne Fitzroy, Victoria, Australia, 3065 收起 << |
NCT01834404 | Obesity | Phase 4 | Completed | - | United States, Minnesota ... 展开 >> Mayo Clinic in Rochester Rochester, Minnesota, United States, 55905 收起 << |
NCT01164501 | Diabetes Mellitus, Type 2 ... 展开 >> Renal Insufficiency 收起 << | Phase 3 | Completed | - | - |
NCT01164501 | - | Completed | - | - | |
NCT02491801 | Type 2 Diabetes Mellitus ... 展开 >> Obesity 收起 << | Not Applicable | Completed | - | Canada, Ontario ... 展开 >> Department of Nutritional Sciences, FitzGerald Building Toronto, Ontario, Canada, M5S 3E2 收起 << |
NCT02769728 | Type 2 Diabetes ... 展开 >> Obesity 收起 << | Not Applicable | Active, not recruiting | November 2018 | Austria ... 展开 >> Dept. of Internal Medicine, Medical University of Graz Graz, Austria, 8036 收起 << |
NCT02404376 | ST Elevation Acute Myocardial ... 展开 >>Infarction 收起 << | Phase 3 | Recruiting | November 2018 | Spain ... 展开 >> Hospital Universitari Germans Trias i Pujol Recruiting Badalona, Barcelona, Spain, 08916 Contact: Antoni Bayés Genís, MD, PhD +34 93 497 89 15 abayesgenis@gmail.com Principal Investigator: Antoni Bayés- Genís, MD, PhD Principal Investigator: Eduard Fernández-Nofrerias, MD Hospital Clínico Universitario de Santiago de Compostela Recruiting Santiago de Compostela, La Coruña, Spain, 15706 Contact: José Ramón González Juanatey, MD, PhD Jose.Ramon.Gonzalez.Juanatey@sergas.es Hospital de la Santa Creu i Sant Pau Not yet recruiting Barcelona, Spain, 08026 Contact: Joan García Picart, MD JGarciaPi@santpau.cat Hospital Universitario Valle de Hebron Recruiting Barcelona, Spain, 08035 Contact: Gerad Marti, MD +34 93 274 6134 ext 6134 drgmarti@googlemail.com Contact: Imanol Otaegui, MD +34 93 274 6155 iotaegui@vhebron.net Principal Investigator: David García- Dorado García, MD PhD Hospital Universitari de Girona Josep Trueta Not yet recruiting Girona, Spain, 17007 Contact: Joan Bassaganyas Vilarrasa, MD, PhD jbassaganyas.girona.ics@gencat.cat Hospital Universitario Arnau de Vilanova Recruiting Lleida, Spain, 25198 Contact: Fernando Worner Diz, MD, PhD fworner.lleida.ics@gencat.cat Hospital Universitario Fundación Jiménez Díaz Recruiting Madrid, Spain, 28040 Contact: Borja Ibáñez Cabeza, MD, PhD bibanez@cnic.es Hospital Universitari de Tarragona Joan 23 Recruiting Tarragona, Spain, 43005 Contact: Alfredo Bardají Ruíz, MD, PhD abardaji.hj23.ics@gencat.cat 收起 << |
NCT02440932 | Phenylketonuria (PKU) | Not Applicable | Completed | - | United Kingdom ... 展开 >> Human Nutrition, School of Medicine, University of Glasgow Glasgow, United Kingdom, G31 2ER 收起 << |
NCT00829569 | Type 2 Diabetes | Not Applicable | Completed | - | Norway ... 展开 >> Department of Medicine, Division of Endocrinology, St. Olavs Hospital Trondheim, Norway, N-7006 收起 << |
NCT02837211 | Obesity | Not Applicable | Completed | - | United States, North Carolina ... 展开 >> Wake Forest University Health Sciences Winston-Salem, North Carolina, United States, 27157 收起 << |
NCT02057172 | Type 2 Diabetes | Phase 2 | Completed | - | United States, California ... 展开 >> Hanmi pharmaceutical CA, California, United States 收起 << |
NCT00951899 | Type 2 Diabetes | Phase 4 | Completed | - | United States, Minnesota ... 展开 >> Mayo Clinic Rochester, Minnesota, United States, 55905 收起 << |
NCT01993511 | - | Unknown | June 2014 | Denmark ... 展开 >> Hvidovre University Hospital Recruiting Copenhagen, Hvidovre, Denmark, 2650 Contact: Anna Kirstine Bojsen-Møller, MD +45 30 25 22 06 kirstine.bojsen-moeller@regionh.dk Principal Investigator: Anna Kirstine Bojsen-Møller, MD 收起 << | |
NCT02055014 | Type 2 Diabetes ... 展开 >> Obesity Diabesity 收起 << | Phase 4 | Unknown | March 2017 | United Kingdom ... 展开 >> Department of Diabetes, City Hospital Birmingham, United Kingdom, B18 7QH Glasgow Royal Infirmary Glasgow, United Kingdom, G0 Department of Diabetes, Guy's and St Thomas' Hospitals London, United Kingdom, SE1 Diabetes Research Group, King's College London London, United Kingdom, SE5 9RS 收起 << |
NCT01401127 | - | Completed | - | United Kingdom ... 展开 >> Wycombe Hospital High Wycombe, Buckinghamshire, United Kingdom, HP11 2TT 收起 << | |
NCT01514149 | Type 2 Diabetes Mellitus (T2DM... 展开 >>) 收起 << | Phase 2 | Terminated(Business decision) | - | - |
NCT01703637 | Type 2 Diabetes Mellitus | Not Applicable | Unknown | - | China, Shandong ... 展开 >> YuCheng people's hospital Recruiting Dezhou, Shandong, China, 253000 Contact: Pengfei Li lpf9669@163.com Hospital of SINOTRUK Recruiting Jinan, Shandong, China, 250010 Contact: Xiling Fu fxl1936@163.com Jinan central hospital Recruiting Jinan, Shandong, China, 250010 Contact: Shuguang Pang shuguangpang@163.com The jinan military region general hospital Recruiting Jinan, Shandong, China, 250010 Contact: Zhaoshun Jiang zhaoshunjiang@sohu.com Qianfoshan Hospital Recruiting Jinan, Shandong, China, 250012 Contact: Lin Liao, MD 8615168888260 liaolin@medmail.com.cn People's Hospital of Qingdao Chengyang Recruiting Qingdao, Shandong, China, 266100 Contact: Xiaopang Rao 123raoxiaopang@163.com Zibo central hospital Recruiting Zibo, Shandong, China, 255000 Contact: Xiaodong Zhao 19xiaodong@163.com Zibo eighth people's hospital Recruiting Zibo, Shandong, China, 255000 Contact: Ling Dai +86 13853388549 收起 << |
NCT00951899 | - | Completed | - | - | |
NCT03502083 | Coronary Stenosis ... 展开 >> Type2 Diabetes Angina, Stable 收起 << | Not Applicable | Completed | - | - |
NCT02929459 | Gut Microbiota | Phase 2 | Recruiting | December 2018 | Netherlands ... 展开 >> Medical Microbiology, UMCG Groningen Recruiting Groningen, Netherlands, 9713 Contact: Mehdi Sadaghian Sadabad, D.V.M PhD +31-50-36 15 186 m.sadaghian@umcg.nl 收起 << |
NCT01514149 | - | Terminated(Business decision) | - | - | |
NCT02068001 | - | Active, not recruiting | - | Netherlands ... 展开 >> Rijnstate Hospital Arnhem, Gelderland, Netherlands, 6800 TA Gelderse Vallei Hospital Ede, Gelderland, Netherlands, 6716 RP Wageningen University Wageningen, Gelderland, Netherlands, 6700 EV 收起 << | |
NCT02259907 | Healthy | Phase 1 | Completed | - | - |
NCT03047668 | Type 2 Diabetes ... 展开 >> NAFLD Obesity Dyslipidemia Hypertension Metabolic Syndrome 收起 << | Not Applicable | Recruiting | December 2018 | Germany ... 展开 >> DIfE (German Institute for Human Nutrition) Recruiting Berlin, Germany, 12203 Contact: Stefan Kabisch, Dr. med. 030 450 514 429 stefan.kabisch@dife.de 收起 << |
NCT02285907 | - | Completed | - | - | |
NCT02744313 | - | Completed | - | Canada, Ontario ... 展开 >> Centre For Addiction and Mental Health Toronto, Ontario, Canada, M5T1R8 收起 << | |
NCT00966654 | CABG | Phase 2 | Terminated(PI left JHU) | - | United States, Maryland ... 展开 >> Johns Hopkins Hospital Baltimore, Maryland, United States, 21205 收起 << |
NCT02285907 | Appetite and General Nutrition... 展开 >>al Disorders 收起 << | Not Applicable | Completed | - | United States, Missouri ... 展开 >> University of Missouri Columbia, Missouri, United States, 65211 收起 << |
NCT00966654 | - | Terminated(PI left JHU) | - | - | |
NCT01347801 | Hypoglycaemia | Not Applicable | Completed | - | Denmark ... 展开 >> Centre of Inflammation and Metabolism - Rigshospitalet 7641 Copenhagen, Denmark, 2100 University of Copenhagen Copenhagen, Denmark, 2400 收起 << |
NCT01607450 | Type 2 Diabetes Mellitus ... 展开 >> Healthy 收起 << | Phase 2 Phase 3 | Completed | - | United States, Indiana ... 展开 >> Indiana Clinical Research Center Indianapolis, Indiana, United States, 46202 收起 << |
NCT01952977 | Obesity | Not Applicable | Completed | - | United States, New York ... 展开 >> New York Obesity Nutrition Research Center New York, New York, United States, 10025 收起 << |
NCT03528174 | Type 1 Diabetes Mellitus | Not Applicable | Completed | - | United States, Oregon ... 展开 >> Oregon Health and Science University Portland, Oregon, United States, 97239 收起 << |
NCT00940134 | Obesity | Not Applicable | Completed | - | Denmark ... 展开 >> Department of Human Nutrition, Faculty of Life Sciences, University of Copenhagen Copenhagen, Denmark, 1958 收起 << |
NCT03133741 | Glucose Metabolism Disorders | Not Applicable | Completed | - | Denmark ... 展开 >> Center for Diabetes Research Gentofte, Copenhagen, Denmark, 2900 收起 << |
NCT03471806 | Bulimia Nervosa ... 展开 >> Food Reward 收起 << | Not Applicable | Enrolling by invitation | May 2020 | Belgium ... 展开 >> Universitaire ziekenhuizen Leuven Leuven, Belgium, 3000 收起 << |
NCT02650206 | Diabetes Mellitus, Type 2 ... 展开 >> Diabetes Mellitus, Type II Diabetes Mellitus, Adult-Onset Inflammation 收起 << | Phase 4 | Recruiting | August 2018 | United States, California ... 展开 >> Freidenrich Center for Translational Research (FCTR) Recruiting Stanford, California, United States, 94305 Contact: Elizabeth Colbert 650-736-2056 ecolbert@stanford.edu Contact: Dalia Perelman 6507362056 daliap@stanford.edu; 收起 << |
NCT01621516 | - | Completed | - | - | |
NCT03415594 | Short Bowel Syndrome | Phase 1 Phase 2 | Recruiting | April 2019 | Denmark ... 展开 >> Rigshospitalet Recruiting Copenhagen, Denmark Contact: Palle Jeppeson, MD 收起 << |
NCT02084550 | Ulcerative Colitis | Not Applicable | Active, not recruiting | September 2017 | Denmark ... 展开 >> Department of Surgery P, Aarhus University Hospital Aarhus C, Denmark, 8000 收起 << |
NCT02229227 | Diabetes Mellitus, Type 2 | Phase 3 | Completed | - | - |
NCT02305199 | Diabetes Mellitus, Type 2 | Not Applicable | Withdrawn(impossible to enroll... 展开 >> participants) 收起 << | - | Korea, Republic of ... 展开 >> Yeungnam University Hospital Daegu, Korea, Republic of, 705-717 收起 << |
NCT02029677 | - | Active, not recruiting | January 2019 | United States, Oregon ... 展开 >> Oregon Weight Loss Surgery Portland, Oregon, United States, 97210 收起 << | |
NCT00283049 | - | Terminated(Due to technical is... 展开 >>sues relating to the Electronic diary data.) 收起 << | - | - | |
NCT00283049 | Diabetes Mellitus, Type 2 | Phase 4 | Terminated(Due to technical is... 展开 >>sues relating to the Electronic diary data.) 收起 << | - | United States, New Jersey ... 展开 >> sanofi-aventis, US Bridgewater, New Jersey, United States, 08807 收起 << |
NCT01618214 | Diabetes Diab... 展开 >>etes Mellitus, Type 2 收起 << | Phase 4 | Completed | - | China, Anhui ... 展开 >> Novo Nordisk Investigational Site Hefei, Anhui, China, 230001 Novo Nordisk Investigational Site Hefei, Anhui, China, 230022 China, Beijing Novo Nordisk Investigational Site Beijing, Beijing, China, 100029 Novo Nordisk Investigational Site Beijing, Beijing, China, 100088 Novo Nordisk Investigational Site Beijing, Beijing, China, 100700 Novo Nordisk Investigational Site Beijing, Beijing, China, 100730 China, Chongqing Novo Nordisk Investigational Site Chongqing, Chongqing, China, 400010 Novo Nordisk Investigational Site ChongQing, Chongqing, China, 404000 China, Guangdong Novo Nordisk Investigational Site Guangzhou, Guangdong, China, 510080 China, Hebei Novo Nordisk Investigational Site Shijiazhuang, Hebei, China, 050051 Novo Nordisk Investigational Site Shijiazhuang, Hebei, China, 050082 China, Hubei Novo Nordisk Investigational Site Wuhan, Hubei, China, 430034 China, Inner Mongolia Novo Nordisk Investigational Site Tongliao, Inner Mongolia, China, 028007 China, Jiangsu Novo Nordisk Investigational Site Nanjing, Jiangsu, China, 210011 Novo Nordisk Investigational Site Yangzhou, Jiangsu, China, 225001 China, Jiangxi Novo Nordisk Investigational Site Nanchang, Jiangxi, China, 330006 China, Jilin Novo Nordisk Investigational Site Changchun, Jilin, China, 130041 Novo Nordisk Investigational Site Siping, Jilin, China, 136000 China, Shaanxi Novo Nordisk Investigational Site Xi'an, Shaanxi, China, 710032 China, Shandong Novo Nordisk Investigational Site Jinan, Shandong, China, 250013 China, Shanghai Novo Nordisk Investigational Site Shanghai, Shanghai, China, 200072 China, Zhejiang Novo Nordisk Investigational Site Hangzhou, Zhejiang, China, 310003 收起 << |
NCT01538355 | Relapsing-Remitting Multiple S... 展开 >>clerosis 收起 << | Not Applicable | Completed | - | Germany ... 展开 >> Charité-Universitätsmedizin Berlin, Germany, 10117 收起 << |
NCT01975259 | - | Completed | - | United Kingdom ... 展开 >> Liverpool Heart and Chest Hospital Liverpool, United Kingdom, L14 3PE 收起 << | |
NCT01618214 | - | Completed | - | - | |
NCT01597024 | Obesity | Not Applicable | Completed | - | Greece ... 展开 >> Harokopia Univeristy Athens, Greece Netherlands University Medical Center Utrecht Utrecht, Netherlands, 3584 CX United Kingdom The Rowett Institute of Nutrition and Health, University of Aberdeen Aberdeen, Aberdeenshire, United Kingdom, AB21 9SB 收起 << |
NCT02004678 | Type 2 Diabetes Mellitus | Phase 1 | Completed | - | United States, Florida ... 展开 >> Clinical Pharmacology of Miami, Inc. Miami, Florida, United States 收起 << |
NCT01550133 | Obese Overwei... 展开 >>ght 收起 << | Not Applicable | Unknown | December 2016 | United States, Indiana ... 展开 >> Purdue University West Lafayette, Indiana, United States, 47907 收起 << |
NCT01237119 | Nonalcoholic Steatohepatitis | Phase 2 | Completed | - | United Kingdom ... 展开 >> NIHR BRU Centre for liver research, Queens Elizabeth University Hospital Birmingham Birmingham, West Midlands, United Kingdom, B152TT 收起 << |
NCT03053284 | Congenital Hyperinsulinism ... 展开 >> Insulinoma Hyperinsulinism 收起 << | Phase 2 | Withdrawn(Funding was withdraw... 展开 >>n by Sponsor prior to start of study) 收起 << | April 2018 | - |
NCT03190148 | Bariatric Surgery Candidate ... 展开 >> Pregnancy Complications Pregnancy Related Glucose Metabolism Disorders 收起 << | Not Applicable | Completed | - | - |
NCT02147496 | Diabetes Prevention ... 展开 >> Obesity Prevention 收起 << | Phase 1 Phase 2 | Completed | - | Canada, Ontario ... 展开 >> University of Toronto Toronto, Ontario, Canada, M5S 3E2 收起 << |
NCT02229227 | - | Completed | - | - | |
NCT01518101 | Type 2 Diabetes | Phase 4 | Completed | - | Germany ... 展开 >> Novartis Investigative Site Berlin, Germany, 10115 Novartis Investigative Site Berlin, Germany, 13055 Novartis Investigative Site Dortmund, Germany, 44137 Novartis Investigative Site Falkensee, Germany, 14612 Novartis Investigative Site Meissen, Germany, 01662 Novartis Investigative Site Neunkirchen, Germany, 57290 Novartis Investigative Site Saarlouis, Germany, 66740 Novartis Investigative Site Völlkingen, Germany, 66333 收起 << |
NCT01671579 | Crohn Disease | Not Applicable | Terminated(PI changed institut... 展开 >>ions) 收起 << | - | United States, Michigan ... 展开 >> University of Michigan Hospital Ann Arbor, Michigan, United States, 48109 收起 << |
NCT03422848 | Glucose, High Blood | Not Applicable | Recruiting | September 30, 2021 | Sweden ... 展开 >> KFE, Skåne University Hospital in Malmö Recruiting Malmö, Sweden, SE-20502 Contact: Margaretha M Persson, Ph.D. margaretha.m.persson@skane.se Contact: Olle Melander, M.D., Prof. +46 40 391209 olle.melander@med.lu.se Principal Investigator: Olle Melander, M.D., Professor Sub-Investigator: Sofia Enhörning, M.D., Ph.D. Sub-Investigator: Irina Tasevska, M.D., Ph.D. 收起 << |
NCT01777282 | Diabetes Mellitus | Phase 3 | Completed | - | - |
NCT00508287 | Type 2 Diabetes | Phase 1 | Completed | - | United States, Florida ... 展开 >> Elite Research Institute Miami, Florida, United States, 33169 Orlando Clinical Research Center Orlando, Florida, United States, 32809 United States, Tennessee New Orleans Center For Clinical Research Knoxville, Tennessee, United States, 37920 收起 << |
NCT01762046 | Diabetes Mellitus, Type 2 | Phase 1 | Active, not recruiting | October 2017 | United States, Massachusetts ... 展开 >> Massachusetts General Hospital Boston, Massachusetts, United States, 02114 Brigham and Women's Hospital Boston, Massachusetts, United States, 02116 Joslin Diabetes Center Boston, Massachusetts, United States, 02116 收起 << |
NCT01777282 | - | Completed | - | - | |
NCT01079715 | Retinopathy of Prematurity | Phase 2 Phase 3 | Completed | - | Italy ... 展开 >> Neonatal Intensive Care Unit - Azienda Ospedaliero-Universitaria Meyer Florence, Italy, I-50139 Neonatal Intensive Care Unit - Fondazione IRCCS Cà Granda, Ospedale Maggiore Policlinico Milan, Italy, I-20122 收起 << |
NCT02464514 | Obesity Prade... 展开 >>r Willi Syndrome 收起 << | Not Applicable | Completed | - | United States, North Carolina ... 展开 >> Duke University Medical Center Durham, North Carolina, United States, 27705 收起 << |
NCT01571310 | Type 2 Diabetes | Not Applicable | Completed | - | Israel ... 展开 >> Daniela Jakubowicz Holon, N/A = Not Applicable, Israel, 58100 Venezuela Daniela Jakubowicz Caracas, Venezuela, 410 收起 << |
NCT02246543 | Satiety | Not Applicable | Completed | - | United Kingdom ... 展开 >> Rowett Institute of Nutrition & Health, University of Aberdeen Aberdeen, Aberdeen City, United Kingdom, AB21 9SB 收起 << |
NCT02516956 | Regulation, Appetite ... 展开 >> Eating Behavior Cognition 收起 << | Not Applicable | Completed | - | Italy ... 展开 >> University of Parma Parma, PR, Italy, 43125 收起 << |
NCT00488423 | Diabetes Gast... 展开 >>ric Bypass 收起 << | Phase 1 | Completed | - | United States, Ohio ... 展开 >> Cleveland Clinic Cleveland, Ohio, United States, 44195 收起 << |
尊敬的 Ambeed 客户您好,
请您选择所在区域,我们将转接对应客服为您服务!